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Abstract
Bifidobacteria are a species of GRAS organism present in the human gut flora which are
claimed to confer various health benefits on the host. The antimicrobial activity of
Bifidobacterium longum ITT 13, isolated from the neonatal gut, was evaluated in relation to
both the contribution of organic acids produced by the strain and potential bacteriocin
production. Bacteriocins are antimicrobial peptides produced by bacteria. This study focuses
on the characterisation of the antimicrobial activity produced by B. longum ITT 13.
Heat-inactivated fermentate produced by ITT 13 has shown antimicrobial activity against a
variety of pathogenic and food spoilage associated bacterial and fungal strains.
Physiochemical characterization of the antimicrobial activity has shown that pH stability
testing has indicated activity at pH 5 and below, with activity not detectable above pH 6.
Temperature stability testing has indicated stability of the antimicrobial activity at a
temperature range of -20oC to 100oC, with maximum activity (133-213 Activity Units/ml)
retained

for

48

hours

at

4 oC

and

room

temperature

(20oC

to

24oC).

Antimicrobial activity was found to be partially caused by organic acid production, as the
heterofermentative Bifidobacteria produce several acids during growth. HPLC analysis
determined between 6 mg/ml and 10 mg/ml lactic, acetic and succinic acid produced by B.
longum ITT 13 when grown in De Man, Rogosa and Sharpe broth with and without pH control.
Protease digestion by Actinase E resulted in a reduced minimum inhibitory concentration of
antimicrobial activity and 80% ammonium sulphate precipitation of the fermentate resulted in
the detection of antimicrobial activity in the resuspended precipitate, indicating the presence
of antimicrobial activity associated with a low molecular weight proteinaceous molecule.
Concentration studies on the antimicrobial activity of the fermentate involved membrane
filtration via tangential flow filtration. Use of a 10KDa and 3 kDa filter showed similar
antimicrobial activity present in both the retentate and permeate, together with probable
adsorption of the proteinaceous molecule to the membrane, as it is present in low
concentrations.
Experimental results indicate that the antimicrobial activity associate with B. longum ITT 13
is due to a combination of the production of acids together with a proteinaceous component.
Further studies, using higher starting concentrations of fermentate, could be used to concentrate
and isolate the bacteriocin component of the detected antimicrobial activity.
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CHAPTER 1
Introduction
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1.1 Gut Microflora and Probiotics
The human digestive system is a complex ecosystem of gut microflora with over 1000 known
species of bacteria, which due to its anaerobic environment, comprise many obligate and
facultatively anaerobic species such as Bacteroides, Bifidobacterium, Lactobacilli,
Enterococci and Streptococci among many others (Nie et al., 2018). The digestive system and
its components are important factors in overall health, responsible for the absorption of water
and nutrients, and the commensal organisms present are key players in its effectiveness due to
interactions with host cells and important roles in the contribution to health and disease (Butel,
2014; Heintz-Buschart and Wilmes, 2018). The composition of the human gut flora varies
between individuals due to a variety of factors such as age, geography and diet (Yatsunenko et
al., 2012), as well as consumption of probiotics or antimicrobials (Hugon et al., 2017), yet
Bifidobacterium appears to dominate the gut of infants, decreasing as they age (Yatsunenko et
al., 2012). In a study by Cooke et al., 2005, Bifidobacterium and Lactobacilli, were found to
be more prevalent in the gut of breast fed babies and were thought to contribute to what
constitutes a healthier gut based on bacterial composition.
The beneficial effect of the gut microbiota on the host illustrates the importance of maintaining
a healthy digestive system and a healthy balance of the intestinal ecosystem. They produce a
variety of bioactive compounds such as organic acids, fatty acids and bacteriocins which have
been shown to contribute to the overall health of individuals through preventing colonisation
of the gut by potentially pathogenic bacteria and promoting a healthier gut (Hladíková et al.,
2012; O’Shea et al., 2012; Guinane et al., 2016). Various enteric bacteria also play important
roles in nutrition and maintenance of intestinal integrity and functions, including the production
of beneficial nutrients such vitamin k and folate for the host (Quigley, 2010; Pacheco Da Silva
et al., 2016). The conversion of unabsorbed dietary sugars into SCFA’s is also an important
function of the microflora, as these fatty acids are used as an energy source by the colonic cells
5

for the promotion of epithelial cell growth in the intestine (Quigley, 2010). The preservation
of a healthy and intact intestinal barrier is necessary to maintain overall gastrointestinal health
and can aid in the prevention of diseases such as IBS and Crohn’s disease (O’Flaherty and
Klaenhammer, 2010).
Intestinal bacteria are evidently integral to healthy intestinal function, however they also
contribute to the overall health of the host as studies have shown they have also been linked to
modulating immunity in the prevention of immune-associated diseases or allergies. A study by
Olszak et al (2012) involving mice displayed how the early colonisation of neonatal mice by
commensal gut microbes prevented the accumulation of invariant natural killer T (iNKT) cells
which have been associated with the immune related diseases asthma and inflammatory bowel
disease (IBD). This was in comparison to germ free mice in which an increase in these cells
resulted in higher expression in the intestinal and pulmonary systems of the chemokine ligand
CXCL16, which is associated with these diseases. It is thus evident that the significant impact
these microbes have on human health is immense.
Probiotic bacteria are defined by the World Health Organisation (WHO) as “Live
microorganisms which when administered in adequate amounts confer a health benefit on the
host”, and most commonly include Bifidobacterium and Lactobacillus species (FAO/WHO,
2006; Butel, 2014). The consumption of probiotic bacteria can positively influence the balance
of gut microflora and increase the health of the gut through the mechanisms mentioned
previously (Quigley, 2010; Olszak et al., 2012; Pacheco Da Silva et al., 2016). The necessary
characteristics of probiotic bacteria according to the FAO/WHO (2006) can be grouped into
four main criteria; the strains must be sufficiently characterised, safe for intended use, be
supported by at least one positive human clinical trial carried out according to scientific
standards and be alive in sufficient numbers within the probiotic product to exert an effect
throughout the products shelf-life (Binda et al., 2020). The FAO/Who (2006) also detail how
6

probiotic bacteria should display resistance to the acidic bile conditions of the gastrointestinal
system and the ability to survive and proliferate during the traversal through the gut upon
consumption. Many probiotic bacteria have been isolated from the human gastrointestinal tract,
such as Bifidobacteria, that are described to offer a health benefit similar to that offered by the
hosts natural gut microbiome, by helping to maintain tight junctions of protein to protect the
intestinal barrier and exertion of antimicrobial activity in the gut to prevent infection
(O’Flaherty and Klaenhammer, 2010; Mahmoudi et al., 2013; Jomehzadeh et al., 2020; Wang
et al., 2020). The antimicrobial activity produced by many probiotic strains is claimed to be
primarily associated with organic acid and antimicrobial peptide (AMP) production (Hladíková
et al., 2012; O’Shea et al., 2012; Guinane et al., 2016). These can beneficially affect the host
through the inhibition of potential pathogens in the body and maintain a healthy balance of
microflora (O’Shea et al., 2012). This production of antimicrobial activity aids in the
prevention of infection, as well as in the prevention of enteric disease in individuals who may
have compromised intestinal barriers that can lead to disorders such as Crohn’s disease
(O’Flaherty and Klaenhammer, 2010). E. coli Nissle 1917 is a strain of probiotic bacteria that
has been shown in clinical trials to improve symptoms of irritable bowel diseases such as
ulcerative colitis and of IBS. E. coli Nissle 1917 exerts beneficial effects through modulation
of the immune system, production of antimicrobial peptides by the strain and subsequent
antimicrobial activity against pathogenic bacteria thus preventing their invasion of intestinal
epithelial cells (Altenhoefer et al., 2004; Schultz, 2008; Kruis et al., 2012; Parker et al., 2018).
As indicated in this section, it is evident that commensal gut microbes modulate and contribute
to many functions in the body, both in and outside the gut and play an important role within.
Exposure to microbe colonization earlier in life appears to be the most significant time to
increase health benefits and maximise contribution to future health.
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1.2 Bifidobacteria
Bifidobacteria are a genus of bacteria within the phylum Actinobacteria and order of
Bifidobacteriaceae (Lee and O’Sullivan, 2010) and they were originally isolated from the
faeces of breast-fed babies in 1899 (Tissier, 1899). Bifidobacteria are Gram-positive, nonspore forming, non-motile, anaerobic bacteria with a G+C content of 55-67% and upon growth
a bifid-shaped morphology can be observed, consisting of y or v-shaped branched rods (Lee
and O’Sullivan, 2010; Dhanashree et al., 2017). Upon the original isolation of Bifidobacteria
from the faeces of breast-fed infants by Tissier (1899), their high presence was suggested as
possibly resulting in a lower incidence of diarrhoea or gastroenteritis in infants (Tissier, 1900).
Yamada et al., (2017) discusses the link between breast-fed neonates and higher incidences of
Bifidobacteria species present in their gut microbiome, likely due to the presence of human
milk oligosaccharides (Yamada et al., 2017). Human milk oligosaccharides are complex
carbohydrates present in breast milk, that are not used for energy by the infant but instead are
utilised by and result in the enrichment of beneficial gut microbes such as Bifidobacteria, thus
supporting the formation of a healthy gut microbiome (Yamada et al., 2017; Thomson et al.,
2018). Cooke et al., (2005), also found a higher abundance of both Bifidobacteria and
Lactobacilli in the guts of breast-fed neonates in comparison to formula-fed, with these bacteria
linked to healthier digestive systems.

Figure 1.1: Morphology of A) Bifidobacterium longum subsp. infantis M-63 with uniform rod shape
and B) Bifidobacterium longum BB536 with Y shaped rods (Lau et al., 2015)
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The understanding of the contribution of Bifidobacteria to a healthy human gut and their
importance as probiotic organisms can be traced back to Tissier (1907). The author
administered Bifidobacteria for the treatment of infantile diarrhoea in his research, in the first
recorded instance of this application, and this strain is still widely used for probiotic treatment
today. According to FAO/WHO, (2006) Bifidobacteria and Lactobacilli are primarily used as
probiotic organisms, and are used in food as starter cultures due to their probiotic use and health
benefits on the gastrointestinal system of the host (FAO/WHO, 2006). Probiotic bacteria must
demonstrate resistance to the acidic conditions of the stomach and intestine to be capable of
survival and proliferation while transiting through the gastrointestinal system (FAO/WHO,
2006), which are characteristics many Bifidobacterial strains possess. The strains B. longum
INIA P132 and B. infantis P731 were assessed for their probiotic potential and applicability for
food applications and it was found that both were resistant to acidic pH and bile salts,
additionally B. longum replicated well in milk products and B. infantis displayed high adhesion
to human intestinal lining Caco-2 cells (Llamas-Arriba et al., 2019). Both strains produced
heteropolysaccharides (HePS) (exopolysaccharide production has been attributed to the
beneficial effect on the hosts health by probiotics (Llamas-Arriba et al., 2019)), that appeared
to modulate the immune system with a potential anti-inflammatory response in macrophages
treated with the inflammatory lipopolysaccharide of E. coli. The HePS have also shown to offer
protection against an in vivo enterocolitis model of zebrafish larvae, with a reduction in
mortality when the larvae were treated with the HePS produced by both Bifidobacterial strains
(Llamas-Arriba et al., 2019). Another strain, B.longum subsp. infantis CECT 7210, has also
displayed probiotic properties with resistance to gastric juices, bile salts and a low pH, as well
as prevention of diarrhoea due to inhibition of rotavirus in both cell-cultures and in mice
(Chenoll et al., 2016), further indicating the beneficial properties and applicability of this genus
in food and probiotic use.

9

Bifidobacteria are heterofermentative bacteria, producing a range of metabolites such as
organic acids, upon growth, including lactic, acetic and formic acid (Makras and De Vuyst,
2006; Ruiz-Aceituno et al., 2020). Makras & De Vuyst, (2006) analysed the organic acids
present in a variety of Bifidobacteria strains and found that all strains produced varying
concentrations of lactic and acetic acid, with as low as 20.9 mM acetic acid and 5.7 mM lactic
acid and as high as 60.9 mM acetic acid and 39.9 mM lactic acid. Some strains also produced
formic acid, however, this acid was not detected in the fermentations of B. longum or B. bifidum
in this study, indicating that differing organic acids may be produced by different
Bifidobacteria strains (Makras and De Vuyst, 2006). Ruiz-Aceituno et al., (2020) also detected
the production of acetic, lactic and formic acid by B. longum NCIMB 8809 and B. breve
UCC2003 and assessed the final concentrations of acids produced when using different carbon
sources for growth including glucose, lactose, maltose and raffinose. The highest
concentrations of lactic acid (29.7 mM for B. breve and 37.1 mM for B. longum) and acetic
acid (66.1 mM for B. breve and 67.6mM for B. longum) were produced when using lactose as
a carbon source, while the highest concentration of formic acid was 3.1 mM when using
raffinose as the carbon source and was produced by B. breve UCC2003 alone (Ruiz-Aceituno
et al., 2020). The lowest concentrations of lactic acid were 1.6 mM for B. breve with raffinosyloligofructosides and 0.7 mM for B. longum using maltose as a carbon source, while the lowest
concentrations of acetic acid were 5.6 mM with raffinosyl-oligofructosides and 2.1 mM for B.
longum when using maltose as a growth substrate. Bifidobacteria also produce small
concentrations of succinic acid with usually not more than a single figure millimolar
concentration (Van Der Meulen et al., 2006). Although it is not widely studied yet, it has been
theorised that the succinic acid may be produced for NAD+ regeneration in cells, as small
amounts of NAD+ coenzyme (an integral cofactor in cellular metabolic activities) are
regenerated upon the conversion of phosphoenolpyruvate to succinic acid (Van Der Meulen et
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al., 2006). Van Der Meulen et al. (2006) also suggested a reason for the production of such
small concentrations of succinic acid may be due to the fact that the energy present in
phosphoenolpyruvate dissipates and is lost from the cell when the molecule is converted to
succinic acid.
Bifidobacteria do not fermentate carbohydrates using the typical metabolic glycolic pathway
or the hexose monophosphate shunt pathway, as they lack the required enzymes (De Vries,
Gerbrandy and Stouthamer, 1967). Instead, Bifidobacteria ferment carbohydrates using the
“bifidum pathway” of fermentation (Figure 1.2), which uses the fructose-6-phosphate
phosphoketolase enzyme (Bezkorovainy, 1989). This pathway results in acetate and lactate as
the primary end products and allows Bifidobacteria to produce more ATP from carbohydrates
than conventional pathways with 2.5 ATP produced from one mole of glucose, along with
approximately 1.5 moles of acetate and 1 mole of lactate (Palframan et al, 2003). As varying
amounts of acid are produced by different strains of Bifidobacteria, research has shown that
the carbohydrate source used can affect the amount of acid produced, as discussed in the study
by Ruiz-Aceituno et al., (2020). The specific rate of sugar consumption is also an important
factor in the ratio of the end metabolites produced (Van Der Meulen et al., 2006). A faster
consumption of sugars results in higher concentrations of lactic acid, and less acetic acid,
formic acid and ethanol, while slower consumption results in less lactic acid production and
more acetic acid, formic acid and ethanol (Van Der Meulen et al., 2006).
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Figure 1.2: The bifidum pathway of Bifidobacteria resulting in the formation of lactate and acetate.
The enzymes utilised in this process are numbered (1) hexokinase and fructose-6-phosphate isomerase, (2)
fructose-6-phosphate phosphoketolase, (3) transaldolase, (4) transketolase, (5) ribose-5-phosphate isomerase, (6)
ribulose-5-phosphate-3-epimerase, (7) xylulose-5-phosphoketolase, (8) acetate kinase, (9) enzymes as in the
homofermentative pathway (Gomes and Malcata, 1999).

The organic acids produced by Bifidobacteria are associated with an antibacterial effect, but it
is known that the antimicrobial characteristics of Bifidobacteria can also be associated with the
production of other metabolites including antimicrobial peptides, also known as bacteriocins
(Lee and O’Sullivan, 2010). The antimicrobial activity associated with the production of these
organic acid and bacteriocin metabolites is an important characteristic for probiotic bacteria,
as it is claimed to contribute to the maintenance of a healthy balance of gut microflora through
the inhibition of colonization by pathogenic organisms (Hladíková et al., 2012; O’Shea et al.,
2012; Guinane et al., 2016).
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1.3 Bacteriocins
Antimicrobial peptides (peptide chains displaying an antimicrobial effect) are produced by both
prokaryotic and eukaryotic organisms (Phoenix et al., 2013). They play vital roles in defence
and can be found across many species (Chikindas et al., 2018), with many AMP’s also
produced by leukocytes, now referred to as defensins of the mammalian immune system
(Phoenix et al., 2013). Many bacteria produce metabolites and antimicrobial peptides, also
known as bacteriocins, during growth (Zacharof and Lovitt, 2012), to aid in survival and to
enable them to compete with other bacterial cells for nutrients (Perumal and Venkatesan, 2017).
They are ribosomally synthesised molecules (da Silva Sabo et al., 2014) and display
antimicrobial activity against various bacteria and in some cases fungal species (Ahn et al.,
2017; Aarti et al., 2018; Ruggirello et al., 2018).
Although bacteriocins were first discovered in 1925 (Cavera et al., 2015), they are now
becoming an increasingly important area of research, as an alternative to antibiotics due to
antimicrobial resistance by the latter (Ventola, 2015; Biswas et al., 2017; Morehead and
Scarbrough, 2018) and as potential biopreservatives in the food industry (Gálvez et al., 2007;
Skariyachan and Govindarajan, 2019). The development of antibiotic resistance in modern
times has become a major issue, with bacteria such as Methicillin Resistant Staphylococcus
aureus (MRSA) and Vancomycin Resistant Enterococci (VRE) two prominent pathogens, and
some bacteriocins have reportedly shown activity against these strains (Shokri et al., 2014;
Ahmad et al., 2017) Other applications for bacteriocins which are being actively researched,
include potential use in the food industry in food preservation where they act by inhibiting
foodborne pathogens and degradative microbes that result in food spoilage (Chikindas et al.,
2018). The bacteriocin nisin produced by Lactococcus lactis has been in use for decades as a
preservative in several food applications in some countries (Gyawali and Ibrahim, 2014).
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Bacteriocins are generally small molecules, with a molecular weight range of between 2 kDa
and 300 kDa (Ahmad et al., 2017). They act in both an ’offensive / defensive’ role as they
enable the producing bacteria to inhibit other strains in the environment to allow for an
advantage in the competition for nutrients required for growth and sustainability (Singh et al.,
2015). According to Zacharof and Lovitt (2012), bacteriocins are synthesised during the
primary phase of bacterial growth, and they undergo post translational modifications, which
can involve cleavage or the addition of other molecules such as carbohydrate moieties to the
bacteriocin. An example of a bacteriocin structure can be seen in Figure 1.3, with the primary
structure of nisin presented.

Figure 1.3: Antimicrobial Peptide Nisin (Khelissa et al., 2020). This is the primary structure of the AMP
nisin produced by Lactococcus lactis, where S denotes Sulphur found in Lanthionine and Methyllanthionine

Many bacteriocins are positively charged amphiphilic molecules (due to the presence of large
amounts of the amino acids lysine and arginine in their structure) (Rodríguez et al., 2003; Singh
et al., 2015), and they can interact with pathogen cells due to electrostatic interaction between
the positively charged portion of the bacteriocin and negatively charged cell membrane. The
hydrophobic portion of the polypeptide chain, which is more than 30% of the residues, enables
the bacteriocin to enter within the hydrophobic environment phospholipid bilayer of the cell
membrane (Singh et al., 2015).
14

Gut microflora play an important role in the breakdown of food and nutrients in the body and
thus maintaining a healthy balance of gut flora is important for a healthy digestive ssystem
(O’Shea et al., 2012). Many lactic acid producing bacteria in the gastro-intestinal tract have
gained a reputation for notable production of bacteriocins, with many of these bacteria
considered as GRAS, or generally regarded as safe, thus opening the avenue for their addition
to foodstuffs (Zacharof and Lovitt, 2012). As bacteriocins are proteolytic in nature they can be
degraded by the enzymes within the digestive tract and thus are considered as non-toxic with
an additional benefit of reducing the development of resistance to the bacteriocin's (Zacharof
and Lovitt, 2012).

1.3.1 Classification of Bacteriocins
Bacteriocins produced by lactic acid bacteria are some of the most intensely studied and have
been classified into various groups on the basis of their structure and modes of action.
According to Zacharof and Lovitt (2012), various classifications of bacteriocins have been
proposed over the years with consistent revision of the classes by many academics. The most
widely known classifications are the 4 classes of bacteriocins proposed by Klaenhammer
(1993). A proposition was put forward by Cotter et al., (2005) that they be divided into only
the first two categories stated by Klaenhammer, with a third category separately named
bacteriolysins and the fourth class disregarded. The first two classes of bacteriocins are
generally mentioned academically, however the full four classifications of bacteriocins will be
explored in this review.
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1.3.1.1 Class I Bacteriocins – Lantibiotics
Class I bacteriocins are composed of small peptides of less than 5kDa that are heat stable due
to the presence of rare amino acids (Deegan et al., 2006). These amino acids undergo extensive
levels of post translational modifications resulting in many lanthionine and methyllanthionine
residues, giving rise to the name lantibiotics (Deegan et al., 2006). An example of a bacteriocin
in this group is Nisin which is produced by Lactococcus lactis spp. (Matsusaki et al., 1998;
Balciunas et al., 2013).
The lanthionine (Figure 1.4a) and methyllanthionine (Figure 1.4b) amino acids are not
genetically coded and are formed by post translational modifications and these residues can
interact forming ring structures within the peptide (Woraprayote et al., 2016). The residues are
formed by the enzymatic degradation of serine and threonine, yielding dehydroalanine and
dehydrobutyrine (Deegan et al., 2006). Thiol groups from cysteine residues then interact with
the double bond of either molecule, with dehydroalanine forming lanthionine and
dehydrobutyrine forming methyllanthionine (Deegan et al., 2006).
This class has also been divided into two subgroups based on their structure. Group 1a are
elongated and have a positive charge, with a size between 2 and 4 kDa (Zacharof and Lovitt,
2012), and they act on target cells by pore formation of the cell membrane, causing cellular
contents to leak out (Ahmad et al., 2017). Group 1b are rigid and globular in shape with either
a negative charge or no net charge, and their mode of action is by the inhibition of essential
enzymes of the bacterial cell (Deegan et al., 2006).
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a)

b)

Figure 1.4: Structures of a) Lanthionine (Lanthionine | Sigma-Aldrich, no date) and b)
Methyllanthionine (CompTox Chemicals Dashboard, no date)

1.3.1.2 Class II Bacteriocins
Class II bacteriocins are also small at less than 10 kDa and heat stable, however they do not
contain lanthionine (Singh et al., 2015). They exert antimicrobial activity by inserting
themselves into the cell membrane of the target, causing depolarization and thus cell death
(Balciunas et al., 2013; Singh et al., 2015). This class of bacteriocins is commonly further
divided into three subclasses.
Subclass IIa are referred to as pediocin-like bacteriocins and exert their activity against Listeria
spp. (Balciunas et al., 2013). In their structure the N-terminus, or the start of the peptide chain
with the amine group, contains a beta pleated sheet while the C-terminus, with the exposed
carboxyl group, contains alpha helices (Fimland et al., 2005).
Subclass IIb peptides need two individual peptide chains to work in synchronisation to exert
maximum antimicrobial activity, but each peptide exerts low effects individually (Woraprayote
et al., 2016). Examples of bacteriocins within this group which show a synergistic relationship
include the peptides lactococcin G and lacticin F, which act together as a bacteriocin
(Woraprayote et al., 2016).
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Subclass IIc peptides contain covalent bonds between the N and the C terminals, thus resulting
in a unique cyclical or ring structure (da Silva Sabo et al., 2014; Woraprayote et al., 2016).

1.3.1.3 Class III Bacteriocins
This class of bacteria consist of larger peptides >30 kDa, that are thermolabile, or affected
significantly by heat (da Silva Sabo et al., 2014) and their mechanism of antimicrobial action
is through lysis of the cell wall (Balciunas et al., 2013).

1.3.1.4 Class IV Bacteriocins
This smaller group contains bacteriocins that are modified to contain lipid or carbohydrate
moieties (da Silva Sabo et al., 2014; Ahmad et al., 2017). This section is often disregarded and
is not mentioned frequently in literature.

1.3.2 Biosynthesis of Bacteriocins
The production of bacteriocins by bacterial cells involves many different genes and
mechanisms due to the many proteins involved and the extensive post translational
modification process (McAuliffe et al., 2001). At least four genes of known function code for;
a) the production of the bacteriocin precursor, b) the production of an immunity protein for
self-protection of the cell, c) the production of an ABC transporter and d) the production of an
accessory protein of which the function is not known (da Silva Sabo et al., 2014). The genes
for bacteriocin production are usually located either on the chromosome on transposable
elements (Deegan et al., 2006). Transposable elements are DNA sequences that can move their
location within the genome or on extrachromosomal plasmids (Deegan et al., 2006).
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Bacteriocins are ribosomally synthesised as biologically inactive precursors called prepeptides, that have a leader peptide at the N terminal that renders the pre-peptide inactive
(Deegan et al., 2006). This is a short extension of amino acids between 18 to 30 amino acids
in length (McAuliffe et al., 2001; da Silva Sabo et al., 2014). It has two functions; to prevent
the bacteriocin becoming activated while still inside the cell as it is only active once this is
cleaved upon exportation and also to function as a signal protein for the transport system across
the membrane (da Silva Sabo et al., 2014). The leader peptide is removed either just before,
after or during exportation of the pre-peptide from the cell, forming the active bacteriocin
peptide (Deegan et al., 2006). According to McAuliffe et al (2001), for group 1a lantibiotics
serine proteases are responsible for cleaving the leader sequence, whereas for group 1b
lantibiotics the transporter protein cleaves the peptide simultaneously with export.
The transporter system, called the ATP-binding cassette transporter protein (ABC transporter),
actively transports the bacteriocin across the membrane into the extracellular medium
(McAuliffe et al., 2001). The ABC transporter is composed of two sections; one which
recognises the pre-peptide sequence and the other that hydrolyses the ATP molecule to generate
energy for export of the peptide (Deegan et al., 2006). An example of an ATP-binding cassette
and its mechanism of action can be seen below in Figure 1.5, where the substrate indicated in
the figure represents the bacteriocin peptide.
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Figure 1.5 – An ATP binding cassette (ABC) Transporter (Rees et al., 2009). The ABC transporter used
for the exportation of bacteriocins into the extracellular medium is presented above. a) depicts the structure of
the ABC transporter composed of two transmembrane domains (TMD) and two ATP-binding cassette domains
(ABC). The substrate depicted would be representative of a bacteriocin. b) represents the E. coli vitamin B12
transporter system while c) represents the multidrug exporter of S. aureus Sav1866

There are various enzymes involved in the bacteriocin post translational modification process
during their synthesis and activation and the process is reviewed in detail by McAuliffe et al
(2001) with respect to Lantibiotics which undergo extensive levels of modifications. In terms
of the lantibiotic group, LanB, LanC and LanM enzymes are responsible for the posttranslational modifications, and it has been suggested that these enzymes are responsible for
the reactions resulting in the production of lanthionine and methyllanthionine amino acids
(McAuliffe et al., 2001). Additionally, it has been suggested that LanB catalyses the
dehydration of both serine and threonine, and that LanC follows this dehydration process by
forming thioether molecules (McAuliffe et al., 2001). The above enzymatic reactions have
been discussed in further detail with respect to the formation of lanthionine and
methyllanthionine residues in Section 1.3.1.
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1.4 Mechanisms of Action of Inhibitory Metabolites
1.4.1 Bacteriocins
Bacteriocins have various modes of action for how they exert their antimicrobial effects on
cells (Cavera et al., 2015). To locate the site of action on the susceptible cell, the bacteriocin
molecule recognises receptors on the surface of the cell membrane which enable the bacteriocin
to interact with the membrane and exert its action (Macwana and Muriana, 2012). The cell
surface molecules recognised for interacting with some bacteriocins include the mannose
phosphotransferase system or lipid II molecules (Ahmad et al., 2017). The mechanisms through
which bacteriocins exert their antimicrobial effect vary between the different classes (Section
1.3.1), with some exerting their effect through interference with the cell membrane or through
the inhibition of protein synthesis (Balciunas et al., 2013). The general consensus for the mode
of action of bacteriocins however, is that they primarily affect cell wall integrity by binding to
precursors, or cause pores or lyse the membrane of the cell (Ahmad et al., 2017).
According to Cavera et al (2015); several bacteriocins target the same cellular processes and
systems for production of essential compounds that many antibiotics target. One of the main
targets is synthesis of the cell wall, which is critical to survival of bacteria by maintaining
integrity and morphology of the cell (Cavera et al., 2015). The primary mode of inhibition of
cell wall synthesis is through binding of the bacteriocin to the lipid II molecule, which is a
membrane bound precursor of the cell wall, thus blocking its activity and inhibiting synthesis
which is observed for bacteriocins such as Nisin A and Nukacin ISK-1 (Cavera et al., 2015).
Nisin is unusual however, in the sense that the inhibition of cell wall synthesis is not its only
mode of action. Upon binding to the lipid II complex and interfering with synthesis, it also
causes pore formation in the cell membrane, allowing essential molecules to leak out
(Woraprayote et al., 2016). The two modes of action for nisin are presented in Figure 1.6.
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Figure 1.6 – Inhibition of cell wall synthesis and pore formation by nisin (Ibrahim, 2019). The two
modes of action of the bacteriocin nisin against Gram positive bacteria are presented in the above Figure 1.6. a.
indicates the binding of the nisin peptide to the lipid II molecule of the bacterial cell wall resulting in inhibition
of cell wall synthesis while b. demonstrates the ability of nisin to bind to the lipid II molecule resulting in pore
formation of the membrane and leakage of cellular contents.

Some bacteriocins, such as microcin B17 produced by E. coli and bacteriocins produced by
other colicins, can interfere with the DNA structure of target cells by competitive inhibition of
DNA gyrase that aids in unwinding, thus preventing two newly synthesized DNA molecules
from separating (Cavera et al., 2015).
Colicins have displayed several different mechanisms of activity against target cells, including
colicin M which inhibits peptidoglycan synthesis by enzymatic degradation of a bond between
lipid II and the lipid moiety (O’Shea et al., 2012). Other colicins have been shown to cause
pore formation (O’Shea et al., 2012), along with many other bacteriocins such as those in class
IIa, which consequently affects the proton motive force causing overconsumption of ATP and
cell death (Balciunas et al., 2013). Pores can be formed by the peptides attaching to the
membrane at a perpendicular orientation and folding (Sengupta et al., 2008). Many bacteriocins
that exert their activity by the process of pore formation in the membrane, bind to lipid II or
the mannose phosphotransferase system as mentioned previously in Section 1.4.1, however in
the case of Lacticin Q, it can form toroidal pores by lipid flip flop – the transfer of lipids from
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one membrane to the other (Cavera et al., 2015). An increased peptide to lipid ratio at the
membrane can cause the formation of these pores as this causes the lipid molecules on the
membrane to bend inwards forming a toroidal pore (Figure 1.7), in which the peptides can then
line the interior of the formed pore (Sengupta et al., 2008).

Figure 1.7 – Formation of toroidal pore (Brogden, 2005). In this figure the antimicrobial peptides
aggregate causing the lipid monolayers on the membrane to bend inwards through the pore resulting in the lipid
heads and peptides lining the core. The red region represents the hydrophilic portion of the peptide while the
blue region represents the hydrophobic portion of the peptide.

Colicin A displays a mechanism of inhibition of protein synthesis (Ahmad et al., 2017).
Proteins are integral to many functions of a cell and enzymes catalyse virtually all chemical
reactions in all living organisms, including bacteria (Robinson, 2015). Thus, interference with
them can be detrimental to the cell. Bacteriocins have been shown to cleave the 16s portion of
ribosomal RNA, inhibiting translation of a protein sequence, and some accelerate the depletion
of transfer RNA in the cytoplasm, meaning protein synthesis is thus limited (Cavera et al.,
2015).
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1.4.2 Organic Acids
Organic acids have been shown to display an antimicrobial effect that is generally attributed to
causing membrane interference (Dalié et al., 2010) due to their ability to cross the cell
membrane as a result of the lipophilic nature of the undissociated form of the acid (Dibner and
Buttin, 2002; Gómez-García et al., 2019). According to Dalié et al., (2010), the acids diffuse
through the membrane of microbes in their undissociated form, thus reducing the pH of the
cytoplasm with consequent inhibition of metabolic processes. One of the probable modes of
action of organic acids on the membrane is neutralization of its electrochemical potential, thus
increasing its permeability (Dalié et al., 2010) and affecting membrane porosity resulting in
interference with substrate transportation through the cell membrane of bacterial cells
(Davidson, Taylor and Schmidt, 2013). The overriding effect is probably a general collapse of
the proton gradients required for ATP synthesis due to the binding of free anions with the
periplasmic protons pumped out by the electron transport chain, thus carrying them back across
the membrane (Halstead et al., 2015). However, as the pH of the inside of the cell is higher
than the acid solution outside, the internalised acid will dissociate, thus causing an internal pH
reduction in the cell and an increase in protons as a result of the undissociated acid ionization,
and these protons must then be removed from the cell to prevent conformational changes and
damage of internal structures such as proteins and DNA (Davidson et al., 2013; Halstead et al.,
2015). Additionally, the protons cannot passively diffuse through the membrane and require
high ATP usage for exportation at the expense of the cell, resulting in collapse of the cell
metabolism with the consequent eventuality of cell death (Davidson, Taylor and Schmidt,
2013). Ajingi et al., (2020) also mentions how organic acids can impede the oxidation of the
cofactor nicotinamide adenine dinucleotide (NADH) that transports electrons to the
mitochondria, preventing the electron transport chain receiving reducing agents and thus
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resulting in interference with the production of metabolic energy within the cell required for
cell growth.
The above suggested effects on the membrane of bacteria associated with organic acids has
been observed for lactic acid activity against Gram-negative bacteria (Alakomi et al., 2000).
Alakomi et al., (2000) demonstrated using a fluorescent-probe uptake assay how lactic acid at
concentrations as low as 5 mM and pH 4, acts as a permeabilizer to the outer membrane of the
tested Gram-negative strains E. coli O157:H7, Pseudomonas aeruginosa and Salmonella
enterica serovar typhimurium, resulting in release of LPS and increased uptake of the
fluorescent probe. The outer membrane disruption caused by lactic acid was also stronger than
the effect observed by hydrochloric acid, and according to the authors the effect is likely due
to the undissociated acid molecules (Alakomi et al., 2000).
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1.5 Applications of Probiotic Bacteria and Bacteriocins
1.5.1 Probiotics and Antibiotic Use
It is well documented in the literature that the use of antibiotics on the body can disrupt the
natural balance of microbiota within the gastrointestinal tract (Burdet et al., 2019; Sun et al.,
2019; Zhang, et al., 2019). Probiotic use has been shown to regulate and restore the intestinal
microbiota after antibiotic use in research carried out by Engelbrektson et al., (2009) comparing
the microbiota of individuals administered an antibiotic but no probiotic, to a group taking an
antibiotic and probiotic supplement containing Lactobacilli and Bifidobacteria. Through
culturing and DNA-based terminal restriction fragment length polymorphism to identify the
microbial composition after treatment, in comparison to each subjects’ baseline composition,
a faster return to normal pre-antibiotic baseline microbiota upon consumption of probiotics was
indicated.
The use of antibiotics to treat infections can result in incidence of antibiotic associated
diarrhoea (AAD). This is caused by the disruption of the intestinal flora as a result of antibiotic
use, or direct irritation to the GI tract, that cannot be associated with any other cause of
diarrhoea (Bartlett, 2002; Giannelli, 2017). Clostridioides difficile is one of the most prominent
and important microbes linked to causing AAD, as well as causing nearly all cases of antibiotic
associated pseudomembranous colitis, which is an inflammation of the large intestine, and is
the leading cause of nosocomial diarrhoeal infections in adults (Barbut and Petit, 2001; Zhou
et al., 2014). AAD generally results from overgrowth of pathogenic organisms within the
intestinal mucosa as a result of the disruption of the healthy microflora, or it can also be effected
by a response to a reduction of the healthy intestinal flora, and as a result, can cause a decrease
in carbohydrate metabolism with a consequent accumulation of these solutes resulting in
osmotic diarrhoea due to solute concentration causing malabsorption of water (Varughese et
al., 2013; Zhou et al., 2014).
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Probiotic application can restore the natural balance and help to reduce the incidence of AAD
(Selinger et al., 2013; Hayes and Vargas, 2016; Litao et al., 2018). In one collection of 23
studies observing the effects of the treatment of AAD with probiotic bacteria, patients were
administered the bacteria Bacillus spp., Bifidobacterium spp., Lactobacilli spp., Lactococcus
spp., Saccharomyces spp., Streptococcus spp., Leuconostoc cremoris or Clostiridium
butyricum, either alone or as a combination of strains. A total of 22 of the 23 studies
demonstrated improvement upon probiotic treatment based on the incidence of diarrhoea, with
the incidence of AAD for those administered probiotics at 8%, as compared to occurrence of
19% in the control group who were not administered probiotics (Hayes and Vargas, 2016).
Selinger et al., (2013) assessed the effectiveness of the commercial probiotic treatment VSL#3,
a mixture of various strains of Lactobacilli, Bifidobacteria and Streptococcus (Chapman et al.,
2006), on AAD incidence in hospital patients exposed to antibiotic treatment. This study found
that the group administered the probiotic treatment had a significantly lower incidence of AAD,
with 0% in comparison to an AAD incidence of 11.4% in the placebo treated group, with a
significant p-value of 0.006 (Selinger et al., 2013).
A study carried out by (Mego et al., 2015) investigated the incidence of diarrhoea in patients
undergoing irinotecan chemotherapy for colorectal cancer, whereby the primary metabolite of
the drug (SN-28), was mainly responsible for the development of diarrhoea. The administration
of 10 probiotics including Bifidobacterium bifidum HA-132, Lactobacillus casei HA-108 and
Streptococcus thermopilus HA-110, aided in the reduction of diarrhoea induced by irinotecan
chemotherapy. There was a 0% incidence of severe diarrhoea in the probiotic treated group in
comparison to 17.4% in the control group with placebo treatment and in terms of overall
diarrhoea occurrence, there was a 39.1% incidence within the probiotic treated group as
compared to 60.9% incidence within the control group, with the results obtained indicating a
notable reduction when using a probiotic formulation treatment.
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An alternate way of administration of probiotic organisms and gut bacteria is through faecal
microbiota transplants, which has been shown to improve symptoms of gut disease, aid in the
regulation of a healthy balance of gut microbiota and can be used for hard-to-treat C. difficile
infections (Mattner et al., 2016). A study by Van Nood et al., (2013) used donor faeces in the
treatment of patients with recurrent C. difficile infections in comparison to treatment with the
standard vancomycin treatment. Of the patients that received an infusion of donor faeces, 13
of 16 (81% of the group) had complete resolution of C. difficile-associated diarrhoea after the
first infusion, and 2 of the remaining 3 had resolution after the second, in comparison to the
vancomycin-treated group which only had resolution in 4 of 13 treated patients (31%). The
preferred route of this therapy is generally through lower endoscopy (Mattner et al., 2016), as
it has provided the most favourable and effective results in more ill patients in comparison to
nasogastric administration, however, nasogastric delivery has displayed similar cure-rates in
more healthy patients (Gundacker et al., 2017).

1.5.2 Probiotics and the Food Industry
Aside from the oral consumption of probiotic supplements, many probiotic organisms are
added to food products or occur naturally in these products, such as in fermented milk products
that have been consumed for their health benefits throughout history (Butel, 2014). In modern
day, probiotic dairy beverages produced by the food industry, such as Yakult which contains
L. casei and Actimel which contain S. thermophilus, L. bulgaricus and primarily L. paracasei
(Actimel, 2019; Yakult GB, n.d.) are commonly consumed as a source of these beneficial
microbiota. Using food products as a delivery method for probiotics has displayed benefits
such as a potential synergistic effect between the nutrient rich food components and the
probiotic bacterial strains has been observed and explored, potentially increasing the bacterial
viability and their associated antimicrobial activity (Sireswar et al., 2017). In the study by
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Sireswar et al., (2017), they investigated the relationship between phenolic compounds and
intestinal microbiota and then assessed the effectiveness of using fortified fruit juice matrices
for probiotic delivery over dairy products, and their effect on viability and activity of the
selected probiotic bacteria. A juice matrix of either apple or sea buckthorn juice was fortified
with either whey or malt extract and contained Lactobacilli spp. probiotic strains and
antipathogenic activity (antimicrobial activity toward pathogenic strains) was then assessed. It
was observed that the matrix and supplement influenced the antipathogenic activity and sea
buckthorn juice fortified with malt was a superior matrix for the probiotic strains as it showed
increased antibacterial properties against the pathogens E. coli, Shigella dysenteriae and
Salmonella enteritidis (Sireswar et al., 2017). Another study by Dias et al., (2018) also
investigated the use of passionfruit juice with added B. animalis ssp. lactis BB-12 which was
microencapsulated by a spray drying process with either maltodextrose or inulin as a non-dairy
probiotic beverage. The results indicated 4oC storage was better for viability, the use of inulin
was better for Bifidobacterium survival and also produced more desirable physical
characteristics of the juice including lower moisture and that the microencapsulation was better
for stability of the juice powders (Dias et al., 2018). These studies indicate the potential
suitability for the incorporation of probiotic bacteria into beverages other than those that are
dairy based, which may appeal to a wider range of consumers seeking food-associated health
benefits.
Probiotic strains can also be employed as biocontrol agents in the food industry to prevent
contamination during food production as an alternative to frequently used methods of antibiotic
and disinfectant treatment, that can pose the risk of resistance or is of a high cost (Hossain, et
al., 2017). As many food products originate from livestock and marine life, meaning the
prevention of transmission of common foodborne pathogens such as Salmonella spp., E. coli,
Pseudomonas spp., Micrococcus and Listeria to humans is important, probiotics offer a natural
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alternative of contamination control and can help maintain beneficial microbes within the GI
system of animals consequently preventing colonization by harmful bacteria (Mountzouris et
al., 2009; Shim et al., 2012; Hossain et al., 2017). Probiotics can also be added to animal feed
for supplementation, such as B. cereus var. toyoi which has been added to pig feed (Lodemann
et al., 2008) and a Bifidobacterium lactis-based probiotic and galacto-oligosaccharide prebiotic
fed to broiler chickens, which stimulated favourable growth of Bifidobacteria within the
intestines of the chickens (Jung et al., 2008). Probiotics can also be used as an alternative to
disinfection of surfaces within food-processing plants, with Lactococcus lactis subsp. lactis C1-92 and Enterococcus durans 152 shown to eliminate Listeria from 5 of the 6 floor drains of
a poultry-processing factory after 4 treatments in a week and that remained free of Listeria for
13 weeks after this treatment (Zhao et al., 2013). Pérez Ibarreche et al, (2014) also investigated
the ability of the probiotic strain of Lactobacillus spp. to form biofilms on surfaces such as
stainless steel and polytetrafluoroethylene (PTFE) used in meat-processing plants, with the
strong biofilm forming strain L. sakei CRL1862 showing potential as a biocontrol agent to
prevent Listeria biofilm formation on these surfaces.
Aside from probiotic bacteria supplementation through capsules, these bacteria, namely
Bifidobacteria and Lactobacilli, are also used as starter cultures or additives in biofunctional
foods such as dairy products (Linares et al., 2017; Rodríguez de Olmos et al., 2017).
Biofunctional foods are ordinary foodstuffs that have added components to provide health
benefits (Figure 1.8), such as probiotic bacteria and their bioactive metabolites including
organic acids and bacteriocins, as consumers are increasingly looking for healthy food
alternatives (Linares et al., 2017; Rodríguez de Olmos et al., 2017). Many fermented milk
products such as yoghurt, cheese and kefir are some of the main sources of probiotic delivery,
and non-fermented food supplemented with probiotics include low-fat ice-cream, mousse and
infant formula (Rotar et al., 2007; Linares et al., 2017). Lactic acid bacteria have been used for
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over 4000 years in the production of fermented foods, which involves the microbial process of
converting lactose to lactic acid, altering the structure and texture to produce new fermented
food products (Rotar et al., 2007). Probiotics are becoming more relevant and of interest as
food additives due to an increasing demand for natural healthier food products by consumers
(Rodríguez de Olmos et al., 2017). Bifidobacterial species including B. bifidum, B. infantis
and B. longum were incorporated into the production of Crescenza cheese to introduce
probiotic Bifidobacteria into food products (Gobbetti et al., 1998). Results indicated that the
addition of Bifidobacteria did not inhibit or interfere with the other microflora, including the
strain S. thermophilus that is used for the production of the cheese and sensory evaluation
yielded no significant difference in comparison to the conventional cheese (Gobbetti et al.,
1998). Cheddar cheese was also found suitable for the incorporation of probiotic Bifidobacteria
to generate a probiotic cheese with high Bifidobacteria cell counts and results indicated that
the B. longum BB536 added to the cheese did not adversely affect the composition of the cheese
and the addition of B. lactis Bb-12 resulted in improved flavour (Mc Brearty et al., 2001).
Soybean paste was also selected as another healthy food substrate for the incorporation of
probiotic Lactobacilli and Bifidobacteria as a carrier for these healthy bacteria and for the
production of a healthy vegetarian food with increased nutritional value (Rodríguez de Olmos
et al., 2017).
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Figure 1.8: Health benefits associated with the use of probiotic bacteria in the food industry (Linares
et al., 2017). The beneficial effects associated with the consumption of biofunctional fermented food is
associated with the production of bioactive metabolites produced by LAB. The health effects include anticholesterolemic, immunomodulation and microbiome modulation among others.

1.5.3 Bacteriocins and Probiotics in Food Preservation and Safety
Chemical additives have been added to processed foods at an increasing rate in recent years
(da Silva Sabo et al, 2014), however increased awareness of the extent of additive addition and
the perceived negative impact of chemicals and processed foods on health by consumers has
resulted in a demand for minimally processed foods and more natural preservatives (O’Connor
et al., 2015). Widely used chemical preservatives include sorbic and benzoic acids, however in
some cases these may have an adverse effect on the health of consumers, such as allergic
reactions to benzoates resulting in uticaria and asthma (Tfouni and Toledo, 2002), and the
potential formation of carcinogenic products from chemicals used in preservation, such as
nitrosamines from nitrites (Johnson et al., 2018). Biopreservatives, food preservatives derived
from organisms and their metabolites, are becoming an increasingly popular area of research,
including research into the use of antimicrobial and antifungal peptides produced by bacteria
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for potential in biopreservation (Singh, 2018; Skariyachan and Govindarajan, 2019; Thery et
al., 2020). Lactic acid bacteria are commonly employed for biopreservation due to their
generally regarded as safe (GRAS) status and their use as probiotics (Perez et al., 2014; Singh,
2018). Probiotic LAB have played a role in traditional food preservation through use in
fermented foods, by bacteriocin production to inhibit spoilage bacteria, as well as production
of lactic acid and hydrogen peroxide to ferment the food (O’Connor et al., 2015). Spoilage of
food products by fungi and some bacteria can greatly reduce the shelf-life of products without
the use of preservatives (Garcia et al., 2019), with biopreservatives offering an appealing
alternative to the use of chemical preservatives that are currently the more commonly used
preservative within the food industry (Kıvanc et al., 2014).
Various probiotic bacteria have been used in food for a biopreservation application, including
the class of probiotic bacteria known as dairy propionibacteria, where this class of bacteria are
used as starter cultures and additionally for their production of beneficial metabolites including
organic acids (Rabah et al., 2017). Propionibacteria have been shown to display antifungal
activity against foodborne moulds and yeast as a result of organic acid production, which
includes the production of propionic, acetic and lactic acids (Lind et al., 2005). The most
potency has been detected for propionic acid, with a concentration as low as 20 mM propionic
acid at pH 5 required to inhibit fungal strains (Lind et al., 2005). Other probiotic lactic acid
bacteria have also been shown to offer protection against pathogens in food. One study
demonstrated how a commercial preparation of lactic acid bacteria, LactiGuardTM, reduced E.
coli O157:H7 and Salmonella on spinach leaves during refrigerated storage (Cálix-Lara et al.,
2014). In this study both a bacteriocin-like inhibitory substance and lactic acid detected in the
cell-free fermentates of the LAB strains were found to be associated with antimicrobial activity
(Cálix-Lara et al., 2014). The latter results indicated the potential and efficacy of the probiotic
LAB in LactiGuardTM for preservation of microbial safety in food. Various potentially
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probiotic Lactobacillus and Bifidobacterium species have also displayed antimicrobial activity
against food-related pathogens and spoilage organisms including the yeast C. albicans and
bacterial strains S. aureus, B. cereus and E. coli in a study by Georgieva et al., (2015).
Antimicrobial activity was namely attributed to organic acid production and low pH, and upon
neutralization of the supernatant it was evident that the presence of other inhibitory molecules
produced by the strains were contributing towards the antimicrobial activity and may include
hydrogen peroxide and/or bacteriocins, indicating their potential for use as starter cultures or
bioprotective cultures in the food industry (Georgieva et al., 2015). Another study
demonstrated the antifungal activity of lactic acid bacteria combinations on common fungal
spoilage strains including Penicillium commune, Mucor racemosus, Galactomyces geotrichum
and Rhodotorula mucilaginosa when added to yoghurt, cheese and sour cream (Leyva Salas et
al., 2018). The combinations of Lactobacillus plantarum L244 and either Lactobacillus
harbinensis L172 or Lactobacillus rhamnosus CIRM-BIA1113 were the most effective at
reducing fungal spoilage in cheese and sour cream, delaying the growth by between 2-24 days
on sour cream and between 1-6 days for cheese, thus offering prospects as bioprotective
cultures (Leyva Salas et al., 2018).
Although many lactic acid and probiotic bacteria offer a preservative effect due to the
production of a combination of inhibitory metabolites such as organic acids, hydrogen peroxide
and bacteriocins (Hladíková et al., 2012; Tejero-Sariñena et al., 2012; An et al., 2017), the
isolation of bacteriocins have attracted particular attention as natural peptide biopreservatives
(Balciunas et al., 2013). Bacteriocins are considered to be particularly useful due to their
observed antibacterial and antifungal activity against potential foodborne pathogens and/or
food spoilage organisms (Cálix-Lara et al., 2014; O’Connor et al., 2015; Luz et al., 2017;
Salazar et al., 2017) with their advantages detailed in Figure 1.9. The natural presence in food
and GRAS status of several LAB that produce bacteriocins opens up scope for the use of
34

bacteriocins in food preservation applications for human consumption (Deegan et al., 2006;
Messaoudi et al., 2013). Adding bacteriocins to foodstuffs can be accomplished by either direct
addition of a purified bacteriocin to the food product, or by addition of the bacteriocin
producing starter culture to a fermentation food process (Messaoudi et al., 2013). Nisin is a
bacteriocin produced by Lactococcus lactis (Matsusaki et al., 1998) that has been used since
the late 1950’s as a biopreservative agent in the food industry and that shows activity against
Gram-positive spoilage bacteria, and has been approved for use in over 50 countries (Gyawali
and Ibrahim, 2014). Nisaplin, is a commercial nisin preparation made from the fermentation of
non-fat milk with nisin producing Lactococcus lactis (Deegan et al., 2006). Nisin has been
included in food applications such as pasteurized mashed potato (Thomas et al., 2002) and
meat products to control spoilage of bologna-type sausage meat by LAB strains including
Lactobacillus sake and Lactobacillus curvatus (Davies et al., 1999). It has also been established
as an effective preservative in pasteurized cheese and cheese products to eliminate spores that
the heat processing step does not eliminate as well as other dairy products including desserts –
which cannot be fully sterilised without interfering with the food quality (Davies and DelvesBroughton, 1999). Nisin is also used in pasteurized egg products to remove the risk of spores
and vegetative cells, beer and wine products without interfering with the fermentation of yeast,
and many others including canned foods, yoghurt and bakery products (Davies and DelvesBroughton, 1999).
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Figure 1.9: Advantages of bacteriocins/bacteriocin producing bacteria in the three primary stages of
food production in the food industry (García et al., 2010).

Due to the water and nutrient content of meat and meat products, the risk of microbial
contamination is high, with spoilage bacteria such as Pseudomonas and Enterobacter, as well
as pathogenic bacteria such as E. coli O157:H7, Listeria monocytogenes and Salmonella
species commonly present with the consequent risk of transmission into humans upon
consumption (Woraprayote et al., 2016). Fungal spoilage of food products including fruit and
fruit juice, cereal and baked goods by strains such as Penicillium, Saccharomyces, Candida
and Aspergillus is also a common issue in the food industry (Saleh and Al-Thani, 2019; Snyder
et al., 2019), thus reducing the shelf-life of products. As these organisms can cause spoilage of
food and disease in humans, this research into extending the shelf-life and maintaining food
safety is important.
There have been many studies over the years regarding bacteriocins and their applications in
food as a natural preservative alternative. In one study by An et al., (2017), a bacteriocin
produced by L. plantarum M1-UVs300 that was isolated from a Chinese fermented sausage
exhibited activity against both Gram-positive and Gram-negative bacteria, including the
foodborne pathogens L. monocytogenes and S. typhi. The bacteriocin was also heat resistant
and active over a pH range of pH 2-8 (An et al., 2017). Due to the isolation of this bacteriocin
from a LAB strain and its ability to withstand various elevated temperature conditions that may
occur during food processing, this bacteriocin is considered to have the potential for application
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as a natural bio preservative with the consequent increase in food safety. In a study by Du et
al., (2017), they examined the antimicrobial effectiveness of two bacteriocins, Dur 152A and
enterocin L50B produced by Enterococcus durans 152, against the pathogen L. monocytogenes
in meat, specifically in delicatessen ham, which due to the production process would be
considered a high-risk food. Both bacteriocins were effective in preventing the growth of L.
monocytogenes for 10 weeks at 8 °C and 30 days at 15 °C, a result showing higher efficacy
than with nisin (Du et al., 2017), indicating their potential applicability for use in food safety.
Scannell et al., (2000) carried out a study on the effect of bacteriocins lacticin 3147 and nisin
on the shelf life of fresh pork sausage, with the results obtained indicating that both bacteriocins
displayed similar broad-spectrum activity, and that both were more effective than the inorganic
preservative sodium metabisulfite against pathogenic Clostridium perfringens DSM 756 and
non-pathogenic Listeria innocua DPC 1770. The bacteriocins used in combination with organic
acids also increased activity of both bacteriocins against pathogenic C. perfringens and
Salmonella kentucky AT1 and non-pathogenic L. innocua (Scannell et al., 2000).
Bacillus cereus is a common foodborne pathogen found in a variety of foods and mejucin, a
class II bacteriocin produced by Bacillus subtilis SN7 was found to display antibacterial
activity against this pathogen, as well as against both L. monocytogenes and S. aureus (Lee and
Chang, 2018). The bacteriocin was stable over a wide range of pH values (pH 3 - pH 9) and
temperatures, displaying activity after treatment with temperatures as high as 120oC, thus
showing promising activity under various food processing conditions as a natural preservative
or food biocontrol agent (Lee and Chang, 2018). The LAB Pediococcus acidilactici HW01,
originally isolated from malt, has been shown to produce a bacteriocin, designated HW01, that
was found to display antimicrobial activity against pathogenic bacteria such as S. aureus and
L. monocytogenes. The HW01 bacteriocin also caused inhibition of Pediococcus damnosus and

37

P. claussenii that were isolated from spoiled beer, and thus, may have potential application for
utilisation as an effective starter culture to prevent beer spoilage (Ahn et al., 2017).
Bacteriocins can also display antifungal activity, as observed by Muhialdin et al., (2016), where
peptides produced by the strain L. plantarum IS10 displayed good antifungal activity against
Aspergillus flavus MD3, Penicillium roqueforti MD4 and Eurotium rubrum MD5. In a study
by (Luz et al., 2017), they demonstrated how the LAB strains L. johnsoni CECT 289, L.
rhamnosus CECT 278T, L. planatrum CECT 749 all displayed antifungal activity against
Aspergillus parasiticus CECT 2681 and Penicillium expansum CECT 2268, with L. plantarum
displaying the highest inhibitory activity that was found to be associated with the production
of antifungal bioactive peptides. Overall, the research carried out to date indicates promising
potential applications for antifungal peptides and their lactic acid bacterial producer strains
within the food industry due to the high level of fungal associated food spoilage (Garcia et al,
2019).

1.5.4 Questions Still Surrounding Probiotics
Although the many potential benefits of probiotic administration have been discussed, there
are still questions surrounding the true extent of their efficacy with many reviews, studies and
experts doubting their safety and claimed benefits (Lerner et al., 2019). According to recent
studies, the ways in which probiotic bacteria influence the microbiota of the gut and dysbiosis
is still not completely known (Bezirtzoglou and Stavropoulou, 2011; Laursen et al., 2017; Suez
et al., 2018). Some studies have also shown that the intake of probiotic bacteria does not
significantly affect the composition of the gut microflora (Laursen et al., 2017; Singh et al.,
2018). Singh et al., (2018) administered a probiotic preparation to 14 women for 4 weeks and
monitored the composition of their faecal microbiota before and after administration of the
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probiotic as well as 4 weeks after taking the probiotic. The study found that there was no
significant change in the abundance or diversity of the faecal microbiota at any timepoint
before and after probiotic administration with no change also observed 4 weeks after
discontinuation of the probiotic. Laursen et al.,(2017) carried out a study on the effect of
probiotic administration to children as according to the author the gut microflora of children is
more responsive to external influence than the adult’s gut. A probiotic supplement with
Bifidobacterium animalis subsp. lactis (BB-12®) and Lactobacillus rhamnosus (LGG®) was
administered to more than 200 Danish infants ages 8-14 months, with placebos in place, and
the composition of the gut microflora was assessed before and after administration. It was
found that the probiotic administration did not significantly alter the microbiota community
structure or the microbial diversity within the gut of the children who had taken the probiotic
as compared to the children who had taken the placebo (Laursen et al., 2017).
The safety of probiotic supplementation has also been discussed, with questions surrounding
the administration of probiotics to certain populations including immunocompromised
individuals or patients with short bowel disease who may be more at risk of adverse effects
(Doron and Snydman, 2015; Lerner et al., 2019) The review by Lerner et al. (2019) discusses
reported adverse effects following the consumption of probiotics including D-lactic acidosis,
brain fog, intestinal bacterial overgrowth and bacteremia. Gargar and Divinagracia (2019)
detail how three patients admitted to ICU were administered a Bacillus clausii probiotic that is
widely used in immunocompromised patients. The use of the probiotic resulted in B. clausii
bacteremia in the three patients after a minimum of three days on the treatment, potentially
contributing to one patients death (Gargar and Divinagracia, 2019).Rao et al. (2018)
investigated the link between probiotic use and D-lactic acidosis, as probiotics have been linked
to the condition which is caused by fermentation of carbohydrates in the bowel by D-lactic
producing bacteria such as Lactobacillus and Bifidobacterium. The author evaluated patients
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exhibiting brain fogginess (BF) as this symptom along with elevated D-lactate in the body are
characteristic of D-lactic acidosis, with the patients exhibiting other symptoms such as gas and
bloating. Patients without BF were also assessed. All patients exhibiting BF consumed
probiotics and it was found that D-lactic acidosis and small intestine bacterial overgrowth were
more prevalent in the BF group than the non-BF group. When probiotic use was discontinued
and antibiotics were administered, BF and gastrointestinal symptoms improved, indicating a
potential link in the condition to probiotic use (Rao et al., 2018). Another case described a child
with short-bowel syndrome admitted to hospital with ataxia, neurological symptoms affecting
balance, co-ordination and speech, who had been prescribed a probiotic preparation 2 weeks
previously (Munakata et al., 2010). The diagnosis indicated D-lactic acidosis and the probiotic
was discontinued and antibiotics administered to treat the patient, while the probiotic
preparation was indicated as the likely cause of the condition (Munakata et al., 2010).
The potential of probiotic strains to contribute to the problem of antibiotic resistance has also
been discussed with the possibility of the acquisition of antibiotic resistant genes as well as the
potential to pass on genes of antibiotic resistance to commensal enteric bacteria through
horizontal gene transfer (van Reenen and Dicks, 2010; Lerner et al., 2019). Horizontal gene
transfer between probiotics has been reported for probiotic strains including L. paracasei and
L. rhamnosus among others (Ceapa et al., 2016; Mercanti et al., 2016). Due to the extensive
use of probiotic bacteria in the food industry and medically, this poses the question whether
horizontal gene transfer between the strains may pose a risk for delivering hostile genetic
material such as antimicrobial resistance to the hosts microbiota.
Although research into probiotics has shown various beneficial effects, there are still questions
surrounding the exact benefits, efficacy and safety of probiotics in some populations including
immunocompromised individuals or those with short bowel syndrome.
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1.6 Conclusion
It is evident that the use of probiotic bacteria, especially Bifidobacteria and Lactobacilli, offer
many benefits in areas of human health, such as probiotic supplements or for treatment as postantibiotic therapy with future potential as an alternative to antibiotics. They are also effective
agents in biopreservation within the food industry. They offer a promising alternative to current
chemical preservatives, as alternatives are highly sought after due to the increase in consumer
awareness of the perceived negative impacts of chemical preservatives on human health. The
ability to produce antimicrobial metabolites, including organic acids and bacteriocins, are an
integral characteristic of these probiotic bacteria in providing health benefits such as
immunomodulation and maintenance of healthy gut microbiota, as well as inhibition of
potential pathogens both within the body and within the food industry. It is evident from
research that the production of these various organic acids including lactic, acetic, propionic,
formic acid etc. have displayed potent antimicrobial activity, alongside the production of
bacteriocins by some strains, and both contribute to the potential of these strains for use within
the food industry. The antimicrobial and antifungal properties show significant opportunities
to contribute to overall health, food production and for use as biopreservatives. The latter
potential application to use Bifidobacterium longum ITT 13 strain as a biopreservative in the
food industry is explored within this thesis.
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CHAPTER 2
Materials and Methods
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2.1 Materials
Table 2.1: Materials used throughout project and their associated supplier/manufacturer
Product

Supplier or Manufacturer

90 mm Petri Dish

Cruinn

150 mm Petri Dish

Sarstedt

Sterile Flat Bottomed 96-Well Microtitre Plate

VWR

Serological Pipette 1 ml

Cruinn

Serological Pipette 5 ml

Cruinn

Serological Pipette 10 ml

Cruinn

Sterile Pasteur Pipette

Analab

Sterile Syringe 5 ml

Carl Stuart

Sterile syringe 10 ml

Carl Stuart

0.22 µm Sterile Filter

Sarstedt

0.45 µm Sterile Filter

Sarstedt

Inoculating Loop

Cruinn

Sterile Spreader

Carl Stuart

Weigh Boat

Cruinn

Autoclave Tape

Cruinn

10 ml Polypropylene Sterile Universal Tubes

Sarstedt

50 ml Sterile Centrifuge Tubes

Lennox

0.22 µm Stericup

VWR

0.45 µm Stericup

VWR

Plastic Cuvette

Sarstedt

Quartz Cuvette

HELLMA Worldwide

AnaeroGen Sachets

Analab
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Table 2.2: Reagents and chemicals used throughout project and their associated
supplier/manufacturer
Product

Supplier or Manufacturer

Tryptic Soy Agar (TSA)

VWR

TSB (Tryptic Soy Broth)

VWR

De Man, Rogosa & Sharpe (MRS) Agar

Cruinn

De Man, Rogosa & Sharpe (MRS) Broth

Cruinn

Muller Hinton (MH) Broth

Analab

Potato Dextrose (PD) Broth

Analab

Yeast Peptone Dextrose (YPD) Broth

Fisher Scientific

M17 Broth

VWR

Agar

Fisher Scientific

L-cysteine

Sigma Aldrich

BCA Kit (Catalog no. 23225)

Fisher Scientific

Phosphate Buffered Saline (PBS)

Sigma-Aldrich

Glycerol

Sigma-Aldrich

Lactic Acid

Sigma-Aldrich

Glacial Acetic Acid

Sigma-Aldrich

Hydrochloric Acid (HCl)

Sigma-Aldrich

Sodium Hydroxide (NaOH)

Fisher Scientific

Sodium Acetate

Sigma-Aldrich

Tween20

Sigma-Aldrich

Nisin (2.5%, balance sodium chloride)

Sigma-Aldrich

Natamycin

Analab

Ammonium Sulphate

VWR

Proteinase K

VWR

Pronase E (Actinase E)

Sigma-Aldrich
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2.2 Bacterial Cultivation
2.2.1 Media Preparation
All media utilised was prepared according to manufacturer’s instructions and autoclaved at
121oC at 15 psi for 15 minutes. Sterile molten agar was stored at 55oC before pouring into
sterile petri dishes. Media broth was either prepared and dispensed into test tubes and
autoclaved, or the media broth was batch prepared and autoclaved prior to dispensing into
sterile universal tubes.

2.2.2 Growth and Cryopreservation of Bacterial Stocks
The bacterial strains utilised for this research and their growth conditions are presented in Table
2.3. All strains were quadrant streaked on Tryptic Soy agar (TSA) to ensure purity before an
isolated colony was then added to 10 mls TSB and grown overnight. The cells were then
centrifuged at 2722 x g for 5 minutes, the supernatant decanted and the pellet was then
resuspended in 5 mls of TSB with 10% glycerol to concentrate cells and separated into 1 ml
cryovials for storage at -80oC.

2.3 Gram Stain
Gram staining was carried out as described by Bartholomew and Mittwer (1952). All bacterial
strains cultured were Gram stained before storage at -80oC to ensure purity of cultures.
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Table 2.3: Bacterial Indicator Strains and Growth Conditions
Bacterial Indicator Strain
Bacillus cereus

ATCC 10876

Incubation
Temperature
37oC

Enterococcus faecalis

ATCC 7080

37oC

TSB/TSA

Aerobic

Kocuria rhizophilia

ATCC 9341

30oC

TSB/TSA

Aerobic

Staphylococcus aureus

ATCC 25923

37oC

TSB/TSA

Aerobic

Staphylococcus epidermidis

ATCC 12228

37oC

TSB/TSA

Aerobic

Klebsiella aerogenes (previously
known as Enterobacter aerogenes)
Escherichia coli

ATCC 13048

37oC

TSB/TSA

Aerobic

ATCC 25922

37oC

TSB/TSA

Aerobic

PA01

37oC

TSB/TSA

Aerobic

Bacillus subtilis

ATCC 1174

37oC

TSB/TSA

Aerobic

Streptococcus pyogenes

NCIMB
11841
ATCC 29971

37oC

TSB/TSA

Aerobic

37oC

TSB/TSA

Aerobic

ATCC 29629

37oC

TSB/TSA

Aerobic

ATCC 17765
III.20
NCIMB 3254

37oC

TSB/TSA

Aerobic

37oC

MRS
broth/agar

Anaerobic

NCIMB
11778

37oC

MRS
broth/agar

Anaerobic

Lactococcus cremoris

M176

30oC

M17
broth/agar

Anaerobic

Lactococcus lactis

M179

30oC

M17
broth/agar

Anaerobic

Pseudomonas aeruginosa

Staphylococcus xylosus (previously
known as Micrococcus luteus)
Salmonella typhimurium (Salmonella
enterica subsp. enterica)
Burkholderia cenocepacia
L. paracasei subsp. paracasei
(Lactobacillus plantarum)
Lactobacillus delbruickii subsp.
bulgaricus

Strain ID

Growth
Media
TSB/TSA

Incubation
Conditions
Aerobic

The stocks of bacterial strains were prepared as described in section 2.2 and stocks were stored
at -80oC. The temperature and media in Table 2.3 were used in microdiffusion assay testing
(section 2.6) and for preparation of the indicator organisms for MIC50 testing (section 2.8.4).
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2.4 B. longum ITT 13 Growth and Storage
2.4.1 B. longum ITT 13 Isolation and Storage
The isolate B. longum ITT 13 was previously isolated from the gut flora of neonates (Costello,
M, Personal Communication 2018). It was grown up from 1 ml cryovials stored at -80oC and
incubated anaerobically at 37oC, on MRS agar supplemented with 0.05% L-cysteine for 3-4
days until growth was observed. The ITT 13 strain was sequentially re-streaked to purify before
a single colony was inoculated into 10 tubes, each containing 10 mls of MRS broth
supplemented with 0.05% L-cysteine and grown for 20-24 hours at 37oC. The tubes were
centrifuged at 2722 x g for 5 minutes to pellet the cells, the supernatant was decanted and the
pelleted cells resuspended in 5 mls MRSc broth with 10% glycerol. The resuspended cells were
aliquoted into 1 ml cryovials, yielding a total of 50 cryovials, and frozen at -80oC.

2.4.2 B. longum ITT 13 Fermentate Production
A 0.5% aliquot from a cryovial of B. longum ITT 13 was inoculated from frozen stocks into
MRSc broth of 10-100 ml and grown for 18-20 hours anaerobically at 37oC. A 1% inoculum
of the culture was then transferred to fresh MRSc broth of 100-1000 mls depending on volume
of fermentate required and incubated anaerobically at 37oC for a further 18-20 hours.
The fermentate was heat shocked by incubating at 60oC for 15 minutes. Heat shocking was
required by the project sponsor as a minimally modified fermentate was required for testing
with the inactivated cells present, unless a specific assay required the absence of cells i.e.
testing in microtitre plates. This also meant that no purification methods were employed to
purify the fermentate for testing, with testing carried out in its natural heat shocked form. Prior
to use, the heat shocked fermentate was stored at 4oC and used as required in individual
experiments.
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2.4.3 Cell Free Supernatant of B. longum ITT 13 Fermentate
Cell free fermentate was prepared using the heat shocked fermentate (section 2.4.2). The
fermentate was centrifuged at 2722 x g for 5 minutes to pellet cells. Where large aliquots of
the heat shocked fermentate were used, the supernatant was decanted into fresh tubes and a
second centrifugation required at 2722 x g for 5 minutes due to large cell density.
Prior to addition to tangential flow filtration (TFF) systems, the cell free fermentate was filtered
through 0.45 μm stericups to remove remaining cells and cellular debris. The cell free
fermentate was stored at 4oC prior to use.

2.5 Nisin Preparation
Nisin was prepared according to Aplin and Barrett Nisin Reference Preparation Method. A
commercial preparation of nisin (2.5%, balance sodium chloride) (SigmaAldrich, Co.
Wicklow) was used with activity of 1000 IU/ml. For preparation, 0.1 g was weighed out and
dissolved in 60 mls 0.02N HCl in a glass conical flask. The flask was plugged with cotton wool
and boiled for 10 minutes in a 100oC waterbath, before being cooled to room temperature. The
solution was brought up to 100 mls with 40 mls 0.02N HCl and stored at 4oC for at least 1 hour,
and at maximum for 24 hours, before being frozen at -20oC in 1 ml aliquots.

2.6 Microdiffusion Plate Assay
The microdiffusion assay (M/D assay), also known as the agar/well diffusion assay and for the
purposes of this study was referred to as the microdiffusion or M/D assay, was utilised for
antimicrobial activity testing. The assay was adapted from the method described by Tramer
and Fowler (1964). TSA was prepared by weighing out 2.22 g and suspending in 60 mls of
deionised water for 150 mm petri dishes or 1.11 g TSA suspended in 30 mls deionized water
for 90 mm petri dishes. For Lactobacilli strains 3.72 g of MRS agar with 0.05% L-cysteine was
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weighed and added to 60 mls deionized water. A 20 ml 1:1 mixture of deionised water and
Tween 20 was prepared. The media and Tween 20:H2O were then autoclaved (section 2.1) and
the relevant indicator strain (5%) grown in TSB was added to the molten agar at 55oC and 2%
of the sterile Tween 20:H2O added also. The inoculated agar mixture was poured into a 150
mm or a 90 mm petri dish and allowed to solidify before it was placed into a refrigerator prior
to use. Wells of 10 mm in diameter were cut into the agar on the M/D plates using a size 6 bore
dipped in 100% ethanol or IMS and flamed to sterilise. A volume of 180 μl of the required
samples being tested for activity were placed into the relevant wells and plates incubated for
20-24 hours under the conditions required by the indicator strain (Table 2.1). Nisin was used
as the positive control and sterile media or relevant buffer used as a negative control(s).

2.7 Biolog Identification of Strain ITT 13
The Biolog (TECHNOPATH Distribution Ltd. Ireland) was used for phentotypic identification
of the ITT 13 strain. The Biolog utilises a variety of different carbon sources added to microtitre
plate wells. The strain for testing is added to wells and following incubation there is a resulting
pattern of growth that depends on the carbon sources that can be utilised by the test strain.
Identification of the strain is based on this pattern of growth. Strain ITT 13 was grown on
Biolog universal anaerobe agar in an anaerobic chamber for 48 hours. Colonies were then
inoculated into the Biolog inoculating fluid at 65% Transmission (T). The turbidity was
determined using a turbidometer which was calibrated using a turbidity standard. Colonies
from the universal anaerobe agar plate were inoculated into the fluid until 65%T was reached.
The inoculated fluid was then poured into a sterile reservoir and 100 μl of the inoculated culture
added to each well on the Biolog anaerobic microplate that was then incubated in an anaerobic
jar at 37oC for 20-24 hours before the plate was removed and read using the Biolog plate reader.
The growth pattern on the Biolog anaerobic microplates were read using the Biolog
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MicrostationTM Reader and analysed in comparison to the Biolog Anaerobe database.

2.8 Determination of Antibacterial and Antifungal Spectrum of Activity for B. longum
ITT 13
2.8.1 Antibacterial Assay Evaluation
The most suitable assay for antibacterial activity screening of the B. longum ITT 13 fermentate
was selected from the Kirby-Bauer disk diffusion assay (Kirby et al, 1957, Bauer et al, 1966),
the microdiffusion or well diffusion assay (section 2.6) and the agar spot assay (Nakano et al,
1968). Nisin was used as the antibacterial agent to evaluate each assay and Kocuria rhizophilia
ATCC 9341 was used as the indicator strain for all three assays as it has provided clear zones
of inhibition in previous testing. For the microdiffusion assay, serial dilutions of nisin (1000
iu/ml) from neat to 1/128 were placed into wells and zones measured following incubation of
the plates. The agar spot assay is a solely qualitative assay with a small spot of clearance on
the incubated agar plate indicating inhibition of the indicator strain. The agar spot assay was
carried out using neat to 1/128 serial dilutions of nisin spotted onto the surface of 150 mm TSA
plates inoculated with K. rhizophilia, in 5 µl and 10 µl volumes. The disk diffusion assay was
carried out by impregnating 6 mm sterile disks with 15 µl of each nisin dilution (neat to 1/128)
and then placing the disks on the surface of 150 mm TSA plates inoculated with K. rhizophilia.
The results generated for each assay were compared for effectiveness based on interpretation
of antimicrobial activity.

2.8.2 Antibacterial Spectrum of Activity Determination – Microdiffusion Assay
The microdiffusion assay as described in section 2.6, using B. longum ITT 13 heat inactivated
fermentate (section 2.4.2) serially diluted up to 1/16 with MRSc broth, was used for the
determination of the antibacterial spectrum of B. longum ITT 13 against a variety of Gram50

positive and Gram-negative bacteria. Bacterial indicator strains were selected based on their
relevance to food spoilage and contamination, pathogenesis or their effectiveness as an
indicator strain by providing clear zones of inhibition (ZOI). The microdiffusion assay was
carried out using the 15 bacterial strains detailed in Table 2.2 as the indicator strains. Results
were recorded as the presence or absence of a ZOI at each dilution of fermentate and the
diameter of zones of inhibition were recorded. A minimum of three independent assays (n=3)
with three replicates for each assay were carried out for each indicator strain.
Arbitrary Units (AU)/ml were calculated for the M/D assay to determine the level of
antibacterial activity against each indicator strain by dividing the inverse of the highest dilution
displaying antimicrobial activity by the volume of fermentate, multiplied by 1000 to bring up
to 1 ml (AU/ml =

𝑖𝑛𝑣𝑒𝑟𝑠𝑒 𝑜𝑓 ℎ𝑖𝑔ℎ𝑒𝑠𝑡 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑤𝑖𝑡ℎ ≥50% 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛
𝑣𝑜𝑙𝑢𝑚𝑒 𝑎𝑝𝑝𝑙𝑖𝑒𝑑 𝑡𝑜 𝑤𝑒𝑙𝑙

𝑥 1000).

2.8.3 The Effect of pH on Antibacterial Activity of Fermentate
A volume of 10 mls of heat inactivated ITT 13 fermentate (section 2.4.2) was adjusted from
pH 4.21 to 4.68 using 2 mls of 0.3M NaOH, giving a final concentration of 0.05M NaOH in
the Fermentate. A minimal increase in pH was carried out so as not to eliminate observable
antibacterial activity on the M./D assay as significant pH increases have resulted in a loss of
activity in previous testing. The pH adjusted Fermentate as well as unadjusted Fermentate were
both diluted to 1/2 and added to M/D assay plates (section 2.6). The negative control was
prepared using a volume of 10 mls of MRSc broth adjusted from pH 6.43 to 4.82 with 12 mls
of 60 mM Lactic Acid, giving a final concentration of 33 mM lactic acid. The microdiffusion
assay was carried out using B. subtilis, K. rhizophilia and P. aeruginosa as the microbial
indicator strains, and nisin (neat to 1/4 dilutions) were used as the positive controls. Negative
controls of 0.05M (50 mM) NaOH and 33 mM lactic acid were also used on the microdiffusion
plates. A minimum of three independent experiments (n=3) with three replicates per
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experiment were carried out for each indicator strain.

2.8.4 Minimum Inhibitory Concentration Assay
The minimum inhibitory concentration causing 50% inhibition of growth (MIC50) of the B.
longum ITT 13 heat inactivated fermentate (section 2.4.2) adjusted to pH 4.55 ± 0.02 was
determined used 96-well microtitre plates according to the EUCAST broth microdilution
method (Eucast.org, 2020) as described below.
The bacterial indicator strains used were S. xylosus ATCC 29971, B. subtilis ATCC 1174, E.
faecalis ATCC 7080, P. aeruginosa PA01, S. typhimurium ATCC 29629 and E. coli ATCC
25922 which were freshly grown to mid-log phase and diluted to 1x106 CFU/ml in Mueller
Hinton broth (MH broth). Mid-log phase was identified by growth curves carried out on the
strains. Available growth curves are presented in Appendix A and mid-log phase for P.
aeruginosa was informed by J. Brady – personal communication. A volume of 100 µl of the
1x106 CFU/ml indicator cultures was seeded into each of the wells. In the control wells i.e.
wells without cells, 100 μl of Mueller Hinton broth was added at a 1:1 dilution with the sample
which was then placed into the well. The pH adjusted fermentate was generated by taking a
volume of 10 mls of heat inactivated fermentate and adjusting it to pH 4.55 ± 0.02 with 1 ml
of 0.3M NaOH.
A 100 µl sample of the pH adjusted fermentate was then added to wells with 1x106 CFU/ml of
the indicator strain, giving a final density of 5x105 CFU/ml of the indicator strain and the
highest concentration of the fermentate as an initial dilution of 1/2. Serial dilutions from 1/2 to
a final dilution of 1/128 of fermentate were carried out in the wells. MRSc broth was also
serially diluted in the wells from 1/2 to a 1/128 dilution. The MRSc controls were used to
determine the OD600 of the indicator strain for that well with the specific correlating MRSc
concentration in the ITT 13 fermentate, without any inhibition. The antibacterial effect of each
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dilution of the pH adjusted fermentate was then calculated as a percentage reduction of growth
of the indicator strain in MRSc with and without ITT 13 fermentate.
A volume of 10 mls of MRSc broth was also adjusted to pH 4.55 ± 0.02 with 8-8.5 mls of 0.1
M lactic acid and the pH adjusted MRSc was then used as a control to assess whether the
antibacterial activity of the fermentate could be solely pH associated. The latter evaluation was
based on the MIC50 of the fermentate vs. the MIC50 of the pH adjusted MRSc broth. A growth
control of diluted MRSc broth prepared by adding 8-8.5 mls of sterile H2O to was used to
analyse the effect of the broth dilution. The pH adjusted MRSc broth and diluted MRSc broth
were comparatively determined in each well. Comparative analysis meant the inhibition of the
MRSc broth adjusted to pH 4.55 ± 0.02 could also be calculated as a percentage reduction of
growth based on the growth compared to diluted MRSc and be directly comparable to the
percentage reduction calculated of the ITT 13 fermentate.
Nisin serially diluted from 1/2 to 1/128 was used as a positive control and controls of MRSc
broth at a 1:1 with Mueller Hinton broth and nisin at a 1:1 with Mueller Hinton broth were used
as correction factors to adjust for absorbance due to the MRSc and MH broth mixture or the
nisin and MH broth mixture.
Arbitrary Units (AU)/ml were calculated for the MIC50 assay to determine the level of
antibacterial activity as described in Section 2.8.2. AU/ml was calculated using the MIC50,
which was the highest dilution displaying at least 50% inhibition of the indicator strain.
Generally the MIC is the lowest concentration of an antimicrobial agent that prevents visible
growth of the test organism (EUCAST Definitive Document, 1998), however, in this study, the
minor differences in growth of the indicator strains at each dilution of the test samples and the
controls were extremely important rather than the highest dilution preventing complete growth.
For example, if the test sample and the positive control both prevented visible growth of the
indicator strain at the 1/4 dilution this would generally be the MIC of both, but the test sample
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may prevent 70% of growth at the 1/8 dilution while the control only prevents 10% of growth.
In this case, the MIC would be the same, but there is still a stronger inhibitory effect observed
by the test sample. Therefore, it was decided for this study to take the MIC50 so a more detailed
analysis could be performed and this was what was be used for AU/ml calculation. This is
similar to an IC50 calculation which is the concentration of a drug that is required to inhibit
50% of a biological process and is a measure of a drugs potency and efficacy in
pharmacological research (Aykul and Martinez-Hackert, 2016), but as the concentration of
potential antimicrobial peptides within the fermentate is unknown this was not a suitable
analysis. This method of analysis was adapted from Lim, (2016) who also calculated the
bacteriocin units/ml (equivalent to AU/ml) based on the highest dilution displaying 50%
inhibition.

2.8.5 Antifungal Activity
2.8.5.1 Antifungal Activity Using Soft Agar Overlay Method
A modified version of the soft-agar overlay assay was adapted from Romanens et al. (2019),
using heat in-activated fermentate (Section 2.4.2) and was carried out as a minimum of three
independent experiments (n=3) for each indicator organism. The heat inactivated B. longum
ITT 13 fermentate was used to determine whether any antifungal activity was present against
the five fungal strains Candida albicans ATCC2091, Saccharomyces cerevisiae ATCC18824,
Saccharomyces cerevisiae CBS1171, Rhodotorula mucilaginosa CBS316 and Debaryomyces
hansenii ATCC18110. The five fungal strains were grown on both Yeast Peptone Dextrose
(YPD) and Potato Dextrose (PD) agar, the agar selected for the soft-agar overlay analysis was
based on observation of the greatest confluency of growth on the relevant media. Soft YPD
agar was used for S. cerevisiae and D. hansenii, and soft PD agar was used for R. mucilaginosa
and C. albicans. The assay was carried out by adding 30 ml of TSA bottom layer agar into a
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sterile petri dish allowing it to set, and then adding 10 ml of a soft top agar (PD broth or YPD
broth containing 0.7% agar) inoculated with 1% v/v of the chosen fungal strain.
Natamycin in a YPD or PD broth suspension, depending on the media used as soft agar, was
used at concentrations of 0.1 mg/ml on each plate, as the positive control. YPD/PD broth and
MRSc broth were used as negative controls on all plates. Plates were incubated for 45 hours at
30oC for Saccharomyces cerevisiae ATCC18824, Saccharomyces cerevisiae CBS1171,
Rhodotorula mucilaginosa CBS316 and Debaryomyces hansenii ATCC18110 until confluent
growth resulted. Candida albicans ATCC2091 was incubated for 24 hours at 30oC.

2.8.5.2 Antifungal Activity Using Microtitre Plate/MIC50 Method
The fermentate produced by B. longum ITT 13 was previously screened for antifungal activity
using the agar-spot assay. This assay concluded that there was no observable antifungal activity
displayed by the fermentate, however due to the increased sensitivity of the MIC50 method
using 96-well microtitre plates (Section 2.8.4), antifungal screening was repeated using this
assay. The fungal strains R. mucilaginosa CBS 316, C. albicans ATCC 2091, S. cerevisiae
ATCC 18824 and S. cerevisiae CBS 1171 were grown for 20-22 hours in either PD broth (R.
mucilaginosa and C. albicans) or Yeast Peptone Dextrose broth (S. cerevisiae strains). The
fungi were diluted 1/100 in their respective broth and 100 µl of the diluted culture plated into
the wells on microtitre plates. B. longum ITT 13 fermentate produced in 100 mls MRSc broth
in an anaerobic jar (pH 4.35) as described in Section 2.4.2 and B. longum ITT 13 fermentate
produced in MRSc broth in a 2 L pH-controlled fermentation vessel (pH 4.8) were made cellfree using the method described in Section 2.4.3. The cell free fermentates were added to wells
containing the fungal cells in 100 µl volumes and diluted serially across the wells (1/2 - 1/32
dilution). Natamycin was prepared at a concentration of 0.1 mg/ml as a suspension in YPD and
PD broth as a positive control and serially diluted across wells to a 1/32 dilution equivalent to
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0.0031 mg/ml. MRSc broth pH adjusted to pH 4.36 using 39.9 mM lactic acid and 60.9 mM
acetic acid was also added to wells and diluted to a 1/32 dilution. A negative control of the
respective fungal media used for growth of the tested fungal strain, either YPD or PD media,
was used as a negative/growth control. The microtitre plates were incubated for 22-24 hours
and the growth of the fungal strains determined by the optical density at 600 nm (OD600). A
minimum of three independent assays (n=3) with two replicates per assay were carried out.

2.9 Physiochemical Characterisation
2.9.1 Ammonium Sulphate Precipitation of Fermentate
Ammonium sulphate (AS) precipitation was carried out using a method adapted from
Wingfield (2001). Two variations of the AS precipitation were carried out on the B. longum
ITT 13 fermentate with the aim of identifying an AS fraction that contained antimicrobial
activity. The ammonium sulphate solution interferes with the proteins solubility in water
causing precipitation by increasing hydrophobic interactions, while maintaining the protein
conformation (Wingfield, P., 2001).

2.9.1.1 Ammonium Sulphate Precipitation with Separate Saturation
The first method involved ammonium sulphate (AS) precipitation of the fermentate at four
separate AS saturations. Ammonium sulphate was added at 20%, 40%, 60% and 80%
saturation to 4 separate 40 ml samples of cell free fermentate (section 2.4.2 and 2.4.3). The 4
samples were kept on ice during addition of AS and magnetic stirring rods placed into beakers
on slow speed to allow dissolution of each of the AS concentrations over 1.5 hours. The
samples were placed into sterile centrifuge tubes, stored overnight at 4oC before centrifugation
of the 40 ml samples at 4oC and 13,440 x g for 30 minutes. The supernatant was decanted and
the pellets were resuspended in 1 ml of ultra-pure H2O, except for the 80% pellet which was
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resuspended in 2 ml ultra-pure H2O due to the size of the precipitate. Antimicrobial activity
was screened for each of the supernatant fractions and resuspended pellets using the
Microdiffusion assay A minimum of three independent assays (n=3) were carried out for testing
of all samples plus the negative controls of AS at 20%, 40%, 60% & 80% in MRSc broth and
the positive control was neat nisin (1000 iu/ml).
2.9.1.2 Sequential Ammonium Sulphate Precipitation
The second AS precipitation method involved sequential ammonium sulphate precipitation.
The solutions were kept on ice during addition of AS with magnetic stirring rods in the
solutions at slow speed. The AS concentration in a 100 mls fermentate sample was initially
brought to a 20% saturation by the gradual addition of the AS over 30 minutes to a final weight
of 10.7 grams of AS added, followed by a further 15-minute period of dissolution. The 20%
AS solution was then centrifuged at 4oC and 13,440 x g for 30 minutes. The supernatant from
the 20% was then saturated sequentially to 40% by the addition of 11.5 g AS, 60% (12.2 g AS
added) and up to 80% saturation (13.1 g AS added), with repeated centrifugation and pelleting
of protein after each AS addition. Pellets from each step were resuspended in 1 ml of ultrapure
H2O. Antimicrobial activity was screened for a sample of each supernatant fraction and each
resuspended pellet using the Microdiffusion assay. Nisin (1000 IU/ml) was used as a positive
control and AS at the 20%, 40%, 60% & 80% saturations in MRSc broth were used as negative
controls. A minimum of three independent M/D assays (n=3) were carried out.

2.9.1.3 Ammonium Sulphate Precipitation with Microtitre Plate Analysis
A B. longum ITT 13 heat-inactivated fermentate (pH 4.3) was prepared as described in Section
2.4.2 and made cell-free as described in Section 2.4.3. Ammonium sulphate precipitation was
carried out as described in Section 2.9.1.1 with ammonium sulphate brought up to 20%, 40%,
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60% and 80% saturation in 40 ml aliquots of the cell free fermentate. Precipitated pellets were
resuspended in 2 ml of 50 mM pH 4.3 sodium acetate buffer. As the original fermentation was
carried out in MRSc broth an equivalent ammonium sulphate precipitation fractionation was
carried out with the MRSc media as a control to ensure that if any antimicrobial activity was
detected, then it could not be associated with the protein fractions present in the actual media
itself or the percent saturation of ammonium sulphate used.
S. xylosus cells were freshly grown to mid-log phase and diluted to 1x106 CFU/ml in Mueller
Hinton broth (MH broth). The cell density was known as a growth curve had been carried out
(Appendix A). A volume of 100 µl of the 1x106 CFU/ml cells were seeded into each of the
wells. A 100 µl sample of the resuspended B. longum ITT 13 fermentate and MRSc broth
pellets were then added to wells with 1x106 CFU/ml of the indicator strain, giving a final
density of 5x105 CFU/ml of the indicator strain and the highest concentration of the
resuspended fermentate and MRSc samples as an initial dilution of 1/2. Serial dilutions from
1/2 to a final dilution of 1/128 of fermentate were carried out in the wells. Nisin serially diluted
from 1/2 to 1/128 was used as a positive control and controls of MRSc broth at a 1:1 with
Mueller Hinton broth and nisin at a 1:1 with Mueller Hinton broth were used as correction
factors to adjust for absorbance due to the MRSc and MH broth mixture or the nisin and MH
broth mixture.
The plates were incubated on an orbital shaker at 150 rpm in a 37oC incubator for 18-20 hours
and growth in the wells measured in a microtitre plate reader at 600 nm. The growth for the S.
xylosus cells in the presence of the resuspended B. longum ITT 13 fermentate was compared
to the growth of the cells in the presence of the resuspended MRSc broth at each dilution and
each ammonium sulphate saturation to determine if the resuspended fermentate resulted in
inhibition of the cells that was not observed for the MRSc media. Three independent assays
(n=3) were carried out with three replicates per assay.
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2.9.2 pH Stability Testing of B. longum ITT 13 Fermentate with HCl and NaOH
The pH stability of the ITT 13 heat inactivated fermentate (section 2.4.2) was determined
through the adjustment of neat fermentate to a variety of pH’s (pH 3, 4, 6, 7 and 8) which were
then screened for activity using the microdiffusion assay with S. xylosus as the indicator strain.
Aliquots (10 mls) of ITT 13 heat inactivated fermentate were adjusted to pH 3.18, pH 4.02, pH
5.85, 6.38 and 7.96 with various volumes of 0.3M NaOH and 0.3M HCl. MRSc broth at pH’s
3.00, 4.01, 6.01, 6.98 and pH 8.04 were used as the negative controls, with nisin (1000 iu/ml)
as the positive control and pH unadjusted heat inactivated fermentate used a control for the
expected antimicrobial activity of the fermentate sample. The pH adjusted samples were placed
at room temperature (23oC) for 4 hours with samples taken at 0 hours (T0), 1 hour (T1), 2 hours
(T2) and 4 hours (T4) to determine if antimicrobial activity was reduced over time at any pH.
Microdiffusion assay plates (90 mm) were used to screen for antimicrobial activity at each time
point. All pH adjusted fermentate samples were carried out in three independent assays (n=3)
and dilutions of the fermentate associated with the pH adjustment, were considered in the
analysis.

2.9.3 Detailed pH Stability Assay of B. longum ITT 13 Fermentate with Lactic Acid and
NaOH
Aliquots of B. longum ITT 13 heat inactivated fermentate (5 mls) (Section 2.4.2) were adjusted
to pH 3, pH 4, pH 5 and pH 6 using filter sterilized 0.1 M lactic acid or 0.3 M NaOH.
Volumes of 5.7 mls of 0.1 M lactic acid was used to adjust 5 mls fermentate to pH 3.08, 700
µl of 0.1 M lactic acid was used to adjust 5 mls fermentate to pH 4.00, 1.9 mls of 0.3 M NaOH
was used to adjust 5 mls fermentate to pH 5.12 and 2.7 mls of 0.3 M NaOH was used to adjust
5 mls fermentate to pH 6.10. The pH of the fermentate without pH adjust was pH 4.27.
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MRSc broth was also pH adjusted from pH 6.18 to pH 4.32 with 11.5 mls 0.1 M lactic acid to
allow for more direct comparison to the fermentate (pH 4.27). This was filter sterilized (0.22
µm) and divided into 5 ml volumes to which the same volume of NaOH or lactic acid used to
adjust the fermentate as described above were added. These were used as negative controls to
assess whether any activity of the adjusted fermentate could be primarily due to acid or base.
The volume of NaOH or lactic acid added to the pH 3-6 fermentate samples as described above
were also added to 5 ml volumes of MRSc broth with no pH adjust. This was another control
to determine the antimicrobial activity associated solely with the acid/base used to adjust the
pH of the fermentate.
The analytical and control samples were added to a microdiffusion assay plate (Section 2.6) as
a time 0 sample. Neat nisin (1000 iu/ml) was used as a positive control for the assay. The
unadjusted fermentate was also added to plates for comparison of activity to the pH adjusted
fermentate. The pH adjusted analytical samples and controls were kept at room temperature
(18-20oC) over the course of the assay. Samples were taken and added to microdiffusion plates
at T0 (0 hours), T1 (2 hours), T3 (4 hours) and T4 (24 hours).

2.9.4 Protease Digestion of the B. longum ITT 13 Fermentate in Microdiffusion Plates
The ITT 13 fermentate was digested with a variety of proteases to determine whether the
antimicrobial activity was partially or wholly proteinaceous in nature. Actinase E was prepared
at a concentration of 10 mg/ml in sterile PBS. A volume of 100 µl of protease was incubated
with 100 µl of heat inactivated fermentate (section 2.4.2) at 37oC for 4 and 24 hours, resulting
in a final concentration of 5 mg/ml of protease and a 1/2 dilution of the fermentate. Nisin was
also digested with the proteases as a positive control for the experiment. A 1/2 dilution of the
fermentate and a 1/2 dilution of nisin (500 iu/ml) diluted with sterile PBS and incubated at
37oC for 4 and 24 hours were also carried out for a direct comparison of antimicrobial activity
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with the protease digested samples. Following incubation, a heat inactivation step of the
samples at 80oC for 5 minutes was carried out to inactivate the protease before addition to
plates. Neat samples of the fermentate and nisin were added to Microdiffusion plates to assess
initial activity without dilution (Section 2.6). The M/D assay was carried out to screen for a
loss of activity upon treatment with the proteases using S. xylosus as the indicator strain. Zones
of inhibition of the 1/2 dilutions of the fermentate and nisin control were compared with the
presence or absence of ZOI’s of the protease treated fermentate and nisin control.

2.9.5 Protease Digestion of the B. longum ITT 13 Fermentate in Microtitre Plates
Two B. longum ITT 13 cell free fermentates (fermentate 1: pH 4.35 grown anaerobically in
100 mls MRSc broth, fermentate 2: pH 4.80 grown in MRSc broth anaerobically in a 2 L
fermenter) were digested with both Actinase E and Proteinase K as described in Section 2.9.4
for 22 hours. Samples of both fermentate were also diluted with PBS at a 1/2 dilution and
incubated at 37oC for 22 hours as a direct comparison for the dilution caused by the proteases.
After incubation, the samples were heat treated at 80oC for 5 minutes to inactivate the protease
and added to microtitre plates.
A 100 µl volume of the digested and diluted fermentate samples was added to wells containing
100 µl of 1x106 CFU/ml of S. xylosus as the indicator strain giving a final density of 5x105
CFU/ml and the highest concentration of the fermentate as an initial dilution of 1/4. As the
fermentate samples were either diluted with PBS or digested with Actinase E or Proteinase K
prepared in PBS, a 1:1 of MRSc broth and PBS was prepared and added to wells containing
100 µl of S. xylosus as a growth control to ensure the mix of PBS and MRSc broth alone did
not contribute to similar inhibition of the fermentate. All samples were serially diluted across
up to a 1/256 dilution.
Nisin (1000 iu/ml) was also digested and diluted with PBS in the same manner and added to
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microtitre plates as described above. Instead of a 1:1 of MRSc and PBS added to wells, a
growth control of a 1:1 of 0.02 N HCl and PBS was added as the former is the solvent nisin
used for nisin preparation.

2.9.6 HPLC Analysis of the Organic Acid Production by B. longum ITT 13
In order to identify the composition and concentration of organic acids produced by B. longum
ITT 13 during growth and fermentation, HPLC-UV analysis was carried out based on the
method described by Özcelik et al., (2016) with modifications, using a reverse-phase column
with UV analysis. Samples of the B. longum ITT 13 fermentate were cultured and provided to
C. Lynch who carried out the HPLC analysis using a quaternary solvent management HPLC
instrument. The B. longum ITT 13 fermentate included two variations, the first was cultured in
MRSc broth with 0.11% L-cysteine in 2L fermentation vessels with pH control at pH 4.8
(Section 2.9.5) and the other cultured in MRSc broth with 0.05% L-cysteine without pH control
at pH 4.3 in lab-scale volumes of 200 ml (Section 2.4.2). The HPLC instrument was equipped
with a diode array detector at 210 nm and the column used was C18 reverse phase, Phenomenex
EVO-C18 (100mm x 4.76, 2.6 um particle size) column. A mobile phase composition of orthophosphoric acid and acetonitrile (ACN) was used, with a flow rate of 0.4 ml/min. Each
chromatographic run was carried out for 15 minutes with 5-minute interval periods between
runs to allow for system re-equilibration. An injection volume of 10 µl was used with the
injection port kept at room temperature (20-24oC). An internal standard of methylmalonic acid
was used.
Stock solutions of formic acid, lactic acid, acetic acid, succinic acid, propionic acid and butyric
acid were prepared at 1M concentration and diluted to 200 mM, 100 mM, 50 mM and 25 mM,
for the creation of calibration curves for concentration determination of the organic acids
produced by B. longum ITT 13. For preparation of the B. longum ITT 13 fermentate samples,
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5 ml of the fermentates were centrifuged at 1210 x g for 5 minutes before the cell free
fermentate (CFF) was then filtered through a Whatman syringe filter with pore size 0.45 µm to
remove any remaining cellular debris. The relative centrifugal force used was different to how
the cell-free fermentate was generated for previous testing as the HPLC analysis was carried
out independently by an undergraduate student who designed their own method. The cell-free
fermentate was diluted 1:20 with deionised water before a further 1:1 mixture was generated
of the diluted CFF with the 40 mM internal standard solution – producing a B. longum ITT 13
CFF mixture of a 1:40 dilution. The presence of organic acids in the B. longum ITT 13
fermentate samples were identified based on comparison of the peaks to the retention times of
standards and the concentration of the organic acids present determined using the calibration
curves of the associated standards. The analysis was carried out in duplicate on two individual
days.

2.9.7 Thermostability Studies of the Antimicrobial Activity Produced by B. longum ITT
13
The stability of the antimicrobial activity produced by B. longum ITT 13 was assessed from 20oC to 70oC to determine the effect of heat and storage at various temperatures on the stability
of the antimicrobial activity displayed by the organism. The B. longum ITT 13 fermentate was
grown in MRSc broth in a 2-litre fermentation vessel pH controlled at pH 5 for 16-18 hours.
The fermentation vessel was pH controlled at pH 5 using NaOH to minimise the interference
of organic acid production by B. longum ITT 13. The use of a fermentation vessel produced
higher biomass, with 1011 CFU/ml of B. longum ITT 13 compared to 109 CFU/ml when grown
at laboratory scale in 100-200 ml volumes without pH control.
Cells were removed from the B. longum ITT 13 fermentate as described in Section 2.4.3 and
the CFF was aliquoted into sterile eppendorfs in 2 ml volumes. Replicates of 24 eppendorfs
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were incubated at separate temperatures of -20oC, 4oC, room temperature (20-24oC), 37oC,
55oC and 70oC. These aliquots were then stored over a 28-day period and two replicate
eppendorfs removed at 1 day, 2 days, 7 days, 14 days, 21 days and 28 days incubation. The B.
longum ITT 13 CFS was screened for activity by removing 100 µl volumes from the incubated
samples and tested using the MIC procedure in microtitre plates (Section 2.8.4). Dilutions of
1/2 to 1/128 of the B. longum ITT 13 CFS were performed with S. xylosus as the indicator
strain in the assay. Arbitrary units per ml (AU/ml) were calculated as described in Section 2.8.2
using the highest dilution of the CFS displaying at least 50% inhibitory activity against the
indicator strain: (AU/ml =

𝑖𝑛𝑣𝑒𝑟𝑠𝑒 𝑜𝑓 ℎ𝑖𝑔ℎ𝑒𝑠𝑡 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑤𝑖𝑡ℎ ≥50% 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛
𝑣𝑜𝑙𝑢𝑚𝑒 𝑎𝑝𝑝𝑙𝑖𝑒𝑑 𝑡𝑜 𝑤𝑒𝑙𝑙

𝑥 1000).

A minimum of three independent assays (n=3) with two replicates per assay were carried out
for every temperature and timepoint. Antimicrobial activity was evaluated in relation to the
control of the B. longum ITT 13 fermentate as measured prior to incubation at any of the
temperatures, with an average value of 124.4 AU/ml ± 42.1. If a result was a similar or higher
value than the control it was regarded as unaffected by the temperature, however if it was
reduced below the control value consecutively, it was indicative that a possible reduction in
activity may have taken place after incubation at that temperature.
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2.10 Concentration of Antimicrobial Activity
2.10.1 Small-scale Tangential Flow Filtration (TFF) and Concentration
Small-scale TFF concentration was carried out as described by Grzenia et al (2008) using a
Pellicon® XL 50 Cassette and LabscaleTM TFF System (Millipore).

2.10.1.1 Small-scale TFF with 10 kDa Filter
A volume of 500 mls of ITT 13 CFF was produced by two sequential centrifugation steps at
2722 x g for 5 minutes. After centrifugation a total volume of 450 mls was added to the TFF
Resevoir and was concentrated to 50 mls using a 10 kDa filter by recirculation of the retentate
back into the feed vessel until 400 mls permeate was collected and 50 mls retentate remained
after approximately 2 hours at room temperature (22-25oC). The retentate and the permeate
were assayed for antimicrobial activity using the microdiffusion assay with S. xylosus as the
indicator strain.

2.10.1.2 Small-scale TFF with 3 kDa Filter
2.10.1.2.1 TFF with 3 kDa Filter Run 1
B. longum ITT 13 was grown anaerobically in a 2-litre fermenter in MRSc broth for 17 hours
and a 1 litre sample of the culture taken. The culture was heat shocked at 60oC for 20 minutes
to produce a fermentate and 200 ml of the upper layer of the 1 litre fermentate with was
aspirated as visually there was less cell density present. The cells were centrifuged twice at
2722 x g for 5 minutes and the cell free fermentate was added to a 0.22 μm 200 ml stericup
filtration unit to remove any remaining cells.
The above cell free supernatant (140 mls) was stored at 4oC overnight and 125 ml was used for
a TFF concentration step using a 3 kDa filter. A five-fold concentration was carried out of the
cell free Fermentate reducing the volume from 125 mls to 25 mls. The permeate (filtrate) was
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collected in a sterile duran (Permeate 1) and a 1.5 ml sample of the retentate was kept (Retentate
1). Buffer exchange was carried out to reduce organic acids present in the fermentate and to
minimise any antimicrobial activity associated with acid or pH. Three buffer exchanges were
carried out, each of which involved bringing the 25ml retentate volume to 125 mls and
concentrating back down to 25 mls using sterile 50 mM, pH 4.9 Sodium Acetate buffer.
Permeate and Retentate samples were kept from each run at 4oC until tested. After three buffer
exchanges the final retentate (Retentate 4) with a 25 ml volume was retained for testing.
Antimicrobial activity was screened for each permeate and retentate fraction against S. xylosus
using the microdiffusion assay as described in section 2.6. Test samples were filtered through
a 0.45 µm filter before addition to plates, with the exception of the fermentate containing cells.

2.10.1.2.2 TFF with 3 kDa Filter Run 2
TFF concentration was again carried out using a 3 kDa filter. The B. longum ITT 13 was grown
anaerobically in 200 mls MRSc broth for 19-20 hours at 37oC. The culture was heat shocked
at 60oC for 15 minutes to produce a Fermentate and the cells were removed from 150 mls of
fermentate using centrifugation at 2722 x g for 5 minutes. The supernatant was then filtered
using a 0.22 μm stericup filtration unit to remove any remaining cellular debris. The cell free
supernatant (125 mls) was then used for the TFF concentration step using a 3 kDa filter. A fivefold concentration step was carried out on the cell free fermentate reducing the volume from
125 mls to 25 mls over. The permeate was collected in a sterile duran (Permeate 1) and
approximately 1.5 ml of the retentate was kept (Retentate 1). Two buffer exchanges were
carried out, each of which involved bringing the 25ml retentate volume back to 125 mls and
concentrating back down to a 25 ml volume using 0.02M HCl. The latter solvent was selected
as this is the solvent used for nisin preparation (section 2.5) and shows no antimicrobial effect
at a pH of 1.8 on M/D assay plates. Permeate and retentate samples were kept after each
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exchange at 4oC until testing. A volume of 25 mls of the retentate (Retentate 3) was collected
after the two buffer exchanges.
Antimicrobial activity was screened for each permeate and retentate fraction against S. xylosus
using the microdiffusion assay as described in Section 2.6 and samples were filtered through a
0.45 µm filter before addition to plates, with the exception of the fermentate containing cells.

2.10.1.2.3 TFF with 3 kDa Filter Run 3
The third TFF concentration was carried out using a 3 kDa filter with a bigger volume of
fermentate (950 mls), with the aim to generate a more concentrated sample in order to evaluate
the lack of detectable antimicrobial activity from the methods described in sections 2.9.5.1 and
2.9.5.2. B. longum ITT 13 was grown overnight in 100 mls of MRSc broth and 1% of the fresh
overnight culture was used to inoculate two 500 ml bottles of MRSc broth which were grown
anaerobically at 37oC for a further 20 hours. The 500 ml fermentations were heat shocked at
60oC for 20 minutes due to the larger volume and centrifuged twice at 2722 x g for 5 minutes,
before addition to 0.45 µm stericup to remove any remaining cells. A 15 ml volume of the
fermentate with cells and the cell free fermentate before addition to the TFF were kept for
testing in M/D assay. The cell free fermentate (approximately 950 mls) was added to the TFF
and concentrated to 50 mls (a 19-fold concentration). Using the TFF apparatus the
concentration step took 6 days at room temperature to concentrate the sample.
Two buffer exchanges were carried out on 25 mls of the retentate, by bringing the volume up
to 125 mls and concentrating back down to 25 mls using 50 mM, pH 4.8 NaAc buffer. Permeate
and Retentate samples were kept after each exchange at 4oC until tested. After the two buffer
exchanges 25 mls of the final retentate (Retentate 3) was kept at 4oC until tested. Antimicrobial
activity was screened for each permeate and retentate fraction against S. xylosus using the
microdiffusion assay as described in Section 2.6. Samples were filtered through a 0.45 µm filter
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before addition to plates, with the exception of the fermentate containing cells.
The various parameters and conditions of each TFF run are displayed in Table 2.4.

Table 2.4: Details of Conditions and Parameters of all small-scale Tangential Flow Filtration (TFF)
and large-scale TFF (Crossflow) Concentration Runs of the B. longum ITT 13 Fermentate
Initial
TFF

Vol.

Centrifugation
pH

Media

xg

Run No.

Time
(mins)

Steri
cup
(Filter
size)

Buffer Exchange(s)

Vol. of
Ret.

No.

Final

of

pH

Solvent

After
Conc.

excha
nges

1 (10

450 mls

4.26

MRSc

2722

5

Not

kDa)
2 (3 kDa)

-

-

-

50 mls

3

-

NaAc pH

25 mls

used
125 mls

4.19

MRSc

2722

5

0.22
µm

3 (3 kDa)

125 mls

4.25

MRSc

2722

5

0.22

4.9
2

2.27

µm
4 (3 kDa)

950 mls

4.20

MRSc

2722

5

0.45
µm

0.02N HCl

25 mls

pH 1.8
2

4.67

NaAc pH

50 mls

4.8

Vol. of Ret. after Conc. denotes the final retentate volume after concentration of the fermentate

Table 2.4 displays all the variables and various steps taken for the preparation and
concentration of B. longum ITT 13 fermentate using small-scale TFF concentration. The
initial fermentate volumes used for concentration, their starting pH and the media they were
grown in are compared, as are the centrifugation steps and the use of stericups to produce cell
free fermentate before application to the TFF equipment. After concentration of the
fermentate and buffer exchange the number of buffer exchanges carried out, the solvent used
for buffer exchange and the final pH after buffer exchange were compared. The final volume
the fermentate was concentrated to was also noted. This information allows for direct
comparison of all small-scale TFF assays.
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2.10.2 Large-scale TFF (Crossflow) Filtration and Concentration
2.10.2.1 Crossflow Concentration with MRSc Broth
In order to overcome the issues in relation to the length of the run times on the labscale TFF
system the larger-scale tangential flow filtration Sartoflow Alpha Benchtop Crossflow System
(Sartorius AG, Germany) was used for the production of CFF of ITT 13 and concentration of
fermentate. B. longum ITT 13 was grown in 100 mls MRSc broth and incubated overnight at
37oC under anaerobic conditions. A 1% inoculum of the fresh fermentate was added to three 1
litre bottles of MRSc broth which were incubated anaerobically, without stirring at 37oC for 19
hours. An aliquot of 15 mls was kept from each of the 3 litres of fermentate and combined for
testing as the 3 litres of fermentate was combined when added to the crossflow system. Cells
were removed from the combined 2.95 L using a 0.22 µm filter on the crossflow system. A
total of 2.62 litres of cell free fermentate was collected and then concentrated to 330 mls
(Retentate 1) with a 1 kDa filter and 2.19 L of permeate 1 was collected. The retentate (310
mls) was added back into the crossflow system. Samples of the retentate 1 and permeate 1
were kept at 4oC until tested. A volume of 3 litres of 50 mM pH 4.7 NaAc buffer was gradually
added to Retentate 1 until 3015 mls (3.02 L) of Permeate 2 had been collected. Only 150 mls
of retentate 2 was collected due to losses in the crossflow system. Samples were filtered through
a 0.45 µm filter before testing to ensure no contamination was present from the crossflow
system, with the exception of the fermentate containing cells. Antimicrobial activity was
screened for each permeate and retentate fraction against S. xylosus using the microdiffusion
assay as described in Section 2.6 and the MIC50 assay (Section 2.8.4) however there was no pH
adjustment of the fermentate as described in 2.8.4.
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2.10.2.2 Crossflow Concentration with Modified YPD Broth
B. longum ITT 13 was grown in 100 mls of a modified YPD (mYPD) broth (Meat Peptone
17.5g/L, Soybean peptone 17.5g/L, Glucose 40g/L, Yeast Extract 30g/L, L-Cysteine 0.05%, C. Whelan Personal Communication, 2019) and incubated overnight under anaerobic
conditions for 18 hours. A 1% inoculum of the fresh fermentate was added to three 1 litre
bottles of mYPD broth and incubated anaerobically without agitation at 37oC for 19 hours. The
3 litres of fermentate were combined and 40 mls was retained for testing. Cells were removed
from 2.96 L of the fermentation using a 0.22 µm filter on the crossflow system, with 2.65 litres
of cell free fermentate collected and a sample kept at 4oC until testing. The cell free fermentate
(2.55 L) was added back into the crossflow system and initially concentrated to 350 mls
(Retentate 1) with a 1 kDa filter, with 2.20 L of Permeate 1 collected. Samples of the Retentate
1 and Permeate 1 were kept at 4oC until testing. Retentate 1 (310 mls) underwent a buffer
exchange with 3 litres of 50 mM pH 4.7 Sodium Acetate buffer. The buffer was gradually
added to the vessel until approximately 3 litres of permeate was collected (Permeate 2) and 290
mls of Retentate 2 remained. Samples were filtered through a 0.45 µm filter before testing,
with the exception of the fermentate containing cells. Antimicrobial activity was screened for
each permeate and retentate fraction against S. xylosus by the microdiffusion assay as described
in Section 2.6 and the MIC50 assay as in Section 2.8.4 but without pH adjustment of the
fermentate. Protein concentration of all samples was determined using the BCA assay (Section
2.9.7).
The various parameters and conditions of each Crossflow run are presented in Table 2.5.
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Table 2.5: Details of Conditions and Parameters of all small-scale Tangential Flow Filtration (TFF)
and large-scale TFF (Crossflow) Concentration Runs of the B. longum ITT 13 Fermentate
Initial
TFF

Vol.

Centrifugation
pH

Media

xg

Run No.

Time
(mins)

Steri
cup
(Filter
size)

Buffer Exchange(s)

Vol. of
Ret.

No.

Final

of

pH

Solvent

After
Conc.

excha
nges

5 (Cross

2.62 L

4.21

MRSc

N/A

N/A

N/A

1

4.46

flow

NaAc pH

330

4.7

mls

NaAc pH

350

4.7

mls

1kDa)
6 (Cross

2.55 L

4.60

mYPD

N/A

N/A

flow

N/A

1

4.67

1kDa)

Vol. of Ret. after Conc. denotes the final retentate volume after concentration of the fermentate

Table 2.5 displays the details of the preparation and concentration of the B. longum ITT 13
fermentate for large-scale TFF, also known as Crossflow, concentration. The volumes of
fermentate used for concentration, their starting pH and the media they were grown in are
compared. The cell-free fermentate generated on the crossflow system therefore no
centrifugation or stericup steps were required. The number of buffer exchanges carried out and
the solvent used for the exchange were compared, as well as the final pH of the retentate after
buffer exchange and the final volume. This allows for comparison of both crossflow runs.
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2.11 Bicinchoninic Acid (BCA) Assay
The BCA assay (Pierce™ BCA Protein Assay Kit, Thermo Scientific™) was performed on
fermentate from various assays and permeate and retentate samples from the TFF and crossflow
runs in order to quantify the protein concentration. The BCA reaction involves the reduction
of Cu2+ to Cu1+ by protein, which produces a purple colour (A562 nm) which is proportional
to the concentration of protein in the sample (ThermoFisher Scientific, 2019). Bovine serum
albumin standards of 25, 125, 250, 500, 750, 1000, 1500 and 2000 µg/ml were prepared in
sterile H2O and 25 µl volumes added to microtitre plates. Samples (25 µl) of the fermentate,
permeate, retentate and broth samples were also added to the microtitre plates. The working
reagent was added in 200 µl volumes to each well containing the standard or test sample, the
plate was then mixed on a plate mixer for 30 seconds before incubation at 37oc for 30 minutes.
The A562 nm was read using a plate reader and a calibration curve was constructed for the
concentration of the BSA standards versus the A562 nm. The equation of the line was used to
determine the concentration of the unknown samples.

2.12 Statistical Analysis
Standard deviation was calculated for all replicates using either GraphPad Prism 8 software or
where GraphPad Prism 8 could not be used an online standard deviation calculator was used,
which is available at: https://www.mathsisfun.com/data/standard-deviation-calculator.html.
All statistical analysis including P-value determination was carried out using GraphPad Prism
8 software.
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CHAPTER 3
Spectrum of Antibacterial and Antifungal Activity of the
Bifidobacterium longum ITT 13 Fermentate
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Bifidobacteria are a genus of bacteria that have been isolated from breast-fed neonates with
links to a healthier digestive system (Cooke et al., 2005; Yamada et al., 2017). Bifidobacteria,
along with Lactobacilli, are primarily employed as probiotic organisms and are also introduced
as starter cultures in food due to their probiotic use and health benefits on the gastrointestinal
system of the host (FAO/WHO, 2006). Bifidobacteria display probiotic properties including
resistance to the acidic conditions of the gastrointestinal system and resistance to bile salts,
modulation of the immune system, prevention of diarrhoea and the production of bioactive
metabolites such as organic acids and bacteriocins that display an antimicrobial effect to
prevent pathogen colonisation of the gut (Makras and De Vuyst, 2006; Lee and O’sullivan,
2010; Chenoll et al., 2016; Vlasova et al., 2016; Llamas-Arriba et al., 2019; Ruiz-Aceituno et
al., 2020).
The antimicrobial activity and mechanisms of action associated with both organic acid
production and bacteriocin production by bacteria including Bifidobacteria have been explored
in detail in Sections 1.3 and 1.4. The production of these antimicrobial metabolites are an
important characteristic of probiotic strains to protect the host from pathogenic colonisation
(Vlasova et al., 2016), with potential applications for treatment in regulation of the gut
microbiome and antibiotic associated diarrhoea (Selinger et al., 2013; Hayes and Vargas, 2016;
Litao et al., 2018). These bacteria and their metabolites also have potential application in the
food industry for use in biopreservation to increase the shelf-life of food products, as starter
cultures in fermented food and in food safety applications including use as biocontrol agents
to prevent contamination by pathogens during food production (Butel, 2014; Hossain et al.,
2017; Sireswar et al., 2017; Singh, 2018; Skariyachan and Govindarajan, 2019; Thery et al.,
2020).
A suspected Bifidobacteria strain, designated ITT 13, was isolated from the gastrointestinal
systems of neonates in previous research carried out within our laboratory (Cooke et al., 2005).
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Preliminary research work carried out within previous research projects has indicated that
strain ITT 13 was most likely thought to be a Bifidobacteria strain, specifically B. longum. This
strain displayed significant antimicrobial activity in preliminary research work and was thus
analysed for further identification and assessment within the research carried out in this project.
To further explore the spectrum of activity a combination of screening methods were used
including the microdiffusion assay and MIC50 assay, as carried out by Wayah and Philip (2018),
with both proving effective for determination. This research was also carried out to determine
the nature of the antimicrobial activity produced by ITT 13 and assess its suitability for
potential use as a probiotic or biopreservative by screening against food spoilage related and
industrially relevant bacterial and fungal strains.

Results:
3.1 Characterisation of Strain ITT 13
3.1.1 Characterisation and Colony Morphology of B. longum ITT 13
The cryopreserved stock of strain ITT 13, which had been stored at -80oC, was grown on MRS
agar supplemented with 0.05% L-cysteine (MRSc) and subcultured twice on MRSc agar to
ensure purity of colonies. The colony morphology was that of white, round colonies
approximately 1-2 mm in diameter (Figure 3.1). Gram staining of the colonies revealed they
were Gram positive rods (Figure 3.2), with distinctive bifid ‘v/y’ formation of rods observed
(circled in Figure 3.2), that is commonly observed in Bifidobacteria spp (Dhanashree et al.,
2017). The strain grew well under strict anaerobic conditions, at 37oC in MRSc broth with no
pH control for 20 hours – producing approximately 109 CFU/ml and a pH of pH 4.2-4.3.
CFU/ml were calculated by serially diluting and plating the fermentate before heat inactivation
onto MRSc agar and growing overnight before counting colonies to determine CFU/ml
(calculation not presented).
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Figure 3.1: Colonies of Strain ITT 13 on MRS agar with 0.05% L-Cysteine. Figure 3.1 displays the
colony morphology of the ITT 13 strain on MRSc agar after 3 subcultures from frozen cryovials stored at -80oC.
Colonies observed were white, raised and round with an approximate diameter of 1-2 mm.

Figure 3.2: Gram Stain of Strain ITT 13 Displaying Purple Rods. The distinctive bifid formation of the
ITT 13 rods that are characteristic of Bifidobacteria are circled in Figure 3.2 at 1000x magnification after Gram
staining.
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3.1.2 Phenotypic Characterisation of B. longum ITT 13 using the Biolog System
Biolog identification, as described in Section 2.7, was used to confirm the identity of strain ITT
13. The strain was confirmed to be a Bifidobacterium longum, with 0.995 probability as Biolog
speciation information presented in Figure 3.3.

Figure 3.3: Biolog Identification of Strain ITT 13 as Bifidobacterium longum with 0.955 probability.
Biolog identification was carried out as described in Section 2.7.
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3.2 Antibacterial Activity of B. longum ITT 13
The spectrum of antibacterial activity produced by B. longum ITT 13 fermentate was
determined by exposing a select number of test strains to the heat inactivated fermentate as
described in Section 2.4.2 using the microdiffusion assay (Sections 2.6 and 2.8.2). The results
are presented in Section 3.2.1. The precise dosage required to cause an antibacterial effect was
then more accurately determined for selected strains that were shown to be inhibited by the B.
longum ITT 13 fermentate by using the MIC50 assay (Section 2.8.4). The MIC50 results
generated are presented in Section 3.2.2.
3.2.1 Antibacterial Spectrum of Activity Using Microdiffusion Plate Assay
The microdiffusion (M/D) plate assay is a commonly used method for the screening of
antimicrobial activity produced by microbial sources (Miao et al., 2014; Balouiri, Sadiki and
Ibnsouda, 2016; Mohammadi et al., 2018) and was selected for the initial screening of the B.
longum ITT 13 heat inactivated fermentate. B. longum ITT 13 fermentate was serially diluted
down to 1/16 with MRSc broth and screened for antibacterial activity against 15 bacterial
strains. Nisin was used as a positive control from an undiluted form (neat) to a 1/16 dilution
and MRSc broth was used as a negative control in the M/D assay. Results were interpreted as
the presence/absence of a zone of inhibition at each dilution of fermentate, determining
antibacterial activity against that strain and the diameter of any resulting zone to compare
effectiveness of the antimicrobial activity. Comparative results for the antibacterial activity of
the fermentate against each of the indicator strains in terms of average AU/ml are presented in
Figure 3.4. AU/ml is calculated as described Section 2.8.2. The quantitative analysis of the
M/D plates i.e. diameter of zone of inhibition (mm), against susceptible strains is presented in
Table 3.1 (Gram positive strains) and Table 3.2 (Gram negative strains). Figures 3.5 and 3.6
display M/D plates of a Gram-positive and Gram-negative strain with zones of inhibition due
to the B. longum ITT 13 fermentate.
78

AU/ml

30
28
26
24
22
20
18
16
14
12
10
8
6
4
2
0

s
0
2
6
3
8
1
8
9
1
4
4
0
1
1
87 17 08 34 92 22 97 04 92 A0 84 62 II.2 25 ricu
10 C 1 C 7 C 9 25 12 29 13 25 a P 11 29 5 I B 3 lga
B C 76 I M u
C C C C
C C C C C os
TC AT AT AT TC TC TC TC TC gin CIM TC 17 NC p. b
A
A
A
A
A
A
s
s
a
u
i
N m A C ei bs
l
li
s
s is
r
s
s tili
ili
eu ub eca oph reu mid losu ene a co ae nes ria ATC cas i su
r
ce s s s fa hiz au er xy rog chi nas ge imu ia ara icki
c
o
s
s id
i
u
r
o
li lu cill ccu ria ccu ep cus ae her om py typh epa p. p lbru
c
a co u o
c lla sc d us a
e
s
s
c
a
o
B
c cu c
B
ie E eu cc ell no sub s d
o oc
s co n ce i
er K hylo oc ylo ebs
u
l
t
l
P
o
i
c
e c
h l
o
En
ap lo p K
pt lm ria as a
St phy Sta
re Sa lde rac tob
t
a
S
ho a ac
St
rk us p L
u
B cill
ba
to
c
La

Strain

Figure 3.4: The AU/ml of the B. longum ITT 13 fermentate against a number of indicator Grampositive and Gram-negative bacterial strains. The AU/ml was determined as described in Section 2.8.2, the
absence of AU/ml indicates the lack of antimicrobial activity detected against that indicator strain.

In Figure 3.4, the antimicrobial activity of the B. longum ITT 13 fermentate against the
screened bacterial strains was graphed in AU/ml (Section 2.8.2). Of the 15 strains screened
for antibacterial susceptibility to the fermentate, only six strains did not display growth
inhibition when exposed to the fermentate: Bacillus cereus ATCC 10876, Staphylococcus
aureus ATCC 25923, Staphylococcus epidermidis ATCC 12228, Streptococcus pyogenes
NCIMB 11841, Lactobacillus paracasei subsp. paracasei NCIMB 3254 and Lactobacillus
delbruickii subsp. bulgaricus NCIMB 11778. Bacillus subtilis ATCC 1174 and Enterococcus
faecalis ATCC 7080 both displayed the highest levels of susceptibility to the fermentate,
giving values of 16.7 AU/ml and 20.4 AU/ml respectively. The fermentate generated zones of
inhibition on the M/D assay plates giving an average of 10.2-11.1 AU/ml against Kocuria
rhizophilia ATCC 9341, Staphylococcus xylosus ATCC 29971, Klebsiella aerogenes ATCC
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13048, Escherichia coli ATCC 25922, Pseudomonas aeruginosa PA01, Salmonella
typhimurium ATCC 29629 and Burkholderia cenocepacia ATCC 17765 III.20.

80

Table 3.1: Antibacterial Activity of B. longum ITT 13 Fermentate against selected Gram-Positive
Strains
Sample:

B. subtilis

E. faecalis

K. rhizophilia

S. xylosus

Avg. Zone Size
(mm) ± SD)

Avg. Zone Size
(mm) ± SD

Avg. Zone Size
(mm) ± SD

Avg. Zone Size
(mm) ± SD

Fermentate Undiluted

3.1 ± 0.6

3.6 ± 0.3

3.3 ± 0.2

4.2 ± 0.2

Fermentate 1/2

1.3 ± 0.4

3.2 ± 0.4

1.7 ± 0.4

2.4 ± 0.2

Fermentate 1/4

0.3 ± 0.4

2.3 ± 0.4

0±0

0±0

Fermentate 1/8

0±0

0±0

0±0

0±0

AU/ml of Fermentate

17 ± 6

20 ± 4

11 ± 0

11 ± 0

Nisin Undiluted (1000
IU/ml)
Nisin 1/2 (500 IU/ml)

2.8 ± 0.2

2.4 ± 0.2

3.5 ± 0.4

4.4 ± 0.2

1.8 ± 0.3

1.9 ± 0.2

2.6 ± 0.5

3.8 ± 0.1

Nisin 1/4 (250 IU/ml)

1.0 ± 0

1.3 ± 0.3

1.8 ± 0.3

3.4 ± 0.1

Nisin 1/8 (125 IU/ml)

0.7 ± 0.2

0.8 ± 0.2

1.3 ± 0.3

3.0 ± 0.0

Nisin 1/16 (62.5 IU/ml)

<0.5 ± 0

0.5 ± 0

0.8 ± 0.2

2.5 ± 0.1

0±0

0±0

0±0

0±0

MRSc Broth

Nisin displayed inhibition against the gram-positive strains, while, as expected, no activity was
shown for nisin against the gram-negative strains. Both B. subtilis and E. faecalis displayed the
highest levels of susceptibility to a 1/4 fermentate dilution (average of 16.7 AU/ml and 20.4
AU/ml respectively according to Figure 3.4), with the other strains displaying susceptibility to
a 1/2 dilution (10.2-11.1 AU/ml). The largest zones of inhibition for the B. longum ITT 13
fermentate were observed against S. xylosus at 4.2 mm for the undiluted fermentate and 2.4
mm for the 1/2 dilution. The smallest zones of inhibition were observed against B. subtilis at
3.1 mm for the undiluted fermentate, 1.3 mm for the 1/2 dilution and 0.3 mm for the 1/4
dilution.
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Table 3.2: Antibacterial Activity of B. longum ITT 13 Fermentate against selected Gram-Negative
Strains
Sample:

K. aerogenes

E. coli

P. aeruginosa

S. typhimurium

B. cenocepacia

Avg. Zone Size
(mm) ± SD

Avg. Zone Size
(mm) ± SD

Avg. Zone Size
(mm) ± SD

Avg. Zone Size
(mm) ± SD

Avg. Zone Size
(mm) ± SD

Fermentate
Undiluted
Fermentate 1/2

2.3 ± 0.5

3.6 ± 0.3

3.4 ± 0.3

2.7 ± 0.5

4.1 ± 0.3

1.3 ± 0.4

2.5 ± 0.4

1.5 ± 0.8

1.3 ± 0.4

2.1 ± 0.2

Fermentate 1/4

0±0

0±0

0±0

0±0

0±0

Fermentate 1/8

0±0

0±0

0±0

0±0

0±0

AU/ml of
Fermentate
Nisin Undiluted
(1000 IU/ml)
Nisin 1/2 (500
IU/ml)
Nisin 1/4 (250
IU/ml)
Nisin 1/8 (125
IU/ml)
MRSc Broth

11 ± 0

11 ± 0

10 ± 2

11 ± 0

11 ± 0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

0±0

As gram-negative strains are resistant to nisin (Matsusaki, Sonomoto and Ishizaki, 1998)
inhibition of the selected strains by nisin was not expected nor experimentally determined. The
MRSc broth used as the negative control also displayed no inhibition of the gram-negative
strains selected for testing. Antimicrobial activity by the fermentate was detected up to a 1/2
dilution against all the gram-negative strains tested, with an average of 10-11 AU/ml
determined. The largest zones of inhibition were observed against B. cenocepacia with zones
of approximately 4 mm detected on the M/D plates for the undiluted fermentate and 2 mm for
the 1/2 dilution, thus correlating with 11 AU/ml. B. cenocepacia is an opportunistic pathogen
that can pose a significant risk for cystic fibrosis patients and is known to be naturally resistant
to a variety of antibiotic classes, thus making it a potentially dangerous pathogen (Scoffone et
al., 2017). The ability of B. longum ITT 13 to inhibit this strain with the largest zones of
inhibition is notable. The smallest zones of inhibition were observed against Klebsiella
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aerogenes at 2.3 mm for the undiluted fermentate and 1.3 mm for the 1/2 dilution, which was
also equivalent to 11 AU/ml of activity as the activity was detected up to a 1/2 dilution.
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Figure 3.5: Antibacterial Activity of the B. longum ITT 13 Fermentate against Gram-Positive K.
rhizophilia ATCC 9341. Nisin (62.5 (1/16) - 1000 (neat) IU/ml) was used as a positive control in the assay.
The indicator strain was grown in TSA.

Figure 3.6: Antibacterial Activity of the B. longum ITT 13 Fermentate against Gram-Negative E. coli
ATCC 25922. Nisin (62.5 - 1000 IU/ml) was used as a control in the assay with a lack of activity against the
Gram-negative strain taken as validation of the assay. The opaque ring observed around the negative control and
1/4-1/16 fermentate dilutions are a result of denser growth of the E. coli ATCC 25922 around the well where
additional nutrients have been provided by the MRSc broth as it diffuses into the agar. The indicator strain was
grown in TSA.
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3.2.2 MIC50 Testing of the B. longum ITT 13 Fermentate
The use of more than a single screening procedure was important to determine the antimicrobial
activity of B. longum ITT 13, due to varying sensitivity of the assays. The microdiffusion assay
had been carried out primarily for qualitative screening and select strains were then chosen for
the MIC50 assay in microtitre plates. The MIC assay has been shown to be more sensitive,
which is likely due to the removal of the agar interface, allowing the microbial cells to come
into direct contact with the fermentate in a liquid medium, as observed by Inturri et al., (2019)
as when testing the cell free supernatants of various B. longum and L. rhamnosus strains, higher
levels of antimicrobial activity were detected on average using the MIC microtitre plate
procedure in comparison to the microdiffusion (well-diffusion) method.
Due to time constraints, all indicator strains could not be tested using the MIC50 method,
therefore three gram-positive and three gram-negative strains were selected for the MIC50
assay. This was carried out using the method described in Section 2.8.4, with the fermentate
pH adjusted from pH 4.2 to pH 4.5 to minimise any contribution of the acid produced by the
B. longum ITT 13 strain to the antimicrobial activity. The selected indicator strains used were
B. subtilis ATCC 1174, E. faecalis ATCC 7080, S. xylosus ATCC 29971, E. coli ATCC 25922,
P. aeruginosa PA01 and S. typhimurium ATCC 29629. Results are presented in Figures 3.73.12 and AU/ml were calculated (Section 2.8.2) based on the highest dilution displaying at
least 50% inhibition in comparison to the control, as calculated by Lim (2016).
For assessment of the antibacterial activity of the fermentate at pH 4.5 it was compared to the
growth control of MRSc broth which should cause no inhibition of the tested strains.
A separate sample of MRSc broth was also adjusted to pH 4.5 to assess the antibacterial activity
of this pH and it was compared to a separate growth control of MRSc broth (10 ml volume)
diluted with 8-8.5 mls of sterile H2O. The reason for the dilution of this MRSc broth with 88.5 mls of sterile H2O was due to the fact the pH 4.5 MRSc broth was adjusted with 8-8.5 mls
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of 0.1M lactic acid and the dilution of nutrients in the fermentate meant a growth/negative
control of MRSc broth with diluted nutrients was also required. This allowed the inhibition of
the fermentate at pH 4.5 and of the MRSc broth at pH 4.5 to be directly comparable.
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Figure 3.7: The growth (OD600) of B. subtilis ATCC 1174 and MIC50 determination of the B. longum
ITT 13 Fermentate (pH 4.5) and MRSc broth (pH 4.5). The MIC50 was determined as the highest dilution
displaying at least 50% inhibition of the indicator strain. Nisin undiluted was 1000 IU/ml while each successive
serial dilution reduced the concentration by half. Standard deviations were determined for a minimum of three
independent assays carried out on separate days (n=3) and statistical analysis was carried out using one-way
ANOVA with Tukey’s multiple comparison assay. The pH 4.5 fermentate was compared to the control of MRSc
broth, while the pH 4.5 MRSc media was compared to the control of diluted MRSc at each dilution to assess for
significant deviations in growth, as explained in Section 2.8.4. **** = p-value ≤0.0001, ns = non-significant pvalue >0.05.

Antimicrobial activity for the pH 4.5 fermentate was detected up to a 1/8 dilution (p<0.0001),
equating 80 AU/ml. Antimicrobial activity was detected for the pH 4.5 MRSc broth up to a 1/4
dilution (p<0.0001), however as the inhibition detected was minimal with an OD600 of 1.08
in comparison to the growth control of 1.33, and as the MIC50 is calculated from the dilution
displaying at least 50% inhibition, the pH 4.5 MRSc broth thus displayed inhibition equivalent
to 20 AU/ml as compared to the 80 AU/ml for the fermentate. Nisin as a positive control
displayed antimicrobial activity also up to a 1/8 dilution which is equivalent to 80 AU/ml.
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Figure 3.8: The growth (OD600) of E. faecalis ATCC 7080 and MIC50 Determination for the B.
longum ITT 13 Fermentate (pH 4.5) and MRSc broth (pH 4.5). The MIC50 was determined as the highest
dilution displaying at least 50% inhibition. Nisin undiluted was 1000 IU/ml while each successive serial dilution
reduced the concentration by half. Standard deviations were determined for a minimum of three independent
assays carried out on separate days (n=3) and statistical analysis was carried out using one-way ANOVA with
Tukey’s multiple comparison assay. The pH 4.5 fermentate was compared to the control of MRSc broth, while
the pH 4.5 MRSc media was compared to the control of diluted MRSc at each dilution to assess for significant
deviations in growth as explained in Section 2.8.4. **** = p-value ≤0.0001, ns = non-significant p-value >0.05.

Antimicrobial activity for the pH 4.5 fermentate was detected up to a 1/8 dilution (p<0.0001)
with an OD600 of 0.20 in comparison to the OD600 of the MRSc broth growth control of 0.99.
This indicates more than 50% inhibition of the E. faecalis at this dilution in comparison to the
100% growth of the strain in the MRSc broth growth control, therefore generating an MIC50 of
a 1/8 dilution equating 80 AU/ml for the fermentate.
MRSc broth was adjusted to pH 4.5 for comparison to the fermentate also at pH 4.5, to
determine whether the antimicrobial activity was associated with the low pH. Antimicrobial
activity was detected for the pH 4.5 MRSc broth up to a 1/4 dilution (p<0.0001), however as
the inhibition was less than 50%, with an OD600 of 0.51 in comparison to the growth control
of 0.93, the 1/2 dilution was the MIC50 with 20 AU/ml. Therefore, the pH 4.5 MRSc broth,
which was equivalent to the pH 4.5 fermentate, had 20 AU/ml in comparison to the higher
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activity of 80 AU/ml generated by the pH 4.5 fermentate. The increased antimicrobial activity
of the pH 4.5 fermentate thus indicates that the fermentate has significantly more antimicrobial
activity and can be interpreted as indicative of more than just a pH effect. Nisin as a positive
control displayed antimicrobial activity also to a 1/4 dilution with 40 AU/ml.
Growth of the E. faecalis ATCC 7080 reduced at higher dilutions of all samples, likely
indicative of reduced growth of the strain in the minimal MH media when nutrients provided
by the samples had been diluted out. The samples had likely provided some nutrients at higher
concentrations as they contained MRSc media which B. longum ITT 13 was grown in and
which was used for controls.
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Figure 3.9: The growth (OD600) of S. xylosus ATCC 29971 and MIC50 determination for the B. longum
ITT 13 Fermentate (pH 4.5) and MRSc broth (pH 4.5). The MIC50 was determined as the highest dilution
displaying at least 50% inhibition. Nisin undiluted was 1000 IU/ml while each successive serial dilution reduced
the concentration by half. Standard deviations were determined for a minimum of three independent assays carried
out on separate days (n=3) and statistical analysis was carried out using one-way ANOVA with Tukey’s multiple
comparison assay. The pH 4.5 fermentate was compared to the control of MRSc broth, while the pH 4.5 MRSc
media was compared to the control of diluted MRSc at each dilution to assess for significant deviations in growth
as explained in Section 2.8.4. **** = p-value ≤0.0001, *** = p-value ≤0.001, * = p-value ≤0.05, ns = nonsignificant p-value >0.05.

For S. xylosus ATCC 29971, the fermentate adjusted to pH 4.5 caused 100% inhibition to the
1/8 dilution (p<0.0001) and 47% inhibition at the 1/16 (p=0.0151), therefore equating to 80
AU/ml based on at least 50% inhibition. Antimicrobial activity of at least 50% inhibition was
detected for the pH 4.5 MRSc broth up to a 1/16 dilution (p<0.0001), with 160 AU/ml.
Although the pH 4.5 fermentate visually resulted in more inhibition of the S. xylosus than the
pH 4.5 MRSc broth at the 1/16 dilution, the AU/ml was worked out based on the % inhibition
in comparison to the respective growth control. In the case of the pH 4.5 fermentate at the 1/16
dilution, it only resulted in 47% inhibition in comparison to the growth control of MRSc broth,
however the pH 4.5 MRSc broth resulted in 59% inhibition in comparison to its growth control
of diluted MRSc broth. Therefore, it was undetermined as to whether the antimicrobial activity
caused by the fermentate in this case was primarily pH associated as it is evident that the pH
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4.5 MRSc control displayed higher levels of antimicrobial activity against this strain than seen
in the other strains tested. Nisin as a positive control displayed antimicrobial activity to a 1/8
dilution with 80 AU/ml.
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Figure 3.10: The growth (OD600) of E. coli ATCC 25922 and MIC50 determination for the B. longum
ITT 13 Fermentate (pH 4.5) and MRSc broth (pH 4.5). The MIC50 was determined as the highest dilution
displaying at least 50% inhibition. Nisin undiluted was 1000 IU/ml while each successive serial dilution reduced
the concentration by half. Standard deviations were determined for a minimum of three independent assays carried
out on separate days (n=3) and statistical analysis was carried out using one-way ANOVA with Tukey’s multiple
comparison assay. The pH 4.5 fermentate was compared to the control of MRSc broth, while the pH 4.5 MRSc
media was compared to the control of diluted MRSc at each dilution to assess for significant deviations in growth
as explained in Section 2.8.4.**** = p-value ≤0.0001, *** = p-value ≤0.001, * = p-value ≤0.05, ns = nonsignificant p-value >0.05.

Figure 3.10 depicts the inhibition of E. coli ATCC 25922 by the fermentate adjusted to pH 4.5
and the pH 4.5 MRSc broth. Antimicrobial activity for the pH 4.5 fermentate was detected up
to a 1/8 dilution (p=0.006) with an OD600 of 1.03 in comparison to the MRSc broth growth
control of 1.44 at the 1/8 dilution. Although there is a significant difference at the 1/8 dilution,
as the inhibition was less than 50% of the growth control, the MIC50 result is taken from the
1/4 dilution to give a measured antimicrobial activity of 40 AU/ml. Antimicrobial activity was
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detected for the pH 4.5 MRSc broth up to a 1/2 dilution with 100% inhibition (p<0.0001),
equating 20 AU/ml in comparison to the pH 4.5 fermentate of 40 AU/ml. The higher
antimicrobial activity associated with the pH 4.5 fermentate (40 AU/ml) in comparison to the
equivalent pH 4.5 MRSc broth (20 AU/ml) indicates that the antimicrobial activity is likely not
associated with the low pH alone. Nisin as a positive control displayed antimicrobial activity
also to a 1/2 dilution to give a measured inhibitory level of 20 AU/ml.

P. aeruginosa PA01
2.0

✱✱✱✱
✱✱✱✱

ns

ns

✱✱✱✱

✱✱✱✱

✱

1.5

✱✱✱✱

✱✱✱✱

ns

MRSc Broth Growth
Control

ns
ns

OD600

Fermentate pH 4.5

MRSc pH 4.5

1.0

Diluted MRSc Broth
Growth Control
Nisin (1000 IU/ml)

0.5
0.0
1/2

1/4

1/8

1/16

1/32

1/64

Dilution

Figure 3.11: The growth (OD600) of P. aeruginosa PA01 and MIC50 determination for the B. longum
ITT 13 Fermentate (pH 4.5) and MRSc broth (pH 4.5). The MIC50 was determined as the highest dilution
displaying at least 50% inhibition. Nisin undiluted was 1000 IU/ml while each successive serial dilution reduced
the concentration by half. Standard deviations were determined for a minimum of three independent assays carried
out on separate days (n=3) and statistical analysis was carried out using one-way ANOVA with Tukey’s multiple
comparison assay. The pH 4.5 fermentate was compared to the control of MRSc broth, while the pH 4.5 MRSc
media was compared to the control of diluted MRSc at each dilution to assess for significant deviations in growth
as explained in Section 2.8.4. **** = p-value ≤0.0001, * = p-value ≤0.05, ns = non-significant p-value >0.05.

Antimicrobial activity (100%) was detected against P. aeruginosa PA01 by the fermentate
adjusted to pH 4.5 (p<0.0001) with an MIC50 of the 1/4 dilution giving an inhibitory level of
40 AU/ml. In comparison, the equivalent pH 4.5 MRSc broth displayed antimicrobial activity
only at a 1/2 dilution (p<0.0001), with an average OD600 of 0.11 at the 1/2 dilution in
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comparison to the diluted MRSc broth growth control of 1.28. This equated to a measured
inhibitory level of 20 AU/ml for the pH 4.5 MRSc broth in comparison to the 40 AU/ml of the
pH 4.5 fermentate, indicating higher levels of antimicrobial activity associated with the pH 4.5
fermentate. This indicates the antimicrobial activity of the fermentate against P. aeruginosa is
likely not associated with pH alone. Nisin as a positive control did not display complete
inhibition at any dilution. Nisin is not considered to be active against gram-negative organisms
and as expected, gave no inhibition of the indicator strain of P. aeruginosa. The MRSc broth
control also resulted in decreasing growth of the indicator strain as the dilutions increased
which is likely due to the diluting out of the additional nutrients provided by the MRSc broth.
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Figure 3.12: The growth (OD600) of S. typhimurium ATCC 29629 and MIC50 determination for the B.
longum ITT 13 Fermentate (pH 4.5) and MRSc broth (pH 4.5). The MIC50 was determined as the highest
dilution displaying at least 50% inhibition. Nisin undiluted was 1000 IU/ml while each successive serial dilution
reduced the concentration by half. Standard deviations were determined for a minimum of three independent
assays carried out on separate days (n=3) and statistical analysis was carried out using one-way ANOVA with
Tukey’s multiple comparison assay. The pH 4.5 fermentate was compared to the control of MRSc broth, while
the pH 4.5 MRSc media was compared to the control of diluted MRSc at each dilution to assess for significant
deviations in growth as explained in Section 2.8.4. **** = p-value ≤0.0001, *** = p-value ≤0.001, * = p-value
≤0.05, ns = non-significant p-value >0.05.
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Antimicrobial activity (100% inhibition) was detected against the gram-negative strain S.
typhimurium ATCC 29629 by the B. longum ITT 13 pH 4.5 fermentate to a 1/8 dilution
(p<0.0001) to give an inhibitory measure of 80 AU/ml. The B. longum ITT 13 pH 4.5
fermentate also displayed inhibitory action to the S. typhimurium strain for the 1/16 dilution,
with the significant p-value of p = 0.0221, but as the inhibition was less than 50% (33%) it was
not used for calculation of the MIC50 and AU/ml.
The pH 4.5 MRSc broth displayed antimicrobial activity to a 1/4 dilution (p<0.0001) with an
average OD600 of 0.07 in comparison to the diluted MRSc broth growth control of 0.68, thus
providing an inhibitory level of 40 AU/ml. In comparison to the pH 4.5 fermentate which gave
an inhibitory measure of 80 AU/ml toward the S. typhimurium, the equivalent pH 4.5 MRSc
broth displayed less antimicrobial activity (40 AU/ml), indicating the antimicrobial activity
associated with the pH 4.5 fermentate is likely not solely associated with the low pH. Nisin as
a positive control displayed antimicrobial activity only at a 1/2 dilution, and as nisin would not
be expected to show any significant inhibition of a gram-negative strain, this inhibition at the
1/2 dilution may be associated with sensitivity of the strain to the 0.02N HCl used for the
preparation of 1000 IU/ml nisin.
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Table 3.3: The MIC50 and AU/ml of the B. longum ITT 13 Fermentate (pH 4.5), the MRSc Broth (pH
4.5) and Nisin (1000 IU/ml) Against Various Bacterial Strains.

Strain:

B. longum ITT 13

MRSc Broth pH

Fermentate pH 4.5

4.5

Nisin (1000 IU/ml)

AU/ml

MIC50

AU/ml

MIC50

AU/ml

MIC50

B. subtilis ATCC 1174

80

1/8

20

1/2

80

1/8

E. faecalis ATCC 7080

80

1/8

20

1/2

40

¼

S. xylosus ATCC 29971

80

1/8

160

1/16

80

1/8

E. coli ATCC 25922

40

1/4

20

1/2

N/A

N/A

P. aeruginosa PA01

40

1/4

20

1/2

N/A

N/A

S. typhimurium ATCC 29629

80

1/8

40

1/4

N/A

N/A

The fermentate displayed an MIC50 of a 1/8 dilution and 80 AU/ml against B. subtilis ATCC
1174, E. faecalis ATCC 7080, S. xylosus ATCC 29971 and S. typhimurium ATCC 29629. For
both E. coli ATCC 25922 and P. aeruginosa PA01 an MIC50 of a 1/4 dilution and 40 AU/ml
were achieved by the fermentate.
The MRSc broth (pH 4.5) displayed the highest antimicrobial activity against S. xylosus ATCC
29971 with 160 AU/ml and S. typhimurium ATCC 29626 with 40 AU/ml in comparison to 20
AU/ml for the remaining strains. With the exception of S. xylosus ATCC 29971, the
antimicrobial activity of the MRSc broth adjusted to pH 4.5 was less than the antimicrobial
activity of the fermentate displayed against each strain, indicating that pH effect is likely not
the only factor responsible for activity.
The results for the positive control of nisin were as expected for the gram-positive strains.
Although the IU/ml of the nisin at each dilution is known, AU/ml were calculated for direct
comparison to the samples. The nisin demonstrated inhibition similar to the B. longum ITT 13
fermentate with 80 AU/ml for both nisin and the fermentate against B. subtilis ATCC 1174 and
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S. xylosus ATCC 29971. In the case of E. faecalis ATCC 7080, the nisin displayed 40 AU/ml
of antimicrobial activity in comparison to the higher 80 AU/ml displayed by the pH 4.5
fermentate, indicative of higher activity by the fermentate against this strain. The nisin showed
no significant inhibition for gram-negative strains as expected (Matsusaki, et al., 1998).
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3.3 Antibacterial Testing with pH Adjusted Fermentate
B. longum ITT 13 is known to produce several organic acids such as lactic, acetic and succinic
acid during growth (Section 4.5). Growth of the B. longum ITT 13 strain under conditions
without pH control usually results in a fermentate that has a final value of approximately pH
of 4.2-4.3. To reduce the possible antimicrobial contribution of these acids, present in the low
pH B. longum ITT 13 fermentate, the fermentate was adjusted to pH 4.7 and screened for
activity against selected strains. A pH of 4.7 was chosen as previous testing had indicated a
loss of detectable activity in the microdiffusion assay above pH 4.8. The fermentate was
therefore adjusted to as close to pH 4.7 as could be achieved – which resulted in a pH of pH
4.68. The MRSc broth for comparison to the pH 4.68 fermentate was adjusted to pH 4.82
instead of pH 4.7 as the addition of more acid caused a large decline in pH past pH 4.7. The
pH adjusted fermentate was tested for antibacterial activity using the microdiffusion assay with
K. rhizophilia, B. subtilis and P. aeruginosa used as the indicator strains. Only these strains
were selected to provide a general overview of the effect of pH adjusting the fermentate on
both Gram-positive and Gram-negative strains, instead of carrying out the assay on all
previously tested strains. Fermentate with no pH adjustment was added to the M/D assay plates
for comparison of activity to the pH adjusted fermentate in order to assess whether increasing
the pH in some way affected the antibacterial activity detected for the fermentate.
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Table 3.4: Antibacterial activity (mm) of the B. longum ITT 13 fermentate and pH adjusted
fermentate against K. rhizophilia, B. subtilis and P. aeruginosa
Sample:

K. rhizophilia

B. subtilis

P. aeruginosa

Average Zone Size (mm) ±

Average Zone Size (mm)

Average Zone Size (mm)

SD

± SD

± SD

3.8 ± 0.3

3.8 ± 0.3

0±0

Nisin 1/2 (500 iu/ml)

3.0 ± 0

2.8 ± 0.3

0±0

Fermentate pH 4.21

3.7 ± 0.3

4.2 ± 0.2

4.0 ± 0

Fermentate pH 4.21 1/2

1.8 ± 0.3

3.0 ± 0.9

2.2 ± 0.3

Fermentate pH 4.68 Undiluted

2.3 ± 0.3

4.2 ± 0.8

2.3 ± 0.3

Fermentate pH 4.68 1/2

0±0

3.0 ± 0.9

0±0

MRSc broth pH 4.82

0±0

1.5** ± 0

0±0

MRSc broth (no pH adjustment)

0±0

0±0

0±0

Lactic Acid 33 mM

0±0

*±0

0±0

NaOH 50 mM

0±0

1.7 ± 0.3

0±0

Nisin Undiluted (1000 iu/ml)

*Hairline zone of inhibition **Faint zone and difficult to accurately determine .

In the M/D assay for K. rhizophilia neither the MRSc broth at the original pH 6.42 or adjusted
to pH 4.82 generated zones of inhibition. No zones of inhibition were detectable for the 33 mM
Lactic acid, which is the final concentration of acid present in the pH adjusted MRSc broth, or
for the 50 mM NaOH, which is the final concentration present in the pH adjusted ITT 13
fermentate. The activity for the nisin against the K. rhizophilia indicator strain was comparable
to the activity of the pH 4.21 ITT 13 fermentate, with zones of 3.8 mm and 3.7 mm respectively.
As the antibacterial activity of the pH 4.68 fermentate was reduced in comparison to the pH
4.21 fermentate, with a zone of 2.3 mm, it was not comparable to the nisin with a zone of 1.5
mm less than the nisin. The zone of inhibition detected for the pH 4.68 fermentate was 2.3 mm
in comparison to a 3.7 mm zone for the pH 4.21 fermentate without pH adjustment. This
indicates the original fermentate with no pH adjustment and a lower pH retained more
antibacterial activity against K. rhizophilia than the fermentate which had its pH raised to pH
4.68, indicating increased activity associated with a lower pH. A 1/2 dilution of the ITT 13
fermentate adjusted to pH 4.68 did not generate a zone of inhibition, while activity remained
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for the original pH unadjusted fermentate (pH 4.21), which gave an average zone size of 1.8
mm.
The microdiffusion results for the B. subtilis strain generated faint zones of roughly 1.5 mm
for the control of pH adjusted MRSc broth (pH 4.82), which was not observed for other strains
and indicates a higher susceptibility of B. subtilis to a lower pH. A hairline zone was detectable
for the 33mM Lactic acid, which is the concentration of acid used to adjust the pH 4.82 MRSc
broth, further indicating its susceptibility to more acidic conditions. Incubation of the B. subtilis
with 50 mM NaOH generated a zone of 1.7 mm, thus indicating the sensitivity of this strain to
both acidic and basic solvents. Neither of the other two tested strains displayed any
susceptibility to the lactic acid or the NaOH.
The activity of the nisin against B. subtilis gave zones on the M/D plates that indicated less
antibacterial activity for the nisin than for the pH unadjusted B. longum ITT 13 fermentate (pH
4.21) with zones of 3.8 mm for undiluted nisin and 4.2 mm respectively for the undiluted
fermentate. The pH 4.68 fermentate also had a larger zone of inhibition than the nisin, with an
average zone of 4.2 mm also observed for the pH 4.68 fermentate, as for the pH 4.21
fermentate, and 3.8 mm for the nisin. The average zone of inhibition size of 4.2 mm was the
same for both the original ITT 13 fermentate (pH 4.21) and for the pH adjusted ITT fermentate
(pH 4.68), indicating increasing the pH did not lower the antibacterial activity observed against
B. subtilis as it did for K. rhizophilia. However, it should be noted that although the zone sizes
were measured as the same for both the pH 4.21 fermentate and the pH 4.68 fermentate, there
was more variation for the pH 4.68 fermentate with an SD of 0.764. The zone for the 1/2
dilution of the pH 4.68 fermentate was also the same average size as the zone for the pH 4.21
fermentate (3.0 mm) with the same standard deviation observed of 0.866 observed for both.
This further indicates that increasing the pH of the ITT 13 fermentate did not decrease the
antibacterial activity detected against B. subtilis as it did for K. rhizophilia.
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For P. aeruginosa no zones were detected for the controls of the MRSc broth at the original
pH of pH 6.42 or for the MRSc broth adjusted to pH 4.82, which is similar to K. rhizophilia.
No zones were present for the 33mM Lactic or for the 50 mM NaOH again similar to K.
rhizophilia which was also not susceptible to these concentrations of solvents, indicating they
have no detectable effect on these two indicator strains. The average zone of inhibition for the
undiluted fermentate at pH 4.21 with no pH adjustment was 4.0 mm and for the fermentate
adjusted to pH 4.68 the average zone of inhibition was 2.3 mm. Activity was lost for the 1/2
dilution of the pH 4.68 fermentate but was present for the pH 4.21 fermentate with a zone of
2.2 mm. The reduced zones of inhibition and antibacterial activity for the fermentate adjusted
to pH 4.68 against the P. aeruginosa are similar to the reduction in zones also observed for the
pH 4.68 fermentate against K. rhizophilia which likely indicates that an increase in the pH of
the B. longum ITT 13 fermentate results in a reduction of antibacterial activity and maximum
activity is achieved at a lower fermentation pH.
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Figure 3.13: Antibacterial activity (mm) of B. longum ITT 13 fermentate at pH 4.21 and adjusted to
pH 4.68 against selected indicator strains. The controls included a positive control of undiluted and a 1/2
dilution of nisin (1000 & 500 IU/ml) and a negative control of MRSc broth adjusted to pH 4.82. Three independent
assays (n=3) were used to determine the standard deviation. Statistical analysis was carried out using a one-way
ANOVA with Tukeys multiple comparison assay. The statistical comparison of the pH 4.68 fermentate to the pH
4.21 fermentate is denoted by the symbols directly above the pH 4.68 fermentate bar. The statistical comparison
of the pH 4.69 fermentate to the pH 4.82 MRSc broth is denoted by the symbols above the line connecting both
bars. **** = p-value <0.0001, ** = p-value of 0.0042 and ns = non-significant p-value >0.05.

In Figure 3.13 the statistical analysis was carried out in order to determine the effect of
adjusting the fermentate to a higher pH value and to ascertain whether the antibacterial activity
was primarily or solely attributable to the pH value of the fermentate. For all three strains, the
undiluted fermentate adjusted to pH 4.68, gave a statistically significant different zone of
inhibition when compared with the MRSc Broth (pH 4.83), with a p-value <0.0001 for both
the K. rhizophilia and P. aeruginosa and a p-value of 0.0042 for B. subtilis. This indicates that
the antibacterial activity of the fermentate adjusted to pH 4.68 is likely not solely associated
with a pH effect.
Comparison of the zone sizes in the M/D assays (Table 3.4) for the undiluted original
fermentate with no pH adjustment (pH 4.21) and the undiluted fermentate adjusted to pH 4.68,
gave statistically significant p-values of <0.0001 for K. rhizophilia and P. aeruginosa, but a
non-significant p-value of >0.05 for B. subtilis (Figure 3.13). This indicates that maximum
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antibacterial activity is achieved at a lower pH with activity reduced at increasing pH’s. For
the B. subtilis however this deduction did not apply as there was no significant difference
between the antibacterial activity of the original pH 4.21 fermentate and the fermentate when
adjusted to pH 4.68, indicating increasing the pH of the fermentate did not reduce observed
activity against this strain.
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3.4 Antifungal Activity of B. longum ITT 13
Due to the common problem of food spoilage, the B. longum ITT 13 fermentate was tested for
antifungal activity to assess its potential for application in biopreservation. Antifungal testing
was initially carried out using the soft agar overlay assay (Section 2.8.5.1) and resulted in no
antifungal activity detected against the following indicator strains: R. mucilaginosa CBS316,
S. cerevisiae ATCC18824, S. cerevisiae CBS1171, D. hansenii ATCC18110 and C. albicans
ATCC2091 (data not shown). It was decided to further test the B. longum ITT 13 fermentate
using the more sensitive microtitre plate testing method (Section 2.8.5.2) due to increased
sensitivity of the assay. Cell-free fermentate was prepared from the B. longum ITT 13
fermentate (Section 2.4.3) and was screened against R. mucilaginosa CBS316, S. cerevisiae
ATCC18824, S. cerevisiae CBS1171 and C. albicans ATCC2091 using the MIC50 assay
(Section 2.8.5.2). Testing for the fungal strain D. hansenii was not possible due to Covid
restrictions and associated closing of laboratory access. Natamycin (SigmaAldrich) was used
as a positive control and MRSc broth (pH 6.4) as a negative control. The broth the fungal strain
was grown in was used as a growth control, either YPD or PD broth. An acid control containing
49.9 mM lactic acid and 60.9 mM acetic acid in MRSc broth was also employed as this
combination of acids brought the pH of the MRSc broth to pH 4.3, which is approximately the
pH of the cell-free ITT 13 fermentate used in the MIC50 antifungal testing. Antifungal activity
was detected for the B. longum ITT 13 fermentate at pH 4.3 and for fermentate grown with pH
control at pH 4.8, (Figures 3.14-3.17 and Table 3.5).
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Figure 3.14: The MIC50 determination of the antifungal activity for the B. longum ITT 13 Cell-Free
Fermentate against R. mucilaginosa CBS 316 at a) 1/2-1/32 Dilution and b) a magnification of the 1/8
dilution. The MIC50 was determined as the highest dilution displaying at least 50% inhibition of growth (OD600).
A growth control of PD broth (approx. pH 5.1) was used to determine maximum growth. The AU/ml was
determined as described in Section 2.8.2. Standard deviations were determined for a minimum of three
independent assays (n=3) and statistical analysis was carried out for Figure 3.14 (b) using one-way ANOVA with
Tukey’s multiple comparison assay. **** = p-value ≤0.0001, * = p-value ≤0.05.

Antimicrobial activity was detected against R. mucilaginosa CBS 316 for the ITT 13 cell-free
fermentate grown with pH control (pH 4.80), the cell-free fermentate grown with no pH control
(pH 4.35) and for the MRSc broth adjusted to pH 4.30. Both the pH 4.80 fermentate and the
pH adjusted MRSc broth displayed complete inhibition for the growth of the fungal strain up
to the 1/4 dilution and partial inhibition at the 1/8 dilutions was observed for all but the pH 4.35
fermentate, which displayed complete inhibition of the fungal strain at the 1/8 dilution.
Natamycin gave complete inhibition of the fungal strain at every dilution tested, which was to
be expected as it is a potent antifungal agent.
At the 1/8 dilution (Figure 3.14 (b)) the average OD600 for the pH 4.80 fermentate was 0.50,
for the pH 4.35 fermentate was 0.05 and for the pH 4.30 MRSc broth was 0.78, which is
significantly lower than for the OD600 of 1.18 measured for the growth control of PD broth,
with p-values of <0.0001 recorded for all. This indicates that the pH 4.35 B. longum ITT 13
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fermentate, the pH 4.80 fermentate and the pH 4.30 MRSc broth all displayed some level of
antimicrobial activity at a 1/8 dilution, which was lost at a 1/16 dilution. There was a significant
difference of p<0.05 when comparing the pH 4.35 and pH 4.80 fermentate samples to the
MRSc broth adjusted to the same value as the original pH unadjusted fermentate i.e. pH 4.3.
The latter would indicate that the fermentate has some antifungal activity present which cannot
be accounted for just by the pH present in the fermentate.
The MIC50 was determined for both the pH 4.35 fermentate and pH 4.80 fermentate samples
as well as the pH 4.30 MRSc broth based on the dilution of the sample required to cause at
least 50% inhibition of the fungal strain, with the growth control taken as 100% growth. The
MIC50 for the pH 4.80 fermentate against R. mucilaginosa CBS 316 was 80 AU/ml, while the
value for the B. longum ITT 13 fermentate at pH 4.35 was 80 AU/ml and the antifungal activity
detected for the MRSc pH 4.30 broth was determined as being 40AU/ml.
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Candida albicans ATCC 2091 1/2 Dilution
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Figure 3.15: The Antifungal Activity and MIC50 Determination for the B. longum ITT 13 Fermentate
against C. albicans ATCC 2091 at a) the 1/2-1/32 Dilution and b) the 1/2 dilution magnified. The MIC50
was determined as the highest dilution displaying at least 50% inhibition of growth (OD600). A growth control
of PD broth (approx. pH 5.1) was used to determine maximum growth. The AU/ml was determined as described
in Section 2.8.2. Standard deviations were determined for a minimum of three independent assays (n=3) and
statistical analysis was carried out on Figure 3.15 (b) using one-way ANOVA with Tukey’s multiple comparison
assay. **** = p-value ≤0.0001.

Antimicrobial activity was detected against C. albicans ATCC 2091 by the B. longum, ITT 13
pH 4.80 fermentate, the pH 4.35 fermentate and by the MRSc broth adjusted to pH 4.30 at the
1/2 dilution.
As antimicrobial activity was detected to varying degrees at the 1/2 dilution alone, this was
magnified in Figure 3.15 (b). Only the pH 4.35 fermentate displayed complete inhibition at the
1/2 dilution, while the pH 4.80 fermentate and the pH 4.30 MRSc broth displayed partial
inhibition at this dilution, with average OD600 values of 0.26 and 0.92 respectively, in
comparison to the growth control of PD broth with an average OD600 of 1.48. Statistical
analysis using one-way ANOVA with Tukey’s multiple comparison test was carried out on the
1/2 dilution as the three test samples (the pH 4.35 fermentate, pH 4.80 fermentate and pH 4.30
MRSc broth) displayed varying amounts of inhibition as seen in Figure 3.15 b). The statistical
analysis indicates that all were found to be statistically significant in comparison to the growth
control with p-values below 0.0001, which indicates that all samples displayed some level of
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antimicrobial activity at the 1/2 dilution. When the pH 4.80 B. longum ITT 13 fermentate and
the pH 4.35 B. longum ITT 13 fermentate were compared to the pH 4.30 MRSc broth, statistical
significance was again determined with p-values of <0.0001 for both fermentates, indicating
that they had also displayed higher levels of inhibition than the pH adjusted MRSc broth.
The MIC50 for the pH 4.80 fermentate against C. albicans ATCC 2091 was a 1/2 dilution with
the calculated inhibition being equivalent to 20 AU/ml. For the pH 4.35 fermentate, the MIC50
was also determined as a 1/2 dilution equivalent to 20 AU/ml. There was no inhibition of the
fungal strain of at least 50% associated with the presence of the pH 4.30 MRSc broth and
therefore no AU/ml could be determined.
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Figure 3.16: The antifungal activity and MIC50 determination of the B. longum ITT 13 Fermentate
against S. cerevisiae ATCC 18824 a) 1/2-1/32 dilution and b) the 1/2 dilution magnified. The MIC50 was
determined as the highest dilution displaying at least 50% inhibition of growth (OD600). A growth control of
YPD broth (approx. pH 6.5) was used to determine maximum growth. The AU/ml was determined as described
in Section 2.8.2. Standard deviations were determined for a minimum of three independent assays (n=3) and
statistical analysis was carried out on Figure 3.16 (b) using one-way ANOVA with Tukey’s multiple comparison
assay. *** = p-value ≤0.001, ns = non-significant p-value >0.05.

The pH 4.35 fermentate displayed slight inhibition at a 1/2 dilution with an average OD600 of
1.19 in comparison to the growth control of the fungal strain which was 1.65. No antimicrobial
activity was detected for either the pH 4.80 fermentate or the pH 4.30 MRSc broth.
As the antimicrobial activity detected for the pH 4.35 fermentate was only present at the 1/2
dilution, this dilution was magnified in Figure 3.16 (b). Statistical analysis using a one-way
ANOVA with Tukey’s multiple comparison test was carried out on the 1/2 dilution for the
three test samples in comparison to the growth control, however only the pH 4.35 fermentate
had a significant p-value of 0.0001. When the pH 4.80 fermentate and the pH 4.35 fermentate
were compared to the pH 4.30 MRSc broth, statistical significance was again only determined
for the pH 4.35 fermentate with a p-value of 0.0002 indicating higher antifungal activity than
the pH 4.30 MRSc broth.
There was no inhibition detected of at least 50% for S. cerevisiae ATCC 18824 by the pH 4.35
B. longum ITT 13 fermentate and therefore no AU/ml could be determined. As there was also
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no inhibition of the fungal strain associated with the presence of the pH 4.80 fermentate or the
pH 4.30 MRSc broth, no AU/ml could be determined for these samples.
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Figure 3.17: The antifungal activity and MIC50 determination of the B. longum ITT 13 Fermentate
against S. cerevisiae CBS 1171 a) 1/2-1/32 dilution and b) the 1/2 dilution magnified. The MIC50 was
determined as the highest dilution displaying at least 50% inhibition of growth (OD600). A growth control of
YPD broth (approx. pH 6.5) was used to determine maximum growth. The AU/ml was determined as described
in Section 2.8.2. Standard deviations were determined for a minimum of three independent assays (n=3) and
statistical analysis was carried out on Figure 3.17 (b) using one-way ANOVA with Tukey’s multiple
comparison assay. **** = p-value ≤0.0001, ** = p-value ≤0.01, * = p-value ≤0.05, ns = non-significant p-value
>0.05.

The antifungal activity presented in Figure 3.17 (a) indicates that there was some antimicrobial
activity detected against S. cerevisiae CBS 1171 by the pH 4.35 and pH 4.80 fermentate
samples at the 1/2 dilution.
As both fermentates (pH 4.80 and pH 4.35) displayed slight inhibition at only the 1/2 dilution,
this dilution was magnified in Figure 3.17 (b). An average OD600 of 1.34 for the pH 4.80
fermentate and 1.12 for the pH 4.35 fermentate was determined in comparison to the growth
control of the fungal strain which had an OD600 of 1.56, indicating small amounts of inhibition
relative to the growth control. Statistical analysis using a one-way ANOVA with Tukey’s
multiple comparison test was carried out on the 1/2 dilution for the three test samples in
comparison to the growth control (Figure 3.17 (b)). The pH 4.80 fermentate generated a
significant p-value of 0.0216, the pH 4.35 fermentate had a significant p-value of <0.0001 and
the pH 4.30 MRSc broth did not generate significant results with a p-value >0.05. When the
pH 4.80 fermentate and the pH 4.35 fermentate were compared to the pH 4.30 MRSc broth,
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statistical significance was found for both, with p-values below 0.05, indicating both
fermentates displayed higher antifungal activity than the pH 4.30 MRSc broth. Due to the low
level of inhibition however it is likely not biologically significant.
There was no detectable inhibition for any of the 3 tests samples above the 1/2 dilution. As
there was no antifungal activity detected for the pH 4.35 fermentate, pH 4.80 fermentate or the
pH 4.30 MRSc broth that resulted in at least 50% inhibition of S. cerevisiae CBS 1171, no
AU/ml could be determined.
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Table 3.5: The MIC50 and AU/ml of the B. longum ITT 13 Fermentate (pH 4.80), the B. longum ITT
13 Fermentate (pH 4.35) and MRSc Broth (pH 4.30) against selected fungal strains.

B. longum ITT 13

B. longum ITT 13

Fermentate

Fermentate

pH 4.80

pH 4.35

Strain:

AU/

MIC50

P-value

ml

AU/

MIC50

MRSc Broth
pH 4.30

P-value

ml

AU/

MIC50

P-value

ml

R. mucilaginosa CBS 316

80

1/8

<0.0001

80

1/8

<0.0001

40

1/4

<0.0001

C. albicans ATCC 2091

20

1/2

<0.0001

20

1/2

<0.0001

0

0

<0.0001

S. cerevisiae ATCC 18824

0

0

N/A

0

0

N/A

0

0

N/A

S. cerevisiae CBS 1171

0

0

N/A

0

0

N/A

0

0

N/A

No MIC50 was observed for either the B. longum ITT 13 fermentate at pH 4.8 or pH 4.35 and
for the MRSc broth pH 4.3 against either of the S. cerevisiae strains tested and thus no AU/ml
could be determined. The highest antifungal activity of 80 AU/ml with an MIC50 of the 1/8
dilution was observed for both the pH 4.80 fermentate and the pH 4.35 fermentate samples
against R. mucilaginosa CBS 316. Antifungal activity was observed against C. albicans ATCC
2091 by both the pH 4.80 and pH 4.35 fermentate, however it was lower than that observed for
R. mucilaginosa CBS 316 at 20 AU/ml with a corresponding MIC50 of the 1/2 dilution.
The pH 4.30 MRSc broth, which was equivalent in pH to the pH 4.3 fermentate, displayed less
antifungal activity than both the B. longum ITT 13 pH 4.80 and pH 4.35 fermentate samples,
with 40 AU/ml determined against R. mucilaginosa CBS 316 and no determined activity
against the other three fungal strains. As the calculated activity (AU/ml) was lower for the pH
4.30 MRSc broth than the activity observed by both fermentate samples against R.
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mucilaginosa CBS 316 and C. albicans ATCC 2091, it can be interpreted that the antifungal
observed for these strains is not solely associated with a pH effect.
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3.5 Discussion
3.5.1 Characterisation of Strain ITT 13
Preliminary research work carried out within previous research projects within our laboratory
had indicated that strain ITT 13 was most likely thought to be a Bifidobacterial strain,
specifically B. longum. The strict anaerobicity of the ITT 13 strain (Lee and O’Sullivan, 2010),
along with the requirement for a nutrient rich media for growth, such as MRSc agar/broth
supplemented with 0.05% L-cysteine (Liu et al., 2015), both supported this suggested
identification. Colony morphology and the resultant purple rods with bifid formation after
Gram staining further supported this identification, as these are all characteristic of
Bifidobacteria (Dhanashree et al., 2017).
The phenotypic characterisation using the Biolog was utilised in preference to API test kits, as
it runs a total of 96 assays to confirm identity and growth pattern, and is therefore considered
more accurate than the API test strips which use 20 assays (Shayegani et al., 1978), while also
providing details of carbon sources required for nutrition (Microbial Identification – Biolog).
Identification of the strain was also further validated using 16s rRNA sequencing (C. Whelan
– personal communication). Both 16s rRNA sequencing and the Biolog system confirmed the
identity of strain ITT 13 as a Bifidobacterium longum with certainty (0.995), which confirmed
the use of a GRAS strain (O’Callaghan and van Sinderen, 2016) for the research and production
of antimicrobial compounds and thus safe for potential applicability to the food industry for
possible biopreservation or as a nutraceutical probiotic organism (O’Shea et al., 2012; Liu et
al., 2020). B. longum specifically has been shown in other studies to grow faster at 37oC than
other Bifidobacterium strains (Dhanashree et al., 2017), thus indicating the possibility of the
potential suitability of B. longum ITT 13 for biomass production, which could be an important
factor for the production of the strain as a probiotic organism.
Probiotics have been defined by the World Health Organisation as “Live microorganisms
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which when administered in adequate amounts confer a health benefit on the host”. Many
probiotic bacteria are isolated from the gastrointestinal tract of humans, where they are thought
to provide additional health benefits similar to those of the hosts gut microbiome such as
facilitating the protection of the intestinal barrier by maintaining tight junctions of protein and
modulation of antimicrobial activity within the gut to prevent infection (O’Flaherty and
Klaenhammer, 2010). This production of antimicrobial activity is namely associated with
organic acids and antimicrobial peptides that can be produced by Bifidobacteria spp. and is
considered important for a healthy balance of microflora within the gut and for infection
prevention (Hladíková et al., 2012; O’Shea et al., 2012; Guinane et al., 2016).
Lactic acid bacteria such as Lactobacillus spp. and Bifidobacteria spp. are among the most
common bacteria utilised as probiotic strains (Butel, 2014). B. longum ITT 13 has initially
displayed some characteristics of probiotic organisms, such as the production of antimicrobial
activity and the isolation of the strain from the human gastrointestinal system indicates the
potential to be utilised as a probiotic organism that is capable of both surviving and thriving
with in the gut (Cooke et al., 2005). B. longum subsp. infantis CECT 7210 also exhibits
probiotic properties with resistance to gastric juices, bile salts and a low pH, as well as
prevention of diarrhoea due to inhibition of rotavirus (Chenoll et al., 2016).

3.5.2 Antibacterial Activity of B. longum ITT 13
Several Bifidobacteria have been shown to have antimicrobial activity against various bacterial
strains that has been shown to be associated with the production of antimicrobial peptides
which are generally referred to as bacteriocins (Lee and O’sullivan, 2010). Bifidobacterial
strains have produced bioactive antimicrobial peptides displaying activity against a range of
bacteria including Helicobacter pylori, which was shown to have been inhibited by peptides
produced by six different Bifidobacterium isolates (Collado et al., 2005). The peptide bifidin I
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has displayed broad-spectrum activity against bacteria including Bacilli, Listeria and
Salmonella (Cheikhyoussef et al., 2010). The strains B. bifiidum 174 and Bifidobacterium sp.
27 have produced peptides with broad-spectrum antimicrobial activity against various Grampositive and Gram-negative strains including Streptococcus spp., Clostridioides difficile, S.
typhimurium, E. coli and Klebsiella pneumoniae (Poltavska and Kovalenko, 2012).
Bifidobacteria spp. also produce a range of organic acids upon growth, including formic acid,
lactic acid and acetic acid (Ruiz-Aceituno et al., 2020). Both lactic and acetic acid are primarily
produced during growth and fermentation and are also associated with significant antimicrobial
activity against some bacterial strains (Makras and De Vuyst, 2006).

3.5.2.1 Determination of the Antibacterial Spectrum of Activity using the
Microdiffusion Plate Assay
The indicator strains S. xylosus and K. rhizophilia that were used in the microdiffusion assay,
were chosen based on the efficacy as indicators strains as determined by providing clear zones
of inhibition for the B. longum ITT 13 fermentate in previous work. Indicator strains were also
chosen based on their relevance in food spoilage. Some of these species include Bacillus spp.
which commonly spoil bakery products and potatoes (André et al., 2017; Ajingi et al., 2020),
P. aeruginosa which can spoil meat and animal derived food (Höll et al., 2016) and
Staphylococcus spp., which are commensal bacteria commonly found on the skin and can be
foodborne pathogens resulting in Staphylococcus food poisoning (Wang et al., 2019; Maia et
al., 2020). The strains used for evaluation of the antimicrobial effect of the fermentate were
also chosen based on food associated pathogenicity. E. coli and Salmonella spp. were selected
for testing because of their pathogenicity associated with foodborne illnesses, where they have
been known to contaminate meat, poultry and eggs resulting in food poisoning (Huang et al.,
2019; Vinayaka et al., 2019). Other strains chosen for inclusion in the M/D assays were
115

selected because of their known presence in the gut microflora and included Enterococcus
faecalis (Chen et al., 2018) and Klebsiella aerogenes (Paulose et al., 2019). Finally, several
lactic acid bacteria which are known to be used in fermented foods were screened to determine
if the B. longum ITT 13 fermentate affected their growth as that would have implications for
co-cultivation in future possible fermented probiotic foods, e.g. lactic acid bacteria such as
Lactococcus spp. and Lactobacilli spp. Of the 15 bacterial strains tested for antimicrobial
susceptibility to the B. longum ITT 13 fermentate, it was determined that 9 strains displayed
susceptibility (B. subtilis ATCC 1174, E. faecalis ATCC 7080, K. rhizophilia ATCC 9341, S.
xylosus ATCC 29971, K. aerogenes ATCC 13048, E. coli ATCC 25922, P. aeruginosa PA01,
S. typhimurium ATCC 26929 and B. cenocepacia ATCC 17765 III.20), while 6 displayed
resistance (B. cereus ATCC 10876, S. aureus ATCC 25923, S. epidermidis ATCC 12228, S.
pyogenes NCIMB 11841, L. paracasei subsp. paracasei NCIMB 3254 and L. delbruickii
subsp. bulgaricus NCIMB 11778.
Many bacteriocins only display inhibitory activity to bacteria of a similar ecological niche and
are described as having a narrow spectrum of activity (Zou et al., 2018; Vaičikauskaitė et al.,
2019; Pei et al., 2020). However, the spectrum of activity of B. longum ITT 13 as determined
in M/D assays (Figure 3.4, Table 3.1 & 3.2) indicate that the fermentate displays broad
antimicrobial action against both Gram-positive and Gram-negative organisms from a variety
of ecological environments. In this study, fifteen species were selected as indicated previously
and within the fifteen strains, ten are Gram-positive and five are Gram-negative. In the M/D
assays 4 of the 10 Gram-positive species displayed susceptibility to the antimicrobial activity
of B. longum ITT 13 (Figure 3.4 and Table 3.1), while all 5 Gram-negative species tested
displayed susceptibility (Figure 3.4 and Table 3.2). The susceptibility of the Gram-negative
species to the fermentate was especially of significance given the resistance of many Gramnegative bacteria to antimicrobials such as antibiotics as well bacteriocins produced by some
116

Gram-positive strains (Martin-Visscher et al., 2011; Breijyeh et al., 2020). Higher levels of
antimicrobial activity were observed against some Gram-positive strains in comparison to the
lower-level activity observed against the Gram-negative strains, with the highest levels of
antimicrobial activity detected against the Gram-positive strains E. faecalis ATCC 7080 (20.4
AU/ml) and B. subtilis ATCC 1174 (16.7 AU/ml) (Figure 3.4). The E. faecalis ATCC 7080
and B. subtilis ATCC 1174 strains were also among the most susceptible to the B. longum ITT
13 fermentate in the MIC50 assay (Section 3.2.2).
In a paper by Makras & De Vuyst (2006), a variety of Bifidobacterium strains, including B.
longum, were screened for antimicrobial activity against a variety of Gram-positive and Gramnegative strains. In this paper the antimicrobial activity observed against the Gram-negative
bacterial strains, which included Salmonella and E. coli, was found to be primarily due to the
production of organic acids by the Bifidobacterium spp, in comparison to the activity against
Gram-positive strains which was associated with both organic acid and bacteriocin production.
This may explain the increased activity against some Gram-positive strains by B. longum ITT
13, as they may be susceptible to both bacteriocin and acid production resulting in higher levels
of inhibition. Thus, the susceptibility of the screened Gram-negative strains to the antimicrobial
activity of B. longum ITT 13 may be associated with sensitivity to organic acids alone, or less
sensitivity to potential bacteriocins produced by ITT 13. This in turn may be indicative of why
lower levels of inhibition are detected against some Gram-negative bacteria by B. longum ITT
13, as was observed by Makras & De Vuyst's (2006) study. Some bacteriocins produced by
lactic acid bacteria also have displayed broad spectrums of antimicrobial activity against gramnegative strains. Indira et al. (2018) discovered a bacteriocin produced by Enterococcus
casseliflavus MI001 that displayed antimicrobial activity against both gram-positive and gramnegative strains, including pathogenic gram-negative strains such as P. aeruginosa, K.
pneumoniae and E. coli. An approximately 5.5KDa bacteriocin produced by the LAB
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Lactobacillus sake C2, which was originally purified from a Chinese fermented cabbage,
displayed strong antimicrobial activity against a wide range of bacteria including S. aureus, E.
coli, S. typhimurium and other LAB including Lactobacilli spp. and S. thermophilus (Gao et
al., 2010). The gram-negative antimicrobial activity associated with sakacin C2 is not
commonly seen in LAB and the strain also produced a large amount of lactic acid, with the
authors stating that the acid production and broad spectrum of activity demonstrate the potential
of L. sake C2 as a starter culture and bio-preservative.
A wide spectrum of antimicrobial activity was observed for B. longum ITT 13, with inhibition
detected for the growth of both Gram-positive and Gram-negative food spoilage and
pathogenic organisms.
As previously stated, many bacteriocins display antimicrobial activity against bacteria of a
similar ecological niche, as observed with the inhibition of Lactobacilli by sakacin C2 (Gao et
al., 2010). Lactobacilli are also commonly found as part of the gut microflora (Liu et al., 2020)
like Bifidobacterium spp., however no antimicrobial activity was detected against
Lactobacillus paracasei subsp. paracasei NCIMB 3254 and Lactobacillus delbruickii subsp.
bulgaricus NCIMB 11778 by B. longum ITT 13. The lack of inhibitory activity against these
bacteria by the B. longum ITT 13 fermentate may indicate potential suitability for cocultivation with B. longum ITT 13. This would increase the suitability of B. longum ITT 13 as
a probiotic culture or a starter culture in comparison to the aforementioned sakacin C2
described by Gao et al. (2010), which displayed antimicrobial activity against a variety of
Lactobacilli and Streptococcus thermophilus, a common starter culture in yoghurt making
(Uriot et al., 2017). The production of antimicrobial compounds by probiotic bacteria to
prevent colonisation of pathogenic bacteria within the gut is an important factor of probiotics,
with similar attributes displayed by B. longum ITT 13. Antimicrobial activity by B. longum
ITT 13 was observed against pathogenic bacteria including E. coli and Salmonella, which are
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common foodborne pathogens that contaminate meat, poultry and eggs resulting in food
poisoning (Huang et al., 2019; Vinayaka et al., 2019).

3.5.2.2 MIC50 Testing of the B. longum ITT 13 Fermentate
Increased sensitivity has been displayed using the microtitre plate method in comparison to
well diffusion by Inturri et al., (2019), and as discussed by Balouiri et al., (2016) is suitable for
quantitative analysis of antimicrobial activity.
The fermentate displayed an MIC50 of a 1/8 dilution and 80 AU/ml against B. subtilis ATCC
1174, while the pH 4.5 MRSc broth generated an MIC50 of 1/2 dilution and 20 AU/ml in
comparison with the fermentate at the same pH (Figure 3.7 and Table 3.3). The 1/2 MIC50 of
the MRSc broth was four-fold less than the 1/8 MIC50 of the fermentate, indicating that B.
subtilis ATCC 1174 is likely not inhibited by the pH 4.5 effect alone and therefore there may
be other molecules present in the fermentate contributing to antimicrobial activity. The genus
Bacillus have displayed an ability for growth tolerance in both acidic and alkaline conditions
(Logan and Vos, 2015). Some Bacillus subtilis strains have also been shown to be lactic and
acetic acid producers and would thus possibly display a level of tolerance (Gao et al., 2012;
Yan et al., 2013).
A two-fold difference in activity between the pH 4.5 fermentate and the MRSc broth at the
same pH was the case for E. faecalis ATCC 7080, where the B. longum ITT 13 fermentate
generated an MIC50 of a 1/8 dilution and 80 AU/ml, whereas the pH 4.5 MRSc broth generated
an MIC50 for the 1/2 dilution and 20 AU/ml (Figure 3.8 and Table 3.3). E. faecalis has been
shown to be acid-resistant with growth observed as low as pH 4.0 (Nakajo et al., 2006). The
aforementioned strains E. faecalis and B. subtilis were among the strains displaying the highest
levels of susceptibility to the fermentate in the MIC50 assay (80 AU/ml), as well as the M/D
assay (20.4 and 16.7 AU/ml respectively).
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For E. coli ATCC 25922 (Figure 3.10), P. aeruginosa PA01 (Figure 3.11) and S. typhimurium
ATCC 29629 (Figure 3.12), the B. longum ITT 13 fermentate generated inhibition that was a
single-fold higher than that measured for the pH 4.5 MRSc which was at the same pH as for
the pH adjusted fermentate. The fermentate generated an MIC50 of the 1/4 dilution and 40
AU/ml and the MRSc pH 4.5 broth generated an MIC50 of an 1/2 dilution and 20 AU/ml for
both E. coli ATCC 25922 and P. aeruginosa PA01 (Figure 3.10, Figure 3.11 and Table 3.3).
An MIC50 of a 1/8 dilution and 80 AU/ml for the fermentate and a 1/4 dilution and 40 AU/ml
for the pH 4.5 MRSc broth was observed against S. typhimurium ATCC 29629 (Table 3.3).
In contrast to the results generated from the species previously described, S. xylosus ATCC
29971 displayed higher susceptibility to the pH 4.5 MRSc broth, with an MIC50 of a 1/16
dilution and 160 AU/ml in comparison to an MIC50 of a 1/8 dilution and 80 AU/ml for the
fermentate (Figure 3.9 and Table 3.3). The fermentate displayed an average of 47% inhibition
at the 1/16 dilution, with standard deviation of ± 26% in comparison to the average OD600 of
the control of MRSc broth which was taken as 100% growth. The high standard deviation
indicates fluctuation between replicates and that there was the possibility that activity of the
fermentate had likely risen above 50% inhibition for some replicates. Thus some replicates had
the same MIC50 as the pH 4.5 fermentate. The high standard deviation determined for the
inhibition of S. xylosus by the B. longum ITT 13 fermentate is indicative that the results cannot
be taken to be statistically significant in relation to a higher effect on the inhibitory growth of
the strain for the fermentate than for the pH 4.5 MRSc broth alone. The MRSc broth at pH 4.5
displayed an average of 59% inhibition at the 1/16 dilution in comparison to the OD600 of the
control of the diluted MRSc broth, which would be taken as 100% growth. However, as the
MIC50 was based off the average inhibition and at least 50% inhibition was required to
determine the MIC50 dilution, the B. longum ITT 13 pH 4.5 fermentate displayed an MIC50 of
a 1/8 dilution (80 AU/ml) while the MRSc broth also at pH 4.5 of a 1/16 dilution (16 AU/ml).
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S. xylosus has been shown to be survive at a low pH of 4 (Leroy et al., 2017) with organic acid
production including lactic acid resulting in beer spoilage (Yu et al., 2019). S. xylosus has also
been shown to display susceptibility to bacteriocins produced by Pediococcus acidilactici
MCL11 (512 BU/ml i.e. Bacteriocin Unit/ml - equivalent to AU/ml) and Enterococcus faecium
MCL13 (64 BU/ml) in a study by (Lim, 2016).
As the pH 4.5 MRSc broth displayed less activity than the fermentate in five of the six strains,
this indicates there was likely other constituents other than acidic conditions and low pH
contributing to antimicrobial activity. The increased antimicrobial effect of the fermentate
against some strains may be caused by a combination of organic acids produced by the B.
longum ITT 13 as Bifidobacterium spp. are heterofermentative species (Ruiz-Aceituno et al.,
2020), as only lactic acid was used to adjust the pH of the pH 4.5 MRSc broth. In the study by
Makras and De Vuyst (2006) they demonstrate how a variety of Bifidobacterium strains
exhibited antimicrobial activity associated with bacteriocin productions towards gram-positive
bacterial strains, however the activity exhibited towards gram-negative strains was associated
with organic acid production and the lowering of pH, namely acetic and lactic acid. This may
be the case with B. longum ITT 13, explaining why activity was detected against all gramnegative strains tested for susceptibility using the microdiffusion assay in Section 3.2.1 (Figure
3.4). However, when using the MIC50 assay (Section 3.2.2) for quantitative results less activity
was observed by the fermentate against the gram-negative strains (with 40 AU/ml generated
for two gram-negative strains and 80 AU/ml for the other) in comparison to the gram-positive
strains (80 AU/ml for all strains) (Table 3.3). This was also similar to the microdiffusion assay
(Section 3.2.1) whereby increased antimicrobial activity was detected against the gram-positive
strains than the gram-negative strains, with 11-20 AU/ml detected for the gram-positive strains
(Table 3.1) compared to only 10-11 AU/ml for the gram-negative strains (Table 3.2).
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The activity of the fermentate was also compared to the activity of the nisin positive control
for effectiveness (Figures 3.7-3.12). For B. subtilis ATCC 1174 and S. xylosus ATCC 29971,
the MIC50 of nisin was a 1/8 dilution and 80 AU/ml, which was identical to the antimicrobial
activity of the B. longum ITT 13 fermentate (pH 4.5) against these strains. As the nisin
contained 1000 IU/ml in the undiluted form, the 1/8 MIC50 thus equated to an MIC50 of 125
IU/ml for the nisin against both B. subtilis ATCC 1174 and S. xylosus ATCC 29971. As the
activity had been identical to that of the pH 4.5 fermentate, this can be suggestive of the
fermentate also displaying an MIC50 associated with 125 IU/ml, however, the reason dilutions
of the fermentate are used for the calculation of the MIC50 of the B. longum ITT 13 fermentate
is due to the fact there has been no determined concentration of the actual inhibitory component
present within the fermentate as this has not been solely identified.
For E. faecalis ATCC 7080, the antimicrobial activity detectable for the fermentate was higher
with the MIC50 value determined as being the 1/8 dilution equivalent to 80 AU/ml, in
comparison to nisin with an MIC50 for the 1/4 dilution and 40 AU/ml, equating to 250 IU/ml
(Figure 3.8). The latter results indicate the comparability of the antimicrobial activity
detectable for the B. longum ITT 13 fermentate (pH 4.5) to nisin (1000 IU/ml undiluted),
however it is noted that the nisin used as the positive control is pure, while the fermentate
contains many substances, which individually or collectively could be associated with
antimicrobial activity and therefore would warrant further evaluation. In the M/D assay
(Section 3.2.1) the nisin (1000 IU/ml undiluted) displayed higher levels of inhibition than the
fermentate for all of the gram-positive strains (Table 3.1), with approximately 88.9 AU/ml
(activity detected to as low as 62.5 IU/ml) determined for all of the tested strains in comparison
to the fermentate which had between 10.2 and 20.4 AU/ml against the tested strains (Figure
3.4, Table 3.1 and Table 3.2).
Although some low-level antimicrobial activity was detected for nisin at a 1/2 dilution for both
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E. coli ATCC 25922 and S. typhimurium ATCC 26929 in Figures 3.10 & 3.12, this is likely a
result of dilution of the Mueller Hinton broth nutrients, which is already a nutrient limiting
media and this low-level inhibition is not observed for the MRSc broth controls as the MRSc
broth provides additional nutrients. The nisin is prepared in 0.02N HCl (Section 2.5).
Nisin, produced by Lactococcus lactis, displays antimicrobial activity towards Gram-positive
strains, with limited activity in Gram-negative strains due to the relatively impermeable outer
membrane present in gram-negative cells (Masusaki et al., 1998). A destabilization effect of
the cell membrane may take place with B. longum ITT 13, whereby the organic acids may
weaken cell membranes thus increasing the efficacy of an antimicrobial peptide, resulting in a
synergistic reaction between acid and peptide against some strains. This effect has been
observed in a paper by Ajingi et al. (2020) where the efficacy of nisin was increased to subMIC concentrations against a potato spoiling strain of B. subtilis when used in conjunction with
organic acids such as formic acid and lactic acid, providing a synergistic effect between nisin
and the organic acids.
The antimicrobial activity and the spectrum of activity explored in Section 3.2.1 of the
fermentate produced by B. longum ITT 13, and the GRAS status of Bifidobacterium
(O’Callaghan and van Sinderen, 2016) indicates the potential suitability of B. longum ITT 13
as a biopreservative agent in food applications or as a potential probiotic strain. Nisin inhibits
common gram-positive foodborne bacteria and has been approved for use as a food
preservative in over 50 countries (Gyawali and Ibrahim, 2014). The review of Bifidobacteria
by Cheikhyoussef et al. (2008) discusses the activity of antimicrobial peptides produced by
various Bifidobacterium strains against foodborne pathogens such as E. coli and Salmonella
and the potential of bacteriocins produced by this genus as biopreservatives to increase shelflife and food safety. As B. longum ITT 13 has displayed activity against strains including E.
coli and S. typhimurium this furthers the potential of its application in industry. B. longum ITT
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13 was isolated from the human gut and Bifidobacteria for probiotic consideration are
recommended to be isolated from the same species as intended use, with other requirements
including low pH tolerance (Mahmoudi et al., 2013), exhibited by B. longum ITT 13 which
reduces the pH of its growth medium to pH 4 during growth.
When comparing the MIC50 assay to the Microdiffusion assay, the differences in sensitivity are
evident. It is evident that when comparing the results determined from the M/D assay (Section
3.2.1) with those values obtained from the MIC50 assays (Section 3.2.2), that the antimicrobial
activity in terms of AU/ml was higher when observed for the MIC50 assay. Thus the MIC50 test
can be confirmed to detect higher levels of inhibition in relation to the evaluation of the
antimicrobial activity generated by the fermentate produced by B. longum ITT 13. This
conclusion is in-line with Inturri et al., (2019) who detected stronger inhibition by the
supernatant of B. longum BB536 and L. rhamnosus HL001 against some indicator strains when
using the broth microdilution method in microtitre plates – equivalent to the MIC50 assay
carried out in Section 3.2.2. Combinations of well-diffusion (microdiffusion) and broth
microdilution to determine MIC have been used to screen antimicrobial activity produced by
other bacterial strains. Salivaricin mmaye1, a bacteriocin produced by Lactobacillus salivarius
SPW1, was screened for its antimicrobial spectrum of activity using the well-diffusion assay
and microtitre plates used to determine the MIC (Wayah and Philip, 2018) both proving
effective for determination.

3.5.3 Antibacterial Testing with pH Adjusted Fermentate.
Bifidobacteria are heterofermentative organisms, producing a combination of organic acids
upon growth such as lactic and acetic acid (Ruiz-Aceituno et al., 2020). The production of
organic acids by Bifidobacteria has been associated with some antimicrobial activity displayed
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by the species (Makras and De Vuyst, 2006) and as the B. longum ITT 13 fermentate had a
considerably low pH of approximately pH 4.2-4.3 without pH control during growth, the
impact of low-level pH increases of the fermentate, without pH neutralization, on the
antimicrobial activity were assessed.
The B. longum ITT 13 fermentate was adjusted to pH 4.7 to assess how an increase in pH would
affect the level of antimicrobial inhibition displayed against three test strains in comparison to
the fermentate without any adjustment. The three indicator strains chosen included one gramnegative strain (P. aeruginosa) and two gram-positive strains (B. subtilis and to completely
assess the activity. Several publications report research work involving the neutralisation of the
cell-free supernatant fermentate which contains a bacteriocin and evaluating whether the lack
of acidity has any effect on the overall antimicrobial activity demonstrated from the lactic acid
bacteria (Yang et al., 2012; Liu et al., 2015; Vijayakumar and Muriana, 2015). The results of
a previous research project involving ITT 13 indicated a loss of detectable antimicrobial
activity above pH 5 for the B. longum ITT 13 fermentate in the microdiffusion assay. Therefore,
it was decided to adjust the fermentate to pH 4.7 instead to keep the pH mid-range between the
fermentation pH of 4.2-4.3 and the more neutral pH 5. Although activity has been lost with
pH neutralization of the fermentate above pH 5 in previous work using the microdiffusion
assay, it has been detected above this pH in the more sensitive MIC assay (C. Whelan –
personal communication). The loss of activity at higher pH can indicate the possibility that
organic acids are primarily responsible for antimicrobial activity, however some antimicrobial
products retain higher activity in acidic pH conditions, as the commercially used antimicrobial
peptide of nisin retains higher active at a lower pH and is prepared in 0.02 N HCl for this reason
(Matsusaki et al., 1998).
The results showed that the statistically significant p-values determined for all three of the
strains tested indicated that the antimicrobial activity caused by the fermentate adjusted to pH
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4.68 was significantly different to any antimicrobial activity caused by the pH adjusted MRSc
broth (pH 4.82), meaning the activity of the pH adjusted fermentate was not solely the result
of a pH effect caused by a low pH. The results presented are strongly suggesting that the
antimicrobial activity of the fermentate is not solely associated with the pH values tested.
Bifidobacteria are known to produce a number of acids including acetic, lactic and formic acids
(Makras and De Vuyst, 2006; Ruiz-Aceituno et al., 2020). In carrying out the pH adjustment
experiment above lactic acid was used to adjust the pH and to fully evaluate the effect of this
the acids content and associated pH, the contribution of the various acids needs to be evaluated
further. This can be supported by evidence in the publication by Makras and De Vuyst (2006)
whereby they used a variety of lactic, acetic and hydrochloric acid to adjust the pH of MRSc
broth to pH 4.5 which resulted in significant antimicrobial activity, indicating a combination
of acids may be more effective than just the pH.
Statistical analysis of the activity of both the undiluted and 1/2 dilutions of the fermentate
without pH adjustment (pH 4.2) compared to the undiluted and 1/2 dilutions of the fermentate
pH adjusted to pH 4.68 generated statistically significant p- values that were <0.0001 for both
K. rhizophilia. This indicates that the level of antimicrobial activity displayed by the fermentate
depended on the pH of the fermentate and that increasing the pH reduced the level of
antimicrobial activity. The same conclusions were drawn for the 1/2 dilution of the unadjusted
fermentate compared to the 1/2 dilution of the pH adjusted fermentate for both K. rhizophilia
and P. aeruginosa (Figure 3.13), as the antimicrobial activity had disappeared completely at
the 1/2 dilution of the pH adjusted fermentate while antimicrobial activity remained at the 1/2
dilution for the unadjusted fermentate. The dilution of the pH 4.68 fermentate caused by the
addition of NaOH could be hypothesised as the actual cause for the reduction of activity as the
dilution effect equated to 5-parts fermentate and 1-part NaOH, i.e. a 5/6 dilution, although a
pH effect cannot be ruled out.
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For B. subtilis there was no statistically significant differences between the undiluted or the 1/2
dilutions of the fermentate with no pH adjustment (pH 4.2) and the fermentate adjusted to pH
4.68, with p-values >0.05. This indicates that increasing the pH of the fermentate resulted in
no significant change in antimicrobial activity for this strain.

3.5.4 Antifungal Activity of B. longum ITT 13
Fungi are the most common food spoilage organisms (Saleh and Al-Thani, 2019; Snyder, et
al., 2019) and can greatly reduce the shelf-life of products without the use of preservatives
(Garcia, Bernardi and Copetti, 2019), with biopreservatives offering an appealing alternative
to the use of chemical preservatives that are primarily used within the food industry (Kıvanc,
Kıvanc and Pektas, 2014). Screening of the B. longum ITT 13 fermentate for antifungal activity
as well as antimicrobial activity was of importance due to the widespread spoilage of food
associated with fungal strains, such as the unsolved issue of fungal spoilage in bread and baked
goods (Quattrini et al., 2019). B. longum ITT 13 was screened against selected fungal strains
that have been known to cause food spoilage, including yeast organisms that result in the
conversion of growth substrates within the food matrices to metabolic end products that can
alter the chemical and physical properties of food (Fleet, 2011).
The four fungal strains screened for activity were R. mucilaginosa CBS 316, C. albicans ATCC
2091, S. cerevisiae ATCC 18824 and S. cerevisiae CBS 1171. Fungal strains were supplied by
the sponsor as strains of interest in spoilage. R. mucilaginosa CBS 316 was the most susceptible
strain to the B. longum ITT 13 fermentate both at pH 4.35 (grown without pH control) and pH
4.80 (grown in fermenters with pH control) as well as the pH 4.30 MRSc broth. MIC50 values
of 80 AU/ml for the pH 4.80 fermentate, 80 AU/ml for the pH 4.35 fermentate and 40 AU/ml
for the pH 4.30 MRSc broth were observed for R. mucilaginosa CBS 316 (Figure 3.14). The
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inhibition of R. mucilaginosa CBS 316 was statistically significant with all p-values below 0.05
when compared to the growth control and as the inhibition by the fermentate at both the pH
4.80 and pH 4.35 was detected up to a 1/8 dilution it was also biologically significant. LAB
strains such as Lactobacilli have been shown to display strong antifungal activity against R.
mucilaginosa at densities of 107 CFU/ml as demonstrated by Lačanin et al., (2017). A
combination of Lactobacillus plantarum L244 and Lactobacillus harbinensis L172 inhibited
the growth of R. mucilaginosa for 7 days in sour cream (Leyva Salas et al., 2018), thus high
levels of inhibition by ITT 13 are not unusual given the similarities between Lactobacilli and
Bifidobacterium.
C. albicans ATCC 2091 was also susceptible to both the pH 4.35 and pH 4.80 B. longum ITT
13 fermentate samples, as at a 1/2 dilution the pH 4.80 and pH 4.35 fermentates both had
statistically significant p-values below 0.05 indicating that they caused inhibition of the strain
in comparison to the growth control of Potato Dextrose (PD) broth (Figure 3.15). Both the pH
4.80 and pH 4.35 B. longum ITT 13 fermentate had an MIC50 of a 1/2 dilution and 20 AU/ml
against this strain as both caused at least 50% inhibition at the 1/2 dilution. Although the pH
4.30 MRSc broth caused inhibition it was below 50% and therefore denoted as having 0 AU/ml
– indicating a weaker inhibitory effect than the ITT 13 fermentate. Similar to R. mucilaginosa,
LAB such as Lactobacilli have also displayed antifungal activity against Candida spp., with L.
rhamnosus GR-1 and L. reuteri RC-14 strains displaying antifungal activity against
vulvovaginal candidiasis causing C. glabrata through both autoaggregation and coaggregation
(Chew et al., 2015). The neutralised supernatant of Lactobacillus pentosus LAP1 displayed
potent antifungal activity against various Candida strains using the microdiffusion method
which generated an inhibitory value equivalent to 150 AU/ml against C. albicans (Aarti et al.,
2018), which was significantly higher than the activity of ITT 13. For the fungal strain S.
cerevisiae ATCC 18824, only the fermentate without pH control (pH 4.35) was found to
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display antifungal activity with a significant p-value of 0.0001, while the fermentate which had
been adjusted to pH 4.80 fermentate displayed no significant activity (Figure 3.16). The later
results for the S. cerevisiae ATCC 18824 are compared with those for S. cerevisiae CBS 1171
(Figure 3.17) where both the pH 4.35 and pH 4.80 fermentates displayed significant antifungal
acivity (p-value <0.05). Although statistically significant antifungal activity was detected by
the B. longum ITT 13 pH 4.35 fermentate against S. cerevisiae ATCC 18824 and by both the
pH 4.35 and pH 4.80 fermentates against S. cerevisiae CBS 1172, it may not be biologically
significant, as the antifungal activity was below 50% inhibition for both strains at a 1/2 dilution,
which in terms of the MIC50 calculation equates 0 AU/ml. Future work should include further
concentration of the samples in order to evaluate the effectiveness of the inhibition caused by
the B. longum ITT 13 fermentate's to a greater degree.
Bifidobacterium spp. and other lactic acid bacteria have been previously reported to display
antifungal activity similar to that determined for the B. longum ITT 13 strain in these studies.
In a study by Ghazvini et al (2016) Bifidobacterium bifidum PTCC 1644 and Lactobacillus
fermentum PTCC 1744 were shown to reduce the mycelial mass of Aspergillus parasiticus
PTCC 5286 by 82% and 77% respectively when the fungal strain was cultured in their presence.
Both bacterial strains were also shown to reduce the aflatoxin production by the fungal strain,
which is a carcinogenic mycotoxin and that can contaminate both human and animal food
commodities (Ghazvini et al., 2016). In another study by Fernandez et al (2017), various
Lactobacilli, Propionibacterium and Bifidobacterium animalis subsp. lactis A026 displayed
strong antifungal activity against various fungal strains including Penicillium chrysogenum
LMA-212 and Aspergillus versicolor LMA-370. Lactobacillus rhamnosus A238, both alone
and in combination with Bifidobacterium animalis subsp. lactis A026, inhibited the growth of
P. chrysogenum for 21 days (Fernandez et al., 2017). B. longum BB536 was also shown to
display antifungal activity towards clinical and reference Candida strains (Inturri et al., 2019).
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The fungal strains were also screened for sensitivity to a low pH and organic acids in the pH
adjusted MRSc, where both lactic and acetic acid were used to adjust the pH of the MRSc broth
to pH 4.30. Organic acid have been shown to demonstrate antifungal activity, such as acetic
acid which has been shown to be one of the most relevant antifungal compounds produced by
LAB, with lactic, propionic and sorbic acids also displaying effects (Lind et al, 2005; Quattrini
et al., 2019; Debonne et al., 2020). Samapundo et al., (2016) demonstrated that fermentates
obtained from unidentified bacteria, containing varying concentrations of propionic, lactic and
acetic acids, displayed increasing antifungal activity at lower pH’s against Asperigillus strains.
The pH 4.30 MRSc broth displayed complete inhibition up to a 1/4 dilution and partial
inhibition at a 1/8 dilution, with 40 AU/ml for R. mucilaginosa CBS 316 (Figure 3.14). The pH
4.30 MRSc broth also displayed partial inhibition of C. albicans ATCC 2091 at a 1/2 dilution,
however the inhibition was less than 50% and based on the MIC50 calculation requiring at least
50% inhibition at a given dilution for MIC50 and AU/ml determination, the pH 4.30 MRSc
broth therefore generated 0 AU/ml against C. albicans ATCC 2091 (Figure 3.15). Statistically
significant p-values of less than 0.05 were observed for the fungal growth of both R.
mucilaginosa CBS 316 and C. albicans ATCC 2091 when incubated with the pH 4.30 MRSc
broth in comparison to the growth control of PD broth – indicating the pH 4.30 MRSc broth
containing 39.9 mM lactic acid and 60.9 mM acetic acid displayed an antimicrobial effect. For
both S. cerevisiae strains, the p-value of the pH 4.30 MRSc broth in comparison to the growth
control was non-significant (>0.05), indicating the acids did not display a significant
antimicrobial effect (Figures 3.16 & 3.17). Thus, it is possible for some fungal strains, namely
R. mucilaginosa CBS 316 and C. albicans ATCC 2091, that the inhibition caused by the
fermentates may be partially or completely due to the concentration of organic acids as
produced by B. longum ITT 13.
However, it should be noted that there was higher detectable antifungal activity associated with
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both the pH 4.35 and pH 4.80 B. longum ITT 13 fermentate samples as compared to the
antifungal activity detected for pH 4.30 MRSc broth. The p-values for the antifungal activity
of each fermentate in comparison to the pH adjusted MRSc broth were statistically significant
(<0.05) for all fungal strains (Figures 3.14-3.17), except for the pH 4.80 fermentate with S.
cerevisiae ATCC 18824 compared to the pH adjusted MRSc (Figure 3.16). The overall results
obtained for the antifungal studies thus signify that more potent antifungal activity is associated
with fermentate, even when the fermentate is at the equivalent pH as the pH adjusted pH 4.3
MRSc broth. Therefore, the MIC50 results for the antifungal studies on the selected strains
would indicate that partial antifungal inhibition may be caused by a source other than organic
acids within the fermentate and this suggestion that the antimicrobial activity associated with
the B. longum ITT 13 is associated with more than just organic acid production is further
developed in Chapter 4, with the indication of a possible proteinaceous compound with
antimicrobial activity also produced by B. longum ITT 13 in low concentrations (Sections 4.3
and 4.4). Some proteinaceous molecules produced by lactic acid bacteria have been shown to
display antifungal activity e.g. L. plantarum CECT 749 produced bioactive peptides displaying
antifungal activity against Aspergillus parasiticus CECT 2681 and Penicillium expansum
CECT 2268 (Luz et al., 2017). A synergistic combination of organic acid production and
proteinaceous molecules produced by LAB including Lactobacilli, as detailed by Ruggirello et
al., (2018), was responsible for some antifungal activity against various Penicillium and
Aspergillus strains and may indicate this as a possibility for the antifungal activity of ITT 13
(Chapter 4).
HPLC analysis of the B. longum ITT 13 fermentate grown in MRSc broth both produced in 2L
fermentation vessels at pH 4.80 and grown in an anaerobic chamber without pH control (pH
4.35) was carried out in a supervised undergraduate project within the laboratory, to determine
the organic acid production by the strain (Section 4.5). It was found that the pH 4.80 fermentate
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contained approximately 68.3 ± 10.6 mM lactic acid, 161.0 ± 13.7 mM acetic acid and 67.7 ±
6.2 mM succinic acid. This equates to approximately 34.2 mM lactic acid, 80.5 mM acetic acid
and 33.9 mM succinic acid at the initial 1/2 dilution used in the microtitre plates. The pH 4.35
fermentate contained approximately 92 ± 1.5 mM lactic acid, 147.7 ± 10.3 mM acetic acid and
54.5 ± 3.0 mM succinic acid (46.0, 73.9 and 27.3 mM respectively at a 1/2 dilution in microtitre
plates). The concentrations of the lactic and acetic acid of both the pH 4.35 and pH 4.80
fermentates are both significantly higher than those present in the pH 4.30 MRSc broth – which
were 39.9 mM lactic acid and 60.9 mM acetic acid. The fact that the concentration of lactic
and acetic acid in the B. longum ITT 13 fermentate is higher than in the pH 4.3 MRSc broth
used as a comparison in the antifungal studies, would suggest that further studies with variable
acid concentrations would be beneficial in elucidating the full effect of the organic acids
present in the antifungal activity. B. animalis subsp. lactis A026 which displayed antifungal
activity against various moulds, was determined to have a concentration of 70.5 ± 1.1 mM
lactic acid and 91.6 ± 1.0 mM acetic acid present in the fermentate when cultured in MRSc
broth and 4.9 ± 0.4 mM lactic acid and 40.9 ± 1.5 mM acetic acid when cultured in skim milk
(Fernandez et al., 2017). The concentrations of lactic and acetic acid produced by B. animalis
subsp. lactis A026 in this study are higher in the fermentate cultured in MRSc broth than the
acids in the 1/2 dilutions of the B. longum ITT 13 fermentate which is the first dilution on the
MIC50 plate. However, the concentrations of the lactic and acetic acids in the skim milk
fermentate produced by B. animalis subsp. lactis A026 are lower than the concentrations of the
acids in the B. longum ITT 13 fermentates at the 1/2 dilution in the fungal MIC50 plates, yet the
skim milk fermentate still displayed antifungal activity. This indicates that concentrations of
the lactic and acetic acids lower than those present in the B. longum ITT 13 fermentate are
capable of demonstrating detectable antifungal activity. Another study demonstrated that
concentrations of acetic acid as low as 20 mM in pH 4 media displayed antifungal activity
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against Penicillium nordicum PFE 487 (Schillinger and Villarreal, 2010). C. albicans SC55314
displayed increasing levels of susceptibility to acetic acid from 40-75 mM at pH 4.0-4.5
(Lourenço et al., 2019), which is comparable to the concentration of acetic acid present in the
ITT 13 fermentates (70-80 mM) at the 1/2 dilution, at which C. albicans ATCC 2091 was
inhibited (Figure 3.15). S. cerevisiae has displayed higher tolerances to acetic acids with MIC
values of 110-180 mM (Stratford et al., 2013) and these results are in agreement with those
observed for the B. longum ITT 13 pH 4.3 and pH 4.8 fermentate's at the 1/2 dilutions in the
MIC50 assays. The concentration of acetic acid in the B. longum ITT 13 fermentates was
significantly lower than 110-180 mM at the 1/2 dilution in the microtitre plates (73.9 mM in
the pH 4.35 fermentate and 80.5 mM in the pH 4.80 fermentate at the 1/2 dilution), it offers an
explanation to why there was minimal inhibition of the S. cerevisiae strains with no MIC50
detected (Figures 3.16 and 3.17).
The results generated in the MIC50 testing of the 4 selected indicator fungal strains display
varying levels of susceptibility to both the B. longum ITT 13 pH 4.3 fermentate and the
fermentate at pH 4.8. Significant concentrations of acids are now known to be produced by B.
longum ITT 13 which may result in the observed antifungal activity and further studies are
required to establish the potency of the acid concentrations present.
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CHAPTER 4
Physicochemical Characterisation of Bifidobacterium
longum ITT 13 Antimicrobial Activity
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Characterisation of antimicrobial activity produced by bacteria is an important aspect of
research to determine suitability of bacteria or their metabolites for use in food production or
probiotic application. Characteristics such as thermal stability and pH stability are important
for molecules that can be used in food applications with potential as biopreservatives, due to
high food processing temperatures and various pH processing conditions of food, or the low
pH of fermented food products (Johnson et al., 2018; Bagde and Vigneshwaran, 2019; Castilho
et al., 2020). Bacteria for consideration as probiotics should also be tolerant of low pH for
transition through the stomach and gastrointestinal system (Mahmoudi et al., 2013). As
Bifidobacteria and other LAB strains such as Lactobacilli and Pediococci have been shown to
produce both organic acids and antimicrobial peptides or bacteriocins contributing to
antimicrobial activity (Yildirim and Johnson, 1998; Collado et al., 2005; Yang et al., 2012; Liu
et al., 2015; Delgado et al., 2019; Lourenço et al., 2019; Skariyachan and Govindarajan, 2019),
it is also an important factor to characterise the metabolites contributing to any antimicrobial
activity produced by bacteria. B. longum ITT 13 has been shown to display antibacterial and
antifungal activity, therefore the stability and the properties of this antimicrobial activity were
investigated within this chapter through physiochemical characterisation.
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Results:
4.1 Thermostability Assay of B. longum ITT 13 Fermentate
Food preservation is an important area of human health as improper preservation can result in
human illness and disease outbreaks associated with spoilage organisms (Linscott, 2011;
Singh, 2018). For consideration of the application of antimicrobial peptides in food
preservation, heat stability is an important characteristic as the food industry can involve the
use of high processing temperatures, as stated by Bagde and Vigneshwaran (2019). The
stability of the antimicrobial activity produced by B. longum ITT 13 was assessed from -20oC
to 70oC to determine the effect of heat and storage at various temperatures on the stability of
the antimicrobial activity displayed by the organism.
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Figure 4.1: The antimicrobial activity (AU/ml) of B. longum ITT 13 cell free fermentate incubated at 20oC to 70oC over a 28-day period. The microtitre plate (MIC) procedure (Section 2.8.4) with S. xylosus as
the indicator strain, was used for analysis. AU/ml was calculated as describe in Section 2.8.2. Standard deviations
were determined for a minimum of three independent assays (n=3).

The control used for the experiment was the antimicrobial activity associated with the B.
longum ITT 13 fermentate as measured prior to incubation at any of the temperatures and gave
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an average value of 124.4 AU/ml ± 42.1.
The fermentate stored at the -20oC incubation temperature had a measurement of activity with
an average of 173.3 AU/ml ± 78.7 after 1 day of incubation, which is slightly higher than the
value recorded from the control, however there is notable deviation between replicates due to
the larger error bars for the replicate samples. The activity of the -20oC incubated ITT 13
fermentate drops below the activity of the control after 2 days incubation to an average of 93.3
AU/ml ± 32.7, where it then fluctuates between 80.0 AU/ml ± 0 and 93.3 AU/ml ± 32.7 for the
rest of the time period up to 28 days. The highest activity was thus retained after 1 day of
incubation at -20oC and there was no percent loss after the first day of incubation relative to
the control. Over the 2-28 day incubations there was between 25% and 36% loss of activity
determined in comparison to the control value which was taken as 100% antimicrobial activity
with 124.4 AU/ml.
The B. longum ITT 13 fermentate incubated at 4oC had an average of 213.3 AU/ml ± 82.6 after
1 day of incubation, higher than the control but again comparable as the standard deviation is
large and indicates some replicates were equivalent to the control and some higher. The
antimicrobial activity retained after 2 days (133.3 AU/ml ± 41.3) was also equivalent to the
non-incubated control. It then dropped below the control to an average of 106.7 AU/ml ± 41.3
after 7 days incubation (14% loss), where it remained below the control and fluctuated between
80.0 and 106.7 ± 41.3 AU/ml up to 21 days, before climbing to 120.0 AU/ml ± 43.8 after 28
days. The highest antimicrobial activity was observed within the first two days of incubation
at 4oC, before remaining consistently below the activity of the control by 4-44 AU/ml for the
remainder of the 28-day incubation equivalent to between 3-36% losses relative to the control
of 100% activity. As the percent loss was equivalent to 36% after 21 days incubation at 4 oC,
yet there was minimal loss of activity determined at 28 days with only approximately 3% loss,
this indicates that with the large standard deviation taken into account for the antimicrobial
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activity at some latter timepoints (i.e. day 28) the loss of activity was not consistent at the 4oC
incubation temperature.
The fermentate was also incubated at room temperature, which was monitored as being
between 20oC and 24oC over the evaluation time. The fermentate incubated at room
temperature had an average of 186.7 AU/ml ± 65.3 after 1 day of incubation, which although
slightly higher than the control, the error bars associated with the replicates indicated no
substantial reduction or change in antimicrobial activity relative to the control. After 2 days
incubation the activity dropped to 146.7 AU/ml ± 32.6, which is slightly higher than the value
for the control antimicrobial activity (124.4 AU/ml ± 42.2), however when the error bars are
taken into consideration, there is no significant difference between the control and the samples
incubated at room temperature over the two-day period. After 7 days incubation the activity
dropped below that of the control (124.4 AU/ml ± 42.2) to 80 AU/ml ± 0 (36% loss of activity)
where it again remained below the control between 80 AU/ml ± 0 and 106.7 AU/ml ± 41.3 for
the remainder of the 28-day assay, equivalent to between 14% and 36% losses of activity. The
results would indicate that there is no significant loss of activity over the first 2 days incubation
at room temperature, however when incubating between 7 and 28 days there is a consistent
drop in antimicrobial activity below the average of the control of between 14-36%.
The 37oC incubated B. longum ITT 13 fermentate was equivalent to the control (124.4 AU/ml
± 42.2) after 1-day incubation with an average of 120.0 AU/ml ± 43.8, which dropped to 106.7
AU/ml ± 42 after 2 days (14% loss of antimicrobial activity relative to the control) and then to
80.0 AU/ml ± 0 after 7 days (36% loss). It fluctuated between 80 AU/ml ± 0 and 93.3 AU/ml
± 32.7 between 7 and 28 days incubation and thus retained the highest activity after 1-2 days
incubation, as losses of activity of between 25% and 36% were observed between 7 and 28
days incubation.
The values for antimicrobial activity retained after incubation at the 55oC and 70oC
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temperatures were both equivalent to the control of 124.4 AU/ml ± 42.2 after 1 day of
incubation with 133.3 AU/ml ± 41.3 determined for both incubation temperatures, indicating
initial stability at these temperatures. Apart from the antimicrobial activity measured after 7
days incubation at 55oC (93.3 AU/ml ± 32.7, equivalent to a 25% loss in activity), the activity
of the fermentate never dropped notably below the control and began to increase in activity
after 14 days incubation for both the 55oC and 70oC temperatures. At the 55oC incubation
temperature, the 14-day and 21-day incubations both displayed an increase in activity of 120.0
AU/ml ± 43.8 (3% loss) for both days compared to the 93.3 AU/ml ± 32.7 observed at 7-days.
The antimicrobial activity increased again after 28 days to 133.3 AU/ml ± 41.3 – demonstrating
a gradual increase in activity from days 7-28. The increase in antimicrobial activity was also
observed for the 70oC incubation temperature, with a slight drop to 120.0 AU/ml ± 43.8 after
7 days incubation and an increase to 160.0 AU/ml ± 0 observed for the remaining timepoints
of day 14 to day 28. The lack of any standard deviation indicates no variation in the increased
antimicrobial activity of 160.0 AU/ml at days 14-28 for the 70oC incubation, relative to the
control of 124.4 AU/ml. The increase in antimicrobial activity after 14 days for both incubation
temperatures was the result of a concentration effect observed due to evaporation of the
fermentate at these higher temperatures after multiple weeks of incubation.
There is large fluctuation in antimicrobial activity observed over the 28-day period with the
highest levels of activity concentrated in the first 1-2 days for the -20oC, 4oC, room temperature
(20-24oC) and 37oC, indicating a trend of the highest retention and stability of antimicrobial
activity within 48 hours of incubation at a variety of temperatures. The 4oC incubation
temperature generated the least consistent reduction of antimicrobial activity in terms of
percent loss relative to the control, as it displayed a 36% loss after 21-days incubation however
this increased to only a 3% loss after 28-days, which was similar in activity to the control. The
3% loss at 28-days thus indicated no consistent reduction in antimicrobial activity over the 28
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day storage period at 4oC as this temperature generated the lowest overall losses in activity,
with the exception of the 55oC and 70oC incubation temperatures which were not accurately
comparable due to the evaporation resulting in increased antimicrobial activity.
Statistical analysis using a two-way ANOVA with Dunnet’s multiple comparison assay
resulted in no significant difference between the antimicrobial activity of the fermentate at
any temperature or timepoint and the antimicrobial activity of the control. This absence of
statistical significance for the antimicrobial activity of any timepoint/temperature likely
indicates that temperature does not impact the active agents as the large standard deviation
indicates there was no consistent pattern of reduction of antimicrobial activity for many
samples. Although there was no statistical significance as previously mentioned, a biological
trend was observed for all samples stored at -20oC to 37oC, whereby the maximum
antimicrobial activity was retained for the first 48 hours of storage at each of these
temperatures, before successively dropping to lower levels of activity, which is elaborated on
in discussion Section 4.6.1.
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4.2 pH Stability of B. longum ITT 13 Fermentate
pH stability is an important characteristic of potential biopreservatives due to the wide variety
of matrices and pH processing conditions of food (Johnson et al., 2018; Castilho et al., 2020).
The ability for biopreservation at low pH is important in foods that may contain a starter
culture, such as cheese, which has been shown to decrease in pH over storage time with an
increase in acid production likely as a result of starter culture bacteria or lactic acid bacteria
incorporation into the foodstuff, which was observed by both Ong and Shah, (2009) and
Ulpathakumbura et al., (2016). Stability of activity and tolerance at a low pH is also an
important characteristic of probiotic bacteria, which should be stable enough to resist passage
through the gastrointestinal tract (Mahmoudi et al., 2013) and metabolites such as bacteriocins
should be stable enough to retain activity at a variety of food processing conditions including
pH (Castilho et al., 2020).
4.2.1 pH Stability with HCl and NaOH
The B. longum ITT 13 fermentate was assessed for stability under a variety of pH conditions.
Following fermentation without pH control of the B. longum ITT 13 and heat inactivation to
produce the fermentate (Section 2.4.2) the pH of the fermentate is approximately pH 4.2-4.3.
Antimicrobial activity is detectable at this low pH (Section 3.3). The aim of this section of
work was to assess the effectiveness of the antimicrobial activity at various pH values,
including neutral and basic pH conditions, with the view to potential applicability for use as a
biopreservative in the food industry. Preliminary screening for pH stability was carried out
with HCl and NaOH, rather than with lactic acid (Section 2.9.3) to provide a general evaluation
of the stability of the activity of the fermentate as preliminary work. The fermentate was
adjusted to pH 3-8 using HCl (0.3 M) and NaOH (0.3 M) (described in Section 2.9.2). The
results for the antimicrobial activity detected at the various pH values, where the pH was
adjusted with HCl and NaOH, are presented in Table 4.1.
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Table 4.1: The stability of the antimicrobial activity of the B. longum ITT 13 fermentate adjusted to pH
3-8 with HCl and NaOH.
Fermentate
No pH Adjustment
(pH 4.15)

Hours
Activity of Fermentate
0
++
2
++
24
++
pH 3.18
0
+++
2
+++
24
+++
pH 4.02
0
++
2
++
24
++
pH 5.85
0
2
24
pH 6.38
0
2
24
pH 7.96
0
2
24
- = No antimicrobial activity, + = 1.5-3.0 mm, ++ = 3.1-4.5 mm, +++ ≥ 4.6 mm.

Activity of MRSc (pH Adj.)
N/A
N/A
N/A
+
+
+
-

In Table 4.1, antimicrobial activity was retained for the fermentate adjusted to pH 3.18 and
4.02, and lost at pH adjustment to pH 5.85, 6.38 and 7.96. The zones of inhibition measured
on the M/D plates averaged at ≥ 4.6 mm for the pH 3.18 adjusted fermentate, however there
were smaller zones of inhibition observed for the MRSc broth at the same pH with zones
between 1.5-3.0 mm in diameter (+), indicating that at pH 3.18 there is an antimicrobial effect
associated with the pH conditions. The latter pH adjustment for the fermentate required 0.07
M HCl concentration which could be contributing to the antimicrobial activity present on the
M/D plates.
Antimicrobial activity was observed with zones of inhibition between 3.1-4.5 mm for the
fermentate adjusted to pH 4.02. There was no activity associated with the MRSc broth at pH
4.02, indicating that the measured antimicrobial activity is only associate with something
present within the fermentate and not just specifically pH effect. The zone size of the pH 4
fermentate was similar to the zone for the unadjusted fermentate with zones of inhibition
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measured against the S. xylosus indicator strain of between 3.1-4.5 mm for the latter unadjusted
fermentate on the M/D plates.

4.2.2 pH Stability with Lactic Acid and NaOH
In addition to the use of HCl to adjust the pH, it was decided to also adjust the pH of the
fermentate using lactic acid, given that it is one of the acids that is produced by the
heterofermentative bacterial strain (Makras and De Vuyst, 2006; Ruiz-Aceituno et al., 2020).
The fermentate was adjusted to pH 3, 4, 5 and 6, however as no antimicrobial activity was
detected at the pH values of pH 5 and pH 6 of the pH adjusted fermentate (Figure 4.2), only
the pH 3 and pH 4 results were graphed and presented with statistical analysis carried out.
Subsequent work in our research lab has shown that B. longum ITT 13 fermentate produced
following pH controlled incubation in an optimised yeast peptone glucose (YPD) produces a
fermentate that is active at pH 5 and above when screened using the microtitre plate (MIC)
assay (C. Whelan personal communication).
Three independent assays (n=3) for each pH value and time point were carried out using the
microdiffusion assay with S. xylosus as the indicator strain. The volume of lactic acid or NaOH
used to adjust the pH of the B. longum ITT 13 fermentate to either pH 3, 4, 5 or 6 was added
to MRSc broth pH previously adjusted to pH 4.3 (similar starting pH to the fermentate) and to
MRSc broth with no pH adjustment (initially pH 6.18), as controls to ascertain the activity of
the pH adjusted fermentate screened in this assay was not solely associated with the pH
adjustment (described in detail in Section 2.9.3). For example, the fermentate adjusted to pH 3
had 5.7 mls L.A. to adjust to pH 3, so this volume was also added to the MRSc broth previously
adjusted to pH 4.3, as a direct control for the pH 3 fermentate. The same volume of L.A. was
also added to MRSc broth that was left at its original pH (pH 6.18) to determine the activity
solely associated with acid added to adjust the pH of the fermentate.
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a)

b)

c)

d)

Figure 4.2: pH Stability of the B. longum ITT 13 fermentate at pH 3.08, 4.00, 5.20 and 6.12 at a) 0
hours, b) 2 hours, c) 4 hours and d) 24 hours. The M/D assay plates with S. xylosus indicator strain were
carried out as three independent assays (n=3) to allow for standard deviation (SD) calculation. Zones of inhibition
were measured in mm and the results are presented in Figures 4.3 and 4.4.

Zones of inhibition were detected for the B. longum ITT 13 fermentate after pH adjustment to
pH 3 and pH 4 and incubation over the 24-hour time period, however no antimicrobial
activity was detected for the fermentate adjusted to pH 5 or pH 6 at any time point. The zones
of inhibition of the pH adjusted fermentate to pH 3 and pH 4 and associated controls are
presented and described in Figures 4.3 and 4.4.
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Figure 4.3: The Zones of Inhibition (mm) of the B. longum ITT 13 Fermentate at pH 3.08 from 0-24
Hours. The fermentate was adjusted with 5.7 mls of lactic acid (L.A.) to adjust to pH 3.08. The controls were
MRSc broth pH 6.18 (original pH) with an added 5.7 mls of lactic acid, MRSc broth initially adjusted to pH 4.32
then with a further addition of 5.7 mls of lactic acid and Nisin (1000 IU/ml) as per Section 2.9.3. Three independent
M/D assays (n=3) (Section 2.6) with S. xylosus as the indicator strain were carried out to determine standard
deviation. Zones of inhibition were measured in mm. Tukeys multiple comparison assay was carried out with the
pH 3.08 fermentate compared to the fermentate with no pH adjustment and the pH 4.32 MRSc + 5.7 mls L.A. *
= p-value ≤ 0.05, ** = p-value ≤ 0.01, *** = p-value ≤ 0.001, **** = p-value ≤ 0.0001.

Figure 4.3 displays the activity of the B. longum ITT 13 fermentate at pH 3.08 from 0-24
hours in terms of zone of inhibition (mm). The zones of inhibition (mm) of the fermentate at
pH 3.08 were larger (5.0-5.8 mm) than those of the pH 4.3 MRSc broth + 5.7 mls of lactic
acid (4.5-5.2 mm) at each timepoint (p < 0.05). This is of importance, as these samples are
directly comparable given that the MRSc broth was adjusted to pH 4.32 to match the pH of
the unadjusted fermentate, and both the fermentate and MRSc broth were then adjusted
further with 5.7 mls of lactic acid – bringing the pH of both samples to pH 3 (as described in
Section 2.9.3). As the zone of inhibition of the fermentate was larger than the MRSc broth
with which it is comparable, this indicates it may not just be a pH effect causing
antimicrobial activity against the S. xylosus. The activity of the pH 3.08 fermentate is not
reduced over time and appears to increase at each time point, however this is likely due to
random variation on the M/D plates as the nisin zones of inhibition also increase over time.
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Figure 4.4: The Zones of Inhibition (mm) of the B. longum ITT 13 Fermentate at pH 4.00 from 0-24
Hours. The fermentate was adjusted with 0.7 mls of lactic acid (L.A.) to adjust to pH 4.27. The controls were
MRSc broth pH 6.18 (original pH) with an added 0.7 mls of lactic acid, MRSc broth initially adjusted to pH 4.32
with a further addition of 0.7 mls of lactic acid and Nisin (1000 IU/ml) as per Section 2.9.3. Three independent
M/D assays (n=3) (Section 2.6) with S. xylosus as the indicator strain were carried out to determine standard
deviation. Zones of inhibition were measured in mm. Tukeys multiple comparison assay was carried out with the
pH 4.00 fermentate compared to the fermentate with no pH adjustment and the pH 4.32 MRSc + 0.7 mls L.A.
**** = p-value ≤ 0.0001.

The inhibition zones of the B. longum ITT 13 fermentate at pH 4.00 were considerably larger
in size (4.2-4.9 mm) than those of the MRSc broth at pH 4.32 with 0.7 mls of lactic acid
added (2.2-2.3 mm), as observed in Figure 4.4, with p-values of <0.05 providing statistical
significance. Again these two samples are directly comparable as the MRSc broth was
initially adjusted to pH 4.32 to match the pH of the unadjusted fermentate (pH 4.27), and
both the fermentate and MRSc broth were then adjusted further with 0.7 mls of lactic acid –
b) in Section 2.9.3). The zones of
bringing the
a) pH of both samples to pH 4 (as described

inhibition for the pH 4.00 fermentate did not decrease over the time period tested and in fact
appeared to increase at each timepoint (4.2 mm at 0 hours compared to 4.9 mm at 24 hours),
however this is likely due to random variation on the M/D plates, as the zones of inhibition
for the nisin standards also increased slightly zones over the time points, for both the pH 4.00
fermentate assay the pH 3.08 fermentate assay in Figure 4.3.

c)
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d)

4.3 Ammonium Sulphate Precipitation of the B. longum ITT 13 Fermentate
Bifidobacteria have been shown in many studies to exert an antimicrobial effect through the
production of compounds including organic acids and bacteriocins and the antimicrobial effect
exerted by these compounds subsequently aids in a competitive advantage for the producing
bacteria in relation to access and competition for nutrients and additionally maintenance of a
healthy intestinal microflora through the inhibition of colonisation by pathogens (Lee and
O’Sullivan, 2010). Inhibition of pathogenic bacteria in the gut by these compounds and
favourable growth of the microflora is also an important characteristic of bacteria for
consideration as probiotic strains, as is the safety and GRAS status of the producing strain
(O’Shea et al., 2012; Guinane et al., 2016; Choudhary et al., 2019). Bacteriocins are
ribosomally synthesised peptides produced by a variety of bacteria that display broad or narrow
spectrum inhibitory activity towards other bacterial and fungal strains (Lee and O’Sullivan,
2010; Indira, T. C. Venkateswarulu, et al., 2018; Ruggirello et al., 2018; Zou et al., 2018;
Vaičikauskaitė et al., 2019). Bacteriocin production by probiotic bacteria could offer the
potential for use in biopreservation, with the bacteriocin Nisin produced by the lactic acid
bacterium Lactococcus lactis already approved for use as a food preservative in over 50
countries (Gyawali and Ibrahim, 2014). A method for crude purification or isolation of
antimicrobial peptides present in the supernatant of producing bacteria is ammonium sulphate
(AS) precipitation. This method involves interference with the proteins water solubility causing
precipitation by increasing hydrophobic interactions and maintaining the protein conformation
(Wingfield, 2001). This method has been widely employed to extract the antimicrobial peptides
or bacteriocins produced by bacteria (Contreras et al., 1997; Afshan Naz, Sheikh and Rasool,
2013; Ansari et al., 2018; Ahmad et al., 2019; Skariyachan and Govindarajan, 2019).
In order assess for the presence of any proteinaceous molecules that could be contributing to
the antimicrobial activity produced by B. longum ITT 13 ammonium sulphate precipitation was
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carried out as described in Section 2.9.1.3 and tested using Microtitre plates. Ammonium
sulphate precipitation had previously been carried out and tested using the M/D assay as
described in Sections 2.9.1.1 and 2.9.1.2 however the results were inconclusive. It was decided
to further carry out the ammonium sulphate precipitation and test the B. longum ITT 13
fermentate using the more sensitive microtitre plate testing method due to increased sensitivity
of the assay (Section 2.9.1.3). The ammonium sulphate precipitation was carried out on 40 ml
aliquots of B. longum ITT 13 cell free fermentate (CFS) (pH 4.3). Ammonium sulphate was
brought up to 20%, 40%, 60% and 80% saturation in separate aliquots of the CFS and
precipitated pellets were resuspended in 50 mM pH 4.3 sodium acetate buffer. As the original
fermentation was carried out in MRSc broth an equivalent ammonium sulphate precipitation
fractionation was carried out with the MRSc media as a control to ensure that if any
antimicrobial activity was detected, then it could not be associated with the protein fractions
present in the actual media itself. No antimicrobial activity was found in the 20%, 40% and
60% ammonium sulphate fractionation of the fermentate when tested in an microtitre plate
assay (Section 2.8.4) (Figure 4.5A, 4.5B, 4.5C). Testing of the 80% fraction showed some lowlevel antimicrobial activity present when testing the fraction against the indicator strain S.
xylosus (Figure 4.5D). S. xylosus was the only indicator strain selected for the AS precipitation
assay as the objective of this experiment was to ascertain whether any proteinaceous material
was responsible for antimicrobial activity, and not to determine a spectrum of bacteria
susceptible to any antimicrobial peptides.
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Figure 4.5: Evaluation of the supernatant precipitated with saturations of a) 20%, b) 40%, c) 60% and
d) 80% ammonium sulphate. Three independent (n=3) microtitre plate (MIC) assays were carried out (Section
2.8.4) and used to determine standard deviations. The growth of the indicator strain S. xylosus is represented as
the OD600 nm and the dilution of the resuspended pellets is observed on the x-axis. Statistical analysis was carried
out using a paired t test to compare the test sample and control. **** = p-value <0.0001.

For the 20%, 40%, 60% and 80% that no growth of the indicator strain S. xylosus was detected
for either the 1/2 or the 1/4 dilution for all 4 ammonium sulphate saturation samples for either
of the fermentate or the MRSc broth samples. This is likely associated with either the dilution
of nutrients in the Muller Hinton broth that the S. xylosus cells were seeded into the plates with
or the ammonium sulphate salts used as they were not possible to remove prior to testing, hence
the use of the MRSc broth saturated to the same AS percentages. Growth of the indicator strain
S. xylosus was detected for the 1/4 dilution samples in all four AS saturation samples tested, as
observed for the 20%, 40% and 60% fermentate and MRSc broth samples and the 80% MRSc
broth sample. The growth pattern detected in the microtitre plates is the same for every dilution
of both the fermentate and the MRSc broth samples at 20%, 40% and 60% saturation, indicating

149

no antimicrobial molecules were isolated from the fermentate at these AS saturations as there
was no difference to the MRSc negative control. At the 1/8 dilution of the 80% saturation
however, there is inhibition caused by the resuspended fermentate pellet that is not observed
for the resuspended MRSc pellet, with a p-value of <0.0001. This is not observed for any
dilution at any other AS saturation, whereby the inhibition and growth patterns observed for
the S. xylosus indicator strain in the microtitre plates was the same for both the fermentate and
MRSc broth at 20, 40 and 60% saturations. This inhibition observed by the fermentate for the
80% AS saturation that was not observed for the MRSc at the same saturation is likely
indicative of a low molecular weight proteinaceous molecule (Wingfield, 2001) causing
antimicrobial activity, and this experimental finding is further evaluated in Section 4.4 which
describes the use of protease digestion in determining whether some or all of the antimicrobial
activity present in the fermentate is associated with proteinaceous molecule(s).
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4.4 Protease Digestion
Protease digestion, which uses various enzymes such as Proteinase K, trypsin and Actinase E,
to cleave and inactivate protein structures, is commonly employed to validate the presence and
assess the stability of bacteriocin production by various bacteria (Gautam and Sharma, 2015;
Pilasombut et al., 2015; Biswas et al., 2017; Lv et al., 2018; Ahmad et al., 2019). Nisin is a
bacteriocin that is currently used in food preservation (Gyawali and Ibrahim, 2014), and is
digested by the protease enzymes Proteinase K and Actinase E (Matsusaki et al., 1998).
Proteases inactivate proteins through the cleavage of peptide bonds; the site of cleavage by the
Proteinase K enzyme is the peptide bond adjacent to the carboxyl group of aliphatic and
aromatic amino acids with blocked alpha amino groups (Proteinase K | Sigma-Aldrich;
Saenger, 2013), while Actinase E, (also known as pronase E) exerts hydrolysis on the carboxyl
side of glutamic or aspartic acid (Pronase E | Sigma-Aldrich). Both Proteinase K and Actinase
E are stable from pH 4 above (Proteinase K | Sigma-Aldrich, no date; Sigma-Aldrich, no date;
Saenger, 2013).
Protease digestion was carried out on the B. longum ITT 13 fermentate as described in Section
2.9.5 to further validate that some of the antimicrobial activity produced by the strain was
proteinaceous in nature. A positive result for the presence of antimicrobial peptides would
cause either partial or complete loss of antimicrobial activity. Proteinase K and Actinase E
(each at 5 mg/ml) were the proteases selected due to their capability for digesting nisin, which
was used as the positive control in the assay (Matsusaki et al, 1998). The microtitre plate (MIC)
procedure (Section 2.8.4) was used to evaluate the antimicrobial activity of the digested
fermentate (1:1 sample:protease) in comparison with fermentate diluted 1/2 with PBS (the
buffer for protease preparation), with the dilutions carried out so that the concentrations in the
samples of digested and undigested were equivalent in relation to each other thus allowing for
direct comparison.
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4.4.1 Proteinase K Digestion
The results for the proteinase K digestion as described in Section 4.4 are presented in Figures
4.6 (nisin), 4.7 (B. longum ITT 13 fermentate pH 4.35) and 4.8 (B. longum ITT 13 fermentate
pH 4.80).

Nisin (1000 iu/ml) Digested with Proteinase K
2.0

Nisin (1000 iu/ml) Diluted
1/2 with PBS

OD600

1.5
1.0

Nisin (1000 iu/ml)
Digested 1/2 with
Proteinase K

0.5

0.02N HCl:PBS 1:1
(Growth Control)

0.0
1/4

1/8

1/16 1/32 1/64 1/128 1/256

Figure 4.6: The antimicrobial activity detected for undigested and proteinase K digested nisin (1000
IU/ml) against S. xylosus. The assay was carried out using the microtitre plate procedure (Section 2.8.4) with
S. xylosus as the indicator strain. Standard deviations (SD) were determined for three independent assays (n=3).
The initial dilution is 1/4 as the samples for testing had already been diluted 1/2 with PBS/Proteinase K. The
growth control consisted of a 1:1 ratio of 0.02N HCl:PBS as this is equivalent to the solvent combination present
in the 1:1 of nisin:Proteinase K therefore allowing for accurate dilution of the nutrients in the MH broth used for
the S. xylosus indicator strain in both the growth control and test samples.

It was observed that undigested nisin displays antimicrobial activity up to a 1/16 dilution, while
the digested nisin showed reduced growth inhibition of the S. xylosus and resulted in inhibition
up to a 1/8 dilution.
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Figure 4.7: The antimicrobial activity detected for undigested and proteinase K digested B. longum ITT
13 fermentate at pH 4.35 and controls. The initial dilution is 1/4 as the samples for testing had already been
diluted 1/2 with PBS/Proteinase K. Standard deviations were determined for a minimum of three independent
assays (n=3). ns = non-significant p-value >0.05. The growth control consisted of a 1:1 ratio of MRSc:PBS as this
is equivalent to the combination present in the 1:1 of fermentate:Proteinase K therefore allowing for accurate
dilution of the nutrients in the MH broth used for the S. xylosus indicator strain in both the growth control and test
samples. Nisin (1000 iu/ml) diluted 1/2 with PBS, which is equivalent to the digested and diluted fermentate
samples, was used as a positive control for antimicrobial activity.

Both the undigested and digested pH 4.35 fermentate displayed a similar pattern of inhibition
of the S. xylosus, with antimicrobial activity observed up to the 1/16-1/32 dilutions for both
samples and no inhibition detectable on the plate for the 1/64 dilution. P-values for the activity
of the undigested fermentate in comparison to the digested fermentate at the 1/4-1/32 dilutions
were p > 0.05, which indicated that there was no reduction in activity as a result of protease
digestion with the Proteinase K of the pH 4.35 fermentate. The p-values were only determined
for these dilutions as they displayed the largest difference in the growth of the S. xylosus
indicator strain between the undigested and digested fermentate.
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Figure 4.8: The antimicrobial activity detected for the undigested and proteinase K digested B. longum
ITT 13 fermentate at pH 4.80 and controls. The initial dilution is 1/4 as the samples for testing had already
been diluted 1/2 with PBS/Proteinase K. Standard deviations were determined for a minimum of three independent
assays (n=3). ns = non-significant p-value >0.05. The growth control consisted of a 1:1 ratio of MRSc:PBS as this
is equivalent to the combination present in the 1:1 of fermentate:Proteinase K therefore allowing for accurate
dilution of the nutrients in the MH broth used for the S. xylosus indicator strain in both the growth control and test
samples. Nisin (1000 iu/ml) diluted 1/2 with PBS, which is equivalent to the digested and diluted fermentate
samples, was used as a positive control for antimicrobial activity.

It is observed in Figure 4.8 that the antimicrobial activity of the undigested fermentate begins
to reduce at approximately a 1/8-1/16 dilution and inhibition is lost completely between a 1/161/32 dilution. This pattern of antimicrobial activity is also observed for the digested fermentate
indicating the Proteinase K digestion did not reduce or eliminate antimicrobial activity. It is
also evident that all antimicrobial activity of nisin is lost at a 1/16 dilution. Statistical analysis
was carried out using a one-way ANOVA with Tukey’s multiple comparison test and no
significant difference in activity between the undigested and digested fermentate was detected
(p > 0.05), further validating that the incubation with the Proteinase K did not result in any loss
of antimicrobial activity of the fermentate.
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4.4.2 Actinase E Digestion
The Actinase E digestion as described in Section 4.4 is presented in Figures 4.9 (nisin), 4.10
(B. longum ITT 13 fermentate pH 4.35) and 4.11 (B. longum ITT 13 fermentate pH 4.80).
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Figure 4.9: The antimicrobial activity of undigested and actinase E digested nisin. The initial dilution is
1/4 as the samples for testing had already been diluted 1/2 with PBS/Actinase E. Three independent assays (n=3)
were used to determine standard deviation. The growth control consisted of a 1:1 ratio of 0.02N HCl:PBS as this
is equivalent to the solvent combination present in the 1:1 of nisin:Actinase E therefore allowing for accurate
dilution of the nutrients in the MH broth used for the S. xylosus indicator strain in both the growth control and test
samples.

The nisin digested with Actinase E resulted in good growth of the S. xylosus indicator strain
with an OD600 between 1.5-2.0, which tapered off slightly at the higher dilutions of 1/1281/256. The activity of the nisin digested with Actinase E showed the bacteriocin to be
completely inactivated for the 1/4 and 1/8 dilutions, with an MIC50 for the 1/8 dilution. In
comparison, the undigested nisin displayed inhibition at both the 1/4 and 1/8 dilutions, with
growth for the indicator strain returning for the 1/16 dilution with an average OD600 of 1.40.
The growth also tapered off at higher dilutions of the undigested nisin before reaching an
average OD600 of 0.48 at the 1/256 dilution. The Actinase E enzyme was therefore active as
growth of the indicator strain S. xylosus was not inhibited for the nisin digested by the Actinase
E enzyme in comparison with the undigested nisin. The latter result indicates that the nisin, as
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the positive control for the enzymatic reaction, was digested by the Actinase E enzyme with
the concomitant loss of antimicrobial activity.
Higher levels of growth are noted for all dilutions for the S. xylosus in figure 4.9 when it was
grown in the presence of samples containing the undigested nisin in comparison to the growth
control, which only contains PBS. The higher level of growth may be associated with additional
nutrient being supplied into the minimal Muller Hinton growth media that the nisin provides
when either inactivated by the protease or by higher dilutions. This may also account for why
the growth of the S. xylosus indicator strain tapers at the highest dilutions of both the digested
and undigested nisin, as the nisin is diluted out.
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Figure 4.10a: The Antimicrobial Activity of Undigested and Actinase E digested B. longum ITT 13 pH
4.35 Fermentate. The initial dilution is 1/4 as the samples for testing had already been diluted 1/2 with
PBS/Actinase E. Standard deviations were determined for three independent assays (n=3). ns = non-significant pvalue >0.05. The growth control consisted of a 1:1 ratio of MRSc:PBS as this is equivalent to the combination
present in the 1:1 of fermentate:Actinase E therefore allowing for accurate dilution of the nutrients in the MH
broth used for the S. xylosus indicator strain in both the growth control and test samples. Nisin (1000 iu/ml) diluted
1/2 with PBS, which is equivalent to the digested and diluted fermentate samples, was used as a positive control
for antimicrobial activity.

Nisin inhibited growth at the 1/4 and 1/8 dilutions and the growth of the indicator strain at
higher nisin dilutions was reduced slightly and as described previously for figure 4.9, may be
indicative of less nutrients being added from the inactivated/diluted nisin solution into the
Muller Hinton media. The growth of the indicator strain was inhibited by both the undigested
and the digested pH 4.35 fermentate up to a 1/16 dilution, with inhibition lost completely by
both samples at the 1/32 dilution. However, although the undigested pH 4.35 fermentate
completely inhibited the S. xylosus at the 1/16 dilution, the digested pH 4.35 fermentate did
not completely inhibit the growth at the same dilution and minor growth of the S. xylosus was
observed with an average OD600 value of 0.11. This indicates a small reduction in the
antimicrobial activity for the Actinase E digested pH 4.35 fermentate at the 1/16 dilution, in
comparison to the undigested pH 4.35 fermentate. The results for the Actinase E digested and
undigested samples at the aforementioned 1/16 dilution, together with the controls, are further
evaluated in the box plot presented in Figure 4.10b below.
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Figure 4.10b: A box Plot Displaying the Enlargement of the 1/16 dilution from Figure 4.10a of the B.
longum ITT 13 pH 4.35 Fermentate Digested with Actinase E. Standard deviations were determined for
three independent assays (n=3). ns = non-significant p-value >0.05.

As observed in Figure 4.10a, the digested B. longum ITT 13 pH 4.35 fermentate did not
completely inhibit the growth of the indicator at the 1/16 dilution and minor growth was
observed with an average OD600 value of 0.11 in comparison to an average OD600 of 0.02 for
the undigested pH 4.35 fermentate. Although minor growth was observed for the S. xylosus
with the Actinase E digested pH 4.35 fermentate, it did not significantly reduce antimicrobial
activity in comparison to the undigested pH 4.35 fermentate, with a non-statistically significant
p-value of 0.6973.
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Fermentate pH 4.80 Actinase E Digestion
2.5

Fermentate pH 4.80
Diluted 1/2 with PBS

OD600

2.0

Fermentate pH 4.80
Digested 1/2 with
Actinase e

1.5
1.0

MRSc:PBS 1:1 Diluted
1/2 with MH + Cells
(Growth Control)

✱✱

0.5

Nisin Diluted 1/2 with PBS

0.0
1/4

1/8

1/16 1/32 1/64 1/128 1/256

Dilution

Figure 4.11a: The Antimicrobial Activity of Undigested and Actinase E Digested B. longum ITT 13
pH 4.80 Fermentate. The initial dilution is 1/4 as the samples for testing had already been diluted 1/2 with
PBS/Actinase E. Standard deviations were determined for three independent assays (n=3). ** indicates p-value of
0.0023. The growth control consisted of a 1:1 ratio of MRSc:PBS as this is equivalent to the combination present
in the 1:1 of fermentate:Actinase E therefore allowing for accurate dilution of the nutrients in the MH broth used
for the S. xylosus indicator strain in both the growth control and test samples. Nisin (1000 iu/ml) diluted 1/2 with
PBS, which is equivalent to the digested and diluted fermentate samples, was used as a positive control for
antimicrobial activity.

In figure 4.11 nisin inhibited growth at the 1/4 and 1/8 dilutions and the growth of the S. xylosus
indicator strain at higher nisin dilutions of 1/64-1/256 again progressively reduced as observed
and discussed in Figures 4.9 and 4.10.
The digested and undigested pH 4.80 fermentate also inhibited S. xylosus at both the 1/4 and
1/8 dilutions.
Both the undigested and digested pH 4.80 fermentate samples were compared to the growth
control at each dilution to determine whether they had displayed antimicrobial activity.
Complete inhibition of the S. xylosus indicator strain was observed by both the undigested pH
4.80 fermentate and the Actinase E digested pH 4.80 fermentate at the 1/4 and 1/8 dilutions.
At the 1/16 dilution, no antimicrobial activity was detected for the Actinase E digested pH 4.80
fermentate in comparison to the MRSc growth control, however the undigested pH 4.80
fermentate displayed partial inhibition that was not observed by the digested fermentate
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(p=0.0023). The results for the Actinase E digested and undigested samples at the
aforementioned 1/16 dilution, together with the controls, are further evaluated in the box plot
presented in Figure 4.11b below. This 1/16 dilution is enlarged in Figure 4.11b.
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Figure 4.11b: A box Plot Displaying the Enlargement of the 1/16 dilution of Figure 4.11a, of the B.
longum ITT 13 pH 4.35 Fermentate Digested with Actinase E. The assay was carried out using microtitre
plates as described in Section 2.8.4 with S. xylosus as the indicator strain. Standard deviations were determined
for three independent assays (n=3). (** indicates p-value of 0.0023, ns = p-value >0.05).

The 1/16 dilution of undigested pH 4.80 fermentate inhibited the S. xylosus in comparison to
the growth control, with average OD600 values of 0.20 observed for the undigested pH 4.80
fermentate and 0.64 for the growth control (p = 0.004). This result clearly demonstrates
inhibition of the S. xylosus by the undigested pH 4.80 fermentate.
In comparison, the 1/16 dilution of the Actinase E digested pH 4.80 fermentate resulted in an
average OD600 of 0.55 as compared with the growth control OD600 of 0.64, with statistical
evaluation generating a p-value >0.05, thus indicating no significant difference between the
growth control and the protease digested pH 4.80 fermentate. The latter result suggests
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complete elimination of the antimicrobial activity of the Actinase E digested pH 4.80
fermentate at the 1/16 dilution in comparison to the undigested fermentate, meaning the
antimicrobial activity observed at the 1/16 dilution of the pH 4.80 fermentate may be
proteinaceous in nature. This is likely only observed at the 1/16 dilution as the organic acids
present may have contributed to higher levels of antimicrobial activity at the lower dilutions
thus only allowing the effect of the digested peptide to be seen when the acids were diluted
past the point of causing any antimicrobial activity. As the pH 4.80 fermentate was generated
in a 2L fermenter with a higher cell density (1011 CFU/ml) compared to the pH 4.35 fermentate
produced in laboratory scale conditions (109 CFU/ml) there were likely higher levels of
produced proteins, as well as higher stability of the actinase E at a higher pH resulting in
potentially higher specific activity (Pronase E | Sigma-Aldrich).
Further validating this result is the significant difference in growth of the S. xylosus indicator
strain between the undigested pH 4.80 fermentate and the Actinase E digested fermentate,
which generated a significant p-value of 0.0023. The latter result indicates that there was
significantly higher growth of the S. xylosus in the presence of the digested pH 4.80 fermentate,
which displayed a lack of antimicrobial activity in comparison to the undigested pH 4.80
fermentate that resulted in inhibition. These latter results are indicative of proteinaceous
associated antimicrobial activity caused by the fermentate at a 1/16 dilution, similar to the
hypothesis for the pH 4.35 fermentate digested with Actinase E in Figure 4.10.
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4.5 HPLC Analysis of Organic Acid Production by B. longum ITT 13
Lactic and acetic acids produced by Bifidobacteria have been shown to display antimicrobial
activity against a variety of bacterial strains (Makras and De Vuyst, 2006). Organic acid
concentrations of between 20.9 mM ± 0.3 to 60.9 mM ± 4.2 acetic acid, 5.7 mM ± 0.2 to 39.9
mM ± 3.1 lactic acid and 3.6 mM ± 0.7 to 10.8 mM ± 2.1 mM formic acid were produced by
various Bifidobacterial strains and shown to exhibit antimicrobial activity against both Grampositive and Gram-negative bacterial strains in a study by Makras and De Vuyst (2006). A
study by Tejero-Sariñena et al., (2012) also demonstrated the organic acid production of a
variety of LAB, including Lactobacilli, Lactococci and Bifidobacterium strains, with 44-180
mM lactic acid and 45-99 mM acetic acid detected over 24 hours of growth of these LAB. In
this study by Tejero-Sariñena et al. (2012), antimicrobial activity was correlated with organic
acid production and pH, as the lower the pH the larger the zones of inhibition observed and
through HPLC analysis it was determined that lactic and acetic acid were responsible for pH
reduction and thus antimicrobial activity.
Some LAB are homofermentative, whereby through the glycolysis pathway they produce only
lactic acid as an organic acid metabolite, in comparison, other strains including Bifidobacteria
produce a combination of organic acids including ethanol, lactic acid and acetic acid upon the
metabolization of sugars (Basso et al., 2014; Nguyen et al., 2019). Many other LAB also
produce organic acids such as lactic and formic acid and analysis of these organic acid
concentrations produced by bacteria can be performed using HPLC methods (Özcelik, Kuley
and Özogul, 2016; Nuryana et al., 2019). HPLC analysis was carried out as described in Section
2.9.6. on samples of B. longum ITT 13 fermentate, generated from an MRSc pH-controlled
fermentation at pH 4.8 and an MRSc fermentation grown without pH control to give a terminal
pH of 4.3. Further work in our laboratory has shown that a modified YPD media had been
optimised to maximise cell growth and antimicrobial activity production by B. longum ITT 13
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(C. Whelan, personal communication) and was also assessed for the acid production profiles
using the HPLC analysis. Both qualitative and quantitative measurement of organic acids were
performed to determine the composition of acids produced by B. longum ITT 13, as well as the
concentration of these acids in both the pH 4.80 fermentate and the pH 4.35 fermentate grown
in MRSc and a pH 5.0 fermentate grown in the mYPD, so as to evaluate if the determined acid
composition and concentrations would have a contributory effect to the antimicrobial activity
determined for the strain.
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Figure 4.12: Chromatogram of the B. longum ITT 13 pH 4.3 fermentate (MRSc) HPLC analysis (Run
1). The pH 4.3 B. longum ITT 13 fermentate was analysed in duplicate using the analytical method described in
section 2.9.6. with o-phosphoric acid and acetonitrile as the mobile phase using a Phenomenex C18-EVO (100 x
4.6, Particle Size 2.6 um) column. The peaks for selected acids are indicated as follows - Lactic Acid (A), Acetic
Acid (B), Succinic Acid (C), and Internal Standard of methylmalonic acid (D).

In Figure 4.12, retention times of 3.796 for lactic acid, 3.965 for acetic acid, 6.228 for succinic
acid and 7.899 for the internal standard were detected. The media used for the fermentation
(MRS broth + 0.05% L-cysteine) was compared as a blank, to eliminate peaks associated with
the media, leaving the three peaks associated with the lactic, acetic and succinic acids
identifiable in comparison to the retention times of the organic acid standards ran previously
(Appendix B). The results thus determined in the HPLC analysis would indicate the presence
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of lactic acid, acetic acid and succinic acid in the B. longum ITT 13 pH 4.3 fermentate as
produced by the strain during growth.
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Figure 4.13: Chromatogram of the B. longum ITT 13 pH 4.8 fermentate (MRSc) HPLC analysis (Run
1). The pH 4.8 B. longum ITT 13 fermentate was analysed in duplicate using the analytical method described in
section 2.9.6. with o-phosphoric acid and acetonitrile as the mobile phase using a Phenomenex C18-EVO (100 x
4.6, Particle Size 2.6 um) column. The peaks for selected acids are indicated as follows - Lactic Acid (A), Acetic
Acid (B), Succinic Acid (C), and Internal Standard of methylmalonic acid (D).

In Figure 4.13, the retention times observed were 3.803 corresponding to lactic acid, 3.965
corresponding to acetic acid, 6.240 for succinic acid and 7.909 for the internal standard. The
broth used for the fermentation (MRS broth + 0.11% L-cysteine) was compared as a blank to
eliminate peaks associated with the media, thus resulting in the peaks associated with the lactic,
acetic and succinic acids identifiable as present in the pH 4.80 Fermentate sample but not the
media. The same peaks were observed and labelled for lactic acid, acetic acid and succinic
acid, as well as the peak for the internal standard, for the pH 4.8 B. longum ITT 13 fermentate
with pH control grown in a 2-litre fermentation vessel, as for the pH 4.3 fermentate.
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Figure 4.14: Chromatogram of the B. longum ITT 13 pH 5 (mYPD) fermentate HPLC analysis. The pH
5 B. longum ITT 13 fermentate, grown in mYPD media, was analysed using the analytical method described in
section 2.9.6. with o-phosphoric acid and acetonitrile as the mobile phase using a Phenomenex C18-EVO (100 x
4.6, Particle Size 2.6 um) column. It should be noted that this analysis was carried out as one run with no replicates.
The peaks for selected acids are indicated as follows - Lactic Acid (A), Acetic Acid (B) and Internal Standard of
methylmalonic acid (C).

The use of modified YPD media, a media that had been optimised to maximise cell growth and
antimicrobial activity production by B. longum ITT 13 (C. Whelan, personal communication),
resulted in the acid production profiles presented in Figure 4.14. Both lactic acid and acetic
acid were detected in the analysis with a retention time of 3.720 corresponding to lactic acid
and a retention time of 4.144 corresponding to acetic acid. There was no determined peak for
succinic acid in this fermentation, which was identified in both the pH 4.3 fermentate and pH
4.8 fermentate grown in MRSc media. This indicates that the succinic acid was not produced
in this specific media composition of an mYPD broth and that media composition can thus
influence the organic acid combination produced. A retention time of 7.499 was determined
for the internal standard. The peaks associated with the lactic and acetic acids were identifiable
as present in the pH 4.80 Fermentate as the broth used for the fermentation (mYPD – C.
Whelan, personal communication) was compared as a blank to eliminate peaks associated with
this media.
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Table 4.2: The Concentrations of Organic Acids present in the B. longum ITT 13 pH 4.3 and pH 4.8
Fermentates Grown in MRSc Media and the pH 5 Fermentate Grown in mYPD media.
The concentration of organic acids present in the fermentate were determined using the peak area of the associated
acids detected using HPLC analysis. Duplicate experiments were carried out for average (Avg.) concentration and
standard deviation (SD) determination of the acids.

Organic
Acid

pH 4.3 Fermentate

pH 4.8 Fermentate

pH 5.0 Fermentate

(MRSc media)

(MRSc media)

(mYPD media)

Avg. mM

Avg.

Avg. mM

Avg.

Avg. mM

Avg.

± SD

mg/ml

± SD

mg/ml

± SD

mg/ml

± SD
Lactic Acid

92.22 ± 1.53

8.27 ± 0.17

± SD
68.32 ±

± SD

6.15 ± 0.95

154.98

13.94

9.66 ± 0.82

650.68

39.04

7.99 ± 0.73

0

0

10.62

Acetic

147.72 ±

Acid

10.34

Succinic

54.52 ± 3.00

8.86 ± 0.62

160.95 ±
13.72

6.43 ± 0.35

67.69 ± 6.14

Acid

The concentration of lactic acid was highest in the pH 5.0 B. longum ITT 13 fermentate
(mYPD) at 154.98 mM, as compared to the pH 4.3 B. longum ITT 13 fermentate (MRSc) at
92.22 mM ± 1.53 and the pH 4.8 fermentate (MRSc), which contained 68.32 mM ± 10.62. The
concentration of acetic acid was also the highest in the pH 5.0 fermentate (YPD) at 650.68 mM
in comparison to the pH 4.8 fermentate (MRSc) with 160.95 mM ± 13.72 and the pH 4.3
fermentate (MRSc) with 147.72 mM ± 10.34. Of the fermentates produced in MRSc broth, the
pH 4.3 fermentate had a higher concentration of lactic acid than the pH 4.8 fermentate, while
the latter fermentate had a higher concentration of acetic acid than the pH 4.3 fermentate. The
media composition used for growth of the B. longum ITT 13 strain thus has a direct influence
on the concentration of organic acids and metabolites produced during growth.
The succinic acid was only detected in the two fermentates cultured in MRSc broth. The
concentration of succinic acid was higher in the pH 4.8 fermentate at 67.69 mM ± 6.14 than in
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the pH 4.3 fermentate at 54.52 mM ± 3.00. The lack of succinic acid present in the fermentate
cultured in the mYPD broth indicates the media used for growth also affects the composition
of metabolites produced. A total of 23.56 mg/ml ± 1.14 organic acid was present in the pH 4.3
fermentate (MRSc) and a total of 23.80 ± 2.50 mg/ml of organic acid was detected in the pH
4.8 fermentate (MRSc). Therefore, the two fermentates produced using MRSc media contained
similar total acid concentrations considering the large difference in final fermentation pH. The
pH 4.8 fermentate only contained 0.24 mg/ml more acid than the pH 4.3 fermentate considering
the lower pH of the latter sample. In comparison, a total of 52.98 mg/ml organic acid was
present in the pH 5.0 fermentate (mYPD), which, considering the lack of succinic acid
production, is significantly higher than the total concentration of organic acid produced by the
fermentates produced using MRSc as a growth medium.
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4.6 Discussion:
4.6.1 Thermostability of B. longum ITT 13 Antimicrobial Activity
The stability of the antimicrobial activity produced by B. longum ITT 13 at a variety of
temperatures was an important component for analysis in relation to consideration of the
applicability of the fermentate as a biopreservative in the food industry. The food industry
involves the use of high processing temperatures (Bagde and Vigneshwaran, 2019), thus
indicating the necessary relative stability of potential biopreservatives.
For the -20oC temperature, the activity was higher than any successive day after 1 day of
incubation with an average of 173.3 AU/ml, after which it dropped below the control (124.4
AU/ml) to between 80 and 93.3 AU/ml over the successive 2-28 day incubation period, a 2536% reduction relative to the control. The latter results were not statistically significant
however and indicate no significant reduction in activity relative to the control. Freeze-thaw
effect has sometimes been described in literature when bacteriocins are subjected to freezing
temperatures, such as the study by Ponce et al., (2008) which investigated the antimicrobial
activity associated with four lactic acid bacteria (LAB), Enterococcus faecium, Lactococcus
lactis, Enterococcus hirae and Enterococcus canis. The cell free supernatants of these strains
were subjected to three freeze-thaw cycles over 24 hours to determine the stability, with activity
detected against the indicator strains Lactobacillus plantarum CRL 691, Pediococcus
pentosaceus ATCC 10791, GIIA 30, Listeria monocytogenes, and E. coli. Although the
antimicrobial activity of all the LAB against the indicator strains generally remained stable
relative to the control after the freeze-thaw cycles, the activity produced by E. faecium against
L. plantarum CRL 691, decreased by approximately 42-43% in comparison to the control after
the first freeze-thaw cycle and remained at that same level of reduced activity for the
subsequent cycles. This study indicates that the antimicrobial activity produced by many LAB
can generally remain stable upon freezing, but for some strains as little as one freeze-thaw
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action may reduce the antimicrobial activity produced. As there was no significant loss of
activity by ITT 13 upon freezing the antimicrobial activity detected may display stability upon
freezing.
For the 4oC temperature, the average antimicrobial activity was highest after 1 day of
incubation (213.3 AU/ml) and then dropped slightly to between 133.3 AU/ml after 2 days
incubation and 80 AU/ml after 21 days (36% loss). This indicated a minor loss of activity in
relation to the control. However, the loss of activity was reduced at the 28-day timepoint as
only a 3% loss was observed with 120.0 AU/ml determined. The increase in activity after 28
days and the largest loss of activity observed for only day 21 indicates that the overall losses
were inconsistent with the 4oC temperature and that the reduction in activity did not remain
consistently below the control over the 28-day period as observed with the -20oC, room
temperature and 37oC temperatures, which may be indicative of the most stability at this
temperature. No statistically significant loss of activity was detected further indicating stability
at this temperature.
The highest retention of antimicrobial activity after 2 days of incubation that was observed for
the 4oC incubation temperature was also observed at room temperature (20-24oC), whereby the
activity was highest after 2 days incubation (average of 186.7 AU/ml after 1 day and 146.7
AU/ml after 2 days) before it dropped below the control value of 124.4 AU/ml from 7 days
onwards with losses of activity between 14% and 36%. This indicates maximum stability of
the antimicrobial activity of the fermentate at room temperature for 2 days in relation to the
control, although again no significant losses of activity were detected indicating relative
stability.
For the fermentate incubated at 37oC the average activity was slightly below the control result
of 124.4 AU/ml after the 1 day of incubation period with 120.0 AU/ml (3% loss) and continued
to decrease after 2 days incubation at this temperature to an average of 106.7 AU/ml (14%
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loss), before dropping again and fluctuating between 80.0 and 93.3 AU/ml for day 7-28 (2536% loss of activity). Although the antimicrobial activity was the highest (86-97% activity
retained) for the first two days of incubation before dropping again and fluctuating between
two values (64-75% activity retained) for the remaining days of incubation, like previous
samples there was no significant loss of activity relative to the control at any timepoint.
The average activity observed for 55oC and 70oC was irregular with high levels of fluctuation
(75-128% activity retained relative to the control) and increasing activity at later time points,
with activity increasing from 75% to 107% from day 7-28 at the 55oC incubation temperature
and from 97% to 129% from day 7-28 for the 70oC incubation temperature. This increase is
likely an artefact of the experiments due to evaporation in the samples with the reduction in
volume been associated with a perceived increase in activity.
The activity fluctuated over the time period of the 28-day study for the samples, with a
fluctuation from as low 80 AU/ml (64% activity) to as high as 213 AU/ml (172% activity),
with some AU/ml values increasing rather than decreasing between subsequent timepoints. The
evaluation of the effect of temperature on the antimicrobial activity would possibly indicate
that the antimicrobial activity present seems to retain the highest consistent levels at 4°C and
room temperature storage for up to 48 hours, with some loss (14-36%) over the 28-day period
tested. The latter retention of maximum activity up to the 48 hours was also observed in a
bacteriocin produced by L. plantarum KL-1 described by Pilasombut et al. (2015), as when
thermal stability analysis was carried out, the maximum antimicrobial activity was retained for
2 days at 4oC against the indicator strain L. sakei subsp. sakei JCM1157, before dropping in
the days thereafter.
With this being said however, the overall result indicated that there was no significant loss of
activity at any timepoint or temperature indicating the temperature likely did not impact the
fermentate. Dunnett’s multiple comparison assay was carried out to assess the antimicrobial
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activity determined in the assay at each of the temperatures tested (-20oC to 70oC) over the
time period of 0 to 28 days and compared to the control of the freshly produced fermentate
before incubation at each temperature. No statistically significant difference was determined
(p>0.05), thus the antimicrobial activity detected over the time period at the various
temperatures indicate that the antimicrobial activity produced by B. longum ITT 13 is relatively
stable under all of the incubation conditions tested. Antimicrobial activity previously
associated with bacteriocins produced by Bifidobacterium spp. can be quite thermostable in
nature, with activity often retained after heat treatment above 100oC. The latter thermostability
was observed by Yildirim and Johnson, (1998), whereby the bacteriocin bifidocin B, produced
by Bifidobacterium bifidum NCFB 1454, displayed resistance to heating up to 90oC for 60
minutes and 121oC for 15 minutes, while also retaining biological activity after storage at 20oC for 3 months. Cheikhyoussef et al., (2009) investigated the stability of a partially purified
bacteriocin-like inhibitory substance (BLIS) produced by B. infantis BCRC 14602 that
displayed complete retention of activity upon heat treatment, with 1600 AU/ml activity retained
following heat treatment at 50-90oC for 60 minutes, 100oC for 20 minutes and 121oC for 15
minutes. A study by Liu et al., (2015) explored the characteristics of the bacteriocin bifidocin
A, produced by Bifidobacterium animals BB04, that, like B. longum ITT 13 was isolated from
the gut flora, but in this case from centenarians rather than the infant gut flora. The bifidocin
A peptide was stable at heating to heating of 100oC for 30 minutes and 121oC for 15 minutes,
which was in agreement with the above discussed studies.
It is possible that antimicrobial activity detected for B. longum ITT 13 could be associated with
a proteinaceous component i.e. bacteriocin and/or organic acid production. The results
indicating no significant drop in antimicrobial activity over the temperature and time period of
the thermostability studies for the B. longum ITT 13 fermentate, may indicate that organic acid
production by B. longum ITT 13 likely contributes to some of the antimicrobial effect observed
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by the strain (Makras and De Vuyst, 2006). This organic acid production was explored further
in Sections 4.4 and 4.5. It also does not rule out the contribution of thermostable bacteriocins
to activity as the above previous literature has stated that bacteriocins produced by
Bifidobacteria spp. are relatively thermostable.
Higher stability of the antimicrobial activity was observed for 1-day incubation compared to
subsequent days, as evident for -20oC to 37oC in Figure 4.1, with averages of 120-213 AU/ml
observed for the activity at day 1 of these temperatures, before dropping to as low as 80 AU/ml
on subsequent days. The results generated for each of the temperatures tested over the 28 day
time period, well not generating statistically significant differences from the original control
sample, indicate the trends observed may be biologically significant as it was observed that for
the majority of temperatures (-20oC, 4oC, room temperature and 37oC) that shorter storage
times of 1-2 days seem to be associated with the highest levels of antimicrobial activity. Thus,
the biological trend observed was that the most antimicrobial activity retained up to 1-2 days
incubation for -20oC to 37oC, with decreased activity thereafter. This trend of higher activity
in the first 2 days of incubation and the fact that there was no complete loss of activity, thus
indicates the relative thermostability of the molecule at a wide variety of temperatures. If the
antimicrobial activity detected for the B. longum ITT 13 fermentate has a proteinaceous
component i.e. a bacteriocin, then the results on thermostability would indicate that this
bacteriocin could be either a class I class II bacteriocin which are known to be heat-stable
peptides (Deegan et al., 2006; Singh et al., 2015). As the results have shown thermostability
of the fermentate and previous literature stated has indicated thermostability of many
bacteriocins, it does not rule out the possibility that there may be antimicrobial peptide/s present
in the fermentate.
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4.6.2 pH stability of B. longum ITT 13 fermentate
Like thermostability, pH stability of potential biopreservatives is another important factor for
consideration, due to the wide variety of matrices and pH processing conditions used within
the food industry (Johnson et al., 2018; Castilho et al., 2020) and thus potential
biopreservatives should be able to withstand these processing conditions. Many foodstuffs
containing a starter bacterial culture, i.e. fermented foods, have a low pH including dairy
products such as cheese, which has been shown to decrease in pH over storage time due to acid
production by the starter bacteria (Ong and Shah, 2009; Ulpathakumbura et al., 2016). Stability
at a low pH is also important for probiotic bacteria when passing through the stomach and
gastrointestinal tract (Mahmoudi et al., 2013). The pH stability assay of the B. longum ITT 13
fermentate was initially carried out using HCl (0.3M) and NaOH (0.3M) at a pH range from
pH 3-8 to provide preliminary studies of the stability of the antimicrobial activity over this pH
range. The initial pH studies on the stability of the antimicrobial activity was carried out using
HCl (Section 4.2.1), with antimicrobial activity found to only be detected after adjustment to
pH 3 and 4. It was then decided to repeat the pH studies but using 0.1M lactic acid (L.A.) to
adjust the pH values of the fermentate rather than HCl (Section 4.2.2). The decision to use L.A.
was made on the basis that L.A. (together with other acids) is already produced by
Bifidobacteria, it would be more appropriate to adjust the pH using the L.A. rather than using
HCl (Makras and De Vuyst, 2006; Lee and O’sullivan, 2010; Delgado et al., 2019).
The fermentate adjusted to pH 3.08 (Figure 4.3) displayed higher levels of antimicrobial
activity than the unadjusted fermentate (p<0.05), with averages of 5.0-5.8 mm of inhibition
observed for the pH 3.08 fermentate and 4.0-4.8 mm for the unadjusted fermentate. The
additional antimicrobial activity observed for the pH 3.08 fermentate in comparison to the
unadjusted fermentate could most likely be attributed to the addition of the 5.7 mls of L.A.
used to lower the pH of the fermentate. The concentration of lactic acid as then present in the
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latter pH adjusted media, generated antimicrobial activity with zones of inhibition between 3.6
mm and 4.4 mm of activity on average. The antimicrobial activity of the pH 3.08 fermentate
was compared to the control of the pH 4.32 MRSc broth + 5.7 mls of L.A., as these were
directly comparable as previously discussed i.e. comparing the pH adjusted fermentate with
the pH adjusted MRSc broth using the same volumes of acids, using ANOVA with Tukey’s
multiple comparison assay. The latter comparative analysis showed that although activity was
caused by the acidic pH, there was more activity associated with the fermentate in comparison
to the pH control at each time point of 0-24 hours (p<0.05). The significance i.e. p-value <0.05
in the difference between the pH 3.08 fermentate and the pH adjusted MRSc broth would
indicate that the antimicrobial activity is not associated with the pH value alone. Bifidobacterial
spp. are heterofermentative and produce several acids including acetic and lactic acid (Nguyen
et al., 2019), however only lactic acid was used to adjust the pH of the fermentate and controls.
The fermentate was also diluted by more than 1/2 with the addition of 5.7 mls lactic acid to
adjust the pH, which should consequentially reduce the antimicrobial activity associated solely
with the fermentate, meaning the activity observed at pH 3.08 for the fermentate may be
primarily associated with the addition of acid.
The results for the fermentate adjusted to pH 4.02 (Figure 4.4) generated antimicrobial activity
values similar to those for the original undiluted pH 4.35 fermentate when the 2 sets of results
are compared, indicating no significant difference of the activity between the two samples.
Very little dilution of the fermentate was also carried out when adjusted to pH 4.02, with 0.7
mls L.A. added to 5 mls fermentate, as evidenced by the similarity of the original pH 4.35
fermentate and the adjusted pH 4.02 fermentate.
Comparison of the activity between the pH 4.02 fermentate and the equivalent pH 4.3 MRSc
broth with an additional 0.7 mls L.A. was assessed using ANOVA with Tukey’s multiple
comparison assay. The activity of the pH 4.02 fermentate was significantly higher than the
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MRSc broth with p-values <0.001 at each time point. The p-value of <0.001 is indicative of
the presence of significant antimicrobial activity for the pH 4.02 fermentate, which cannot be
solely attributed to the pH of the media itself.
Antimicrobial activity of the B. longum ITT 13 fermentate was not detected when the
fermentate was pH adjusted to pH 5 and 6 and was in agreement with the results generated by
Yi et al., (2020), whereby the antimicrobial activity of the bacteriocin produced by
Lactobacillus pentosus DZ35, began to reduce in antimicrobial activity above pH 4. However,
later work where the fermentation was carried out in a pH controlled MRSc media fermentation
and separately in an optimised YPD medium and tested using the MIC assay, has shown that
antimicrobial activity is present to pH 5.5 (C. Whelan, personal communication).
The pH activity studies measuring the antimicrobial activity for B. longum ITT 13 fermentate
suggest that the antimicrobial activity is more stable at lower pH values. The results presented
in Section 4.2 indicate that the antimicrobial activity is more stable at pH values of 4 and up to
pH 5, however further fermentation studies were carried out by one of my laboratory colleagues
(C. Whelan, personal communication) which would suggest that in pH controlled
fermentations the antimicrobial activity can be stably detected at values around pH 5 in the
more sensitive microtitre plate MIC assays. The media composition may also be a factor in the
stability of the antimicrobial activity at higher pH’s in the pH controlled fermentations as a
modified YPD medium was utilised for growth of the ITT 13 strain in the pH controlled
fermentations carried out in fermentation vessels. Throughout Sections 4.1 and 4.4, a pH 4.8
B. longum ITT 13 fermentate was used that had been grown with pH control in fermentation
vessels using MRSc media as the growth medium, which also displayed significant
antimicrobial activity. Therefore, the pH stability of the antimicrobial activity at pH 5 is likely
correlated to both the medium used for growth of the B. longum ITT 13 in conjunction with the
use of fermentation vessels for growth as opposed to static growth in laboratory conditions at
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smaller volumes, as the use of fermentation vessels produces cell densities of up to 1011
CFU/ml.
The bacteriocin nisin has also been shown to be more stable in the acidic pH range of pH 5 and
below with the highest stability of the bacteriocin in the lower pH range at around pH 3
(Matsusaki et al., 1998). Increasing the pH to neutral or alkaline pH ranges reduces the
antimicrobial activity associated with nisin (Rollema et al., 1995; Matsusaki et al., 1998) with
a sharp decrease in stability at pH 7-8 (Rollema et al., 1995). The results in this research project
indicate that the B. longum ITT 13 antimicrobial activity, like nisin, is primarily active within
the acidic pH range with antimicrobial activity detected to between pH 5-6 in microtitre plates
(C. Whelan, personal communication) dependent on the YPD or MRSc media used, with
maximum activity around pH 4 which is similar to the stability pattern of nisin.
Many bacteriocins have displayed similar pH stability activity pattern to the B. longum ITT 13
fermentate, with maximum antimicrobial activity in acidic and neutral pH ranges, with activity
decreasing or lost in the alkaline pH range (Yue et al., 2013; Bagde and Vigneshwaran, 2019;
Pei et al., 2020; Yi et al., 2020). In the study by Yue at al., (2013) a bacteriocin produced by
Lactobacillus rhamnosus CICC 20975 remained stable at pH values 3-7 when adjusted to pH’s
2-10 using HCL and NaOH. Bagde and Vigneshwaran (2019) examined the stability of a
bacteriocin from E. faecium LMG 11423(T) at pH 2-12 and found that antimicrobial activity
decreased at alkaline pH, with >4 mm zones of inhibition at pH’s 2, 4 and 6, and <4 mm at pH
8 and 10, with <2 mm zones of inhibition at pH 12 when tested on a microdiffusion plate. Pei
et al. (2020) examined the pH stability of bacteriocin SLG10 produced by L. plantarum SLG10
at pH 2-10 and found that at pH 3-7 there was approximately 200 AU/ml, but the antimicrobial
activity began to reduce at pH 8 and was close to 0 AU/ml for pH 9 and 10. The reduction and
loss of activity at high alkaline pH’s may be associated with intramolecular electrostatic
interactions of the peptides as the electrostatic repulsion of intermolecular and hydrogen bonds
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break, as altering the pH alters the charge on the amino acids within the protein due to their
zwitterionic nature which can have major effect on the electrostatic interactions within the
protein (Yi et al., 2016).
The antimicrobial activity produced by B. longum ITT 13 has been shown to be stable at pH 5
when grown in a modified YPD media with pH control in 2-litre fermentation vessels and
assessed using an MIC microtitre plate assay (C. Whelan personal communication). As all of
the antimicrobial detection for the 2L fermentations were carried out using the more sensitive
MIC microtitre plate assay, there is a possibility that the sensitivity of the microdiffusion assay
versus the MIC assay may have limited detection of activity at the higher pH values of pH 5 or
pH 6, with the research work carried out on the pH stability within this project using the
microdiffusion assay. Additionally, the lack of detection of activity at the higher pH (pH 5-6)
could also have something to do with the specific media and fermentation conditions used for
growing the B. longum ITT 13 in laboratory conditions as opposed to the optimised
fermentation vessel conditions. A lower sensitivity of the microdiffusion assay in comparison
to the microtitre plate MIC assay was observed by Inturri et al., (2019) and this coupled with
the likelihood more antimicrobial peptides would be produced when grown in fermentation
vessels due to a higher cell density of 1011 CFU/ml (C. Whelan personal communication) in
comparison to 109 CFU/ml when grown in static laboratory conditions, may contribute to
activity detectable at higher pH levels when cultured in the fermentation vessels.
The antimicrobial activity observed by B. longum ITT 13 may be from multiple sources as the
pH alone doesn’t contribute fully to the antimicrobial activity as discussed in the results for the
fermentate adjusted to pH 3 and 4. Although the combination of acids produced by the
heterofermentative B. longum ITT 13 cannot be ruled out as causing the majority of
antimicrobial activity, it is also possible that a proteinaceous component may be contributing
to antimicrobial activity as ammonium sulphate precipitation (Section 4.3) and protease
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digestion (Section 4.4) indicated the presence of low-level antimicrobial activity that is
proteinaceous in nature produced by B. longum ITT 13.

4.6.3 Ammonium Sulphate Precipitation of the B. longum ITT 13 Fermentate
Ammonium sulphate precipitation is a method of partial protein purification and concentration
that has been widely used as a method to extract antimicrobial peptides produced by bacteria
from cell free supernatant (Contreras et al., 1997; Afshan Naz, Sheikh and Rasool, 2013;
Ansari et al., 2018). The ammonium sulphate solution interferes with the proteins solubility in
water causing precipitation by increasing hydrophobic interactions, while maintaining the
protein conformation, allowing the peptide to be extracted without denaturation and preserve
activity (Wingfield, 2001).
As the structure of any potential proteinaceous compounds associated with antimicrobial
activity e.g. bacteriocins produced by B. longum ITT 13 are unknown, preliminary saturation
studies were carried out on a range of ammonium sulphate concentrations as it was not obvious
from work within the laboratory as to what the potential size of a potential antimicrobial
peptide/protein would be. Saturations of 20%, 40%, 60% and 80% AS were added to the B.
longum ITT 13 cell free fermentate to determine which saturation would precipitate the
suspected bacteriocin(s). The AS protein pellets were resuspended in 2 ml volumes of 50 mM
sodium acetate buffer – resulting in a 20-fold concentration.
It is evident that at the 1/2 and 1/4 dilutions of the 20%, 40%, 60% and 80% AS saturations,
there is inhibition caused by both the resuspended pellet of the fermentate and by the
resuspended MRSc broth – which is just media. This may be indicative of the ammonium
sulphate contributing to antimicrobial activity at these initial dilutions before it is diluted out
at higher dilutions. It was not possible to remove the ammonium sulphate prior to testing due
to the initial low levels of detection for antimicrobial activity i.e. even at the 1/2 dilutions it is
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sometimes difficult to detect any antimicrobial activity for the fermentate. It is also possibly
due to a result of dilution of the Mueller Hinton broth nutrients, which is already a nutrient
limiting media, as the NaAc buffer was used for resuspension of the fermentate and MRSc
media pellets.
It can be seen in Figure 4.5 a, b and c, that the growth pattern of the indicator strain (S. xylosus)
in the microtitre plates, measured as OD600 nm, was similar at the 20%, 40% and 60% AS
saturations, for both the fermentate precipitate resuspended in 50 mM sodium acetate pH 4.3
and the resuspended MRSc broth precipitate. This growth pattern of the S. xylosus indicates
there was no inhibition detectable for the resuspended pellet of the fermentate at these AS
saturations (20%-60%) in comparison to the resuspended MRSc and thus the results would
indicate that the resuspended precipitates do not contain any antimicrobial activity or possibly
the antimicrobial activity is below the detectable level. In contrast, at the 80% AS saturation,
there is a significant difference (p-value <0.0001) for the OD600 which is significantly lower
for the fermentate pellet (0.277) in comparison to the MRSc broth pellet (1.902) at the 1/8
dilution, indicating a reduction of growth of the indicator strain in the presence of the
resuspended 80% fermentate pellet. The detection of antimicrobial activity causing decreased
growth of the indicator strain when exposed to the resuspended fermentate pellet, would
suggest that some of the antimicrobial activity is proteinaceous in nature. The negative control
of the 80% MRSc broth resuspended pellet did not display similar inhibition at this 1/8 dilution,
possibly eliminating the 80% AS or the 50mM sodium acetate buffer at pH 4.3 causing this
inhibition. The significant difference in the inhibition of the S. xylosus indicator strain when
incubated with the 80% pH 4.3 MRSc resuspended pellet versus the 80% resuspended B.
longum ITT 13 pH 4.3 fermentate pellet, would indicate a strong probability that there is some
low molecular weight antimicrobial proteinaceous material precipitated at the 80% AS
concentration and that the antimicrobial activity is stable when the precipitate is resuspended.
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Makras and De Vuyst (2006) used 40% and 70% AS saturations to extract the bacteriocins of
many Bifidobacterium strains and found that the higher saturation of 70% resulted in the
precipitation of the antimicrobial peptides in comparison to the 40% AS. The use of the high
80% AS concentration to generate a precipitate from the B. longum ITT 13 fermentate that
exerts antimicrobial activity is thus in agreement with the studies of Makras & De Vust (2006).
The requirement of a high AS concentration for precipitation may be common for many
bacteriocins produced by Bifidobacterium spp. as this further suggested by Lievin et al., (2000)
who used a concentration of 60% AS saturation to precipitate the spent culture supernatants of
Bifidobacterial strains CA1 and F9, determining that activity was associated with the
production of proteinaceous material.
Fujiwara et al., (1997) assessed the production of antimicrobial activity by B. longum SBT
2928, used ammonium sulphate as a salting out method by bringing the saturation to 85%,
which resulted in binding-inhibitory activity i.e. inhibition of the binding activity of various
bacteria, of this fraction that was comparable to the activity of the supernatant before AS
precipitation. The precipitate reduced the binding activity of E. coli, P. aeruginosa and B.
cepacia to gangliotetraosylceramide (GA1), a sphingoglycolipid that is present in the intestinal
brush border membrane of the mouse and the use of AS to isolate the activity indicated the
likely proteinaceous nature of the binding inhibitor.
The concentration of ammonium sulphate required to precipitate target proteins depend on the
physiochemistry of the protein, as low molecular weight proteins require higher salt
concentrations for precipitation and as the AS decreases solubility of the protein, highly soluble
proteins would also require higher salt concentrations for precipitation (Wingfield, 2001). As
the 80% AS saturation was required to precipitate the proteinaceous material causing
antimicrobial activity in the B. longum ITT 13 fermentate, this indicates it is likely of a low
molecular weight and highly soluble. Both class I and class II bacteriocins are of a low
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molecular weight, at less than 10 kDa (Deegan et al., 2006; Singh et al., 2015). Many
bacteriocins in various studies have been shown to be of a low molecular weight in studies,
such as for the bacteriocin HW01, produced by P. acidilactici HW01, which had a molecular
weight of 6 kDa (Ahn et al, 2017) and E. faecium MMT21 produced two bacteriocins of 4.8
kDa (enterocin A) and 5.5 kDa (enterocin B). The commercially used bacteriocin nisin also is
a low molecular weight peptide of approximately 3.4 kDa (Williams and Delves-Broughton,
2003), which is used as a positive control in many of the experiments carried out in this
research. Two bacteriocins produced also by a Bifidobacterial strains (CA1 and F9), were
found to have molecular weights estimated at lower than 3.5 kDa, indicating low-molecular
weight peptides, which may be in agreement with the possible antimicrobial peptide produced
by B. longum ITT 13.
The antimicrobial activity of the 80% AS precipitated fermentate was compared to the activity
of nisin, as the antimicrobial activity associated with organic acid production in the fermentate
was eliminated by resuspension of the AS precipitate in an NaAc buffer. Nisin displayed
antimicrobial activity against S. xylosus ATCC 29971 to a 1/8 dilution, equating 125 IU/ml,
with growth of the S. xylosus indicator strain returning at the 1/16 nisin dilution in the microtitre
assay plates (Section 3.2.2). The antimicrobial activity associated with the nisin thus equated
to 125 IU/ml or 80 AU/ml, which was also the same antimicrobial activity in AU/ml associated
with the precipitated protein of the B. longum ITT 13 fermentate with 80% AS saturation. The
dilution is used to calculate the MIC50 values of the B. longum ITT 13 fermentate as there has
been no determined concentration of the actual inhibitory component present within the
fermentate. Further studies would be required on a purified bacteriocin to elicit more
information in relation to the nature and activity of the bacteriocin and its comparability to
nisin.
The MIC50 results of 80 AU/ml observed against S. xylosus for the precipitated peptide
181

produced by B. longum ITT 13 are comparable to a peptide produced by Enterococcus faecium
MCL13, which displayed 64 BU/ml (bacteriocin units/ml - equivalent to AU/ml) against S.
xylosus in a study by Lim, (2016). The activity of the precipitated B. longum ITT 13 fermentate
is comparable to the antimicrobial activity produced by E. faecium MCL13 in this study, as it
was also crudely purified using ammonium sulphate precipitation and tested using microtitre
plates, with determination of the BU/ml for E. faecium MCL13 calculated similarly to the
AU/ml calculation of the fermentate in Section 2.8.2.
As a gradual reduction in antimicrobial activity with an increasing pH was observed for the
antimicrobial activity produced by B. longum ITT 13 in Section 4.2, indicative of antimicrobial
activity caused by low pH, it may suggest the possibility of a synergistic effect between the
detected proteinaceous component causing antimicrobial activity and the lactic and acetic acid
produced by ITT 13. This synergistic effect was described by Pasteris et al. (2014) and would
account for the absence/reduction of activity with an increase in pH observed for the
antimicrobial activity produced by B. longum ITT 13. The study by Pasteris et al. (2014)
described how Lactococcus lactis CRL 1584 produced antimicrobial activity found to be
proteinaceous in nature, that was indicative of a bacteriocin which inhibited the growth of
Listeria monocytogenes through synergistic activity with organic acids, as well as hydrogen
peroxide. The cell free supernatant was tested for antimicrobial activity using the
microdiffusion assay and the synergism was determined as the zone of inhibition decreased
upon neutralization of the supernatants and additionally when catalase was added, which
inactivated the hydrogen peroxide and thus overall were indicative of organic acids and
hydrogen peroxide as causing antibacterial activity. The antibacterial effect observed was then
completely eliminated by further treatment with α-chymotrypsin, indicating a proteinaceous
nature of some inhibitory molecules, and suggesting a combination of all three molecules
caused the observed antimicrobial activity. Therefore, upon the evident antimicrobial activity
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caused by a proteinaceous component of the B. longum ITT 13 fermentate observed with the
ammonium sulphate precipitation at 80% saturation, couples with the antimicrobial activity
associated with the organic acids produced by the strain, synergism is a possibility.

4.6.4 Protease Digestion
Many LAB and probiotic bacteria demonstrate antimicrobial activity through the production
of both organic acids and antimicrobial peptides i.e. bacteriocins, which aim to prevent
colonisation of the host by pathogenic bacteria (Vlasova et al., 2016). The antimicrobial nature
of various strains is often proteinaceous in nature, with various Bifidobacteria in a study by
Makras and De Vuyst, (2006) shown to produce antimicrobial activity both proteinaceous and
partially or wholly associated with organic acid production. Bacteriocin production is an
important factor for probiotic bacteria (O’Shea et al., 2012; Choudhary et al., 2019) and would
further indicate the suitability for the use of B. longum ITT 13 as a probiotic strain, or for
biopreservation similar to the use of the bacteriocin nisin. Enzymatic digestion with proteases
is carried out to confirm the proteinaceous nature of molecules and commonly employed to
determine the nature of antimicrobial activity associated with potential bacteriocins (Miao et
al., 2014; Du et al., 2017; Lv, Ma, et al., 2018) and was carried out to determine the nature of
the antimicrobial activity produced by B. longum ITT 13. Proteinase K and Actinase E (Pronase
E) were chosen as the proteases for digestion of the B. longum ITT fermentate as they have
been shown in previous studies to digest nisin which is also involved in food preservation
(Matsusaki et al, 1998).
The inhibition of S. xylosus by nisin was detected in the assays at a 1/4 and 1/8 dilution (250
and 125 IU/ml of nisin), with no inhibition detected at the 1/16 dilution (62.5 IU/ml) (Figures
4.6-4.11). Incubation of nisin with Proteinase K caused a reduction in nisins ability to inhibit

183

the growth of S. xylosus, with inhibition only detectable at the 1/4 dilution (250 IU/ml) of the
nisin, rather than at the 1/8 of the undigested nisin (Figure 4.6). Incubation of nisin with
Actinase E caused a complete loss of ability of the bacteriocin to inhibit the growth of S.
xylosus, with no inhibition detected at any dilution in the microtitre plate (Figure 4.9). This
reduction or loss of antimicrobial activity of the nisin control when incubated in the presence
of proteases confirms the enzymatic activity of the Proteinase K and Actinase E.
The results generated for the statistical analysis of the Proteinase K incubated pH 4.35
fermentate versus the undigested pH 4.35 fermentate generated non-significant results with the
P-value above 0.05, indicating the Proteinase K did not reduce or eliminate the antibacterial
activity of the fermentate.
For the pH 4.80 fermentate (Figure 4.8) the statistical analysis was carried out only on the 1/16
dilution, as this was the only dilution displaying a visual difference between the growth of the
indicator strain for the undigested and the digested fermentate samples. There was no
significant difference detected between the growth of the S. xylosus with either the pH 4.80
fermentate samples incubated with or without Proteinase K at the 1/16 dilution, with the
generated p-value > 0.05. The comparison of the Proteinase K digested pH 4.80 fermentate to
the S. xylosus growth control generated p-values of <0.0001, indicating significant inhibition
was observed by the Proteinase K digested pH 4.80 fermentate, and that incubation with the
Proteinase K did not reduce or eliminate the antimicrobial activity produced by B. longum ITT
13.
The fact that the antimicrobial activity is not lost for the pH 4.35 or pH 4.8 fermentate's
following incubation with the Proteinase K is not indicative that there is no proteinaceous
component contributing to the antimicrobial activity, as it is possible that whatever potential
proteinaceous molecule present in the fermentate's may be resistant to Proteinase K digestion.
Bacteriocin sensitivity to various proteases appears to be variable, with many susceptible to a
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wide range of proteases and others resistant to various proteases. BAC-IB17, a bacteriocin
produced by Bacillus subtilis KIBGE-IB1 and described by Ansari et al., (2018), was found to
be completely resistant to various proteases including Proteinase K and Protease V8 after a 2
hour incubation and only a 50% reduction in antimicrobial activity was detectable after
treatment with the proteases for 24 hours. Aureocin A53, a class II bacteriocin, displayed high
resistance to Trypsin with 90-95% of the peptide intact after an 18-hour incubation with the
protease (Netz et al., 2002), indicating not all proteinaceous material with antibacterial activity
is reduced or eliminated with protease treatment. Some bacteriocins have also displayed
resistance to Proteinase K including BM1157, produced by Lactobacillus crustorum MN047,
which only had a 6% reduction in activity when treated with the enzyme (Yi et al., 2018).
For the Actinase E digestion, the pH 4.35 fermentate incubated with the enzyme showed no
significant difference in antimicrobial activity (p>0.05) when compared with the undigested
fermentate (Figure 4.10). However, it was observed that there was low-level growth of the S.
xylosus at the 1/16 dilution (average OD 600 = 0.11) for the digested pH 4.35 fermentate as
compared to the undigested fermentate which had no growth of the S. xylosus with an average
OD 600 of 0.02 (Figures 4.10a and 4.10b). The difference in the OD 600 measurements for the
digested versus undigested pH 4.35 fermentate was not statistically significant with a p-value
>0.05, but there is a possibility that the difference observed indicates potential biological
significance that may warrant further investigation around the 1/16 dilution as a small amount
reduction in antimicrobial activity may be indicative of proteinaceous material at a very low
concentration that is contributing to the antimicrobial activity.
The growth observed for the pH 4.80 fermentate digested with Actinase E (Figure 4.11) was
similar to that of the S. xylosus growth control (p >0.05), indicating no significant antimicrobial
activity was observed for the digested pH 4.80 fermentate and that the Actinase E had
inactivated possible proteinaceous material contributing to the antimicrobial activity. There
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was a significant difference between the antimicrobial activity of the original pH 4.80
fermentate that was not incubated with Actinase E and the Actinase E digested pH 4.80
fermentate (p = 0.0023). This indicates that the fermentate with no Actinase E digestion still
displayed antimicrobial activity, but that the antimicrobial activity was then reduced after
digestion with the Actinase E enzyme. It is likely the digestion of the pH 4.80 fermentate and
reduction of activity were only observed at the 1/16 dilution as it is known that B. longum ITT
13 produces a combination of organic acids resulting in some antimicrobial activity. As these
acids are more concentrated at the lower dilutions the antimicrobial activity of the organic acids
is likely stronger than that associated with the proteinaceous material, with the activity of the
latter not detected until the acids have been diluted. As the pH 4.80 fermentate was generated
in a 2L fermenter with a higher cell density (1011 CFU/ml) compared to the pH 4.35 fermentate
produced in laboratory scale conditions (109 CFU/ml) there were likely higher levels of
produced proteins which may offer explanation to why there was significant reduction in
antimicrobial activity only for the pH 4.80 fermentate upon digestion in comparison to the pH
4.35 fermentate. Another possibility is that as the pH of the pH 4.80 fermentate is higher, and
that actinase E displays higher levels of stability of the at higher pH (pH 5-8) (Pronase E |
Sigma-Aldrich) resulting in potentially higher specific activity and increased digestion of the
pH 4.80 fermentate. The statistically significant partial reduction in antimicrobial activity when
the B. longum ITT 13 pH 4.80 fermentate is incubated with the Actinase E is indicative that
the antimicrobial activity observed for the strain is partially associated with an antimicrobial
proteinaceous molecule. As the MIC50 dilution is calculated on the basis of at least 50%
inhibition of the indicator strain (see Section 4.1), it can be deduced that the MIC50 of the pH
4.80 fermentate was a 1/16 dilution and the MIC50 of the same fermentate after digestion with
Actinase E was the 1/8 dilution. Actinase E is an enzyme that has been shown to digest
bacteriocins produced by many bacteria. A bacteriocin produced by the LAB Pediococcus
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acidilactici HW01, was inactivated by various proteases including Actinase E (stated as
Pronase E in the study), when the cell free supernatant was incubated with the enzymes and
tested using the well diffusion assay (Ahn et al., 2017). The supernatant of the strain
Enterococcus faecium MMT21 that had displayed antimicrobial activity was digested with
Trypsin, Proteinase K and Actinase E (Protease E in the study) and tested for activity using the
well diffusion (microdiffusion) assay with Listeria ivanovii BUG 496 as the indicator strain,
with all activity lost after digestion (Ghrairi et al., 2008). In another study by Biswas et al.,
(2017) various LAB including Lactobacillus, Pediococcus and Enterococcus, were shown to
display antimicrobial activity that was inactivated after digestion with various proteases
including Pronase E (Actinase E). Many of the species indicated in the above studies are found
in the intestinal flora – similar to B. longum ITT 13 which was isolated from the neonatal gut
flora in a previous research project carried out in our laboratory (Cooke et al., 2005) and may
display similarities due to being found within the same ecological niche.
The results observed at the 1/16 dilution for the pH 4.35 fermentate, although non-significant,
suggest a trend that is in agreement with the Actinase E digestion effect on the pH 4.80
fermentate and it is possible that as the amount of antimicrobial proteinaceous molecule is at a
very low concentration in the pH 4.35 fermentate, that the effect of the digestion by the
Actinase E may just be below the limit of detection and it is suggested that further studies be
carried out on a concentrated pH 4.35 fermentate. The pH 4.80 fermentate may have displayed
a larger decrease in antimicrobial activity when digested with Actinase E due to the fact that
this fermentate would be expected to have a larger concentration of antimicrobial peptides, as
it was cultured in a 2L fermenter leading to higher levels of growth (1x1011 CFU/ml). This is
in comparison to the pH 4.35 fermentate, which was grown at a smaller scale (100 mls) in an
anaerobic chamber and had less cell growth (1x109 CFU/ml) and in turn would be expected to
have less bacteriocin production.
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Antimicrobial activity was observed at the 1/4 and 1/8 dilutions for the Actinase E digested pH
4.80 fermentate in Figure 4.11a, even though the enzyme had successfully digested
antimicrobial peptides and reduced activity at the 1/16 dilution. The observance of
antimicrobial activity at the lower dilutions after the enzymatic digestion may be indicative of
antimicrobial activity most likely associated with organic acid production and this acid may
only be diluted out by the 1/16 dilution, at which point the effect of the incubation with the
Actinase E was observable in relation to the difference in activity between the digested and
undigested pH 4.80 fermentate. The latter effect can be taken as indicative of the contribution
of a proteinaceous molecule to the antimicrobial effect of the B. longum ITT 13 fermentate.
It was observed that the antimicrobial activity of the B. longum ITT 13 fermentate was reduced
by the Actinase E, however there was no observable statistically significant decrease in
antimicrobial activity when the incubated with Proteinase K. In a study by Collado et al.,
(2005), the antimicrobial activity of bacteriocins produced by Bifidobacterium strains were
reduced when treated with multiple proteases including Protease A, a component of Pronase E
(Actinase E). However, in the case of Proteinase K, the enzyme did not inhibit the antimicrobial
activity and instead displayed a synergistic effect by increasing the antimicrobial activity
observed against Helicobacter pylori (Collado et al., 2005). This finding is comparable to the
activity of ITT 13, as it is also a Bifidobacterium strain with resistance to Proteinase K and
susceptibility to Pronase E (Actinase E). Although synergism has not been observed with the
Proteinase K digested fermentate of B. longum ITT 13, antimicrobial peptides may be present
in such a low concentration the effect may not be observed, and this is something that would
warrant further investigation with a concentrated fermentate.
The fact that the Actinase E was demonstrated to show the presence of a proteinaceous
component contributing to the antimicrobial activity is a statistically and biologically
significant result and thus is in agreement with the detection of antimicrobial activity for the
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resuspended 80% ammonium sulphate fraction. It should be noted that the 80% AS fraction
was resuspended in a 50 mM NaAc pH 4.3 buffer and thus the antimicrobial activity would not
be considered to be associated with the presence of organic acids. As the Actinase E enzymatic
digestion resulted in inactivation of the proteinaceous material contributing to the antimicrobial
activity, this could indicate the possible presence of aspartic and glutamic acids in the peptide,
as some of the possible sites of action of Actinase E, which is a mix of enzymes with multiple
potentials sites, are the carboxyl side of glutamic and aspartic acid (Sigma-Aldrich, 2020). In
studies glutamic acid and aspartic acid have been shown to increase the solubility of proteins
due to their negative charge, whereby negative charge is associated with increased solubility
(Trevino, et al., 2007; Kramer et al., 2012), indicating the possibility the antimicrobial peptide
may be a soluble protein. If this is the site of action in the peptide, the agreement between the
protease digestion and ammonium sulphate precipitation results indicates the possibility of a
low molecular weight, potentially soluble, likely negatively charged peptide.

4.6.5 HPLC Analysis of the B. longum ITT 13 Fermentate
Organic acids including lactic and acetic acid are widely produced by Bifidobacteria (Lee and
O’Sullivan, 2010; Delgado et al., 2019; Nguyen et al., 2019) and organic acid production by
bacteria has been associated with antimicrobial activity against both Gram-positive and Gramnegative bacteria, as well as anti-fungal activity against both mould and yeast fungal strains
(Schillinger and Villarreal, 2010; Yang et al., 2012; Lourenço et al., 2019; Ajingi et al., 2020;
Chen et al., 2020). HPLC analysis has been used to identify and quantify the organic acid
production of many LAB (Özcelik et al., 2016; Nuryana et al., 2019) and in this study was
carried out on the fermentate produced by B. longum ITT 13, both without pH control at pH
4.3 and pH controlled during growth in a 2-litre fermentation vessel with a final pH in the
fermentate of pH 4.8.
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Lactic, acetic and succinic acids were determined as the organic acids produced by B. longum
ITT 13 during growth and fermentation in the MRSc broth medium for both the fermentation
with and without pH control (Figures 4.12 and 4.13). In comparison, only lactic and acetic acid
were specifically determined as the organic acids produced by B. longum ITT 13 when cultured
in the mYPD media (C. Whelan – personal communication).
For the fermentates produced using MRSc media, the pH 4.8 fermentate, grown with pH
control, was found to produce higher levels of acetic acid and succinic acid, with concentrations
of 160.95 mM ± 13.72 and 67.69 mM ± 6.14 respectively, compared to 147.72 ± 10.34 acetic
acid and 54.52 ± 3.00 succinic acid for the pH 4.3 fermentate. In comparison, the lactic acid
concentration was higher for the pH 4.3 fermentate at 92.22 mM ± 1.53 compared to 68.32 mM
± 10.62 for the pH 4.8 fermentate.
The pH 5.0 fermentate produced in the mYPD media in our laboratory (C. Whelan – personal
communication) and grown with pH control contained higher levels of lactic acid and
substantially higher levels of acetic acid than the fermentates grown in MRSc, with 154.98 mM
and 650.68 mM respectively. Both the pH 4.8 fermentate grown in MRS media + 0.11% Lcysteine and the pH 5.0 fermentate grown in mYPD in 2L fermentation vessels with pH control
generated a high cell count of 1011 CFU/ml, which would likely correspond to the higher levels
of production of organic acids by the B. longum ITT 13 in both fermentates. In comparison,
the pH 4.3 fermentate grown as static low volume cultures (100-200 mls) in MRSc without pH
control grew at a lower density of approximately 109 CFU/ml and also has lower production of
organic acids except lactic acid.
The media used for growth also demonstrates an effect on the composition and concentration
of organic acids produced due to the significantly higher concentrations of both lactic and
acetic acid produced by the pH 5.0 fermentate grown in an mYPD and the lack of succinic acid
produced in the same fermentation.
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The concentrations of lactic and acetic acid produced by various LAB including Bifidobacteria
were analysed in a study by Tejero-Sariñena et al., (2012), with 180 mM lactic acid and <50
mM acetic acid produced by B. longum PXN 30 and 99 mM acetic acid and <50 mM lactic
acid produced by B. infantis PXN 27. In comparison, B. longum ITT 13 cultured in MRSc broth
produced less lactic acid, but more acetic acid than B. longum PXN 30 and higher
concentrations of both lactic and acetic acid than B. infantis PXN 27 (Table 4.3). These results
indicate the variability in acid production between different Bifidobacterial strains, as all were
cultured using the same MRS media.
The organic acid production profile of two B. longum strains, CA1 (grown in MRSc) and F9
(grown in modified Columbia medium (mCOL)), was also assessed in a study by Makras and
De Vuyst, (2006). Strain CA1 was found to produce 60.9 mM ± 4.2 acetic acid and 39.9 mM
± 3.1 lactic acid with a final pH of 4.34, and strain F9 was found to produce much lower
concentrations of 28.0 mM ± 2.4 acetic acid and 17.8 mM ± 1.2 lactic acid (Table 4.3), with a
final pH of 4.14. This further demonstrates how different B. longum strains have the ability to
produce vastly different concentrations of acid, as the B. longum ITT 13 fermentate with no
pH control had a pH of 4.30-4.35 comparable to the pH of B. longum CA1 at pH 4.34, yet much
higher concentrations of acid were detected in the fermentate of ITT 13 even though they were
grown in the same media. It is also evident that the concentration of these acids does not directly
correlate to the pH as F9 contained much lower acetic and lactic acid concentrations than both
CA1 and ITT 13, yet had the lowest pH profile of all three strains. The media used for growth
also appears to affect the concentration and composition of acids produced as B. longum F9
cultured in mCOL had the lowest concentrations of lactic and acetic acid produced out of all
assessed strains, while B. longum ITT 13 cultured in the mYPD media (C. Whelan – personal
communication) had the highest lactic and acetic concentrations in comparison to ITT 13
cultured in MRSc (Table 4.3).
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Table 4.3: Lactic and Acetic Acid Concentrations Produced by Bifidobacteria
Strain + media

Lactic acid (mM)

Acetic acid (mM)

(1)

B. longum PXN 30 (MRSc)

180

<50

(1)

B. infantis PXN 27 (MRSc)

<50

99

40

61

18

28

92

147.72

68

161

155

651

(2)

B. longum CA1 (MRSc)

(2)

B. longum F9 (mCOL)

B. longum ITT 13 (pH 4.3 fermentate)
(MRSc)
B. longum ITT 13 (pH 4.8 fermentate)
(MRSc)
B. longum ITT 13 (pH 5 fermentate)
(mYPD)

The acid concentrations (mM) produced are as described by

(1)

Tejero-Sariñena et al., (2012), (2) Makras and De

Vuyst, (2006) and by B. longum ITT 13. It is evident upon comparison that the B. longum ITT 13 fermentations
both pH controlled at pH 4.8 and cultured without pH control at pH 4.3 produced higher concentrations of acetic
acid than the various other Bifidobacterial strains cultured in MRSc broth. B. longum PXN 30 produced the highest
concentrations of lactic acid at 180 mM in comparison to the other strains, while B. longum ITT 13 cultured in
mYPD produced significantly higher levels of acetic acid than all strains.

Although the acid concentrations may differ between B. longum strains, the profile of acids
produced may be similar within the various Bifidobacterial species, as in the study by Makras
and De Vuyst, (2006), where formic acid was detected in supernatants produced by multiple
strains of B. animalis and B. bifidum, yet not by either of the B. longum strains CA1 or F9, and
was also not detected in this study by B. longum ITT 13. This may indicate that formic acid is
not produced by B. longum strains or is produced below detectable levels compared to other
Bifidobacteria spp.. Succinic acid is not mentioned in either paper for comparison to B. longum
ITT 13.
Antimicrobial activity associated with the organic acid production of Bifidobacteria has been
documented (Lee and O’Sullivan, 2010). In a study by Georgieva et al. (2015), the acidic and
neutralized cell-free supernatant of various Lactobacilli and Bifidobacterium strains were
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tested for activity and it was found that the Bifidobacteria generally lost their antimicrobial
activity once neutralized to pH 7, except for B. animalis subsp. lactis L3, when tested in the
microdiffusion assay against the indicator strain S. aureus NBIMCC 3703. The results
indicated in the aforementioned study indicate that the organic acid production contributes to
antimicrobial activity alongside the low molecular weight proteinaceous material exhibiting
activity (Section 4.3 and 4.4). Makras and De Vuyst, (2006) determined that 39.9 mM lactic
acid and 60.9 mM acetic acid was produced by B. longum CA1. When these concentrations of
acid were tested for antimicrobial activity by the authors, they were found to display
antibacterial activity through inhibition of the growth of Salmonella enterica ser. typhimurium
SL1344 and a decrease in viability of E. coli C1845 cells in time-kill assays, which was the
same as the antimicrobial activity observed by the B. longum CA1 cell-free fermentate
indicating the activity was associated with the organic acids present in the fermentate. As the
acid concentrations produced by B. longum ITT 13 are higher than the concentrations
displaying activity produced by CA1, it is probable that the concentration of the acids are
contributing to the antimicrobial activity and further indicate the likelihood of synergism
between acid and peptide resulting in activity, in agreement with the studies observed by
Pasteris et al., (2014).
A destabilisation effect of the cell membrane may also take place with B. longum ITT 13,
whereby the organic acids may weaken cell membranes thus increasing the efficacy of the
antimicrobial peptide, resulting in a synergistic reaction between acid and peptide. This effect
has been observed in a study by Ajingi et al. (2020) where the activity of nisin was increased
to sub-MIC concentrations against a potato spoiling strain of B. subtilis, as well as other
bacteria including S. aureus and E. coli, when used in conjunction with organic acids such as
formic acid and lactic acid. This increase in the antibacterial activity of nisin indicated a
synergistic effect between nisin and the organic acids. For example, in this study by Ajingi et
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al. (2020) the MIC concentrations of 0.25% lactic acid and 0.016% nisin were observed against
B. subtilis, with the MIC decreasing to 0.025% lactic acid and 0.0016% nisin when both were
used in conjunction, which was indicative of synergism. This synergistic effect was also
observed for nisin in combination with many organic acids including formic, citric and malic
acid, against both Gram-positive and Gram-negative indicator strains (Ajingi et al., 2020). A
probable mode of action of organic acids could be interference with subtrate transportation
through the cell membrane of bacterial cells by interference with the porosity of the membrane
(Davidson et al., 2013).
Due to the organic acid production by B. longum ITT 13 of lactic, acetic and succinic acid and
the production of potentially low-molecular weight, antimicrobial proteinaceous material, a
synergistic effect is a potential scenario in this case. This is another possibility for the
antimicrobial activity observed against all tested Gram-negative species susceptible to the B.
longum ITT 13 fermentate which are more susceptible to inhibition by organic acid production
(Makras and De Vuyst, 2006). Therefore, the organic acid produced by B. longum ITT 13 may
cause interference with the cell membrane as described above, thus making the cells highly
susceptible to the antimicrobial effects of the antimicrobial peptide produced at low
concentrations. Further concentration and purification of the antimicrobial activity produced
by B. longum ITT 13 may concentrate and isolate these produced antimicrobial molecules
allowing future testing and insight into the specific modes of action of the antimicrobial peptide
production and possible synergistic activities between the proteinaceous material and the
organic acids produced by the strain.
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CHAPTER 5
Partial Purification and Concentration Studies of the
Bifidobacterium longum ITT 13 Fermentate
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The production of antimicrobial metabolites are an important characteristic of probiotic strains
to protect the host from pathogenic colonisation (Vlasova et al., 2016). Bacteriocins are of a
particular interest as these are ribosomally synthesised peptides that have demonstrated an
antimicrobial effect towards various bacteria and fungi, including those associated with food
spoilage and pathogenesis (Cheikhyoussef et al., 2010; Poltavska and Kovalenko, 2012; Lim,
2016; Luz et al., 2017; Aarti et al., 2018). The results indicated within Chapter 4 suggest that
B. longum ITT 13 produces antimicrobial activity associated with an antimicrobial peptide
produced at low concentrations, as well as antimicrobial activity associated with the production
of organic acids including lactic acid, acetic acid and succinic acid. In order to increase the
antimicrobial activity produced by B. longum ITT 13 for analysis, methods of concentration of
the fermentate were evaluated.
Cross flow filtration has been reported by the International Union of Pure and Applied
Chemistry (IUPAC) recommendation as “flow through a membrane module in which the fluid
on the upstream side of the membrane moves parallel to the membrane surface and the fluid on
the downstream side of the membrane moves away from the membrane in the direction normal
to the membrane surface” (Koros et al., 1996). It is a method of filtration whereby the sample
flows tangentially to the surface of the filter, consisting of a semi-permeable membrane with a
particular pore size and a pump system is used to promote the feed flow throughout the system
to the membrane (Musumeci et al., 2018). Therefore, it can be used to separate molecules above
a certain size from those small enough to pass through the membrane, separating the filtered
fluid into a retentate which cannot pass through the filter, and a filtrate or permeate which
passes through and is collected, allowing for separation of two samples or a concentration effect
of the retentate (Musumeci et al., 2018) (Figure 5.1). It is becoming increasingly used as a key
step in the biotechnology, pharmaceutical and food industries (Holland et al., 2012; Kelly et
al., 2014; Musumeci et al., 2018; Pires and Palmer, 2021; Tan et al., 2021).
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To enable further detailed studies of the component(s) contributing to the antimicrobial activity
observed for B. longum ITT 13 fermentate it is necessary to purify them. This chapter looks at
methods evaluated to concentrate the antimicrobial activity together with preliminary
purification studies. One of the experimental methods evaluated in concentration of the
antimicrobial activity was crossflow filtration as this method has been used previously as a step
in purification schemes for antimicrobial activity produced by bacteria (Izquierdo et al., 2009;
Lv, Ma, et al., 2018). To concentrate the antimicrobial activity produced by B. longum ITT 13
in the fermentate, the filtration method of tangential flow filtration was employed by using both
a Pellicon® XL 50 Cassette and LabscaleTM TFF System (Millipore) and larger-scale tangential
flow filtration Sartoflow Alpha Benchtop Crossflow System (Sartorius AG, Germany).

Figure 5.1: A diagram representation of a Tangential Flow Filtration system (Musumeci et al., 2018).
In the schematic representation of a TFF system, the samples for concentration are applied to the sample reservoir
where they travel through the system propelled by the feed pump to the filtration module, which consists of a
membrane of specified pore size. Samples that pass through the filter are collected as the filtrate/permeate, while
the retained molecules are fed back toward the sample reservoir. Repeated circulation is carried out until the
retentate is of the required, concentrated volume.

197

Results
5.1 Small-scale TFF Concentration Experimental Results
For the small-scale TFF concentration of the B. longum ITT 13 fermentate, a Pellicon® XL 50
Cassette and a LabscaleTM TFF System (Millipore) benchtop laboratory system were used, with
various experiments carried out using filter sizes between 3 kDa and 10 kDa. The filtration of
the fermentate was carried out as describe in Section 2.10.1.
Table 5.1: Details of Conditions and Parameters of all small-scale Tangential Flow Filtration (TFF)
Runs of the B. longum ITT 13 Fermentate
TFF
Run +
Filter
Size

Initial Information

1. TFF

10 kDa
2. TFF

3 kDa (1)
3. TFF

3 kDa (2)
4. TFF

3 kDa (3)

Centrifugation

Buffer Exchange(s)

Vol. of
Ret.
After
Conc.

Final
Conc.
(x-fold)

BCA
Test
(Y/N)

Vol.

pH

Media

xg

Time
(mins)

Steri
cup
(µm)

No.

Final
pH

Solvent

450
mls

4.26

MRSc

2722

5

No

-

-

-

50 mls

9-fold

Yes

125
mls

4.19

MRSc

2722

5

0.22

3

NaAc pH
4.9

25 mls

5-fold

No

125
mls

4.25

MRSc

2722

5

0.22

2

2.27

25 mls

5-fold

No

950
mls

4.20

MRSc

2722

5

0.45

2

4.67

0.02N
HCl pH
1.8
NaAc pH
4.8

50 mls

19-fold

Yes

A total of 4 TFF runs were carried out, with either no use of a stericup or stericups of 0.22 or
0.45 µm used and either no buffer exchange or a buffer exchange in either 50 mM pH 4.9 NaAc
buffer, 50 mM pH 4.8 NaAc buffer or 0.02N HCl. A BCA protein assay test was performed on
TFF runs 1 and 4.
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5.1.1 Small-scale TFF Run 1 (10KDa)
The first TFF run carried out on the B. longum ITT 13 fermentate involved the use of a 10
kDa membrane.
Table 5.2: The Antimicrobial Activity of each Fraction of the B. longum ITT 13 Fermentate After
TFF Concentration (Run 1)
The results were only noted up to a 1/4 dilution as this is the highest dilution at which antimicrobial activity was
detected for the samples. AU/ml was not calculated for the positive control of nisin and it was not relevant for
this experiment.
Avg. Zone (mm) ± SD
Sample
Undiluted
TFF
(10 kDa)

1/2

1/4

Average
AU/ml

Permeate (pH 4.28)

4.0 ± 0

1.7 ± 0.2

0±0

11 ± 0

Retentate (pH 4.26)

4.0 ± 0

2.0 ± 0

0±0

11 ± 0

Nisin (1000 IU/ml undiluted)

2.3 ± 0.2

1.2 ± 0.3

0.7 ± 0.2

N/A

MRSc broth

0±0

N/A

N/A

N/A

Both the permeate and retentate samples gave equivalent levels of antimicrobial activity,
which could not be statistically differentiated. For both, the antimicrobial activity was
detected up to a maximum of a 1/2 dilution with activity equivalent to 11 ± 0 AU/ml.
A BCA assay was carried out to determine the protein content of the fractions (Table 5.3). As
no BCA assay or microdiffusion assay was carried out on the fermentate before concentration
using TFF, the protein concentration and activity could not be determined for the original
fermentate. The entire volume of fermentate was used for TFF concentration with no
fermentate kept for activity or BCA testing before concentration.
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Table 5.3: Activity table for TFF concentration (Run 1) of the B. longum ITT 13 Fermentate against
S. xylosus
Sample

Total
Volume

Protein
Conc.
(mg/ml)

Activity
(AU/ml)

N/A

Protein
Content
(Total
mg)
N/A

Fermentate
(pH 4.26)

450 mls

Permeate
(pH 4.28)

400 mls

Retentate
(pH 4.26)

50 mls

Specific
Activity
(AU/mg)

N/A

Total
Activity
(AU/ml x
total vol.)
N/A

12.30

4,920

% Volume
Recovery

N/A

N/A

11

4,400

0.9

89%
100%

23.63

1182

11

550

0.5

11%

No sample of the initial fermentate was available for testing using the BCA method for protein
concentration determination. Both the permeate and retentate had 11 AU/ml of antimicrobial
activity, even though the retentate had almost double the protein concentration (23.63 mg/ml)
in comparison to the permeate (12.30 mg/ml). The lower protein concentration of 12.3 mg/ml
and antimicrobial activity of 11 AU/ml for the permeate generated a specific activity of 0.9
AU/mg, which is almost double that of the retentate which had a specific activity of 0.5 AU/mg.
The results presented in Table 5.3 show that although there was a ninefold concentration effect
from 450 ml to 50 ml, and the retentate contained nearly double the protein concentration of
the permeate, the specific activity decreased by almost 50% and most of the antimicrobial
activity is still present in the permeate. This indicates that although a concentration effect was
observed for the retentate as expected, the antimicrobial activity observed was not reflective of
this as the AU/ml remained the same for both samples. The pH of the permeate and retentate
was equivalent at pH 4.28 and pH 4.26 respectively, indicating that this low pH and the
contribution of organic acids in the B. longum ITT 13 fermentate (see Section 4.5) may have
masked any activity associated with the protein concentration within the retentate.
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5.1.2 Small-scale TFF Run 2 (3KDa filter using 50 mM NaAc exchange buffer at pH 4.9)
The second TFF run carried out on the B. longum ITT 13 fermentate involved the use of a
smaller 3 kDa membrane in place of the 10 kDa membrane to concentrate the activity within
the retentate.

Table 5.4: Antimicrobial activity of B. longum ITT 13 fractions following TFF concentration using a
3 kDa filter and pH 4.9, 50 mM NaAc buffer exchange (Run 2).
The results were noted up to a 1/4 dilution, as this is the highest dilution antimicrobial activity was detected. Zones
detected for the 1/4 dilution were faint in appearance. The fermentate containing cells as well as the cell free
fermentate after cell removal were both tested for activity. AU/ml was not calculated for the positive control of
nisin and it was not relevant for this experiment.
Avg. Zone (mm) ± SD
Sample
Undiluted

TFF
(3 kDa)

1/2

1/4

Average
AU/ml

Fermentate (pH 4.19)

4.2 ± 0.2

2.2 ± 0.2

1.7 ± 0.2

22 ± 0

Cell Free Fermentate

3.8 ± 0.2

2.2 ± 0.2

1.5 ± 0.4

22 ± 0

Permeate 1 (no buffer exchange)

3.7 ± 0.6

2.0 ± 0

1.3 ± 0.9

18 ± 5

Permeate 2 (1 buffer exchange)

0±0

0±0

0±0

0

Permeate 3 (2 buffer exchanges)

0±0

0±0

0±0

0

Permeate 4 (3 buffer exchanges)

0±0

0±0

0±0

0

Retentate 1 (no buffer exchange)

3.3 ± 0.5

N/A

N/A

N/A

Retentate 2 (1 buffer exchange)

1.2 ± 0.2

N/A

N/A

N/A

Retentate 3 (2 buffer exchanges)

0±0

N/A

N/A

0

Retentate 4 (3 buffer exchanges)

0±0

0±0

0±0

0

Nisin (1000 IU/ml undiluted)

2.5 ± 0.1

2.0 ± 0.2

1.4 ± 0.2

N/A

MRSc broth

0±0

N/A

N/A

N/A

NaAc buffer pH 4.9

0±0

N/A

N/A

N/A

No BCA assay was carried out on these samples to determine protein concentration and
distribution after TFF concentration. The pH of the samples was also not monitored throughout
the buffer exchange. The fermentate before concentration displayed antimicrobial activity to a
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maximum of a 1/4 dilution with 22 ± 0 AU/ml and the cell free fermentate displayed equivalent
antimicrobial activity i.e. the 1/4 dilution gave an activity value of 22 ± 0 AU/ml.
Permeate 1 from TFF run 2, obtained following filtration with a 3kDa filter but with no buffer
exchange, showed only slightly lower antimicrobial activity at 18+ 5 AU/ml as compared to
the original fermentate (22+ 0 AU/ml). As this was the initial permeate and did not involve a
media exchange, any constituents of the fermentate smaller than the 3kDa filter size would be
excluded in this permeate, therefore, permeate 1 was the only permeate diluted to 1/16 for
AU/ml determination.
Retentate 1, generated before buffer exchange, would contain particles small enough to be
retained by the filter and should thus remain in the retentate throughout the TFF process.
Therefore, only the final retentate after the buffer exchange was diluted to a 1/16 dilution for
AU/ml determination. Retentate 1 was plated in its undiluted form using the microdiffusion
assay to determine whether antimicrobial activity was present, and generated a zone of
inhibition of 3.3 mm ± 0.5, approximately 0.4 mm less than permeate 1 in the undiluted form
which had a zone of 3.7 mm ± 0.6, however both values were very similar when standard
deviation is taken into account.
Microdiffusion assay results for Permeate 2 and Retentate 2 showed that while there is no
detectable activity present in the permeate, the zone size for the retentate had decreased to 1.2
mm ± 0.2 relative to the original cell-free fermentate (3.8 mm ± 0.2). As Retentate 2 was
screened for activity qualitatively in the undiluted form, no AU/ml could be determined. The
results indicate that there was antimicrobial activity detectable in the retentate after the buffer
exchange which was either absent or below the limit of detection in the more dilute permeate.
Both permeates 3 and 4 and retentates 3 and 4 generated after subsequent buffer exchanges
retained no antimicrobial activity even in the undiluted form.
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5.1.3 Small-scale TFF Run 3 (3KDa filter using pH 1.8, 0.02N HCl as exchange buffer)
The third TFF run carried out on the B. longum ITT 13 fermentate was repeated with the use
of a 3 kDa membrane to concentrate the antimicrobial activity with buffer exchanges carried
out using 0.02N, pH 1.8 HCl, which is the same solvent used for preparation of the bacteriocin
nisin (Section 2.5) and does not display antimicrobial activity despite its low pH.

Table 5.5: The Antimicrobial Activity of each Fraction of the B. longum ITT 13 Fermentate after TFF
concentration using a 3 kDa filter and buffer exchange with pH 1.8, 0.02N HCl (Run 3).
The results were only noted up to a 1/4 dilution as this is the highest dilution activity was present at. The fermentate
before cells were removed as well as the cell free fermentate after cell removal were both tested for activity.
AU/ml was not calculated for the positive control of nisin and it was not relevant for this experiment.
Avg. Zone (mm) ± SD
Sample
Undiluted

TFF
(3 kDa)

1/2

1/4

Average
AU/ml

Fermentate (pH 4.25)

4.5 ± 0

2.5 ± 0

1.0 ± 0.7*

18 ± 5

Cell Free Fermentate

4.3 ± 0.2

2.2 ± 0.2

0.7 ± 0.9*

15 ± 5

Permeate 1 (no buffer exchange)

3.7 ± 0.2

0±0

0±0

6±0

Permeate 2 (1 buffer exchange)

1.8 ± 0.3

N/A

N/A

N/A

Permeate 3 (2 buffer exchanges)

0±0

N/A

N/A

N/A

Retentate 1 (no buffer exchange)

3.8 ± 0.2

N/A

N/A

N/A

Retentate 2 (1 buffer exchange)

1.8 ± 0.2

N/A

N/A

N/A

Retentate 3 (2 buffer exchanges) (pH
2.27)
Nisin (1000 IU/ml undiluted)

0±0

0±0

0±0

0

4.9 ± 0.3

4.5 ± 0.4

3.9 ± 0.3

N/A

MRSc broth

0±0

N/A

N/A

N/A

0.02N HCl (negative control)

0±0

N/A

N/A

N/A

*indicates the zones of inhibition were hazy in comparison to other zones on the microdiffusion plates.

Both the original fermentate (with cells) and the cell free fermentate displayed similar
antimicrobial activity that was detected up to a maximum of the 1/4 dilution, with 18 ± 5 AU/ml
associated with the fermentate with cells and 15 ± 5 AU/ml associated with the cell free
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fermentate. Although both the fermentate samples displayed activity to the same dilution, the
cell free fermentate displayed zones of inhibition 0.2-0.3 mm smaller than those produced by
the fermentate with cells at every dilution tested using the micro-diffusion assay.
Antimicrobial activity was only detected for Permeate 1, with no buffer exchange, in the neat
form (6 ± 0 AU/ml), indicating a loss of antimicrobial activity in comparison to the fermentate
and cell free fermentate before TFF concentration. Retentate 1 was screened for the presence
of antimicrobial activity in its undiluted form, as described previously for Table 5.4, and
displayed antimicrobial activity with an average zone of inhibition of 3.8 mm ± 0.2, similar to
permeate 1 which generated an average zone of 3.7 mm ± 0.2. Antimicrobial activity testing
for Permeate 2 and Retentate 2, following a single buffer exchange with pH 1.8, 0.02N HCl (in
comparison to NaAc buffer used in Run 2), generated zone sizes averaging 1.8 mm for both
samples. Both permeate 2 and retentate 2 were only screened for antimicrobial activity
qualitatively in the undiluted form as described previously in Table 5.4, therefore no AU/ml
calculation was determined. Antimicrobial activity testing of the Permeate 3 and Retentate 3
fractions that had undergone 2 buffer exchanges showed no detectable antimicrobial activity
on the microdiffusion assay.
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5.1.4 Small-scale TFF Run 4 (3KDa filter using 50 mM NaAc exchange buffer at pH 4.8)
The fourth TFF concentration run carried out on the B. longum ITT 13 fermentate was carried
out with the use of the 3 kDa membrane to concentrate the antimicrobial activity detected
within the fermentate and two subsequent buffer exchanges with 50 mM, pH 4.8 NaAc buffer.

Table 5.6: The Antimicrobial Activity of each Fraction of the B. longum ITT 13 Fermentate After TFF
Concentration and pH 4.8, 50 mM NaAc buffer exchange (Run 4).
The results were only noted up to a 1/4 dilution as this is the highest dilution at which antimicrobial activity was
detected for the samples. The fermentate before cells were removed as well as the cell free fermentate after cell
removal were both tested for activity. AU/ml was not calculated for the positive control of nisin and it was not
relevant for this experiment.
Avg. Zone (mm) ± SD
Sample
Undiluted

4. TFF
(3 kDa)

1/2

1/4

Average
AU/ml

Fermentate (pH 4.20)

4.7 ± 0.5

2.7 ± 0.5

0.8 ± 0.6

18 ± 5

Cell Free Fermentate (pH 4.18)

4.8 ± 0.2

2.8 ± 0.2

1.7 ± 0.5*

22 ± 0

Permeate 1 (no buffer exchange) (pH
4.20)
Permeate 2 (1 buffer exchange)

4.3 ± 0.2

2.5 ± 0

0.5 ± 0.7*

15 ± 5

1.2 ± 0.2

N/A

N/A

N/A

Permeate 3 (2 buffer exchanges)

0±0

0±0

0±0

0

Retentate 1 (no buffer exchange) (pH
4.22)
Retentate 2 (1 buffer exchange) (pH
4.43)
Retentate 3 (2 buffer exchanges) (pH
4.67)
Nisin (1000 IU/ml undiluted)

4.5 ± 0

2.5 ± 0

0.3 ± 0.5*

15 ± 5

1.3 ± 0.3

N/A

N/A

N/A

0±0

0±0

0±0

0

4.7 ± 0.3

3.9 ± 0.3

3.3 ± 0.2

N/A

MRSc broth

0±0

N/A

N/A

N/A

pH 4.8 50 mM NaAc Buffer

0±0

N/A

N/A

N/A

* indicates the zones of inhibition were hazy in comparison to other zones on the microdiffusion plates.

Both the fermentate (with cells) and the cell free fermentate which had cells and cellular debris
removed via centrifugation and the use of a 0.45 µm Stericup, displayed antimicrobial activity
to a 1/4 dilution with 18 ± 5 AU/ml and 22 ± 0 AU/ml respectively.
Retentate 1, permeate 1 and the fermentate samples all generated similar detectable
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antimicrobial activity to the 1/4 dilution. The undiluted zones of inhibition for both fermentate
samples, permeate 1 and retentate 1 were similar in size and between 4.3 and 4.8 mm and the
1/2 diluted samples were also similar with a diameter between 2.5 and 2.8 mm. At the 1/4
dilution, the fermentate with cells, permeate 1 and retentate 1 displayed average zone
measurements between 0.3-0.8 mm and the cell free fermentate displayed a larger average zone
size of 1.7 mm, however it should be noted that there was higher fluctuation in zone sizes
across the replicates at this dilution and the zones were hazy in comparison to the undiluted
and 1/2 dilutions. Both the Retentate 1 and Permeate 1 fractions demonstrated antimicrobial
activity of 15 ± 5 AU/ml, which was less than the activity determined for the fermentate
samples (18 ± 5 AU/ml and 22 ± 0 AU/ml).
Permeate 2 and retentate 2 which had undergone one buffer exchange were screened for
antimicrobial activity using the microdiffusion assay and were tested in their undiluted form,
with similar zones of inhibition of 1.2 mm ± 0.2 detected for permeate 2 and 1.3 mm ± 0.3
detected for retentate 2.
No antimicrobial activity was detected using the microdiffusion assay for both permeate 3 and
retentate 3, which had undergone two buffer exchanges. An M/D assay plate displaying the
analysis of permeate 2 and 3 and retentate 2 and 3 can be seen in Figure 5.3.
A BCA assay was carried out on all samples to assess the protein concentration and distribution
of each sample from each step of the TFF run and is displayed in Table 5.7.
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Table 5.7: Activity table for TFF concentration (Run 4) of the B. longum ITT 13 Fermentate with
TFF Concentration
Sample

Total
Volume

Protein
Conc.
(mg/ml)

Protein
Content
(Total
mg)

Activity
(Avg.
AU/ml)

Specific
Activity
(AU/mg)

% Volume
Recovery

% Protein
Recovery

18

Total
Activity
(AU/ml
x total
vol.)
18,000

Fermentate
(pH 4.20)

1000
mls

18.16

18,160

1.0

N/A

N/A

Cell Free
Fermentate

950 mls

16.97

16,122

22

20,900

1.3

N/A

N/A

Permeate 1
(pH 4.20)

900 mls

14.52

13,068

15

13,500

1.0

95%

Retentate 1
(pH 4.22)

50 mls

24.43

1,222

15

750

0.6

5%

Permeate 2

100 mls

0.52

52

N/A

N/A

N/A

80%

Retentate 2
(pH 4.43)
Permeate 3

25 mls

3.79

95

N/A

N/A

N/A

20%

100 mls

0

0

0

0

0

80%

25 mls

0

0

0

0

0

20%

Retentate 3
(pH 4.67)

81%
100%

8%

89%

9%
100%

16%

25%

0%
100%

0%

0%

From the results for TFF (Run 4) presented in table 5.7 it is evident that after the first TFF
concentration of the fermentate, 100% of the initial volume was recovered in both the permeate
1 and retentate 1, however only 89% of the initial protein concentration was recovered,
indicating possible losses in the filtration concentration protocol.
Of the total protein concentration in Retentate 1 (24.43 mg/ml), which was then used for the
second TFF concentration with a buffer exchange, only a total of 25% of the protein
concentration was recovered, even though 100% volume was recovered, indicating potential
losses through absorbance on the filter. Although the protein concentration of Retentate 2 was
3.79 mg/ml prior to the final TFF filtration and the second buffer exchange, no detectable
protein or antimicrobial activity was detected in either Retentate 3 or Permeate 3, indicating a
complete loss of protein.
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Although there were evident protein losses with repeated TFF cycles, for both Retentate 1 and
Permeate 1 together with Retentate and Permeate 2, the concentration effect was somewhat
effective, as the protein concentration in the retentates was higher than for the permeates.
Retentate 1 had 24.43 mg/ml protein, while permeate 1 contained 14.52 mg/ml and retentate 2
had 3.79 mg/ml while permeate 2 had 0.52 mg/ml protein.
Activity values were calculated for the B. longum ITT 13 fermentate and cell free fermentate,
Permeate 1, Retentate 1, Permeate 3 and Retentate 3. However, the activity values were not
calculated for Permeate 2 and Retentate 2, as these samples were only evaluated for the
presence or absence of antimicrobial activity on the micro-diffusion plates and thus only plated
in the undiluted form. The fermentate had an average of 18 AU/ml of antimicrobial activity,
while the cell free fermentate was slightly higher at 22 AU/ml. As there was less protein in the
cell free fermentate yet higher activity, this resulted in a higher specific activity of 1.3 AU/mg
of protein for the cell-free fermentate in comparison to the fermentate with cells which had 1.0
AU/mg. The activity was slightly reduced as compared to the original fermentate after the first
TFF cycle to 15 AU/ml for both the permeate 1 and retentate 1. The higher concentration of
protein in Retentate 1 (24.43 mg/ml) generated a specific activity of 0.6 AU/mg as compared
to a protein concentration of 14.52mg/ml for Permeate 1, which thus generated a slightly higher
specific activity of 1.0 AU/mg as the activity was equivalent to the retentate yet there was less
protein present. Antimicrobial activity was detected at low level for the undiluted samples of
Permeate 2 & Retentate 2 and then was completely undetectable following the final buffer
exchange via TFF in Permeate 3 and Retentate 3. Following the reduction of protein
concentration from Retentate 1 and Permeate 1 to Retentate 2 and Permeate 2, there was a
complete loss of detectable protein in Retentate 3 and Permeate 3.
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Figure 5.2: The antimicrobial activity of Permeate 1 and Retentate 1 (no buffer exchange) obtained
from the TFF run 4. The samples in Figure 5.2 were produced using TFF concentration using a 3 kDa filter.
The analysis of antimicrobial activity was carried out using the M/D assay (Section 2.6), with S. xylosus as the
indicator strain and serial dilutions of nisin from undiluted (neat) to a 1/16 dilution (1000-62.5 IU/ml) as a
positive control.

Figure 5.3: The antimicrobial activity of permeates 2 and 3, and retentates 2 and 3 with buffer
exchange(s) from TFF run 4. The samples in Figure 5.3 were produced using TFF concentration with a 3 kDa
filter. The analysis of antimicrobial activity was carried out using the M/D assay (Section 2.6) with S. xylosus as
the indicator strain and serial dilutions of nisin from undiluted (neat) to a 1/16 dilution (1000-62.5 IU/ml) as a
positive control.
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5.2 Large-scale TFF (Crossflow) Concentration Experimental Results
To increase the volume of fermentate utilised for concentration and minimise run time, thus
maximising efficiency and increasing potential concentrated yield of antimicrobial molecules,
the larger-scale TFF Sartoflow Alpha Benchtop Crossflow System (Sartorius AG, Germany)
was utilised. Crossflow filtration experimentation was carried out, initially on a B. longum ITT
13 fermentation produced using MRSc broth as the growth medium for the strain and secondly
using a modified YPD media which had been previously optimised in our laboratory to
maximise growth of the B. longum ITT 13 strain (C. Whelan – personal communication).

Table 5.8: Conditions and Parameters for Crossflow Concentration Runs of the B. longum ITT 13
Fermentate
Crossflow
Run +
Filter Size
TFF 1.

Initial Information

Buffer Exchange(s)

Vol. of
Ret.
After
Conc.

BCA
Test

Vol.
(L)

pH

Media

No.

Final
pH

Solvent

2.62

4.21

MRSc

1

4.46

NaAc pH 4.7

330 mls

Yes

2.55

4.60

mYPD

1

4.67

NaAc pH 4.7

350 mls

Yes

Cross flow
1 kDa
TFF 2.

Cross flow
1 kDa

The initial fermentate volumes used for the Crossflow concentrations, the starting pH of the
fermentates and the media they were grown in were compared in Table 5.8. As the fermentate
with cells could be applied directly to the Crossflow system to generate cell free fermentate
(Section 2.10.2), there was no requirement for centrifugation steps or the use of a Stericup to
remove cells and cellular debris prior to the crossflow concentration. After concentration of the
fermentate and buffer exchange, the number of buffer exchanges carried out, the solvent used
for buffer exchange and the final pH after buffer exchange were compared. The final volume
the fermentate was concentrated to was also noted.
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5.2.1 Crossflow Run 1
The initial run using the larger-scale TFF Crossflow system was carried out on the B. longum
ITT 13 fermentate cultured in MRSc broth. The cell free fermentate was generated through the
use of a 0.22 µm filter in the system before a 1 kDa membrane was used for concentration of
the fermentate. The antimicrobial activity of the fractions generated from the first crossflow
run with a single buffer exchange using 50 mM NaAc buffer at pH 4.7 were determined using
both the microdiffusion and MIC50 assays and are presented below in in Table 5.9. The graphed
results of the MIC50 plate are presented in Appendix C.

Table 5.9: Antimicrobial activity for the B. longum ITT 13 fermentate (MRSc broth) fractions
following Crossflow concentration and buffer exchange with 50 mM, pH 4.7 NaAc buffer (run 1)
Antimicrobial activity was detected using both the M/D assay (Section 2.6) and the MIC50 assay (Sections 2.8.4
and 2.10.2.1) with S. xylosus as the indicator strain. Three independent assays (n=3) were used to determine the
standard deviation (SD) Antimicrobial activity was only detected as far as the 1/4 dilution and therefore the
negative results for higher dilutions factors were not recorded. AU/ml was not calculated for the positive control
of nisin and it was not relevant for this experiment.
Avg. Zone (mm) ± SD
Sample

Undiluted

1/2

1/4

AU/ml

AU/ml

M/D assay

MIC50 Assay

Fermentate (pH 4.21)

3.8 ± 0.2

2.7 ± 0.2

2.0 ± 0

22 ± 0

N/A

Run 1.

Permeate 1 (no buffer

3.8 ± 0.2

2.7 ± 0.5

1.3 ± 0.9

18 ± 5

160

Crossflow

exchange) (pH 4.22)
0±0

0±0

0±0

0

40

4.0 ± 0

2.7 ± 0.2

2.5 ± 0.4

22 ± 0

160

0±0

0±0

0±0

0

20

Nisin (1000 IU/ml undiluted)

3.6 ± 0.3

2.9 ± 0.5

2.6 ± 0.5

N/A

N/A

MRSc Broth

0±0

N/A

N/A

N/A

N/A

50 mM pH 4.7 NaAc buffer

0±0

N/A

N/A

N/A

N/A

1 kDa

Permeate 2 (buffer exchange)

MRSc

(pH 4.42)
Retentate 1 (no buffer
exchange) (pH 4.21)
Retentate 2 (buffer exchange)
(pH 4.46)
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Antimicrobial activity was detected up to a 1/4 dilution, with 22 AU/ml for the initial
fermentate before the crossflow concentration. Permeate 1 also displayed antimicrobial activity
up to a 1/4 dilution equivalent to 18 ± 5 AU/ml and similar average zones of inhibition to the
fermentate, with average zone diameters of 3.8 mm and 2.7 mm for the undiluted (neat) and
1/2 dilutions, for both the fermentate and permeate 1. The 1/4 dilution of Permeate 1 generated
a smaller zone size of 1.3mm + 0.9 as compared to the fermentate, that had an average zone of
2.0 mm ± 0, however the standard deviation was significantly larger for permeate 1 and may
account for the smaller average. Retentate 1 also displayed antimicrobial activity up to the 1/4
dilution, with a value of 22 ± 0 AU/ml, generating the same activity values as the fermentate.
Although retentate 1 had similar average zones of inhibition to the fermentate and permeate,
with 4.0 mm and 2.7 mm for the undiluted and 1/2 dilution samples, the 1/4 dilution displayed
a slightly larger zone of inhibition than the original fermentate at 2.5 mm ± 0.4. This may
suggest that the smaller zone of the 1/4 dilution of permeate 1 in comparison to the original
fermentate and the larger zone of the 1/4 dilution of retentate 1 may be due to a slight
concentration effect. The antimicrobial activity generated for the permeate 1 and retentate 1
samples on the M/D assay can be seen in Figure 5.4.
No antimicrobial activity was detected after the buffer exchange for either permeate 2 or
retentate 2 using the microdiffusion assay, however the MIC50 assay (graphically presented in
Appendix C) detected low-level antimicrobial activity of 40 AU/ml for permeate 2, with
antimicrobial activity detected to the 1/4 dilution, and 20 AU/ml for retentate 2 i.e.
antimicrobial activity was detected up to the 1/2 dilution. The activity for permeate two and
retentate two, generated after a buffer exchange, were significantly lower than the values
obtained for the permeate 1 and retentate 1 samples prior to buffer exchange which had an
average MIC50 value of 160 AU/ml on the MIC50 assay in microtitre plates.
Upon determination of the antimicrobial activity of the samples generated from the crossflow
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concentration and buffer exchange, a BCA assay was performed to assess the protein
concentration in each of the fractions generated and is presented in Table 5.10.
Table 5.10: Activity results for Crossflow concentration (Run 1) of B. longum ITT 13 Fermentate
cultured in MRSc media
The antimicrobial activity results as determined using the M/D assay (Table 5.9) were used to determine the
activity relative to the protein concentration within Table 5.10 below
Sample

Total
Volume

Protein
Conc.
(mg/ml)

Protein
Content

Activity
(Avg.
AU/ml)

Specific
Activity
(AU/mg)

22

Total
Activity
(AU/ml
x total
vol.)
57,640

% Volume
Recovery

% Protein
Recovery

Fermentate
(pH 4.21)

2620
mls

20.59

53,946

1.07

N/A

N/A

Permeate 1
(pH 4.22)

2290
mls

17.89

40,968

18

41,220

1.01

87%

Retentate 1
(pH 4.21)

330 mls

22.54

7,438

22

7,260

0.98

13%

Permeate 2
(pH 4.42)

3015
mls

1.81

5,457

0

0

0

91%

Retentate 2
(pH 4.46)

150 mls

0.47

76%
100%

90%
14%
78%

96%
71

0

0

0

5%

79%
1%

The activity was calculated using the antimicrobial activity results of the M/D assay (Table
5.9) rather than the MIC50 assay for comparability with the TFF results in Section 5.1. During
the initial concentration of the B. longum ITT 13 fermentate, 100% of the volume was
recovered between the Permeate 1 and Retentate 1, along with 90% of the protein present in
the original fermentate used for the Crossflow concentration. Of the 310 mls of Retentate 1
used for the buffer exchange to produce Permeate 2 and Retentate 2, 96% of the total volume
was recovered from the crossflow system and 79% of protein. Only one buffer exchange was
carried out using the crossflow system as larger volumes (up to 3L) of buffer could be used in
a single run, which also minimised protein losses on the membrane caused by subsequent runs
as previously observed with the TFF results presented in Table 5.7.
After separation of the initial fermentate into Permeate 1 and Retentate 1, it was evident that a
concentration effect was observed as Retentate 1 had a higher concentration of protein with

213

22.54 mg/ml in comparison to Permeate 1 which had 17.89 mg/ml. This concentration effect
of protein in the retentate was only partially reflected in the activity, as Permeate 1 showed an
average antimicrobial activity of 18 AU/ml, while Retentate 1 had an average of 22 AU/ml of
antimicrobial activity, which was the same as for the antimicrobial activity of the fermentate
at 22 AU/ml. A similarity in the generated specific activity values for both Permeate 1 and
Retentate 1 were observed, with 1.01 AU/mg and 0.98 AU/mg respectively, despite the
difference in protein concentration levels between the two fractions.
The Retentate 1 was used for the Crossflow buffer exchange, resulting in the production of
Permeate 2 and Retentate 2. It was evident that the concentration effect of the protein was not
observed as the Retentate 2 had a lower concentration of protein at 0.47 mg/ml as compared to
Permeate 2 which had 1.81 mg/ml. There was a significant reduction in antimicrobial activity
following the buffer exchange as antimicrobial activity at a low level was detectable in the
more sensitive MIC50 assay but not with the M/D assay. The M/D assay for Permeate 1 and
Retentate 1 is presented in Figure 5.4.

Figure 5.4: The antimicrobial activity of permeate 1 and retentate 1 with no buffer exchange from
crossflow concentration experiment 1. Samples analysed in Figure 5.4 were produced using crossflow
concentration with a 1 kDa filter. The analysis of antimicrobial activity was carried out using the M/D assay
(Section 2.6) with S. xylosus as the indicator strain and nisin (undiluted (neat) to 1/16 dilution) as a positive
control.
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5.2.2 Crossflow Run 2
The second concentration experiment using the Crossflow system was carried out with the B.
longum ITT 13 fermentate produced in a mYPD media. A 0.22 µm filter within the Crossflow
system was used to generate the cell free fermentate before a 1 kDa membrane was used for
concentration. The antimicrobial activity of the fractions generated from the second crossflow
run with a single buffer exchange using 50 mM NaAc buffer at pH 4.7 were determined using
both the microdiffusion and MIC50 assays and are presented below in in Table 5.11. The
graphed results of the MIC50 plate are presented in Appendix C.
Table 5.11: Antimicrobial activity for the B. longum ITT 13 fermentate (mYPD broth) fractions

following Crossflow concentration and buffer exchange with 50 mM, pH 4.7 NaAc buffer (run 2).
Antimicrobial activity was detected using both the M/D assay (Section 2.6) and the MIC50 assay (Sections 2.8.4
and 2.10.2.1) with S. xylosus as the indicator strain. Three independent assays (n=3) were used to determine the
standard deviation (SD). The results were only noted up to a 1/4 dilution as this is the highest dilution activity was
present at. AU/ml was not calculated for the positive control of nisin and it was not relevant for this experiment.
Avg. Zone (mm) ± SD
Sample

2.
Crossflow
1 kDa
mYPD

Undiluted

1/2

1/4

AU/ml

AU/ml

M/D

MIC50

Assay

Assay

Fermentate (pH 4.57)

4.8 ± 0.2

2.3 ± 0.2

0±0

11 ± 0

N/A

Cell Free Fermentate (pH 4.64)

4.8 ± 0.2

1.5 ± 1.1

0±0

9±2

160

Permeate 1 (no buffer exchange)

4.7 ± 0.2

0.7 ± 0.9

0±0

8±2

160

0±0

0±0

0±0

0

40

4.8 ± 0.2

0.7 ± 0.9

0±0

8±2

160

0±0

0±0

0±0

0

20

Nisin (1000 IU/ml undiluted)

4.1 ± 0.1

3.3 ± 0

2.9 ± 0.1

N/A

N/A

MRSc broth

0±0

N/A

N/A

N/A

N/A

mYPD Broth

3.7 ± 0.5*

0±0

0±0

6±0

40

(pH 4.60)
Permeate 2 (buffer exchange)
(pH 4.67)
Retentate 1 (no buffer exchange)
(pH 4.62)
Retentate 2 (buffer exchange)
(pH 4.67)

* indicates the zones of inhibition that were less clear/defined than other zones .
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Table 5.11 displays the antimicrobial activity of all the fractions produced during the second
crossflow run of the B. longum ITT 13 fermentate produced in modified YPD (mYPD) broth,
which was detected using both the microdiffusion assay (Section 2.6) and MIC50 assay (Section
2.8.4). Both the M/D and MIC50 methods of antimicrobial evaluation were employed for
analytical purposes, with the latter presented visually in Appendix C. The results of the MIC50
assay are presented visually in Appendix C. The mYPD broth used as the growth medium for
the B. longum ITT 13 was also tested for antimicrobial activity as a negative control. The
mYPD broth itself displayed antimicrobial activity on the microdiffusion assay against S.
xylosus. Zones of inhibition smaller than those of the fermentate, permeate or retentate samples
were determined, at an average of 3.7 ± 0.5 mm and equivalent to 6 AU/ml attributed to the
media. No antimicrobial activity was detected on this assay beyond the undiluted form of the
mYPD broth and the zones of inhibition had less clarity than those for the undiluted fermentate,
permeate and retentate samples.
Antimicrobial activity was detected up to a 1/2 dilution for both the fermentate and cell free
fermentate in the M/D assay, with 11 ± 0 AU/ml and 9 ± 2 AU/ml respectively. Although the
average zones of inhibition for both the undiluted fermentate and cell free fermentate samples
were equivalent at 4.8 mm ± 0.2, the diameter of the 1/2 dilutions were variable, with 2.3 mm
± 0.2 for the fermentate and 1.5 mm ± 1.1 for the cell free fermentate and the standard deviation
is notably larger for the cell free fermentate and thus the results are not significantly different.
The cell free fermentate could be screened using the MIC50 assay however the fermentate with
cells could not, as only cell-free samples can be screened using this method. Antimicrobial
activity equivalent to 160 AU/ml was thus determined for the cell-free fermentate using the
MIC50 assay.
Permeate 1 and Retentate 1 after crossflow concentration displayed similar antimicrobial
activity, with activity detected to a 1/2 dilution and equivalent to 8 ± 2 AU/ml for both in the
216

M/D assay. The zones of inhibition on the M/D assay were also equivalent with 4.7 mm ± 0.2
and 0.7 mm ± 0.9 for the undiluted and 1/2 dilutions of Permeate 1, and 4.8 mm ± 0.2 and 0.7
mm ± 0.9 for the undiluted and 1/2 dilutions of Retentate 1. Using the MIC50 assay, both
Permeate 1 and Retentate 1 were also found to have equivalent antimicrobial activity of 160
AU/ml. These similarities in antimicrobial activity, using both assays, indicate that there was
likely no concentration effect on the antimicrobial activity observed for Retentate 1 using the
1kDa filter in the Crossflow.
For Permeate 2 and Retentate 2, which had both undergone a buffer exchange with 50 mM
NaAc buffer, pH 4.7, there was no detectable antimicrobial activity using the microdiffusion
assay, however similar to the previous Crossflow run (Run 1), 40 AU/ml was detected for
Permeate 2 and 20 AU/ml was detected for Retentate 2 when using the MIC50 assay. Thus,
there was noticeably reduced antimicrobial activity present following buffer exchange with
values of 160 AU/ml determined for the cell free fermentate, Permeate 1 and Retentate 1.
Upon determination of the antimicrobial activity of the samples generated from the crossflow
concentration and buffer exchange, a BCA assay was performed to assess the protein
concentration in each of the fractions generated and is presented in Table 5.12.
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Table 5.12: Activity results for Crossflow concentration (Run 2) of B. longum ITT 13 Fermentate
cultured in mYPD media
Sample

Total
Volume

Protein
Conc.
(mg/ml)

Protein
Content

Activity
(AU/ml)

Specific
Activity
(AU/mg)

11

Total
Activity
(AU/ml
x total
vol.)
32,560

% Volume
Recovery

% Protein
Recovery

Fermentate
(pH 4.57)

2960
mls

39.49

116,890

0.28

N/A

N/A

Cell Free
fermentate
(pH 4.64)
Permeate 1
(pH 4.60)

2550
mls

36.44

92,922

9

22,950

0.25

N/A

N/A

2200
mls

32.19

70,818

8

17,600

0.25

86%

Retentate 1
(pH 4.62)

350 mls

33.84

11,844

8

2,800

0.24

14%

Permeate 2
(pH 4.67)

3010
mls

3.03

9,120

0

0

0

91%

Retentate 2
(pH 4.67)

290 mls

2.08

76%
100%

89%
13%
87%

100%
603

0

0

0

9%

93%
6%

The activity was calculated using the antimicrobial activity results of the M/D assay (Table
5.11) rather than the MIC50 assay for comparability with the TFF results in Section 5.1. Of the
2.55 L of the cell free fermentate used for the crossflow concentration, 100% of the volume
was recovered between both Permeate 1 and Retentate 1. Of the protein present within the
fermentate 89% of the total protein content was recovered between Permeate 1 and Retentate
1 – equating to an 11% protein loss. Of the 310 mls of Retentate 1 used for the buffer exchange
with 3 L of 50 mM, pH 4.7 NaAc buffer, close to 100% of the total volume of the Retentate 1
and buffer solution was recovered between Permeate 2 and Retentate 2, along with 93% of the
protein that had been present in the solution – equating to a 7% protein loss from the protein
content present in the initial Retentate 1 and buffer solution. A single buffer exchange was
carried out on the crossflow system, as a much larger volume of buffer could be used in one
run, which, while allowing for considerable buffer exchange, minimise multiple pass
requirements through the membrane and minimised protein fouling on the membrane which
can occur in these systems (Kujundzic et al., 2011).
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After separation of the cell free fermentate into Permeate 1 and Retentate 1, it was evident that
there was only a minor concentration effect observed with 33.84 mg/ml protein in the Retentate
1, as opposed to 32.19 mg/ml in Permeate 1, which constitutes only a minimal concentration
difference of 1.65 mg/ml. As observed for Crossflow concentration experiment (Run 1), there
was no concentration effect but rather a significant protein loss after the buffer exchange on
Retentate 1 which was used to generate Permeate 2 and Retentate 2. Permeate 2 contained 3.03
mg/ml protein, in comparison to 2.08 mg/ml determined for Retentate 2. The results obtained
for the buffer exchange in Crossflow (Run 2) thus indicate that there was no successful protein
concentration effected in this method following buffer exchange.
In comparison to the results for the Crossflow concentration experiment (Run 1) (Table 5.10),
the calculated specific activity results for Run 2 were lower than expected which may be a
result of the higher protein concentrations present in the samples, as compared to the detectable
antimicrobial activity. The calculated specific activity was similar across all samples tested –
between 0.28 AU/mg and 0.24 AU/mg for the Fermentate (with cells), the cell free Fermentate,
Permeate 1 and Retentate 1. Permeate 2 and Retentate 2 displayed no antimicrobial activity
and therefore had a specific activity of 0 AU/mg. The overall results obtained for the crossflow
experiment (Run 2) suggest that this protocol is not suitable for concentration of the
antimicrobial activity detected in the original fermentate because there was no increased
activity associated with the retentate fraction as would be expected. The similar antimicrobial
activity observed for both the retentate and permeate fractions may be associated with organic
acid production by B. longum ITT 13 (Section 4.5), which is masking the low-level
antimicrobial activity associated with the potential proteinaceous molecule as determined in
Sections 4.3 and 4.4 that would likely be concentrated within the retentate. This protocol is
thus not suitable as the buffer exchange used to remove the media and these organic acids
contributing to activity results in a complete elimination of detectable antimicrobial activity,
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possibly as a result of adsorption of the low-molecular weight peptide to the TFF filter at the
protein concentrations used in the experiment, which can be known to occur in these systems
(Kujundzic et al., 2011).
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5.3 Discussion
Partial purification and concentration studies were carried out on the B. longum ITT 13
Fermentate through the use of tangential flow filtration (TFF) methods, including bench top
TFF and Crossflow filtration systems. These TFF methods have previously been used in
various studies for the concentration of metabolites produced by various organisms, including
the purification of proteins which is widely reported in literature (Musumeci et al., 2018). Pires
and Palmer, (2021) used TFF to purify complexed human serum albumin using an anti-HSA
polyclonal immunoglobulin G (IgG) from a haemoglobin mixture, while Aspelund and Glatz,
(2010) employed the ultrafiltration technique of TFF to evaluate its effectiveness for the
purification of recombinant proteins from aqueous corn endosperm and germ extracts, proving
effective for the separation and purification of proteins above 100 kDa with 89-99% purity.
TFF has been utilised as a purification method within the food industry to reduce microbial
load of raw wines (Umiker et al., 2013) and for beer clarification and pasteurization (Fillaudeau
and Carrère, 2002). TFF has also been used within the pharmaceutical industry for the
manufacturing and purification of nanoparticles used in nanomedicine by removing impurities
and carrying out buffer exchange (Musumeci et al., 2018; Roces et al., 2020; Webb et al.,
2020). In terms of bacteriocin production, TFF has been widely utilised as a step within
purification and/or concentration protocols to purify and isolate bacteriocins from the
supernatants of producing strains, enabling further characterization studies of these peptides
(Izquierdo et al., 2009; Amado et al., 2016; Kumar and Tiwari, 2017; Lv, Ma, et al., 2018).
The B. longum ITT 13 fermentate was initially concentrated through the use of a Pellicon® XL
50 Cassette and LabscaleTM TFF System (Millipore) benchtop laboratory system for smallscale concentration using volumes of 125-950 mls of fermentate. A variety of filter sizes of 3
kDa to 10 kDa were used for these TFF concentration experiments and the details of the four
TFF runs can be found in Table 5.1, including filter size, volumes of fermentate used and
221

whether a buffer exchange was carried out on the fermentate after concentration. Small-scale
TFF systems have been previously used for the purification of antimicrobial peptides, such as
in the study by Nanjundan et al., (2019) whereby a miniature TFF module from PALL
Lifesciences was employed for the purification of the surfactin lipoprotein produced by
Bacillus amyloliquefaciens SR1 that had displayed antimicrobial activity against fungal plant
pathogens.
The first TFF experimental run involved the concentration of 450 mls of the B. longum ITT 13
fermentate to a final volume of 50 mls using a 10 kDa filter and no buffer exchange carried out
in order to solely assess the concentration effect on the fermentate (Table 5.1 & Table 5.2).
Both the Permeate and Retentate were screened for antimicrobial activity using the
microdiffusion assay (Section 2.6), with antimicrobial activity detected up to a 1/2 dilution
equivalent to 11 AU/ml for both the Retentate and Permeate (Table 5.2). A BCA assay was
carried out to assess the protein distribution between the Retentate and Permeate in order to
assess the concentration effect on the total protein content in addition to assessing the
antimicrobial activity (Table 5.3). The Permeate was determined as having 12.30 mg/ml of
protein, whereas the Retentate had nearly double this concentration with 23.63 mg/ml protein.
Therefore, although a concentration effect for the protein in the Fermentate was evident for the
Retentate fraction, this did not correlate with higher levels of antimicrobial activity for the
Retentate fraction as compared to the Permeate fraction. This indicates that a pH or acid effect
was likely the overriding cause of antimicrobial activity here as there was no increase in activity
associated with concentrated protein.
The second lab scale TFF run involved the use of a smaller filter size of 3 kDa as opposed to
the 10 kDa used in run 1, to concentrate 125 mls of the B. longum ITT 13 fermentate to 25 mls
– equivalent to a five-fold concentration (Table 5.1). A total of 3 buffer exchanges were also
carried out on the Retentate after the initial concentration to 25 mls using pH 4.9 NaAc buffer
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(Table 5.1 & Table 5.4). The buffer exchanges were carried out to remove the organic acids
present in the Fermentate that may mask the antimicrobial activity associated with the
concentration of proteinaceous compounds (Makras and De Vuyst, 2006; Tejero-Sariñena et
al., 2012; Georgieva et al., 2015). It should be noted that the retentate was not tested for the
presence of organic acids to determine whether residual or lower concentrations of acid
remained, though due to large volumes of buffer used for the exchange it was assumed they
would have been diluted below the point of causing antimicrobial activity. Both the B. longum
ITT 13 fermentate with cells and the cell free fermentate had 22 AU/ml of antimicrobial activity
before concentration and after the initial concentration prior to the buffer exchange Permeate
1 displayed activity equivalent to 18 AU/ml ± 5. The initial Retentate before the buffer
exchange (Retentate 1) was not diluted on the M/D plates for an AU/ml determination and only
screened for antimicrobial activity in the undiluted form. It displayed antimicrobial activity
with zones of inhibition of 3.3 ± 0.5 mm which was similar to the zones produced for the
undiluted Permeate 1 of 3.7 ± 0.6 mm, indicating no obvious concentration of antimicrobial
activity for the Retentate fraction. A total of 3 buffer exchanges were carried out generating
Permeates 2, 3 and 4 and Retentates 2, 3 and 4, however no antimicrobial activity was detected
for any of these Permeate samples indicating that there was no detectable activity present
following the buffer exchanges. No antimicrobial activity was detected for Retentate 3 and 4
however, Retentate 2 displayed antimicrobial activity when tested in the undiluted form with
an average zone of inhibition of 1.2 ± 0.2 mm. The lack of detectable antimicrobial for
Permeate 2 after the first buffer exchange, in comparison to the antimicrobial detected for
Retentate 2 indicates that either a source other than organic acid may be responsible for the
antimicrobial activity and that a concentration effect was observed within the Retentate.
Izquierdo et al., (2009) used TFF as the second step within the purification process of an
antimicrobial peptide produced by E. faecalis WHE 96, whereby the use of a 10 kDa filter
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resulted in the peptide detected within the Permeate and the use of a 5 kDa filter resulted in
retention of the peptide. This indicated that the size of the peptide was between 5 kDa and 10
kDa. The use of a 3kDa filter during TFF filtration run 2 (Section 5.1.2) as opposed to the use
of the 10 kDa filter run 1 (Section 5.1.1) of the B. longum ITT 13 Fermentate, resulted in higher
antimicrobial activity detected in the Retentate as opposed to the Permeate, with the result
suggestive that the proteinaceous component of the antimicrobial activity may be between
3kDa and 10 kDa. Another study involving the concentration of an antimicrobial peptide DY42 produced by L. plantarum DY4-2, using TFF with 10 kDa, 5 kDa and 1 kDa determined the
presence of the peptide in the Permeate after the use of the 10 kDa and 5 kDa filters, however
the 1 kDa filter retained the peptide indicating a size of between 1-5 kDa (Lv, Ma, et al., 2018).
Many antimicrobial peptides are small, with both Class I and Class II bacteriocins less than 10
kDa (Deegan et al., 2006; Singh et al., 2015). Thus, there is the likelihood that the potential
antimicrobial peptide produced by B. longum ITT 13 is of a low molecular weight – as
previously discussed in Chapter 4 (Section 4.6). The lack of detection of antimicrobial activity
in the Retentate 3 and 4 fractions could potentially be reflective of significant losses associated
with adsorption to the TFF filter at the protein concentrations used in the experiment that can
occur in these systems (Kujundzic et al., 2011) due to the repeated circulation throughout the
instrument for each buffer exchange. Although this is likely a potential reason for the lack of
activity in Retentates 3 and 4 this could not be definitively proven as transmembrane pressure
was not monitored during the run.
A third TFF run was carried out with the same volumes (125 mls concentrated to 25 mls) and
conditions as for the previous TFF run 2, however instead of a buffer exchange with a 50 mM
NaAc pH 4.9 buffer, buffer exchanges were instead carried out using 0.02 N HCl (pH 1.8)
(Table 5.1), which is an acidic solvent used for nisin preparation (Section 2.5). The reason this
solvent was chosen was on the basis that some antimicrobial peptides, e.g. nisin, display
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maximum activity in the lower pH range below pH 5 (Rollema et al., 1995; Matsusaki et al.,
1998) and as the fermentate had retained maximum detectable antimicrobial activity in the
microdiffusion assay below pH 5 in Section 4.2, an acidic solvent with no antimicrobial effect
(Table 5.5) was chosen for the buffer exchange. The B. longum ITT 13 fermentate with cells
and the cell free fermentate before TFF concentration were diluted to a 1/16 dilution and
displayed antimicrobial activity up to the 1/4 dilutions equivalent to antimicrobial activity
values of 18 ± 5 and 15 ± 5 AU/ml respectively on the M/D assay plates (Table 5.5).
Permeate 1 was also diluted to a 1/16 dilution but only displayed antimicrobial activity in the
undiluted form with 6 ± 0 AU/ml, indicating a loss of activity in the Permeate in comparison
to the original fermentate (Table 5.5). Retentate 1 (no buffer exchange) was only screened for
activity in the undiluted form to determine qualitatively whether antimicrobial activity was
absent or present. Retentate 2, Permeate 2 and Permeate 3 were also only screened for
antimicrobial activity in their undiluted form to determine whether any antimicrobial activity
was retained after buffer exchange. The final retentate after the two buffer exchanges
(Retentate 3) was diluted to a 1/16 dilution and antimicrobial activity determined quantitatively
with an AU/ml calculation, however no activity was detected (Table 5.5). The zone of
inhibition for the undiluted Retentate 1 was 3.8 ± 0.2 mm, which was comparable to the zone
of the undiluted Permeate 1 at 3.7 ± 0.2 mm thus indicating similar activity for the undiluted
forms of both. Permeate 2 and Retentate 2, which had undergone a single buffer exchange with
100 mls of 0.02 N HCl, also displayed comparable antimicrobial activity on the microdiffusion
plates, with a zone of inhibition of 1.8 ± 0.3 mm detected for Permeate 2 and 1.8 ± 0.2 mm
detected for Retentate 2 (Table 5.5). The above results are in contrast to the antimicrobial
activity detected for the previous TFF Run 2 with a pH 4.9 NaAc buffer exchange, whereby
after the single buffer exchange, Retentate 2 retained some antimicrobial activity, however no
activity was detected for Permeate 2 (Table 5.4). The results generated in TFF run 3, which
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give similar results for the permeate and retentate despite the differences in volume, do not
indicate any appreciable concentration of the antimicrobial activity. Following the second
buffer exchange step with 0.02N HCl, no antimicrobial activity was detectable on an M/D assay
for either the Retentate or the Permeate. The buffer exchange using the acidic 0.02N HCl in
the TFF step therefore did not generate antimicrobial activity results that would be suggestive
of a successful concentration step. This result was not anticipated as the antimicrobial activity
produced by B. longum ITT 13 had previously displayed antimicrobial activity at a more acidic
pH range (Section 4.2) and antimicrobial peptides produced by LAB have often displayed
stability at a lower pH, including nisin which retains maximum antimicrobial activity in the
lower pH range below pH 5 (Rollema et al., 1995; Matsusaki et al., 1998). A bacteriocin
designated bovicin HC5, produced by Streptococcus bovis HC5, demonstrated a greater ability
to cause pore formation in the cellular membrane of the target cells of S. bovis JB1 at a more
acidic pH of pH 5.5 as compared to the peptide at pH 7, causing a greater measurable loss of
potassium from the cells (Houlihan et al., 2004). Pei et al. (2020) also examined the pH stability
of bacteriocin produced by L. plantarum SLG10 at a pH range of pH 2-10, determining that at
the more acidic pH range of pH 3-7 there was increased antimicrobial activity of approximately
200 AU/ml, however the antimicrobial activity began to decline at pH 8 and was close to 0
AU/ml for pH 9 and 10.
As the pH 1.8 HCl did not have any discernible beneficial effect for the buffer exchange, the
buffer for the fourth TFF concentration run was reverted back to 50 mM NaAc buffer at pH
4.8. The pH of the buffer was reduced from pH 4.9 in TFF Run 2 to pH 4.8 to try preserve
antimicrobial activity after the buffer exchange which may only be active at a lower pH, as the
pH of the original fermentate was pH 4.2-4.3. The volume size of the fermentate to be
concentrated was also increased to 950 mls concentrated to 50 mls to increase the concentration
of any potential antimicrobial compounds from 5-fold in TFF Run 2 to a 20-fold concentration
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in TFF Run 4 (Table 5.1). The B. longum ITT 13 fermentate with cells displayed antimicrobial
activity at an average of 18 ± 5 AU/ml, while the cell free fermentate displayed an average of
22 ± 0 AU/ml (Table 5.6). Upon the initial TFF separation of the cell free fermentate, the
activity was reduced to an average of 15 ± 5 AU/ml for both the Permeate (Permeate 1) and
the Retentate (Retentate 1) (Table 5.6). This pattern of the antimicrobial activity decreasing
slightly in the Permeate and Retentate after the initial separation, but before buffer exchange,
was also observed in the previous TFF runs and may be indicative of binding of some
antimicrobial constituents in the Fermentate to the 3 kDa filter.
A total of two buffer exchanges were carried out, with reduced antimicrobial activity detected
for both the Permeate 2 and the Retentate 2 generated after the first buffer exchange in
comparison to Permeate 1 and Retentate 1, with the zone of inhibition for the undiluted
fractions decreasing from an average of 4.3 ± 0.2 mm for Permeate 1 to 1.2 ± 0.2 mm for
Permeate 2 and from 4.5 ± 0.0 for Retentate 1 to 1.3 ± 0.3 for Retentate 2 (Table 5.6). The
pattern observed previously in Runs 2 and 3 whereby only the retentate retained antimicrobial
activity after the buffer exchange was not observed on this run. It is possible that the buffer
exchange reduced the antimicrobial activity due to a combination of the removal of the organic
acids produced by B. Longum ITT 13 e.g. acetic acid, lactic acid and formic acid, together with
a probable loss of antimicrobial activity through absorption on the filter (Makras and De Vuyst,
2006; Kujundzic et al., 2011; Tejero-Sariñena et al., 2012; Delgado et al., 2019).
No antimicrobial activity was detected for any dilution of Permeate 3 and Retentate 3 after the
second buffer exchange in TFF run 4 (Table 5.6). The unfortunate observed complete loss of
antimicrobial activity following more than a single buffer exchange for TFF runs 2-4 could be
due to the overall TFF concentration process. TFF involves repeated circulation of the retentate
through the equipment, which should enable retention of any fermentate components larger
than 3kDa within the instrument e.g. antimicrobial proteinaceous molecules, but the multiple
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passes through the filter would increase the risk for adsorption of proteinaceous molecules to
the filter (Kujundzic et al., 2011), especially as the filter was not depolarised during runs.
Grund et al. (1992) discussed how issues may arise at the filter interface when concentrating
soluble proteins on crossflow/TFF membranes. High flow rates during concentration of
proteins can be impeded through the concentration of soluble proteins, due to rejection of these
proteins at the surface of the membrane causing the formation of a concentration-polarization
layer. The formation of this layer then often increases the build-up of soluble protein at the
filter, which in turn mediates protein adsorption onto the surface of the membrane. The latter
adsorption, combined with proteins that enter the pores causing blockage, can also cause
resistance to the flow rates of the permeate. Thus, liquid permeation of the membrane/filter is
affected by the protein adsorption onto the membrane through protein membrane interactions
and adsorption of protein on the membrane surface due to soluble protein mediated protein
interactions (Grund et al, 1992).
Another possibility is that the production of antimicrobial molecules, such as bacteriocins, may
be at a very low concentration and therefore much larger volumes of multiple litres may be
required to generate significant detectable antimicrobial activity when concentrating and
carrying out buffer exchanges. Antimicrobial peptides are generally produced at a low
concentration unless a complex, specific media is used for growth, therefore purification and
concentration methods are commonly employed to increase yield, as discussed in the review
by Garsa et al., (2014). Garsa et al., (2014) details the many small and large-scale purification
processes often employed in the food and pharmaceutical industries to increase bacteriocin
yield, including various chromatographic methods (gel-filtration, hydrophobic interaction
chromatography, cation exchange), ultrafiltration and precipitation methods (ammonium
sulphate, ethanol etc.). Previous bacteriocin purification work carried out in our laboratory has
also indicated low bacteriocin purification levels. The latter consideration was the reason for
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the decision to carry out concentration using the larger scale Crossflow concentration process.
A BCA assay was carried out on all the samples from the fourth TFF run (Table 5.7). This
determined that the cell free fermentate used for the TFF concentration contained
approximately 16.97 mg/ml of protein, which was equivalent to a total of 16,122 mg protein in
the 950 ml volume of fermentate. The initial separation into Permeate 1 and Retentate 1 would
be expected to show an increase in concentration of protein for the Retentate and a decrease
for the Permeate in comparison to the Fermentate used for the separation and that was what
was observed with a decreased average of 14.52 mg/ml protein determined for Permeate 1 and
an increase to 24.43 mg/ml observed for the Retentate 1. This larger concentration of protein
within the Retentate 1 was not reflective of an increase in antimicrobial activity however, as
observed in Table 5.6, with the same average activity determined for both Retentate 1 and
Permeate 1 at 15 ± 5 AU/ml. However, the antimicrobial activity associated with the organic
acid production by B. longum ITT 13 may have masked any small differences in antimicrobial
activity associated with the concentration of potential antimicrobial peptides. The overall
recovery of protein was 89% in comparison to the cell free Fermentate, indicating binding is
likely taking place within the TFF instrument incurring losses which may be associated with
the observed protein loss.
With the first buffer exchange, this likely binding of the protein to the filter or within the tubing
of the instrument, became even more evident as only 25% of the total protein from Retentate 1
that was used for the buffer exchange was recovered. The distribution of protein between
Permeate 2 and Retentate 2 indicated that a concentration effect was still taking place, however
the overall concentration in the recovered samples protein were lower than for the original
Retentate 1 sample applied for the buffer exchange step, with only 0.52 mg/ml present in
Permeate 2 and 3.79 mg/ml present within Retentate 2.
The second buffer exchange resulted in a complete loss of any detectable protein, meaning the
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recirculation of the samples throughout the instrument during the buffer exchanges resulted in
complete protein loss and the latter protein loss possibly accounts for the complete loss of
antimicrobial activity detected for each TFF run when any more than a single buffer exchange
was carried out. The Pierce™ BCA Protein Assay Kit (Thermofisher) procedure used detects
protein concentration as low as 20 µg/mL indicating high sensitivity of the assay and sufficient
sensitivity for the analysis of the samples generated through TFF as they are measured in mg/ml
(PierceTM BCA Protein Assay Kit).
The use of TFF to purify an antimicrobial peptide was utilised by Izquierdo et al., (2009), who
generated an activity table through AU/ml calculated using the spot-on-lawn assay and A280
readings for protein concentration. The author found that after purification using TFF
concentration with a 5 kDa filter, the AU/ml increased from 100 AU/ml for the culture extract
to 1600 AU/ml upon purification using TFF, with a total of 70% of activity present in the 220
mls of the retentate generated from the 5000 mls of the culture extract that contained 100% of
activity. In the reported case, the TFF concentration of the peptide was efficient in partial
purification and concentration of the antimicrobial activity. This was not the case for the
concentration of the B. longum ITT 13 fermentate as in the TFF experiments Runs 1-4 carried
out, it was observed that there was no significant concentration of the B. longum ITT 13
antimicrobial activity, as the AU/ml was not increased for the Retentate in comparison to the
original cell-free Fermentate (Tables 5.4-5.6).
Due to the limitations of the labscale TFF runs including repeated recirculation causing protein
losses, the volume limitations of the equipment allowing only 450-500 mls of fermentate at a
time and the length of the run times to efficiently concentrate the fermentate, a larger scale
Crossflow filtration system was utilised allowing for the concentration of larger Fermentate
volumes of up to approximately 3L in a shorter timeframe. A total of two crossflow runs were
carried out, with the initial run involved the growth of the B. longum ITT 13 Fermentate in an
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MRSc media and the second run involved the production of Fermentate using a modified YPD
(mYPD) media (C. Whelan – personal communication). The fractions produced from each
crossflow run i.e. the Permeates and Retentates, were tested for antimicrobial activity using
both the microdiffusion assay (Section 2.6) and the more sensitive microtitre plate MIC50 assay
(Section 2.8.4). Nakamura et al., (2013) produced a concentrated fraction of Gassericin A, a
circular bacteriocin produced by Lactobacillus gasseri LA39, from the culture supernatant
using crossflow filtration with a 30 kDa membrane, by concentrating 9L of supernatant to a
600 ml retentate resulting in a 15-fold concentration effect. This method of concentration
resulted in a concentrated fraction with antimicrobial activity 16-times higher (3940 AU/ml)
than that of the culture supernatant (246 AU/ml) and was used for further characterization
studies including temperature and storage stability testing.
The first crossflow concentration run involved cultivation of the B. longum ITT 13 in MRSc
broth and after the initial concentration step, a single buffer exchange was carried out on the
retentate using pH 4.7 NaAc buffer. The microdiffusion assay yielded antimicrobial activity
equivalent to 22 ± 0 AU/ml for the original B. longum ITT 13 Fermentate produced in MRSc
broth, 18 ± 5 AU/ml for the Permeate 1 and 22 ± 0 AU/ml for the Retentate 1 with both samples
produced prior to buffer exchange (Table 5.9). The antimicrobial activity measurements for the
Permeate 1 and Retentate 1 are only marginally different as the standard deviation results do
not indicate any significance in the difference. Buffer exchange of Retentate 1 (310 ml) with 3
L of 50 mM pH 4.7 NaAc buffer was used to generate Permeate 2 and Retentate 2. The buffer
exchange resulted in no detectable antimicrobial activity when samples were tested in the
microdiffusion assay with 0 AU/ml calculated for both Permeate 2 and Retentate 2.
Samples were additionally tested on the more sensitive MIC50 assay and these results, together
with the M/D assay results, are presented Table 5.9. The MIC50 was determined as the dilution
inhibiting at least 50% of the growth of the S. xylosus indicator strain. Both Permeate 1 and
231

Retentate 1 generated antimicrobial activity with an MIC50 for the 1/16 dilution, equivalent to
160 AU/ml (Table 5.9), which indicates that both samples were similar in activity. The latter
equivalent results for both Permeate 1 and Retentate 1 in the MIC50 assay thus indicates that
the lower detected activity of 18 ± 5 AU/ml for Permeate 1 in the microdiffusion plates in
comparison to 22 ± 0 AU/ml for the Retentate 1 was likely due to variation in the M/D assay
replicate results for Permeate 1. Small amounts of antimicrobial activity were detected for both
the Permeate 2 with an MIC50 of a 1/4 dilution, equivalent to 40 AU/ml (Table 5.9) and
Retentate 2, with an MIC50 of a 1/2 dilution, equivalent to 20 AU/ml (Table 5.9). The results
generated were disappointing in that the expected results would be where the retentate should
likely contain everything retained by the filter and thus display more antimicrobial activity due
to the presence of concentrated antimicrobial molecules such as bacteriocins. Nanjundan et al.,
(2019) used ultrafiltration to successfully purify surfactin lipopeptides produced by Bacillus
amyloliquefaciens with antifungal activity against a variety of plant pathogens, using a
miniature TFF instrument with 1 kDa and 3 kDa membranes to purify the peptides. Golneshin
et al., (2020) also carried out purification and concentration steps of a bacteriocin, plantacyclin
B21AG produced by Lactiplantibacillus plantarum B21, using ultrafiltration techniques with
a 10 kDa membrane, which resulted in 16-fold concentration of the bacteriocin increasing the
antimicrobial activity from 800 AU/ml to 12,800 AU/ml. Amado et al., (2016), also employed
TFF as a partial purification method of a bacteriocin produced by Pediococcus acidilactici
NRRL B-5627, however the author retained the bacteriocin of 2.7 kDa in the permeate through
use of a 10 kDa filter, to exclude and reduce higher molecular weight molecules present in the
culture media. The latter idea of reducing the high molecular weight compounds in the
fermentate could be used in partial purification of the B. longum ITT 13 fermentate though it
is noted that this would not concentrate activity. Further membranes with a smaller molecular
weight cut off could be used for concentration of the permeate containing the antimicrobial
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peptide produced by ITT 13 after the use of the 10 kDa membrane to remove larger molecular
weight molecules, which in turn would likely reduce protein adsorption to the 3 kDa membrane
and minimise fouling.
A BCA assay was carried out to determine the protein distribution to assess whether a
concentration effect had taken place. The results for the protein concentrations obtained from
the BCA assay as presented in Table 5.10 indicate that following the initial concentration step
but prior to the buffer exchange, the Retentate 1 contained a slightly higher concentration of
protein at 22.54 mg/ml in comparison to Permeate 1 which had 17.89 mg/ml. The results are
suggestive that a low-level concentration had taken place with slightly higher concentration of
protein present in the Retentate. When the buffer exchange was carried out however, the
concentration of protein was greatly reduced for both the Permeate 2 and the Retentate 2,
whereby Retentate 2 had a lower protein concentration at 0.47 mg/ml in comparison to the
Permeate 2 value of 1.81 mg/ml. The higher concentrations of protein in the permeate was not
expected as the original sample applied for buffer exchange had already been run through the
1 kDa filter. The lower protein concentrations determined in the BCA assay for Retentate 2 in
comparison to Permeate 2 could be taken to account for the lower-than-expected antimicrobial
activity detected for Retentate 2 in comparison to Permeate 2 in the MIC50 assay (Appendix C).
The significant protein losses experienced previously using the TFF apparatus were not
experienced with the Crossflow system, as upon the initial concentration of the fermentate
producing Permeate 1 and Retentate 1, 90% of the protein was recovered and when carrying
out the buffer exchange step using 310 mls of the Retentate 1, 79% of the protein was recovered
(Table 5.10). Therefore, although losses of 10-21% protein were observed for the crossflow
system, they were not comparable to losses of up to 100% experienced using the smaller TFF
system with significantly more cycles through the filter to enable concentration. Considering
the high protein recovery yet lack of concentrated antimicrobial activity, it may be plausible in
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future work to utilise much larger volumes of the B. longum ITT 13 fermentate, as work by
Nakamura et al., (2013) demonstrated that a 15-fold concentration of 9 litres of a cell-free
supernatant to a 600 ml retentate, resulted in a 16-fold increase of antimicrobial activity by the
bacteriocin Gassericin A, produced by Lactobacillus gasseri LA39, against Lb. delbrueckii
subsp. bulgaricus JCM 1002T.
The second crossflow concentration took place with a B. longum ITT 13 Fermentate grown in
a modified YPD (mYPD) media that had been modified to yield greater levels of antimicrobial
activity (C. Whelan – personal communication). As with crossflow Run 1, buffer exchange
was carried out using 50 mM pH 4.7 NaAc buffer, with the aim of removing the contribution
of any acids produced by B. longum ITT 13 to the detected antimicrobial activity. The
Permeates and Retentates generated were tested for antimicrobial activity using both the
microdiffusion assay (Section 2.6) and the microtitre plate MIC50 assay (Section 2.84). The B.
longum ITT 13 Fermentate with cells grown in the mYPD media displayed antimicrobial
activity in the microdiffusion assay plates equivalent to 11 ± 0 AU/ml, whereas the cell-free
fermentate gave a slightly lower antimicrobial activity value of 9 ± 2 AU/ml, and both the
Permeate 1 and Retentate 1, before the buffer exchange, displayed the same activity equivalent
to 8 ± 2 AU/ml (Table 5.11). As with the results obtained for the crossflow run 1 fractions, no
antimicrobial activity was detected for the Permeate 2 and Retentate 2 fractions that had
undergone a buffer exchange with 3L of 50 mM, pH 4.7 NaAc buffer (Table 5.11).
In contrast to the media used in the previous crossflow run 1, it was noted that the mYPD media
by itself generated small zones of partial inhibition in the M/D assay with zone sizes of 3.7±
0.5 mm, equivalent to 6 ± 0 AU/ml as compared to the larger clear zones of 4.7-4.8 mm
generated by the undiluted Fermentate, Permeate 1 and Retentate 1 (Table 5.11). The source
of inhibition observed for sterile mYPD media alone was not ascertained. However, a possible
suggestion for the inhibition observed in the M/D assay for the mYPD media may be a result
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of the high solute and sugar concentration within the media which had a glucose concentration
of 40 g/L. Sugars have been used as preservatives in industry, with high sugar contents,
including glucose, shown to inhibit the growth of various microbes to varying degrees (White,
2018; Mizzi et al., 2020).
Results for the microtitre plate MIC50 assay (Table 5.11), showed an MIC50 for the 1/16 dilution
equivalent to 160 AU/ml detected for the cell free Fermentate, Permeate 1 and Retentate 1,
indicating similar levels of activity across all three samples. Some of the antimicrobial activity
may be primarily due to organic acid production as discussed previously in Sections 4.6.4 and
4.6.5. The mYPD media also displayed antimicrobial activity to a 1/4 dilution - equivalent to
40 AU/ml, however it never completely inhibited the growth of the S. xylosus ATCC 29971
indicator strain when the media was diluted further as the other samples did. After the buffer
exchange, reduced antimicrobial activity was detected for Permeate 2 and Retentate 2, with
levels of activity similar to those detected for the previous Crossflow run 1 and an MIC50
recorded for the 1/4 dilution equivalent to 40 AU/ml for Permeate 2 and a slightly lower MIC50
value of the 1/2 dilution and 20 AU/ml for Retentate 2 (Table 5.11). The lower antimicrobial
activity detected in the Retentate as opposed to the Permeate was not the expected result, as
the Retentate should retain all the molecules unable to pass through the filter, as they had
already been passed once through the 1 kDa filter and thus it would be expected that the
antimicrobial activity should be retained within the Retentate.
The protein concentrations of the fractions were determined in the BCA assay (Table 5.12), the
cell-free fermentate had 36.44 mg/ml of protein and this concentration of protein was not
effectively further concentrated in Retentate 1 which gave similar values of 33.84 mg/ml
protein, while 32.19mg/ml was measured in Permeate 1. As also observed in the previous
crossflow Run 1, the Permeate 2 had a slightly higher concentration of protein at 3.03 mg/ml
compared to 2.08 mg/ml for Retentate 2 after the buffer exchange (Table 5.12). The higher
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concentration of protein in the permeate was not expected as the original retentate sample
applied for buffer exchange had already been run through the 1 kDa filter and the buffer
exchange involved only a change of media.
In the activity tables generated for TFF run 4 and crossflow runs 1 and 2, it is observed that the
specific activity was not increased for the Retentate as would be expected with a successful
partial purification and concentration effect, with the original fermentate or cell free fermentate
retaining the highest specific activity in comparison to the generated Retentate or Permeate.
For the activity table produced for TFF run 4 (Table 5.7), the fermentate with cells displayed
specific activity of 1.0 and the cell free Fermentate generated calculated specific activity of 1.3
AU/mg, while Permeate 1 and Retentate 1 had specific activity values of 1.0 AU/mg and 0.6
AU/mg respectively. For the first crossflow run using MRSc broth as the media for growth, the
Fermentate had displayed a specific activity of 1.07 AU/mg, which was reduced to 1.01 AU/mg
for Permeate 1 and 0.98 AU/mg for Retentate 1. The specific activity for the Fermentate with
cells of the second crossflow experiment using mYPD as the growth medium was 0.28 AU/mg,
for the cell free Fermentate and Permeate 1 the specific activity was 0.25 AU/mg and for
Retentate 1 was 0.24 AU/mg. These specific activity values were much lower as the media
which the bacteria were grown in has significant protein content and this would have a
significant effect on the measured specific activity and total protein present. The results
obtained above indicate that the specific activity of the retentate was never increased, as would
be expected with a successful concentration of the Fermentate. The concentration effect upon
the use of tangential flow filtration methods has been observed in other studies, such as the
study by Lv et al., (2018) where the supernatant of L. plantarum DY4-2 was concentrated using
the TFF ultrafiltration method with a 1 kDa filter, similar to the 1 kDa filter used for both
crossflow concentration runs of the B. longum ITT 13 fermentate. This use of ultrafiltration by
Lv et al., (2018) resulted in a specific activity of 507 AU/mg for their Retentate in comparison
236

to the initial cell free supernatant which had a specific activity value of 51 AU/mg, the results
indicating a ten-fold increase of antimicrobial activity with the use of TFF. In another study,
the class II bacteriocin Enterocin 96 was subjected to multiple purification steps which included
TFF with a 10 kDa filter as the first step (Izquierdo et al., 2009). The specific activity as
determined by Izquierdo et al., (2009) was calculated as AU/ml divided by the A280 protein
readings and the specific activity increased from 7.13 AU.ml-1/A280 for the crude culture extract
to 17.85 AU.ml-1/A280 for the Retentate after TFF and there was no detection of the peptide in
the permeate. These are the expected results when using TFF to efficiently concentrate and
partially purify crude supernatant and it is evident this was not the case for the antimicrobial
activity produced by B. longum ITT 13, with future work required to efficiently develop the
method.
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5.4 Future Work/Potential Studies
TFF systems have been used widely to concentrate and partially purify protein molecules
including bacteriocins (Li et al., 2003; Freiherr Von Roman et al., 2014; Amado et al., 2016;
Golneshin et al., 2020). In theory, the concentration of the antimicrobial activity through the
retention and concentration of the antimicrobial peptides present in the fermentate would have
been the desired outcome for the experiments described in Sections 5.1 and 5.2. Subsequent
buffer exchanges would have been expected to remove the acidic medium surrounding the
retained and concentrated peptides allowing for accurate determination of the antimicrobial
activity associated solely with these molecules. Use of the benchtop TFF system and the larger
Crossflow filtration system, as discussed in Section 5.3, was associated with loss of both
protein from the retentate, as well as the antimicrobial activity that was present in the original
samples. The latter findings would suggest that the techniques tested to date would need
significant optimisation in order to be useful in a concentration and partial purification
procedure for the antimicrobial activity observed for the B. longum ITT 13 fermentate. As
discussed previously (Section 5.3), protein fouling due to soluble-protein–adsorbed-protein
interactions and protein-membrane interactions, may have been the cause of a loss of protein
(Grund et al., 1992) when samples were being recycled through the various filters. Given that
TFF technology has been successfully applied in the purification of antimicrobial peptides, it
is suggested that the technology should be useful, but requires significant optimisation for ITT
13 (Izquierdo et al., 2009; Amado et al., 2016; Kumar and Tiwari, 2017; Lv, Ma, et al., 2018).
Antimicrobial activity associated with bacteriocins tends to be produced at relatively low
concentrations and thus it would be preferable to work with larger scale equipment to increase
larger initial volumes of fermentate in the concentration steps. The production of low
concentrations of these peptides increases the need for concentration of the activity in industry
(Garsa et al., 2014), thus it would be preferable to work with larger volumes of the B. longum
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ITT 13 fermentate. Nakamura et al., (2013) used crossflow filtration as a method to
successfully concentrate the antimicrobial activity associated with Gassericin A, produced by
Lactobacillus gasseri LA39, against Lb. delbrueckii subsp. bulgaricus JCM 1002T, by
concentrating a large volume of 9 litres of the culture supernatant to a 600 ml concentrate
(retentate), that resulted in a 16-fold increase of antimicrobial activity. The volumes of the B.
longum ITT 13 fermentate used in this thesis research were up to 2.6L, and suggest a
requirement to work with larger volumes on the Crossflow apparatus to generate a successfully
concentrated fraction. Coronel et al. (2019) described the use of a single-use bioreactor used
with a TFF system to produce the influenza A virus. In this study, a large-scale 12L bioreactor
connected to a TFF system was utilised for the production of a high cell concentration of
influenza A. This type of bioreactor coupled with a TFF system could be explored as a future
possibility for the production and concentration of high volumes of the B. longum ITT 13
fermentate. The use of a bioreactor similar to the one described by Coronel et al., (2019) would
enable efficient and rapid TFF concentration upon growth of the strain in the bioreactor at high
concentrations, resulting in potentially higher concentrations of antimicrobial peptide
production and minimising the risk of loss of protein activity due to storage. Bhugaloo-Vial et
al., (1997) used a bioreactor coupled with a crossflow filtration system for continuous
bacteriocin production. The author described the use of the system with a membrane of a large
molecular weight cut-off of 5 x 105 Da. However, even with the use of a large membrane a
higher bacteriocin concentration was retained within the retentate with l08 AU/ml as compared
to l03 AU/ within the permeate. Fouling of the membrane occurred after 75 hours and 102 hours
growth (Bhugaloo-Vial et al., 1997), however this could likely be combatted with batch
production in place of continuous, as B. longum ITT 13 had been shown to display optimum
antimicrobial activity between 16-18 hours growth in fermentation vessels (C. Whelan –
personal communication).

239

A larger scale TFF system with a filter of a larger surface area could also be used for future
fermentate concentration, as described by Cai et al. (2015). In the latter study, microbes in
water samples were concentrated and separated from water samples through the use of TFF
with a) a smaller scale filtration system of 50 cm2 that could filter several litres of water, similar
to the crossflow system used for B. longum ITT 13, and b) a large scale system with a filter of
0.5 m2, which could filter hundreds of litres of water. A TFF system with a filtration membrane
of a large surface area, similar to the latter large-scale system, would be a viable option for the
filtration of the B. longum ITT 13 fermentate, thus enabling the concentration of much larger
volumes while potentially minimising membrane fouling due to the large surface area of the
membrane.
Another form of TFF exists called alternating tangential flow filtration (ATF), whereby reverse
flow is used once per cycle to minimise membrane fouling (Kelly et al., 2014), which could be
promising for application in the concentration of the B. longum ITT 13 fermentate. Tan et al.
(2021) discussed the use of this ATF method in terms of continuous buffer exchange in
downstream processing of bioproducts using a single piece of equipment. As the retentate flows
through a channel between two membranes, one which removes permeate and the other which
supplies a buffer, the use of an alternating flow direction of diafiltration buffer through the
membranes reduces the incidence of concentration polarization at the membrane (Tan et al.,
2021). Concentration polarization has already been discussed as a major factor and mediator
in the fouling and interaction of soluble proteins at the membrane interface (Grund et al., 1992).
By employing the ATF method described above, the fouling of membranes within the TFF and
crossflow systems may be reduced with consequent improvement in the flow rates and
minimisation of protein losses, as observed during the successive buffer exchanges carried out
with B. longum ITT 13 Fermentate.
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A study by Pires & Palmer (2021) describes the use of TFF to purify and isolate proteins,
however instead of concentrating the proteins in the Retentate they were kept in the Permeate
through the use of target-protein binding molecules and a filter with a molecular weight cutoff (MWCO) below the target protein. This allowed impurities below the MWCO to be
extracted in the Retentate, while the target protein remained in the Permeate. A target-protein
binding molecule was then added to form protein-protein complexes with the target protein,
which was the only complex larger than the MWCO thus enabling this complex to be
selectively separated from the other protein components in the sample. A buffer exchange was
carried out allowing for dissociation of the target protein from the binding molecule and
separation using a membrane with a MWCO between the molecular weight of the protein and
the binding molecule. An issue arose with low protein-protein complex recovery from the TFF
system, however based on mathematical models this could be combatted and recovery
increased with a series of three filters of the same MWCO in sequence, whereby the Permeate
of the first system is fed into the second and the second is fed into the third filter system (Pires
and Palmer, 2021). This study could be indicative of a potential option for future TFF
concentration and purification of the B. longum ITT 13 fermentate, although the fermentate
would likely need partial purification in advance to remove larger proteins that would also be
above the MWCO of the filter alongside the antimicrobial peptide-binding molecule complex.
The isolation of the peptide in the Permeate would potentially minimise protein interactions
with the membrane when collecting the Retentate for concentration. Using the above method,
a suitable specific target-protein binding molecule would also be required to isolate the
antimicrobial peptide produced by B. longum ITT 13, meaning the biochemistry of the specific
ITT 13 peptide molecule would need to be understood and as the antimicrobial peptide
produced by ITT 13 is likely of low molecular weight indicated by the TFF work, this process
may not be suitable.
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Another option for future concentration and purification studies would be to consider other
methods of protein concentration including techniques such as ammonium sulphate
precipitation. The latter method, which is widely employed in current literature to extract and
concentrate antimicrobial peptides (Afshan Naz, Sheikh and Rasool, 2013; Ansari et al., 2018;
Lei et al., 2020), was utilised in Chapter 4, Section 4.3 and 4.6.3 to extract antimicrobial
proteinaceous compounds. As evidenced in Sections 4.3 and 4.6.3, antimicrobial activity was
isolated in the 80% ammonium sulphate saturation that was validated as associated specifically
with the proteins produced within the B. longum ITT 13 fermentate. Due to limitations with
apparatus, only small-scale volumes of 40 ml were used for the ammonium sulphate
precipitation, however as this method was successful in the isolation of antimicrobial peptides,
it could potentially be employed on a large-scale basis in future work. To minimise repeated
passes through the TFF and crossflow membrane systems with buffer exchanges, ammonium
sulphate precipitation could be carried out on large volumes of the already concentrated
retentate post TFF concentration, subsequently removing the protein from the acidic medium
without the requirement for a buffer exchange. This could be a suitable method for scale up
studies, as the ammonium sulphate solution interferes with the solubility of protein in water by
increasing hydrophobic interactions resulting in precipitation that maintains protein
conformation and preventing denaturation (Wingfield, 2001). Therdtatha et al. (2016) used
ammonium sulphate precipitation as the first of three purification steps for a bacteriocin
produced by Lactobacillus salivarius KL-D4, whereby a 20% ammonium sulphate saturation
was utilised. A large volume of 1 litre of the L. salivarius KL-D4 cell-free supernatant solution
was employed and left stirring in the ammonium sulphate solution for 18 hours to facilitate full
saturation of the ammonium sulphate in the solution. Once the protein pellets were isolated
following centrifugation, they were then resuspended in another 1 litre volume of a buffer
solution to dilute the salt concentration of the ammonium sulphate (Therdtatha et al., 2016).
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Volumes of this size would be ideal to increase the concentration of antimicrobial peptide
present and thus concentrate the antimicrobial activity produced by B. longum ITT 13. In
addition, instead of resuspending the extracted protein in the same volume, it could be
resuspended in a reduced volume, as it was done in Section 4.3 for the B. longum ITT 13
ammonium sulphate precipitation previously carried out. This would both concentrate and
partially purify the activity on a larger scale. A potential issue with the resuspension of the AS
pellets in a minimal volume would likely result in high salt concentration present within the
sample which would require removal to minimise interference. To combat this issue, the use
of hydrophobic interaction chromatography (HIC) could be administered as the next step in a
purification protocol, as the high salt concentration would facilitate binding on the hydrophobic
resin (Galeotti et al., 2020; Muca et al., 2020). HIC is a form of chromatography often used
extensively in the biotechnology and pharmaceutical industries for the downstream processing
of proteins and is based on the differences in hydrophobic properties between the target
proteins for purification and the impurities within the sample (Muca et al., 2020). Bacteriocins
are generally hydrophobic in nature with large hydrophobic portions present within the peptide
chain to facilitate interaction and penetration of the phospholipid bilayer of target cell
membranes (Singh et al., 2015; Daba and Elkhateeb, 2020). In HIC, a salt or salt mixture is
often utilised within the protein sample to promote adsorption to the HIC media, including salts
used in protein precipitation such as ammonium sulphate (Galeotti et al., 2020; Muca et al.,
2020) and thus HIC is additionally suitable for a suggested next step in a potential purification
process. Ray Mohapatra and Jeevaratnam, (2019) used HIC as a purification step for isolation
and characterization of a bacteriocin produced by Lactobacillus plantarum subsp.
argentoratensis SJ33. The supernatant suspended in 0.1 N NaCl was partially purified using
gel permeation chromatography, which generated an active fraction that was passed through
HIC (Sep-Pak C18 cartridge) and eluted with 20%, 30% and 50% of isopropanol to obtain
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various fractions with different polarity. The active fraction containing the bacteriocin was
further purified using reverse phase HPLC, before antimicrobial and characterization studies
were carried out on the peptide (Ray Mohapatra and Jeevaratnam, 2019). Deraz et al., (2005)
also used HIC as part of a purification process of a bacteriocin produced by Lactobacillus
acidophilus DSM 20079, designated acidocin D20079, following ammonium sulphate
precipitation and cation exchange chromatography, generating a purified peptide suitable for
characterization including partial sequencing and molecular weight determination.
Experiments carried out by Lv et al. (2018) and Izquierdo et al. (2009) using TFF as a single
step in a purification process, provide another option in place of carrying out TFF with a
subsequent buffer exchange on the same system. Lv et al. (2018) first carried out an ethyl
acetate extraction on 1 litre of the cell free supernatant of Lactobacillus plantarum DY4-2 that
contained the bacteriocin, resulting in a crude extraction from the culture media, with a specific
activity value of 493 AU/mg in a 200 ml volume. This was then subjected to tangential flow
filtration at 10 kDa, 5 kDa and 1 kDa to further purify and concentrate to an 80 ml volume
fraction with 507 AU/mg, of which 2 ml was then subjected to further purification by sizeexclusion chromatography on a Sephadex G25 column with bacteriocin-containing fractions
pooled, freeze-dried and resuspended in 6 ml of ultrapure water, resulting in a sample which
had a specific activity of 1064 AU/mg. The final purification step for the concentrated
bacteriocin fraction involved the use of a HPLC method, with the eluted fraction containing
the peptide collected and concentrated to 1 ml by freeze-drying, with a final specific activity
of 3560 AU/mg (Lv, Ma, et al., 2018). The overall method therefore did not involve repeated
passages through a TFF filter to facilitate buffer exchanges. The TFF in combination with other
purification methods thus successfully concentrated and increased the antimicrobial activity of
the bacteriocin produced by L. plantarum DY4-2.
A similar purification process to that described in the previous paragraph was carried out by
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Izquierdo et al., (2009), whereby TFF was employed as a single step in the purification process.
A 5-litre volume of the cell free supernatant of E. faecalis WHE 96 grown in MRS broth was
first ultrafiltered using a TFF system with a 10 kDa filter and the Permeate was concentrated
to 220 mls using a 5 kDa filter resulting in specific activity of 17.85 AU.ml-1/A280 (70% activity
yield). Instead of carrying out a buffer exchange, the retentate was pH adjusted to pH 5.5 using
NaOH before the next purification step of cation exchange chromatography, which resulted in
specific activity of 1,564 AU.ml-1/A280 (16% activity yield), followed by the application of the
active fractions to reverse-phase HPLC generating a concentrated bacteriocin fraction with
specific activity of 206,451 AU.ml-1/A280 (10% activity yield). The active fractions containing
the concentrated bacteriocin, detected at 280 nm, were then vacuum dried and resuspended in
deionized water for testing (Izquierdo et al., 2009). The specific activity was calculated as the
bacteriocin activity (AU/ml) divided by the A280. The above method resulted in significant
concentration of the bacteriocin and its associated antimicrobial activity without repeated TFF
circulation and eliminated a buffer exchange, which is where the largest concentrations of
protein in the B. longum ITT 13 fermentate were lost in the practical approach described in this
thesis (Section 5.1). Therefore, future work could likely entail the design of a series of
purification steps that incorporates TFF concentration without the subsequent use of a buffer
exchange. The overall aim with B. longum ITT 13 was concentration of the antimicrobial
activity within the fermentate rather than purification, in order to generate a more concentrated
sample for physiochemical characterization work including protease digestion and temperature
stability. As discussed through Sections 5.3 and 5.4, successful concentration of the
antimicrobial activity within the B. longum ITT 13 fermentate was not achieved with the
practical approach of TFF described, thus the methods described above in Section 5.4 may be
explored for future concentration of the activity.
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Aside from purification and concentration, characterisation of the proteinaceous material
displaying antimicrobial activity produced by B. longum ITT 13 is an important area of research
and could be carried out using commonly used methods of protein analysis such as sodium
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), 2D gel electrophoresis or
matrix assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry.
SDS-PAGE is used to determine the molecular weight of proteins in a mixture through
denaturation of the proteins using SDS and separation of the proteins on a polyacrylamide gel
using electrophoresis that separates the proteins based on their molecular mass (Nowakowski
et al., 2014). Yamamoto et al., (2003) utilised SDS-PAGE to determine the molecular weight
of a bacteriocin produced by E. faecalis RJ-11 and determined the bacteriocin to be of
approximately 5 kDa. Lv et al., (2018) also used SDS-PAGE to determine the molecular weight
of plantaricin JY22, which is a bacteriocin produced by Lactobacillus plantarum JY22 that
displays activity against Bacillus cereus. The author determined the approximate molecular
weight of the bacteriocin as 4.1 kDa (Lv et al., 2018). Both authors separated the gel into two
after the electrophoresis was ran, with half of the gel stained for molecular weight
determination and the other half of the gel used for antimicrobial testing to determine any bands
on the gel displaying antibacterial activity which would indicate bacteriocins (Yamamoto et
al., 2003; Lv et al., 2018). This was carried out by overlaying the gels with a soft agar
inoculated with an indicator bacteria and incubation to grow the bacteria within the soft agar
before examining the growth for any areas of inhibition associated with protein bands on the
gel (Yamamoto et al., 2003; Lv et al., 2018). This latter method is a useful method for
determining if any separated protein bands on the gel display antimicrobial activity, thus
validating that there are antimicrobial peptides present as well as determining which bands to
use for molecular weight determination. This method would be useful for future testing of the
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B. longum ITT 13 fermentate to further validate the presence of suspected antimicrobial
peptides thus allowing for molecular weight determination.
Mulyawati et al., (2019) also partially purified and characterised bacteriocins produced by
Lactobacillus plantarum SB7 and Bacillus amyloliquefaciens BC9 using SDS-PAGE. The
bacteriocins were partially purified from cell-free supernatant by precipitation using the
ammonium sulphate precipitation method at 80% saturation followed by dialysis using a semipermeable membrane with a 5 kDa cutoff. SDS-PAGE was then employed to determine the
molecular weight of the bacteriocins. The samples were all ran in duplicate on separated wells
of the same gel which was cut in half following the electrophoresis as also carried out in the
above studies. Half of the gel was stained with Coomassie blue R-250 and the other half used
for the soft agar overlay assay inoculated with indicator bacteria to confirm antibacterial
activity. Potential bacteriocin bands produced by both L. plantarum SB7 and B.
amyloliquefaciens BC9 were found to be approximately 48 kDa in size based off staining and
antimicrobial activity associated with both L. plantarum SB7 on the gel in the soft agar overlay
assay indicated activity associated with bands of 48 and 17 kDa in size. The authors noted that
the antimicrobial activity associated with B. amyloliquefaciens BC9 had disappeared when the
SDS-PAGE gel was added to the soft agar overlay assay and hypothesised this was to do with
denaturation of the protein by the SDS, advising that MALDI-TOF mass spectrometry would
be a more suitable method of molecular weight determination. It would also be possible to
carry out a PAGE gel without SDS denaturation on the B. longum ITT 13 proteins to prevent
denaturation and loss of activity of samples.
MALDI-TOF involves ionisation of a sample with a laser beam, with the ions accelerated
causing them to separate based on their mass to charge ratio (m/z), which can be measured
based on the length of time they take to pass down the flight tube and reach the TOF analyser
(Singhal et al., 2015). MALDI-TOF was the first mass spectrometry technique employed to
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detect bacteriocins within the cell free supernatant (Rose et al., 1999). In the study by Rose et
al., (1999) they determined that spotting the sample onto the MALDI-TOF probe, allowing it
to dry and a simple wash of the probe with milli-Q water for 30 seconds was effective for
removing contaminants from the sample. The author tested the supernatant of L. lactis ATCC
11454 which should contain nisin and detected a bacteriocin in the samples ranging between
3.355 and 3.359 kDa, likely indicating nisin which has a molecular mass of 3.354 kDa. Rose
et al., (1999) also successfully detected the bacteriocins enterocin A and B, brochocin A and
B and pediocin from the cell free supernatants of the producing cultures. Goh and Philip (2015)
also used MALDI-TOF mass spectrometry to determine the molecular weight of a bacteriocin
produced by Weissella confusa A3, which was found to produce a bacteriocin of approximately
2.7 kDa that displayed antibacterial activity towards the pathogens E. coli, P. aeruginosa and
B. cereus among others. This method of MALDI-TOF seems to suggest a potential method of
analysis of any bacteriocins produced by B. longum ITT 13, requiring minimal modification
due to the detection of bacteriocins in the cell-free supernatants with only a water wash of the
sample to remove contaminants as described by Rose et al., (1999).
As described there are many potential avenues of characterisation and purification of potential
antimicrobial peptides produced by B. longum ITT 13 that can be explored in future work. As
only some characterisation of the organic acids produced using HPLC was carried out, this
could also be explored further to determine the full antimicrobial effect of the acids. Further
HPLC analysis with more replicates could be carried out to ensure accuracy in the
determination of the concentration of acids produced by B. longum ITT 13. The organic acids
could also be quantified at various timepoints during the growth of ITT 13 to determine the
time point that contains the least concentration of organic acids within the fermentate yet still
retains antimicrobial activity. This time point analysis would also be useful to monitor how the
antimicrobial activity increases proportionally to acid production during growth of B. longum
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ITT 13. From the quantification of the concentrations of lactic, acetic and succinic acids
produced during growth, the antimicrobial activity of these concentrations alone and in
combination should be screened against all bacterial and fungal indicator strains tested within
the thesis to determine the levels on inhibition associated solely with the acids. The study by
Makras and De Vuyst (2006) involved the quantification of the organic acids produced by
HPLC, with concentrations of 60.9 mM acetic acid and 39.9 mM lactic acid found to be
produced by B. longum CA1. This combination of acids at these concentrations was then used
as a control for comparison to the antimicrobial activity of the cell-free supernatant generated
by B. longum CA1 to determine whether the activity associated with the supernatant was solely
the result of organic acid production. When tested against S. typhimurium it was found that the
antibacterial activity observed was associated with the concentration of organic acids present.
Similar antibacterial results were also found for the supernatant produced by B. longum BB536
against E. coli and for the MRSc control with the same amount of organic acids as present
within the supernatant. These results coupled with results from testing the supernatants and
controls against Gram-positive strains led the authors to determine the organic acids were
responsible for antibacterial activity against Gram-negative strains while bacteriocins were
responsible for activity against Gram-positive strains. Therefore, this sort of detailed analysis
involving a control of the concentration of organic acids within the fermentate should be carried
out for B. longum ITT 13 against all tested bacteria and fungi to aid in determining the source
of antimicrobial activity against all tested microbes.
There are several concentration and purification methods for bacteriocins detailed in the
literature which could provide several different approaches to future experimental work on the
concentration and purification of the antimicrobial activity identified to be produced in the B.
longum ITT 13 fermentate. It is evident throughout Chapter 4, from the ammonium sulphate
precipitation, protease digestion and organic acid analysis work, that the detectable
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antimicrobial activity produced by B. longum ITT 13 is most probably associated with a low
molecular weight proteinaceous molecule produced in low concentrations. Additional to the
antimicrobial activity associated with the proteinaceous molecule some of the antimicrobial
activity is associated with the production of the organic acids by B. longum ITT 13. To enable
full physicochemical characterisation of the antimicrobial activity associated with the
proteinaceous compound it will be necessary to purify out the bacteriocin and remove any
interference from the produced organic acids. Approaches to the concentration and purification
of the activity produced by B. longum ITT 13 would incorporate methods already utilised for
bacteriocin studies such as ammonium sulphate precipitation, tangential flow filtration systems
and various chromatographic approaches. Overall, the results presented in this thesis showing
that the antimicrobial activity is active against a number of different organisms, warrants
further research in the purification and characterisation of the antimicrobial activity produced
by the GRAS organism B. longum ITT 13.
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CHAPTER 6
Summary
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Probiotics are defined by the World Health Organisation (WHO) as “Live microorganisms
which when administered in adequate amounts confer a health benefit on the host”, and most
commonly include Bifidobacterium and Lactobacillus species (FAO/WHO, 2006; Butel,
2014). Probiotic bacteria are said to contribute to the maintenance of a healthy gastrointestinal
system by offering health benefits similar to the hosts natural gut microflora. These benefits
include the maintenance of tight junctions of protein to protect the intestinal barrier and
exertion of antimicrobial activity in the gut to prevent infection and colonisation by pathogenic
bacteria (O’Flaherty and Klaenhammer, 2010; Mahmoudi et al., 2013; Jomehzadeh et al.,
2020; Wang et al., 2020). The production of antimicrobial activity by probiotic bacteria is
primarily associated with organic acid and antimicrobial peptides, also known as bacteriocins
(Hladíková et al., 2012; O’Shea et al., 2012; Guinane et al., 2016). Bacteriocins are
ribosomally synthesised proteinaceous molecules produced by bacteria that display
antimicrobial activity against other bacterial and in some cases fungal species (Ahn et al., 2017;
Aarti et al., 2018; Ruggirello et al., 2018).
Bifidobacteria are Gram-positive, non-spore forming, non-motile, anaerobic bacteria that are
commonly utilised as probiotic strains (Lee and O’sullivan, 2010; Dhanashree et al., 2017).
They are heterofermentative bacteria and produce metabolites such as organic acids including
lactic and acetic acid upon growth (Makras and De Vuyst, 2006; Ruiz-Aceituno et al., 2020).
Bifidobacteria have also been associated with the production of other metabolites including
bacteriocins (Lee and O’Sullivan, 2010). Probiotic bacteria have been used to restore the
balance of gut flora following antibiotic treatment (Engelbrektson et al., 2009) and help to treat
antibiotic associated diarrhoea (Selinger et al., 2013; Litao et al., 2018), and many are used for
the production of fermented or biofunctional food products such as fermented dairy products
including yoghurt, cheese and infant formula (Rotar et al., 2007; Butel, 2014; Linares et al.,
2017). It is noted however, that there are still questions surrounding the exact benefits, efficacy
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and safety of probiotics in some populations including immunocompromised individuals or
those with short bowel syndrome (Munakata et al., 2010; Rao et al., 2018; Gargar and
Divinagracia, 2019), as well as some experts doubting their claimed benefits (Lerner et al.,
2019).

.

Bacteriocins have also been used in the food industry as potential biopreservatives in place of
the use of chemical preservatives, which have an increasingly perceived negative impact on
health (Paula M O’Connor et al., 2015; Skariyachan and Govindarajan, 2019). Bacteriocins are
considered to be particularly useful in the food industry due to their observed antibacterial and
antifungal activity against potential foodborne pathogens and/or food spoilage organisms
(Cálix-Lara et al., 2014; O’Connor et al., 2015; Luz et al., 2017; Salazar et al., 2017).
This study aimed to characterise the antibacterial and antifungal activity produced by
Bifidobacterium longum ITT 13 and determine whether the nature of the activity was associated
with either organic acid or bacteriocin production, or a combination of both.
Various methods were implemented to characterise the antimicrobial activity produced by B.
longum ITT 13. The bacteria was grown anaerobically in MRSc broth that was heat-inactivated
by incubation at 60oC for 15 minutes without removal of the cells to generate a fermentate. A
heat inactivated fermentate was required at the behest of the project sponsor instead of using
cell-free supernatant, as a minimally modified media with the ITT 13 cells present was of
interest. Heat inactivated fermentate was screened for antimicrobial activity against a variety
of bacterial and fungal strains using a combination of the microdiffusion assay, also known as
the well diffusion assay, and a microtire plate MIC50 assay. The strains were selected primarily
based on their pathogenicity and role in food spoilage or food poisoning. Various Grampositive and Gram-negative bacteria were screened for susceptibility including Bacilli,
Staphylococci, Escherichia coli, Pseudomonas aeruginosa, Salmonella typhimurium and
Enterococcus faecalis. Screened fungal species include Saccharomyces cerevisiae, Candida
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albicans Rhodotorula mucilaginosa and Debaryomyces hansenii.
Physiochemical characterisation was carried out to determine the temperature and pH stability
of the B. longum ITT 13 fermentate by incubation of the fermentate at various temperature or
pH conditions, followed by antimicrobial screening to observe any losses or reduction in
activity. The nature of the antimicrobial activity was determined through protease digestion,
ammonium sulphate precipitation and HPLC analysis. Concentration studies on the
antimicrobial activity of the fermentate involved membrane filtration via small-scale TFF and
large-scale TFF on a crossflow system with the use of 10 kDa, 3 kDa and 1 kDa membranes.
This was carried out to concentrate the antimicrobial activity of the fermentate without the use
of a purification protocol.
B. longum ITT 13 was identified through Gram-staining, cell morphology and Biolog
identification using the Biolog system (TECHNOPATH Distribution Ltd. Ireland). 16s
ribosomal RNA sequencing was also carried out to verify the identity of the strain (C. Whelan
– personal communication). The antimicrobial activity of the strain was then assessed as
previous work had indicated antibacterial properties. The microdiffusion assay was carried out
to screen 15 bacterial strains for susceptibility to the B. longum ITT 13 fermentate, of which 9
displayed growth inhibition when exposed to the fermentate. These were Bacillus subtilis
ATCC 1174, Enterococcus faecalis ATCC 7080, Kocuria rhizophilia ATCC 9341,
Staphylococcus xylosus ATCC 29971, Klebsiella aerogenes ATCC 13048, Escherichia coli
ATCC 25922, Pseudomonas aeruginosa PA01, Salmonella typhimurium ATCC 29629 and
Burkholderia cenocepacia ATCC 17765 III.20.
The fermentate adjusted to pH 4.5 and a control of MRSc broth at pH 4.5 were added to
microtitre plates for an MIC50 assay as a more detailed analysis of the antibacterial activity and
pH effect of the fermentate. This assay was screened against 6 selected bacterial strains and
although conventional MIC assays assess dilutions of the analyte causing inhibition of visible
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growth of the indicator strain, this MIC50 assay involved calculation of arbitrary units (AU)/ml
of activity using the highest dilution displaying at least 50% activity for detailed analysis of
inhibition compared to controls. The pH 4.5 fermentate had 80 AU/ml against B. subtilis and
E. faecalis while the pH 4.5 MRSc broth had 20 AU/ml against both, the pH 4.5 fermentate
had 40 AU/ml against E. coli and P. aeruginosa while the pH 4.5 MRSc broth had 20 AU/ml
against both strains, the pH 4.5 fermentate had 80 AU/ml against S. typhimurium while the pH
4.5 MRSc broth had 40 AU/ml and the pH 4.5 fermentate had 80 AU/ml against S. xylosus
while the pH 4.5 fermentate had 160 AU/ml. Although the latter result indicated more activity
associated with the pH 4.5 MRSc broth indicating its sensitivity to acid, it should be noted that
the pH 4.5 fermentate eliminated complete growth at the 1/8 dilution while the pH 4.5 MRSc
broth had partial growth at this dilution. These results indicate that there may be more than a
pH effect contributing to antibacterial activity as there was more activity associated with the
fermentate than the control.
To assess how raising the pH of the fermentate affected the associated antibacterial activity the
pH was increased to pH 4.68 and compared to a control of MRSc broth adjusted to pH 4.82 for
comparison. This was tested against K. rhizophilia, B. subtilis and P. aeruginosa and the
inhibition associated with the fermentate was significantly higher than the pH 4.82 MRSc broth
control for all three strains (p<0.05) further indicating that antimicrobial activity is likely
associated with more than a pH effect.
The fermentate was also screened against the fungal strains R. mucilaginosa CBS316, S.
cerevisiae ATCC18824, S. cerevisiae CBS1171 and C. albicans ATCC2091 using the
microtitre plate MIC50 assay to screen for antifungal activity. The fermentate at pH 4.35 and
pH 4.80 was screened for antifungal activity, along with a control of MRSc broth at pH 4.30.
Both the pH 4.80 and pH 4.35 fermentates displayed antifungal activity towards R.
mucilaginosa and C. albicans while no notable antifungal activity was detected against either
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S. cerevisiae strain. S. cerevisiae are relatively resistant to organic acids (Stratford et al., 2013),
therefore it is possible that the antifungal activity is primarily pH associated.
Physiochemical characterisation was carried out to assess the stability of the fermentate in a
variety of temperature and pH conditions due to high food processing temperatures and various
pH processing conditions within the food industry (Johnson et al., 2018; Bagde and
Vigneshwaran, 2019; Castilho et al., 2020) if the strain or its fermentate were to be considered
for this application. A thermostability assay was carried out by incubating 2 ml samples at
temperatures of -20oC, 4oC, room temperature (20-24oC), 37oC, 55oC and 70oC over a 28-day
period with multiple time-points taken. The results indicated no significant reductions in
antibacterial activity over the course of the 28-day period, indicating the fermentate as a whole
is relatively thermostable, however as any potential bacteriocins were not isolated the stability
of these alone could not be determined. For the pH stability assay the fermentate was adjusted
to pH 3, 4, 5 and 6 using lactic acid and NaOH and incubated for up to 24 hours. No
antibacterial activity was detected when the fermentate was adjusted to pH 5 or 6, thought it
should be noted that this assay was carried out using the less sensitive microdiffusion assay
and the more sensitive MIC assay has detected activity at pH 5. The fermentate was stable for
24 hours at pH 3 and pH 4 with no significant reduction in activity over the entire 24-hour
period.
The nature of the antimicrobial activity was investigated using ammonium sulphate
precipitation, protease digestion and HPLC analysis. Saturations of 20%, 40%, 60% and 80 %
ammonium sulphate were used to precipitate the proteins present within the fermentate. There
was no significant antibacterial activity associated with the fermentate precipitated at 20%,
40% or 60% saturations in comparison to the control, however the 80% saturation resulted in
the precipitation of proteinaceous material displaying an antibacterial effect in comparison to
the control. This indicates the presence of a low-molecular weight proteinaceous molecule.
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Protease digestion was carried out with pH 4.80 and pH 4.35 fermentate. Digestion of the
fermentate at both pH’s with Proteinase K resulted in no reduction of antibacterial activity
indicating there was no successful digestion of any antimicrobial peptides. Digestion of the pH
4.35 fermentate with Actinase E also resulted in no reduction in activity, however digestion of
the pH 4.80 fermentate resulted in a reduction of activity relative to the fermentate without
Actinase E digestion at the 1/16 dilution. This indicates that a proteinaceous element of the pH
4.80 fermentate was contributing to the antimicrobial activity observed. It is likely that the pH
of the pH 4.35 fermentate may have been too low for maximal activity of the Actinase E
enzyme.
HPLC using a reverse-phase column with UV analysis was carried out to quantify the organic
acids present within the fermentate. Fermentate at pH 4.35 generated in MRSc broth in labscale conditions in an anaerobic chamber, pH 4.80 fermentate also generated in MRSc broth in
a 2 litre pH-controlled fermentation vessel and pH 5.0 fermentate generated in a modified YPD
(mYPD) broth in a 2 litre pH-controlled fermentation vessel were analysed. The pH 4.35
fermentate had 147.72 mM ± 10.34 acetic acid, 92.22 mM ± 1.53 lactic acid and 54.52 mM ±
3.00, the pH 4.80 fermentate had 160.95 mM ± 13.72 acetic acid, 68.32 mM ± 10.62 lactic acid
and 67.69 mM ± 6.14 succinic acid, while the pH 5.0 fermentate had 650.68 mM acetic acid,
154.97 mM lactic acid and no succinic acid detected.
Concentration studies involved concentrating volumes of between 125-2620 mls of fermentate
using membrane filtration via small-scale TFF and large-scale TFF (crossflow). Use of a
10KDa and 3 kDa filter showed similar antimicrobial activity present in both the retentate and
permeate of the fermentate after small-scale TFF concentration. Use of a 1 kDa filter also
showed similar activity in both the retentate and permeate after concentration using the largescale TFF crossflow system. Buffer exchanges were carried out to remove organic acids to
assess activity associated solely with other molecules within the fermentate, however no
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concentrated activity was detectable after buffer exchanges. This

could

indicate

possible

adsorption of the proteinaceous molecule to the membrane as it is present in low concentrations
and a BCA assay showed losses of protein within the samples with each successive buffer
exchange.
Experimental results indicate that the antimicrobial activity associate with B. longum ITT 13
is due to a combination of organic acid production together with a low molecular weight,
proteinaceous component. Further studies, using higher starting concentrations of fermentate,
could be used to concentrate and isolate the bacteriocin component of the detected
antimicrobial activity when concentrating using TFF methods. Other methods to further
validate the presence of an antimicrobial peptide could include larger scale ammonium sulphate
precipitation, the use of chromatographic methods such as hydrophobic interaction
chromatography to isolate and purify the peptide and methods including SDS-PAGE and
MALDI-TOF mass spectrometry.
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Appendix A
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Figure 7.1: Growth curve of Bacillus subtilis ATCC 1174 in TSB showing OD600 and
CFU/ml over time
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Figure 7.2: Growth curve of Enterococcus faecalis ATCC 7080 in TSB showing OD600 and
CFU/ml over time
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S. xylosus ATCC 29971
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Figure 7.3: Growth curve of Staphylococcus xylosus ATCC 29971 in TSB showing OD600
and CFU/ml over time
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Figure 7.4: Growth curve of Escherichia coli ATCC 25922 in TSB showing OD600 and
CFU/ml over time
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Appendix B
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Figure 7.5: Chromatogram of 100 mM standard of formic acid standard. Formic acid (A) and 10 mM IS
Methylmalonic Acid (B). Chromatogram is representative of one of n=3.

A

B

Figure 7.6: Chromatogram of 100 mM standard of lactic acid standard. Lactic acid (A) and 10 mM IS
Methylmalonic Acid (B). Chromatogram is representative of one of n=3.
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Figure 7.7: Chromatogram of 100 mM standard of acetic acid standard. Acetic acid (A) and 10 mM IS
Methylmalonic Acid (B). Chromatogram is representative of one of n=3.
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Figure 7.8: Chromatogram of 100 mM standard of succinic acid standard. Succinic acid (A) and 10 mM
IS Methylmalonic Acid (B). Chromatogram is representative of one of n=3.
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Figure 7.9: Chromatogram of 100 mM standard of butyric acid standard. Butyric acid (A) and 10 mM IS
Methylmalonic Acid (B). Chromatogram is representative of one of n=3.

All tested organic acids were used to spike the fermentate samples. An increase in peak size
of any peaks already present indicated that the associated organic acid was present within
the fermentate and produced by B. longum ITT 13. An introduction of a new peak to the
chromatogram indicated that the associated acid was not produced by B. longum ITT 13.
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Figure 7.10: The growth (OD600) of S. xylosus ATCC 29971 and MIC50 determination of the B. longum
ITT 13 permeates and retentates grown in MRSc broth after Crossflow concentration (Run 1). The MIC50
was determined as the highest dilution displaying at least 50% inhibition in comparison to the growth control.
The AU/ml was determined as described in Section 2.8.2. Standard deviations and averages were determined for
three independent assays (n=3).

Figure 7.10 details the growth of S. xylosus ATCC 29971 in the presence of the various samples
from the Crossflow run 1 of the B. longum ITT 13 fermentate generated in MRSc broth. The
growth control consisting of S. xylosus cells in MH broth had an average OD600 value of 0.48,
indicating 100% growth in this medium and anything with an OD600 of less than 50% of this
growth control was taken as the MIC50 value. Permeate 1 and retentate 1 generated from the
first pass through the Crossflow were tested for inhibitory activity, along with permeate 2 and
retentate 2 that were generated from the buffer exchange using 50 mM NaAc buffer at pH 4.7.
It is evident from the graph in Figure 7.10 that the MIC50 for permeate 1 and retentate 1 was a
1/16 dilution with antimicrobial activity of 160 AU/ml. For Permeate 2, the MIC50 value was
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generated from the 1/4 dilution, with the equivalent antimicrobial activity of 40 AU/ml, while
for Retentate 2, it was lower with an MIC50 value of a 1/2 dilution equivalent to 20 AU/ml.
Nisin as a positive control displayed complete inhibition to a 1/8 dilution, with no antimicrobial
activity then observed beyond this dilution. The Permeate 1 and Retentate 1 samples displayed
the highest amount of growth by S. xylosus beyond their MIC50 values in comparison to the
Permeate 2, Retentate 2 and nisin samples, which is likely attributed to the presence of nutrients
in the original MRSc fermentation broth, as the MRSc broth has been exchanged for the 50
mM NaAc buffer pH 4.7 in Permeate 2 and Retentate 2.
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Figure 7.11: The growth (OD600) of S. xylosus ATCC 29971 and MIC50 determination of the B. longum
ITT 13 permeates and retentates grown in modified YPD broth after Crossflow concentration (Run 2).
The MIC50 was determined as the highest dilution displaying at least 50% inhibition in comparison to the growth
control. The AU/ml value was determined as described in Section 2.8.2. Standard deviations were determined for
three independent assays (n=3).

The growth control of MH broth and S. xylosus cells for this assay had an average OD600 of
0.37 and the MIC50 for all samples was determined as the dilution with at least 50% inhibition
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in comparison to the growth control. The mYPD media was also diluted to 1/128 and assessed
using this assay for any inhibition, as it had resulted in small potential zones of inhibition on
the microdiffusion assay. Based on the average OD600 values, the fermentate had an MIC50 of
a 1/16 dilution with antimicrobial activity of 160 AU/ml, Permeate 1 also had an MIC50 value
of a 1/16 dilution and 160 AU/ml, as did Retentate 1. Similar to the previous Crossflow
concentration with MRSc broth, the Permeate 2 had an MIC50 value of a 1/4 dilution and 40
AU/ml, while Retentate 2 displayed an MIC50 for the 1/2 dilution and 20 AU/ml. The mYPD
broth displayed an MIC50 of a 1/4 dilution and antimicrobial activity of 40 AU/ml, however
although it did have an MIC50 value, the broth did not completely inhibit the growth of S.
xylosus ATCC 29971 at any dilution, unlike the Fermentate, Permeate and Retentate samples
which all generated complete inhibition at both the 1/2 and/or 1/4 dilutions. In agreement with
previous results, nisin displayed complete inhibition to a 1/8 dilution, which was the MIC50
value and indicated 80 AU/ml, with complete growth detected with dilutions beyond the 1/8
dilution. The growth of S. xylosus in the presence of nisin after the 1/8 dilution decreases with
each subsequent dilution, however this pattern has been observed in all other graphs containing
nisin diluted to this extent.
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